Session » 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 7L

A Phase 2 Study of Safety and Efficacy of Anabasum (JBT-101), a Cannabinoid Receptor Type 2 Agonist, in Refractory Skin-Predominant Dermatomyositis

9:00AM-11:00AM: Abstract Number: 15L

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients with Osteoarthritis of the Hip or Knee

9:00AM-11:00AM: Abstract Number: 9L

Circulating Type I, II and III Interferons (IFNs) Associate with IFN-Scores, but Define Distinct Subsets of Active SLE

4:30PM-6:00PM: Abstract Number: 1L

Efficacy and Safety of Intra-Articular Sprifermin in Symptomatic Radiographic Knee Osteoarthritis: Results of the 2-Year Primary Analysis from a 5-Year Randomised, Placebo-Controlled, Phase II Study

4:30PM-6:00PM: Abstract Number: 6L

Efficacy and Safety of Ustekinumab, an Interleukin 12/23 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: Results of a Phase 2, Randomized Placebo-Controlled Study

4:30PM-6:00PM: Abstract Number: 2L

Efficacy and Safety Results from a Phase 2 Trial of Risankizumab, a Selective IL-23p19 Inhibitor, in Patients with Active Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 12L

Evaluation of Intravenous Injection of Tc 99m Tilmanocept in Static Planar Gamma Emission Imaging and Fused SPECT/CT Imaging for Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 4L

Final Results of an Open Label Phase 2 Study of a Reversible B Cell Inhibitor, Xmab®5871, in IgG4-Related Disease

9:00AM-11:00AM: Abstract Number: 16L

Incidence of Thromboembolic Events in the Tofacitinib Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis and Ulcerative Colitis Development Programs

9:00AM-11:00AM: Abstract Number: 14L

Miv-711, a Novel Cathepsin K Inhibitor Demonstrates Evidence of Osteoarthritis Structure Modification: Results from a 6 Month Randomized Double-Blind Placebo-Controlled Phase IIA Trial

9:00AM-11:00AM: Abstract Number: 8L

Prevalence of Blindness in a Cohort of Rheumatologic Patients Treated with Hydroxychloroquine

4:30PM-6:00PM: Abstract Number: 5L

Rapamycin Vs. Placebo for the Treatment of Inclusion Body Myositis: Improvement of the 6 Min Walking Distance, a Functional Scale, the FVC and Muscle Quantitative MRI

9:00AM-11:00AM: Abstract Number: 11L

Risk of Second Malignant Neoplasm and Mortality in Rheumatoid Arthritis Patients Treated with Biological Dmards: A Danish Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 18L

Rituximab As Re-Induction Therapy in Relapsing ANCA-Associated Vasculitis

4:30PM-6:00PM: Abstract Number: 3L

Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 13L

Significant, Sustained Improvement in Knee Function after Intra-Articular TPX-100: A Double-Blind, Randomized, Multi-Center, Placebo-Controlled Phase 2 Trial

9:00AM-11:00AM: Abstract Number: 17L

Subcutaneous Secukinumab Inhibits Radiographic Progression in Psoriatic Arthritis: Primary Results from a Large Randomized, Controlled, Double-Blind Phase 3 Study

9:00AM-11:00AM: Abstract Number: 10L

Upadacitinib (ABT-494) in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological Dmards: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of a Selective JAK-1 Inhibitor

9:00AM-11:00AM: Abstract Number: 107

A Blended Learning Approach to Clinical Skills Teaching: E-Learning for Paediatric Gait, Arms, Legs and Spine Examination (pGALS)

9:00AM-11:00AM: Abstract Number: 41

A Fine Bioinformatical Analysis of Lymphocyte Distribution Predicts the Diagnosis of Systemic Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 451

A Matrix Risk Model for Prediction of Radiographic Progression in Early Rheumatoid Arthritis Based on Treatment Response at 3 Months

9:00AM-11:00AM: Abstract Number: 321

A Meta-Analysis of 4 Clinical Trials of Denosumab Compared with Bisphosphonates in Postmenopausal Women Previously Treated with Oral Bisphosphonates

9:00AM-11:00AM: Abstract Number: 296

A Module of Genes Describing Low Density Granulocytes Can be Identified and Followed in the Periphery of Lupus Patients

9:00AM-11:00AM: Abstract Number: 671

A New Histological Index for Predicting a Decline in Kidney Function in Patients with Lupus Nephritis. a Mexican Cohort Study of 186 Patients with a Kidney Biopsy

9:00AM-11:00AM: Abstract Number: 87

A Novel Histone Deacetylase 6 Inhibitor, CKD-M808, Regulates the Adhesion and Migration of Fibroblast-like Synoviocytes, and Enhances Suppressive Function of Regulatory T Cells in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 264

A Novel Method to Assess Subchondral Bone Formation Using Naf-PET in the Evaluation of Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 291

A Novel Real-Time Imaging Technique to Quantify Neutrophil Extracellular Traps and Distinguish Mechanisms of Cell Death in Neutrophils

9:00AM-11:00AM: Abstract Number: 25

A Novel Role for Galectin-3 Binding Protein in B Cell Biology and Antibody Secretion

9:00AM-11:00AM: Abstract Number: 681

A Panel of Lupus Biomarkers for the Monitoring of Systemic Lupus Erythematosus: Performance Characteristics in Distinct SLE Cohorts

9:00AM-11:00AM: Abstract Number: 781

A Patient Based Reliability Exercise of Omeract Ultrasound Definitions in Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 374

A Pilot Study of Infrared Thermal Imaging to Detect Active Bone Lesions in Children with Chronic Nonbacterial Osteomyelitis

9:00AM-11:00AM: Abstract Number: 99

A Pilot Study of the Use of a Validated Gout Script Concordance Test Assessment in an Interdisciplinary Musculoskeletal Education Program

9:00AM-11:00AM: Abstract Number: 768

A Positive Feedback Loop between Estrogen and IL-6 Leads to Fibrosis in Human Skin

9:00AM-11:00AM: Abstract Number: 113

A Primer on Exercise: An Interactive, Online Educational Module Incorporating Spaced Education to Supplement the ACR Core Curriculum Outline for Rheumatology Fellowship Programs

9:00AM-11:00AM: Abstract Number: 112

A Qualitative Assessment of a CME “City Rounds” Workshop Educational Program to Meet the Educational Needs of Rheumatologists

9:00AM-11:00AM: Abstract Number: 318

A Randomized Alendronate-Controlled Trial of Romosozumab: Results of the Phase 3 Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk

9:00AM-11:00AM: Abstract Number: 373

a Retrospective Study of Clinical Factors Influencing the Development of Overlapping Disease Features in Pediatric Patients with Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Spondyloarthropathies (SpA)

9:00AM-11:00AM: Abstract Number: 157

A Systematic Review of the Upper Limb Soft Tissue Comorbidities in Patients with Type 2 Diabetes Mellitus

9:00AM-11:00AM: Abstract Number: 59

Abaloparatide, a Novel PTHrP Analog, Increased Bone Mass and Density at Cortical and Trabecular Sites in an Orchiectomized Rat Model of Male Osteoporosis

9:00AM-11:00AM: Abstract Number: 419

Abatacept Initiation in Chilean Patients with Long Lasting Rheumatoid Arthritis. Hospital Padre Hurtado Experience

9:00AM-11:00AM: Abstract Number: 680

Abnormalities in Complement System Are Related to Disease Severity in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 14

Abnormalities in Th1, Th2 and Th17 Lymphoid Subpopulations in Long-Term Evolution Primary Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 462

ABP 710: Matching Critical Biological Functions with Infliximab

9:00AM-11:00AM: Abstract Number: 57

Accelerated Development of Aging-Associated and Instability-Induced Osteoarthritis in 12/15-Lipoxygenase Deficient Mice

9:00AM-11:00AM: Abstract Number: 340

Accessing Positive (but Not Negative) Online Reviews Is Associated with Increased Willingness to Take Medication

9:00AM-11:00AM: Abstract Number: 799

Acetylcholinesterase Is Highly Expressed in the Inflamed Vessel Wall of Patients with Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 432

ACPA and RF As Predictors of Sustained Clinical Remission in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 578

Added Value of Biomarkers Compared to Routine Clinical Parameters for the Prediction of Radiographic Spinal Progression in Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 461

Additions to Methotrexate with Conventional and Biologic Dmards in Rheumatoid Arthritis: Are There Differences in Subsequent Time to Treatment Failure?

9:00AM-11:00AM: Abstract Number: 543

Adverse Events in Rheumatoid Arthritis Patients Treated with Disease Modifying Biological Drugs at Hospital Docente Padre Billini in Santo Domingo

9:00AM-11:00AM: Abstract Number: 183

Allele-Dependent Binding of a Viral Protein to Autoimmune Disease-Associated Genetic Variants

9:00AM-11:00AM: Abstract Number: 402

Alteration of the Intestinal Microbiome in the Preclinical Phase of Experimental Arthritis and the Efficacy of Microbiota Modulation in Established Arthritis in Mice

9:00AM-11:00AM: Abstract Number: 798

Altered Phenotype of Platelets and Neutrophils Toward Neutrophil-Platelet Interaction in Circulation of Small and Large Vessel Vasuculitis

9:00AM-11:00AM: Abstract Number: 214

Ambulatory and Hospital Care for Arthritis and Related Conditions in Ontario, Canada

9:00AM-11:00AM: Abstract Number: 720

Ambulatory Blood Pressure and Skin Sodium Concentrations in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 696

An ANA Screening Assay Containing Multiple Antigens Increases the Sensitivity and Specificity of ANA Testing By Indirect Immunofluorescence

9:00AM-11:00AM: Abstract Number: 184

An Epigenome-Guided Approach to Causal Variant Discovery in Autoimmune Disease

9:00AM-11:00AM: Abstract Number: 409

An Evaluation of Absolute Neutrophil Count As a Biomarker of Inflammatory and Clinical Disease Activity in Baricitinib-Treated Patients

9:00AM-11:00AM: Abstract Number: 745

An International Qualitative Research Study Exploring the Patient Experience of Raynaud’s Phenomenon in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 398

An on-Demand Drug Delivery System for the Treatment of Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 645

An Oral Tyk2 Inhibitor Effectively Suppresses the Development of Murine Th17 Cells In Vivo and Prevents Joint Damage in Experimental Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 250

An Ultrasonographic Study for Investigating Relationships with the Signs of Uric Deposition and Bone Erosion in Patients with Hyperuricemia

9:00AM-11:00AM: Abstract Number: 298

Anabasum (JBT-101) Enhances Resolution of Inflammation in Humans

9:00AM-11:00AM: Abstract Number: 202

Analysis of Provider-to-Provider Variability in the Use of Biologics: Data from the Rheumatology Informatics System for Effectiveness Registry

9:00AM-11:00AM: Abstract Number: 455

Analysis of Real-World Treatment Patterns in a Matched Sample of Rheumatology Patients with Continuous Infliximab Therapy or Switched to Biosimilar Infliximab

9:00AM-11:00AM: Abstract Number: 439

Analysis of Rheumatoid Arthritis Patients That Did Not Achieve the Treatment Goal By the Treat-to-Target Strategy in Daily Practice

9:00AM-11:00AM: Abstract Number: 386

Analysis of the Effectiveness of Immunization with Pneumococcal Polysaccharide Vaccine in Children with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 685

Anti-C1q Antibodies and Disease Activity in a Multi-Ethnic Lupus Cohort

9:00AM-11:00AM: Abstract Number: 480

ANTI-Carbamylated Protein Antibodies (CARP) in Palindromic Rheumatism: Prevalence and Clinical Significance

9:00AM-11:00AM: Abstract Number: 486

Anti-Citrullinated Protein Antibody Reactivities in Treatment NaïVe Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 397

Anti-Fractalkine Monoclonal Antibody Ameliorates Joint Destruction in Collagen-Induced Arthritis Model through Suppression of Osteoclast Precursor Cell Survival and Migration

9:00AM-11:00AM: Abstract Number: 571

Anti-Modified Protein Antibody Response Pattern in Primary Sjögren’s Syndrome: Clinical and Prognostic Implications

9:00AM-11:00AM: Abstract Number: 562

Anti-Muscarinic Receptor 3 Antibodies – a Cross Reactive Result of Ro60 Immunization

9:00AM-11:00AM: Abstract Number: 483

Anti-Peptidylarginine Deiminase-4 Antibodies Are Present in the Sputum of RA Patients and Can Activate Peptidylarginine Deiminase-4 Enzyme Activity

9:00AM-11:00AM: Abstract Number: 1

Anti-Phosphatidylserine/Prothrombin Antibodies (aPS/PT) As Potential Diagnostic Markers and Risk Predictors of Venous Thrombosis and Obstetric Complications in Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 16

Anti-Phosphatidylserine/Prothrombin Antibodies in Primary Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 708

Anti-RNP/Sm Antibodies Plus Lupus Anticoagulant As Risk Factor for Thrombosis in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 684

ANTI-RO52 KDa and ANTI-RO60 KDa Analysis in Systemic LUPUS Erythematous Patients to Detect ANTI-RO False-Negatives

9:00AM-11:00AM: Abstract Number: 287

Anti-TNF Agents Induce Alternative Macrophages

9:00AM-11:00AM: Abstract Number: 724

Antibodies Against the Chemokine Receptors CXCR3 and CXCR4 Predict Progressive Lung Fibrosis in Systemic Sclerosis (SSc)

9:00AM-11:00AM: Abstract Number: 12

Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository Analysis: Pregnancy Outcomes Since Inception

9:00AM-11:00AM: Abstract Number: 8

Antiphospholipid Syndrome Leukocytes Demonstrate Increased Adhesive Potential: a Search for Novel Therapeutic Targets

9:00AM-11:00AM: Abstract Number: 760

Antisense Long Noncoding RNA HAND2-AS1 and OTUD6B-AS1 Have Important Roles in the Pathogenesis of Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 791

Aortic Dilatation in Patients with Large Vessel Vasculitis: A Longitudinal Case Control Study Using Positron Emission Tomography/Computed Tomography

9:00AM-11:00AM: Abstract Number: 689

Apolipoprotein L1 Risk Variants Associate with Hypertension and Nephritis Progression Despite Lower dsDNA Titers in Ghanaian Systemic Lupus Erythematous Patients

9:00AM-11:00AM: Abstract Number: 764

Application of a Novel Computational Approach to Identify New Targets and Pathways for Therapeutic Intervention in Scleroderma

9:00AM-11:00AM: Abstract Number: 268

Applications of Salivary Gland Ultrasonography in Sjögren Syndrome and Sicca Symptoms: A Single Center Experience

9:00AM-11:00AM: Abstract Number: 173

Applying Urine Proteomics for Discovery of Lupus Nephritis Damage Biomarkers in a Pediatric Cohort

9:00AM-11:00AM: Abstract Number: 487

ARE ANTI-Citrullinated Protein Antibody Levels Associated with Periodontal Disease in Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 648

Are Choline Metabolites Associated with Inflammation in Psoriatic Arthritis?

9:00AM-11:00AM: Abstract Number: 236

Are Magnetic Resonance Imaging Features of the Hand Associated with Patient Reported Physical Function, Global Assessment of Disease Activity, Pain and Health Related Quality of Life in Rheumatoid Arthritis in Clinical Remission? – Longitudinal Results from an Observational Cohort

9:00AM-11:00AM: Abstract Number: 144

Are RA Patients at a Higher Risk for Car Accidents?

9:00AM-11:00AM: Abstract Number: 638

Are There Clinical Demographic or Subclinical Ultrasonographic Data That Can Predict Flare in Psoriatic Arthritis Patients during a Phase of Minimal Disease Activity after Spacing of Anti-TNF Blockers Injections?

9:00AM-11:00AM: Abstract Number: 10

Arterial Events in Primary Antiphospholipid Syndrome Are Associated with High Values of the Adjusted Global Antiphospholipid Syndrome Score

9:00AM-11:00AM: Abstract Number: 251

Articular Cartilage of Knee and First MTP Joint Are the Preferred Sites of Urate Crystal Deposition in Asymptomatic Hyperuricemic Individuals

9:00AM-11:00AM: Abstract Number: 808

Assessing the Possible Link between Varicella Zoster Virus and Giant Cell Arteritis Using Clinical Assessment, Serology and Biopsy Antigen Detection – Interim Results from the Giant Cell Arteritis and PET Scan (GAPS) Cohort

9:00AM-11:00AM: Abstract Number: 499

Assessment of Early Improvement in Pain and Other ACR Components As Predictors for Achieving Low Disease Activity or Remission in Three Phase 3 Trials of RA Patients Treated with Baricitinib

9:00AM-11:00AM: Abstract Number: 533

Assessment of Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Data from an Open-Label Long-Term Extension Study over 3 Years

9:00AM-11:00AM: Abstract Number: 779

Assessment of Treatment Response By 18f-Fludeoxyglucose Positron Emission Tomography (FDG-PET) in Patients with Large Vessel Vasculitis (LVV)

9:00AM-11:00AM: Abstract Number: 410

Association between Anti-Citrullinated Protein Antibody Status and the Incidence of Erosive Disease in Patients with RA

9:00AM-11:00AM: Abstract Number: 510

Association between Clinical Response and Normalization of Patient-Reported Outcome Measures in Rheumatoid Arthritis: Post-Hoc Analysis from Two Phase 2b Filgotinib Studies

9:00AM-11:00AM: Abstract Number: 327

Association of Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index with Low Bone Mineral Density in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 164

Association of Natural Killer Cell Ligand Polymorphism, HLA-C Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block

9:00AM-11:00AM: Abstract Number: 644

Association of Osteonectin, Osteopontin and Osteocalcin with Inflammation and Cardiovascular Risk in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 688

Associations between Standard Serological Markers and Different Clinical Phenotypes in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 583

Associations of Changes of Radiographic Disease and Spinal Mobility Measures in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 718

Atherosclerotic Vascular Events in a Multinational SLE Inception Cohort: Description and Predictive Risk Factors over a 17 Year Period

9:00AM-11:00AM: Abstract Number: 333

Atypical Femoral Fracture in Patients of a Rheumatology Service: Clinical, Radiographic and Bone Histomorphometric Data

9:00AM-11:00AM: Abstract Number: 23

Auto-Reactive B Cells Escape Peripheral Tolerance Checkpoints in Patients with PR3-ANCA Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 747

Autoantibodies to Rpp25 (Th/To) Are Specific Markers for Systemic Sclerosis and Are Associated with Limited Cutaneous Disease and Young Age at Disease Onset

9:00AM-11:00AM: Abstract Number: 130

Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks Who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database

9:00AM-11:00AM: Abstract Number: 33

B Cell Abnormalities in Patients with Chronic Cutaneous Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 807

B Cells in Giant Cell Arteritis: a Novel Target for Treatment?

9:00AM-11:00AM: Abstract Number: 40

B-Cell Attracting Chemokine-1 (BCA-1) and Macrophage Inflammatory Protein-3 Alpha (MIP-3α) Act Synergistically in the Recruitment of B Cells in the Rheumatoid Synovium

9:00AM-11:00AM: Abstract Number: 35

B-Cell Subset Differences in Inflammatory Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 56

Baicalein, a Plant-Derived Small Molecule, Activate Nrf2/Autophagy Signaling Axis Via MEK1/2-ERK1/2-Elk1 Pathway to Suppress the Expression of IL-6 in Human Osteoarthritis Chondrocytes

9:00AM-11:00AM: Abstract Number: 415

Baricitinib Reduces GlycA Levels in Phase 2 and Phase 3 Clinical Trials in Patients with Moderate to Severe Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 225

Barriers to the Use of Methotrexate in Ethiopia: Survey of Pharmacy Providers

9:00AM-11:00AM: Abstract Number: 436

Baseline Anemia As a Predictor of Radiographic Progression in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analyses from Two Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 134

Baseline Characteristics and Rates of Hospitalized Infections in Patients with Rheumatoid Arthritis Treated with Non-TNF Inhibitors in Denmark and Sweden

9:00AM-11:00AM: Abstract Number: 672

Baseline Hyperuricemia As a Predictive Value for Development of Lupus Nephritis in Premenopausal SLE Patients

9:00AM-11:00AM: Abstract Number: 610

Baseline Structural Damage Predicts Response to Abatacept in Patients with Psoriatic Arthritis: A Post Hoc Analysis from a Phase III Study

9:00AM-11:00AM: Abstract Number: 412

Baseline Values for Plantar Pressure and Background Characteristics As Indicators for the Limit of Conservative Treatment of Rheumatoid Forefoot Deformity

9:00AM-11:00AM: Abstract Number: 465

Basement Membrane Remodeling in Rheumatoid Arthritis Associates with Disease Activity, Response to IL-6 Inhibitor Treatment and Radiographic Progression: Analysis of Two Phase III Clinical Trials

9:00AM-11:00AM: Abstract Number: 540

Being Elderly Is Not a Predictive Factor of Discontinuation of Abatacept Due to Adverse Events in Rheumatoid Arthritis Patients with Concomitant Methotrexate: A Retrospective Observational Study Based on Data from a Japanese Multicenter Registry Study

9:00AM-11:00AM: Abstract Number: 45

BIIB063, a Potent Anti-CD40 Antagonistic Monoclonal Antibody (MAb): Lessons Learned from an Early Development Program.

9:00AM-11:00AM: Abstract Number: 299

Bik Plays an Important Role of Cell Proliferation Caused By Nitric Oxide in Rheumatoid Arthritis Synovium

9:00AM-11:00AM: Abstract Number: 307

Biochemical Intervertebral Disc Alterations in Patients with Low Back Pain and Radiculopathy

9:00AM-11:00AM: Abstract Number: 572

Biopsy Accuracy in Sjögren’s Syndrome: Analysis of 803 Patients Presenting with Sicca Syndrome Referred to Labial Salivary Gland Biopsy

9:00AM-11:00AM: Abstract Number: 226

Biopsy Proven Giant Cell Arteritis in African Descent Populations: Incidence and Characteristics in Martinique, French West Indies

9:00AM-11:00AM: Abstract Number: 503

BMS-986195 Is a Highly Selective and Rapidly Acting Covalent Inhibitor of Bruton’s Tyrosine Kinase with Robust Efficacy at Low Doses in Preclinical Models of RA and Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 514

BMS-986195, a Novel, Rapidly Acting, Covalent Inhibitor of Bruton’s Tyrosine Kinase: Safety, Pharmacokinetic and Pharmacodynamic Profiles in Healthy Participants

9:00AM-11:00AM: Abstract Number: 609

Body Mass Index Does Not Influence the Efficacy of Subcutaneous Abatacept in Patients with Psa: Results from a Phase III Trial

9:00AM-11:00AM: Abstract Number: 22

Bone Regulatory Cytokine Production By B Cells in Rheumatoid Arthritis Is Dependent on NF-κb Activation and Autophagy Pathways

9:00AM-11:00AM: Abstract Number: 29

BTK Inhibition Ameliorates Lupus-Associated Neuropsychiatric and Skin Disease

9:00AM-11:00AM: Abstract Number: 3

Burden of Antiphospholipid Syndrome in a Thromboembolic Disease Registry

9:00AM-11:00AM: Abstract Number: 364

Canakinumab First or Second Choice in Systemic Juvenile Idiopathic Arthritis – Experience from Clinical Practice

9:00AM-11:00AM: Abstract Number: 365

Canakinumab Treatment in Patients with Still’s Disease: A Pooled Analysis of Systemic Juvenile Idiopathic Arthritis Data By Age Groups

9:00AM-11:00AM: Abstract Number: 403

Cardiac Immune Cells in SKG Mice with Inflammatory Arthritis before and after Myocardial Infarction

9:00AM-11:00AM: Abstract Number: 741

Cardiac MRI in Systemic Sclerosis As Prognostic Tool of Cardiac Mortality in Symptomatic Patients

9:00AM-11:00AM: Abstract Number: 735

Cardiopulmonary Exercise Testing to “Detect” Pulmonary Arterial Hypertension in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 803

Cardiovascular Risk Factors and Comorbid Diseases in Takayasu’s Arteritis

9:00AM-11:00AM: Abstract Number: 527

Cardiovascular Safety of Tocilizumab Versus Abatacept in Patients with Rheumatoid Arthritis: A Multi-Database Study

9:00AM-11:00AM: Abstract Number: 58

Cartilage-like Tissue Generation By 3D-Bioprinting of Induced Pluripotent Stem Cells

9:00AM-11:00AM: Abstract Number: 331

Case Series: Comparison of Repository Corticotropin Injection (H.P. Acthar Gel) Versus Glucocorticoids on Bone Density in SLE Patients

9:00AM-11:00AM: Abstract Number: 145

Cause-Specific Mortality in a Large Population-Based Cohort of Rheumatoid Arthritis Patients in Italy

9:00AM-11:00AM: Abstract Number: 673

Cell Bound Complement Activation Products Distinguish Systemic Lupus Erythematosus from Other Diseases Among Patients with High Antinuclear Antibody Titers and Normal Complement

9:00AM-11:00AM: Abstract Number: 463

Certolizumab Pegol for Fatigue in Chronic Inflammatory Rheumatic Diseases: A Meta-Analysis

9:00AM-11:00AM: Abstract Number: 189

Challenges and Opportunities of Implementing a Patient-Reported Measure of Physical Function through an Online Electronic Health Record Patient Portal in Routine Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 330

Change in Bone Mineral Density in Patients with Rheumatoid Arthritis: Minimal 10-Year Follow-up

9:00AM-11:00AM: Abstract Number: 795

Characteristics and Treatment Outcomes of Giant Cell Arteritis with Large-Vessel Lesions in a Nationwide, Retrospective Cohort Study in Japan

9:00AM-11:00AM: Abstract Number: 709

Characteristics of Cardiac Diseases in Systemic Lupus Erythematosus and Risk Factors of Different Echocardiographic Features

9:00AM-11:00AM: Abstract Number: 435

Characteristics of Rheumatoid Arthritis Patients Who Have a DMARD Interruption and the Impact of Using a Bridging Medication on Clinical and Patient Reported Outcomes

9:00AM-11:00AM: Abstract Number: 603

Characterization of Clinical Benefits in Subjects Classified As ACR20 Non-Responders at Week 104 of Apremilast Treatment: Subanalysis of 3 Long-Term, Phase III Trials

9:00AM-11:00AM: Abstract Number: 290

Characterization of Neutrophil Subsets and Neutrophil Extracellular Traps in Pyogenic Arthritis, Pyoderma Gangrenosum and Acne (PAPA) Syndrome

9:00AM-11:00AM: Abstract Number: 44

Characterization of Novel Stromal-Derived Autoantigens Recognized By RA Synovial Monoclonal Antibodies

9:00AM-11:00AM: Abstract Number: 222

Characterization of Unexpected Autoantibody Specificities in American Indian SLE Patients

9:00AM-11:00AM: Abstract Number: 228

Characterizing Indigenous Community Engagement Patterns in Published Arthritis Studies: A Systematic Review of the Literature

9:00AM-11:00AM: Abstract Number: 641

Children with Treatment-Naive Enthesitis-Related Arthritis Have Decreased Fecal Abundance of Faecalibacterium Prausnitzii A2-165 and Bacteroides Fragilis: A Multi-Center Collaborative Study

9:00AM-11:00AM: Abstract Number: 227

Chinese-American Rheumatology Patients Who Use Traditional Chinese-Medicine Have Worse Patient Reported Outcomes

9:00AM-11:00AM: Abstract Number: 401

Cigarette Smoking Dose-Dependently Facilitates the Onset of Arthritis and Aggravates Arthritis in Female Experimental Arthritis Mice

9:00AM-11:00AM: Abstract Number: 776

Circulating Fibrocytes in Systemic Sclerosis Patients and Healthy Subjects: An in Vitro Study

9:00AM-11:00AM: Abstract Number: 579

Circulating MiR-145 As a Marker of Therapeutic Response to Anti-TNF Therapy in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 82

CKD-506, a Novel Inhibitor of Histone Deacetylase 6 (HDAC6) Has a Therapeutic Potential in Rheumatoid Arthritis and Inflammatory Bowel Disease

9:00AM-11:00AM: Abstract Number: 47

Claudin-11 Regulates Bone Homeostasis Via Bidirectional EphB4-EphrinB2 Signaling

9:00AM-11:00AM: Abstract Number: 490

Clinical and Biomarker Factors in the Prediction of Future Inflammatory Arthritis in ACPA Positive Subjects without Inflammatory Arthritis at Baseline

9:00AM-11:00AM: Abstract Number: 639

Clinical and Sonographic Analysis of Patients with Psoriasis without Musculoskeletal Complaints. Preeliminary Results of a Prospective Study: The PRE-Psa Cohort

9:00AM-11:00AM: Abstract Number: 520

Clinical and Structural Responses of Patients with Active Rheumatoid Arthritis (RA) Using Step-up Dosing of Tofacitinib in a Treat to Target Approach

9:00AM-11:00AM: Abstract Number: 215

Clinical Pharmacist As Part of the Interprofessional Team Improves Quality of Care in Patients with Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 814

Clinical Presentation and Outcome of Orbital Mass in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides

9:00AM-11:00AM: Abstract Number: 560

Clinical Relevance of Serum Free Light Chain Level As Biomarker in Primary Sjögren′s Syndrome

9:00AM-11:00AM: Abstract Number: 470

Clinical Response to the First Biologic in Rheumatoid Arthritis Patients with Moderate Disease in a Real World Clinical Cohort

9:00AM-11:00AM: Abstract Number: 662

Clinical Significance of Non-Albumin Proteinuria for Severity Assessment of Tubulointerstitial Inflammation in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 5

Clinical Utility of the Global Antiphospholipid Syndrome Score (GAPSS) for Risk Stratification: A Pooled Analysisfrom 2273 Patients

9:00AM-11:00AM: Abstract Number: 703

Clinical Value of Autoantibodies for Lupus Myelitis and Its Subtypes: A Systematic Review

9:00AM-11:00AM: Abstract Number: 729

Clinically Relevant Serum Proteins in Patients with Early Diffuse Cutaneous Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 400

Combination of the Collagen-Induced Arthritis and Organic Dust-Induced Airway Inflammation Models As a Model of Interstitial Lung Disease in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 135

Comorbidity Measures Differentially Predict Longitudinal Disease Activity, Remission, and Disability in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 531

Comparative Effectiveness of Tofacitinib Versus Baricitinib in Rheumatoid Arthritis Using a Systematic Review and Network Meta-Analysis of Randomized Trials

9:00AM-11:00AM: Abstract Number: 526

Comparative Pulmonary Safety of Abatacept and Tumor Necrosis Factor Inhibitors in Patients with RA and Chronic Pulmonary Condition

9:00AM-11:00AM: Abstract Number: 617

Comparing Tofacitinib Safety Profile in Patients with Psoriatic Arthritis in Clinical Studies with Real-World Data

9:00AM-11:00AM: Abstract Number: 816

Comparison between Giacta Trial and a Multicenter Series of Giant Cell Arteritis Patients from Clinical Practice with Tocilizumab

9:00AM-11:00AM: Abstract Number: 746

Comparison of Disease Characteristics in Patients with Juvenile-Onset and Adult-Onset Progressive Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 551

Comparison of Drug Tolerability and Discontinuation Reasons between 7 Biologics in Patients with Rheumatoid Arthritis -Results from Kansai Consortium for Well-Being of Rheumatic Disease Patients (ANSWER cohort)-

9:00AM-11:00AM: Abstract Number: 310

Comparison of Flexed and Extended Knee Arthrocentesis and the Role of Constant Compression

9:00AM-11:00AM: Abstract Number: 539

Comparison of Oral Versus Parenteral Methotrexate in Rheumatoid Arthritis: A Meta-Analysis

9:00AM-11:00AM: Abstract Number: 334

Comparison of Outcomes in Osteoporosis in Patients on Denosumab between Standard and Non-Standard Dosing Intervals

9:00AM-11:00AM: Abstract Number: 474

Comparison of Tofacitinib Efficacy in Patients with Moderate Vs Severe Rheumatoid Arthritis: Pooled Analysis of Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 682

Complement Activation in Peripheral Blood in Relation to Lupus, Antiphospholipid and Rheumatoid Arthritis Autoantibodies: Insights from Clinical Laboratory Evaluations

9:00AM-11:00AM: Abstract Number: 568

Complement Consumption As a Predictor of Pulmonary Manifestation in Patients with Primary Sjögren’s Syndrome: Results from a Unicentric Observational Study

9:00AM-11:00AM: Abstract Number: 561

Comprehensive Immuno-Phenotyping of Follicular Helper T Cell and B Cell Subpopulations in Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 309

Compression Assisted Arthrocentesis and Intraarticular Injection

9:00AM-11:00AM: Abstract Number: 201

Computer Learning (artificial intelligence) to Create a Computer-Based Triage Tool Classifying Referrals As Inflammatory or Non-Inflammatory Requiring Only Patient Reported Information

9:00AM-11:00AM: Abstract Number: 546

Concomitant Hydroxychloroquine Impact on Anti-TNF Persistence in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 110

Consensus-Building on a Rheumatology Musculoskeletal Ultrasound Scanning Protocol for Rheumatology Fellowship Programs

9:00AM-11:00AM: Abstract Number: 604

Consistent Safety Profile with up to 4 Years of Apremilast Treatment: Analysis of Data from 1,493 Subjects with Psoriatic Arthritis in 3 Large, Phase III, Long-Term Studies

9:00AM-11:00AM: Abstract Number: 375

Controlled Discontinuation of Colchicine Therapy in Familial Mediterranean Fever Patients with Single MEFV Mutation

9:00AM-11:00AM: Abstract Number: 62

Convergence of Joint Repair and Pain Pathways Via Nerve Growth Factor and p75 Expressing Mesenchymal Stem Cells in Established Osteoarthritis

9:00AM-11:00AM: Abstract Number: 818

Correlation between the Routine Assessment of Patient Index Data (RAPID3) and Inflammatory Markers in Patients with PMR

9:00AM-11:00AM: Abstract Number: 734

Correlation of the American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis with Serum Biomarkers of Fibrogenesis in an Observational Cohort

9:00AM-11:00AM: Abstract Number: 252

Correlations between Clinical and Ultrasound Scores of Peripheral Enthesitis and Disease Activity Scores in a Cohort of Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 278

Corticosteroid Use, Biologic Therapy Switching, Smoking and Renal Failure Are Associated with Serious Infections in Rheumatoid Arthritis Patients Treated with Biologics: Data from Two Latin-American Registries

9:00AM-11:00AM: Abstract Number: 408

CR6086 Is Highly Effective and Improves Methotrexate Effect in a Mouse Model of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 216

Creation of the First Massive Open Online Course for Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 38

Cytokine Production By CpG-Activated B Cells Require Glutaminolysis to Drive mTOR Activation, Aerobic Glycolysis and Mitochondrial Respiration

9:00AM-11:00AM: Abstract Number: 710

D-Dimer As an Early Marker in Patients with Lupus Mesenteric Vasculitis

9:00AM-11:00AM: Abstract Number: 784

Damage and Predictors of Damage in Takayasu’s Arteritis

9:00AM-11:00AM: Abstract Number: 553

Decreased Circulating CXCR3+CCR9+ Th Cells Coincides with Elevated Levels of Their Ligands CXCL10 and CCL25 in the Salivary Gland of Sjögren’s Syndrome Patients Which Synergistically Facilitate Th Cell Migration

9:00AM-11:00AM: Abstract Number: 223

Decreased Medication Adherence Is a Major Cause for Increased Risk of Hospitalizations Among High Risk Lupus Patients

9:00AM-11:00AM: Abstract Number: 541

Decreasing Trend of Serious Infections Incidence Rate Along Years in Rheumatoid Arthritis Patients Exposed to Biologics. Data from Two Latin America Registries

9:00AM-11:00AM: Abstract Number: 391

Defective Glucose and Lipid Metabolism in Rheumatoid Arthritis Is Determined By Chronic Inflammation in Metabolic Tissues

9:00AM-11:00AM: Abstract Number: 121

Depression As a Risk Factor for the Development of Rheumatoid Arthritis: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 162

Depression Versus Frustration

9:00AM-11:00AM: Abstract Number: 704

Detection of dsDNA Antibodies By New Fluoroimmunoassay with Comparable Diagnostic Sensitivity and Specificity to Farr-Ria

9:00AM-11:00AM: Abstract Number: 587

Detection of Structural Lesions on T1 Weighted MRI Versus Radiography of the Sacroiliac Joints in Early Axial Spa: 2-Year Data

9:00AM-11:00AM: Abstract Number: 357

Determinants of Patient and Physician Disagreement on Presence of a Gout Flare

9:00AM-11:00AM: Abstract Number: 90

Developing a Pediatric Rheumatology Curriculum for Pediatric Residents

9:00AM-11:00AM: Abstract Number: 246

Development and Validation of a Flourescence Optical Imaging Rheumatoid Arthritis Scoring System for Synovitis in the Wrist and Hand

9:00AM-11:00AM: Abstract Number: 695

Development of a Multimarker Model for the Detection of Systemic Lupus Erythematosus Based on New and Traditional Autoantibodies

9:00AM-11:00AM: Abstract Number: 91

Development of Musculoskeletal Physical Examination Checklists: A Formal Consensus Project Involving National Educators

9:00AM-11:00AM: Abstract Number: 581

Diagnostic Value of Anti-CD74 Antibodies in Early Axial Spondyloarthritis: Data from the Spondyloarthritis Caught Early (SPACE) Cohort

9:00AM-11:00AM: Abstract Number: 127

Diet Change and Omega-3 Supplementation in the First Three Years Following a Diagnosis with Rheumatoid Arthritis in Sweden

9:00AM-11:00AM: Abstract Number: 777

Differences between Temporal Artery Biopsy-Positive and Biopsy-Negative Giant Cell Arteritis: A Comparative Cohort Study

9:00AM-11:00AM: Abstract Number: 485

Different Citrullination Profiles in Spontaneous Versus Leukemia-Associated Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 722

Differential Diagnosis of Autoimmune Diseases, Outlier Detection Plus Subgrouping in Clinical Trials By High Content Autoantibody Profiling

9:00AM-11:00AM: Abstract Number: 167

Differentially Co-Expressed Gene Networks in Previously DMARD-Naïve Patients with Early RA Achieving Sustained Drug-Free Remission after Step-up Methotrexate Therapy

9:00AM-11:00AM: Abstract Number: 750

Diltiazem Gel As a New Local Treatment for Scleroderma Digital Ulcers

9:00AM-11:00AM: Abstract Number: 281

Direct Medical Costs Associated with the Extrahepatic Manifestations of Hepatitis C Virus Infection in France

9:00AM-11:00AM: Abstract Number: 207

Direct Medical Costs of Systemic Lupus Erythematosus in South Korea

9:00AM-11:00AM: Abstract Number: 821

Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu’s Arteritis

9:00AM-11:00AM: Abstract Number: 347

Disease Burden at One Academic Rheumatology Routine Care Setting Is Similar in Osteoarthritis (OA) and Rheumatoid Arthritis (RA) at First Visit but Significantly Greater in OA at a 6-Month Follow-up Visit

9:00AM-11:00AM: Abstract Number: 459

Disease Course in Seronegative RA Patients Classified According to the 2010 ACR/EULAR Criteria

9:00AM-11:00AM: Abstract Number: 450

Disease Duration and Withdrawal of Biologic Agents Predict Radiological Progression in a Cohort of Rheumatoid Arthritis Patients in Latin America. a Real World Study

9:00AM-11:00AM: Abstract Number: 219

Disparities in Patients’ Expectations of Foot and Ankle Surgery

9:00AM-11:00AM: Abstract Number: 575

Distinct Clinical and Immunological Features of Anti-Centromere Antibody Positive Primary Sjögren’s Syndrome: A Single Center Cross-Sectional Cohort Study

9:00AM-11:00AM: Abstract Number: 679

Distinct Interferon Scores Are Separately Associated with Activity and Long Term Sequelae in SLE

9:00AM-11:00AM: Abstract Number: 707

Distinctive Features of Positive Anti-Cell Antibody Tests on HEp-2 Cells (HEp-2-ANA) in Patients with Non-Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 229

Divergent Measures of Lupus Disease Damage and Severity Among Asians in an Ethnically Diverse Cohort

9:00AM-11:00AM: Abstract Number: 294

DNA Area and Netosis Analysis (DANA): A High-Throughput Method to Quantify Neutrophil Extracellular Traps in Fluorescent Microscope Images

9:00AM-11:00AM: Abstract Number: 221

Do Immigrant Communities Play a Role in Total Knee Arthroplasty (TKA) Outcomes?

9:00AM-11:00AM: Abstract Number: 444

Do Rheumatoid Arthritis Clinical Disease Activity Index Based Treat-to-Target Treatment Decisions Always Correspond to Usual Care Treatment Decisions at Point of Care?

9:00AM-11:00AM: Abstract Number: 427

Do We Treat Men and Women Differently, and Is This a Good Thing?

9:00AM-11:00AM: Abstract Number: 697

Does Erythrocyte Sedimentation Rate Reflect and Discriminate Flare from Infection in Systemic Lupus Erythematosus? Correlation with Clinical and Laboratory Parameters of Disease Activity

9:00AM-11:00AM: Abstract Number: 381

Down’s Arthritis (DA) – Clinical and Radiological Features of Arthritis in Children with Trisomy 21

9:00AM-11:00AM: Abstract Number: 4

Downregulation of microRNAs in Plasmacytoid Dendritic Cells Is Associated with a Type I Interferon Signature in Systemic Lupus Erythematosus and Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 642

Downstream Effects of Apremilast in Human Arthritic Ex Vivo Models

9:00AM-11:00AM: Abstract Number: 737

Dynamic Prediction of Pulmonary Hypertension Development in Systemic Sclerosis Patients Using Landmark Analysis – Comparison of Two Models

9:00AM-11:00AM: Abstract Number: 405

Dynamics of Transcriptional Signatures from Purified Synovial Macrophage Subsets during Acute and Chronic Murine Models of Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 657

Dyslipidemia Management Is Insufficient in Psoriatic Arthritis Despite Increased Cardiovascular Morbidity and Mortality

9:00AM-11:00AM: Abstract Number: 114

Early Diagnosis and Treatment of RA: Clinical Performance and Economic Outcomes from a Continuing Education Initiative

9:00AM-11:00AM: Abstract Number: 442

Early Treatment with Hydroxychloroquine Is Associated with Better Long-Term Outcomes in a Group of Hispanic Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 413

Economic Burden Associated with Anti-Cyclic Citrullinated Peptide Antibody Positivity in Patients Newly Diagnosed with RA

9:00AM-11:00AM: Abstract Number: 478

Ectopic Lymphoid Tissue in the Lung Is Uniquely Associated with the ACPA IgA Isotype Even in Absence of Classifiable RA

9:00AM-11:00AM: Abstract Number: 535

Effect of a Step-up or Step-Down in Tofacitinib Dose on Efficacy and Safety in Long-Term Extension Studies

9:00AM-11:00AM: Abstract Number: 636

Effect of Adding MTX to TNF Inhibitors on Joint Severity Indices and Skin Scores in Psoriatic Arthritis: A Post-Hoc Meta-Analysis of Randomized, Controlled Trials

9:00AM-11:00AM: Abstract Number: 654

Effect of Anti Tnfα Drugs on the Frequency of Circulating CD19+CD24hiCD38hi Breg Cells in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 534

Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study

9:00AM-11:00AM: Abstract Number: 469

Effect of Patient Involvement in Treatment Decision Making on Disease Outcomes in Rheumatoid Arthritis in the USA

9:00AM-11:00AM: Abstract Number: 185

Effect of Pre-Appointment Consult Triage on Patient Selection and Revenue Generation in a University Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 751

Effect of Probiotics on the Gastrointestinal Symptoms and Immune Parameters in Patients with Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

9:00AM-11:00AM: Abstract Number: 613

Effect of Tofacitinib on Efficacy and Patient-Reported Outcomes in Psoriasis Patients with Baseline Psoriatic Arthritis: A Pooled Analysis of 2 Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 596

Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 614

Effect of Tofacitinib on Reducing Pain in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 149

Effect of Vitamin D Supplementation in Chronic Widespread Pain: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 611

Effectiveness of Early Adalimumab Therapy in Psoriatic Arthritis Patients from Reuma.Pt

9:00AM-11:00AM: Abstract Number: 536

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen Cohort

9:00AM-11:00AM: Abstract Number: 314

Effects of Exercise on Anxiety in Adults with Arthritis: A Systematic Review with Meta-Analysis

9:00AM-11:00AM: Abstract Number: 27

Effects of High Titers of Anti-Chimeric Antibodies Following Rituximab

9:00AM-11:00AM: Abstract Number: 630

Effects of Intravenous Golimumab, an Anti-Tnfα Monoclonal Antibody, on Mental and Physical Functioning and Health-Related Quality of Life in Active Psoriatic Arthritis: 24-Week Results of a Phase 3 Trial

9:00AM-11:00AM: Abstract Number: 392

Effects of Synthetic Dmards on the Insulin Resistance and Obesity Associated with Rheumatoid Arthritis: An Obese Mouse Model of Arthritis

9:00AM-11:00AM: Abstract Number: 150

Effects of Taping Therapy in the Management of Fibromyalgia: A Randomized Controlled Study

9:00AM-11:00AM: Abstract Number: 627

Efficacy and Safety of Apremilast through 104 Weeks in Subjects with Moderate to Severe Psoriasis Randomized to Placebo, Apremilast, or Etanercept Who Continued on or Switched to Apremilast after Week 16 in a Phase 3b Study

9:00AM-11:00AM: Abstract Number: 530

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials

9:00AM-11:00AM: Abstract Number: 315

Efficacy of a Wearable-Enabled Physical Activity Counselling Program for People with Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 516

Efficacy of Adding Iguratimod Therapy in Rheumatoid Arthritis　Patients Who Had Inadequate Response to Biologic Dmards

9:00AM-11:00AM: Abstract Number: 425

Efficacy of Monotherapy of the Biologic Dmards in Patients with Rheumatoid Arthritis: Real Life Data from the Hong Kong Biologics Registry

9:00AM-11:00AM: Abstract Number: 615

Efficacy of Tofacitinib By Background Methotrexate Dose in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Pooled Data from 2 Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 495

Efficacy of Tofacitinib in Patients with Moderate to Severe Rheumatoid Arthritis By Baseline C-Reactive Protein Levels and Erythrocyte Sedimentation Rates

9:00AM-11:00AM: Abstract Number: 598

Efficacy of Ustekinumab in Psoriatic Arthritis Patients By Prior Treatment Exposure and Disease Duration

9:00AM-11:00AM: Abstract Number: 512

Efficacy Response to Baricitinib Based on Baseline Characteristics in Patients Who Are Inadequate Responders to Conventional DMARD

9:00AM-11:00AM: Abstract Number: 525

Efficacy, Tolerability and Reasons for Changing Dmards, Biologics and Small Molecule Drugs in RA Patients without RA Lung Disease from a United States Tertiary Referral Center

9:00AM-11:00AM: Abstract Number: 706

Elevated Erythrocyte Sedimentation Rate Among Obese Patients with SLE- Not Always a Marker of Disease Activity

9:00AM-11:00AM: Abstract Number: 767

Elevated MeCP2 Expression in Diffuse Cutaneous Systemic Sclerosis Dermal Fibroblasts Is Associated with Anti-Fibrotic Effects

9:00AM-11:00AM: Abstract Number: 646

Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Is a Susceptibility Factor for Early Axial Spa Meeting the ASAS Classification Criteria: Results from the Spondyloarthritis Caught Early and DEvenir des Spondyloarthrites Indifférenciées Récentes Cohorts

9:00AM-11:00AM: Abstract Number: 686

Endothelial Dysfunction in Systemic Lupus Erythematosus Patients without Cardiovascular events and Risk Factors: Correlation with Microvascular Alterations and angiogenic t Cells

9:00AM-11:00AM: Abstract Number: 489

Endotypic Clustering of Rheumatoid Arthritis Patients through the Use of Tissue Specific Serum Biomarkers Identifies Structural Progressors

9:00AM-11:00AM: Abstract Number: 233

Engaging Community Stakeholders through a National Lupus Education Workshop

9:00AM-11:00AM: Abstract Number: 220

English Language Proficiency and Total Joint Replacement Outcomes: Is There a Relationship?

9:00AM-11:00AM: Abstract Number: 557

Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Peripheral Blood Mononuclear Cells in Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 85

Enhanced IFN-γ STAT1 Signaling in CD4 T Cell Populations and Attenuated IL-2 STAT5 Signaling Contribute to the Pathogenesis of Rheumatoid Arthritis (RA)

9:00AM-11:00AM: Abstract Number: 209

Epidemiologic Subsets Drive a Differentiated Thoracic and Extrathoracic Presentation of Sarcoidosis: Analysis of 1082 Patients from the Sarcogeas-SEMI Registry

9:00AM-11:00AM: Abstract Number: 806

Epidemiological Study of Giant Cell Arteritis Using a Japanese Administrative Database

9:00AM-11:00AM: Abstract Number: 13

Epidemiology of Antiphospholipid Syndrome: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 589

Erosions at the Sacroiliac Joints and Fatty Lesions at the Spine Are the Most Discriminant Lesions for Recent Onset Axial Spondyloarthritis Recognition

9:00AM-11:00AM: Abstract Number: 140

Estimating Prevalence and Cost of Depression Among Japanese RA Patients: A Retrospective Claims Data Base Analysis

9:00AM-11:00AM: Abstract Number: 733

Ethnic Variation in Systemic Sclerosis Morbidity and Mortality

9:00AM-11:00AM: Abstract Number: 783

European League Against Rheumatisms Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice

9:00AM-11:00AM: Abstract Number: 193

Evaluation of a Diversionary Back Pain Service

9:00AM-11:00AM: Abstract Number: 242

Evaluation of Bone Erosions in Rheumatoid Arthritis Patients Using Cone Beam Computed Tomography, Magnetic Resonance Imaging, and Ultrasound

9:00AM-11:00AM: Abstract Number: 368

Evaluation of Efficacy and Safety of Opocalcium Colchicine, and Anti-IL1 Treatment in Childhood Colchicine-Resistant Familial Mediterranean Fever

9:00AM-11:00AM: Abstract Number: 323

Evaluation of Invasive Oral Procedures and Events in Women with Postmenopausal Osteoporosis Treated for up to 10 Years with Denosumab: Results from a Phase 3 Open-Label Extension Study

9:00AM-11:00AM: Abstract Number: 360

Evaluation of the Educational Needs in Argentinian Patients with Rheumatoid Arthritis Using the SpENAT Questionnaire

9:00AM-11:00AM: Abstract Number: 517

Evaluation of the Effectiveness of Injectable Methotrexate for the Treatment of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 295

Ex Vivo Induced Neutrophil Extracellular Traps Are Intrinsically Different in Anca-Associated Vasculitis and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 70

Excessive Cyclic Compressive Stress Increases Susceptibility to IL-1 in 3D-Cultured Chondrocytes

9:00AM-11:00AM: Abstract Number: 293

Expanded Therapeutic ACPA Utility for Different NET-Driven Human (Autoimmune) Diseases

9:00AM-11:00AM: Abstract Number: 118

Experiences and Perceptions of Patients with Rheumatoid Arthritis Participating in an Online Support Group: The Use of Social Media

9:00AM-11:00AM: Abstract Number: 418

Exploratory Analysis to Identify Factors Associated with Risk of Structural Progression, Defined As Change from Baseline

9:00AM-11:00AM: Abstract Number: 125

Exposure to Passive Smoking and RA Risk; Results from a Swedish Case-Control Study

9:00AM-11:00AM: Abstract Number: 505

Exposure-Response Analyses of the Effect of Upadacitinib on ACR Responses in the Phase 2b Rheumatoid Arthritis Trials in Patients with Inadequate Response to Methotrexate or to Anti-Tumor Necrosis Factor Therapy

9:00AM-11:00AM: Abstract Number: 817

Extension of Affected Vascular Territories in Secondary Aortitis Is Associated to Different Clinical Subtypes?

9:00AM-11:00AM: Abstract Number: 387

F4/80hi Synovial Macrophages in the Pathogeneses of Spontaneous Inflammatory Arthritis in CD11c-Flip-KO (HUPO) Mice

9:00AM-11:00AM: Abstract Number: 584

Factors Associated with the “Bamboo Spine” Phenotype – Data from the Comospa Study

9:00AM-11:00AM: Abstract Number: 75

Factors Associated with TNF Receptor 2 Levels Above the Measurable Range in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 434

Factors Associated with Treatment Adherence in Rheumatoid Arthritis: A Systematic Literature Review

9:00AM-11:00AM: Abstract Number: 329

Factors Associated with Worsening Serum Vitamin D Deficiencies in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study

9:00AM-11:00AM: Abstract Number: 411

Factors That Drive Treatment Recommendation during Rheumatoid Arthritis Patient´s Follow-up, Differ According to Physician Experience

9:00AM-11:00AM: Abstract Number: 565

Fatigue in Primary Sjögren’s Syndrome (pSS) Is Associated with Lower Levels of Proinflammatory Cytokines: A Validation Study

9:00AM-11:00AM: Abstract Number: 262

FDG PET/CT Visualization of Inflammation in Temporal and Maxillary Arteries in Treatment-Naive GCA Patients

9:00AM-11:00AM: Abstract Number: 394

Female Tumor Necrosis Factor Transgenic Mice Have More Severe Arthritis Than Males and Supporessed Levels of Bifidobacterium Pseudolongum in Their Gut Microbiome

9:00AM-11:00AM: Abstract Number: 163

Fibromyalgia Patients Identify More Causes of Disease Flare Ups Than RA Patients

9:00AM-11:00AM: Abstract Number: 160

Fibromyalgia Screening Form in the Diagnosis of Concomitant Fibromyalgia

9:00AM-11:00AM: Abstract Number: 519

Filgotinib, a Selective Janus Kinase 1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects

9:00AM-11:00AM: Abstract Number: 171

Finding Transcriptional Regulators Central to RA with Transcriptomics of IL17 Dose Response, Time Series, and siRNA Silencing in Stromal Cells

9:00AM-11:00AM: Abstract Number: 240

Finger Joint Cartilage Thickness Evaluated By Semiquantitative Ultrasound Score in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 445

FLARE-RA Instrument Detects RA Flares Independent of Disease Activity

9:00AM-11:00AM: Abstract Number: 111

Focused Musculoskeletal Ultrasound Teaching: Effect on Medical Students’ Physical Examination Skills

9:00AM-11:00AM: Abstract Number: 276

Follow-up of Patients with Musculoskeletal Manifestations Related to Chikungunya Fever

9:00AM-11:00AM: Abstract Number: 585

Frequencies of Ligament Ossification in Patients with Ankylosing Spondylitis According to Several Ligaments Around Spine By Whole Spine CT Scan

9:00AM-11:00AM: Abstract Number: 274

Frequency of Chronic Joint Pain Following Chikungunya Infection: A Colombian Cohort Study

9:00AM-11:00AM: Abstract Number: 154

Frequency of Fibromyalgia in Patients with Antiphospholipid Syndrome. a Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 308

Frequency, Morbidity and Healthcare Utilization of Diffuse Idiopathic Skeletal Hyperostosis (DISH) Patients at a University Hospital

9:00AM-11:00AM: Abstract Number: 302

From Monocytes to Macrophages: the Pathogeneses of Spontaneous Inflammatory Arthritis in CD11c-Flip-KO (HUPO) Mice

9:00AM-11:00AM: Abstract Number: 79

Functional Analysis of the Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)

9:00AM-11:00AM: Abstract Number: 658

Functionally Active MAIT Cells in Psoriatic Arthritis: A New Member of the IL-23/IL-17 Cytokine Network

9:00AM-11:00AM: Abstract Number: 49

G Protein-Coupled Receptor Kinase 3 Modulates Mesenchymal Stem Cell Proliferation and Differentiation through Sphingosine-1-Phosphate Receptor Regulation

9:00AM-11:00AM: Abstract Number: 647

Gene Expression in Cellular Subsets in Psoriatic Disease

9:00AM-11:00AM: Abstract Number: 182

Genetic Determinants of Fatigue in Primary Sjögren`s Syndrome – a Genome Wide Association Study

9:00AM-11:00AM: Abstract Number: 532

Genetic Predictors of Iguratimod Clinical Response and Toxicity in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 170

Genome-Wide Association Study of Clinically-Ascertained Gout and Subtypes Identifies Multiple Susceptibility Loci Including Transporter Genes

9:00AM-11:00AM: Abstract Number: 755

Genome-Wide DNA Methylation Pattern in Systemic Sclerosis Microvascular Endothelial Cells: Identification of Epigenetically Affected Key Genes and Pathways

9:00AM-11:00AM: Abstract Number: 66

Genome-Wide DNA Methylation Profiling of OA PBMCs Reveals Slowed Epigenetic Aging Among Rapid Radiographic Progressors: Data from the Osteoarthritis Initiative (OAI)

9:00AM-11:00AM: Abstract Number: 178

Genome-Wide DNA Methylation Study in Lupus in an Admixed Mexican Population

9:00AM-11:00AM: Abstract Number: 650

Genome-Wide DNA Methylation, Transcriptomics, and Proteomics of Psoriasis and Psoriatic Arthritis in Monozygotic Twins

9:00AM-11:00AM: Abstract Number: 95

Globalisation of Paediatric Musculoskeletal Matters’ (PMM)

9:00AM-11:00AM: Abstract Number: 792

Glucocorticoid Use and Adverse Events in Patients with Polymyalgia Rheumatica in a Contemporary Population-Based Cohort

9:00AM-11:00AM: Abstract Number: 36

GM-CSF-Producing B Cells: A Novel B Cell Subset Involved in the Pathogenesis of Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 404

Gut Microbiota Modify Inflammatory Arthritis through Autoantibody Generation and Mucosal Cytokines Alteration

9:00AM-11:00AM: Abstract Number: 379

H Syndrome: Five New Cases from the United States with Novel Features and Responses to Therapy

9:00AM-11:00AM: Abstract Number: 289

HDL Modified with Malondialdehyde-Acetaldehyde (MAA) Is Bound and Rapidly Internalized By Human THP-1 Monocytes

9:00AM-11:00AM: Abstract Number: 255

Healing Time and Blood Perfusion By Laser Speckle Contrast Analysis in Patients with Systemic Sclerosis and Digital Ulcers

9:00AM-11:00AM: Abstract Number: 195

Health Care Costs of Patients with Systemic Lupus Erythematosus (SLE) Versus Control Patients As a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness Fund

9:00AM-11:00AM: Abstract Number: 342

Health Related Quality of Life Is Comparable in Psoriatic Arthritis and Rheumatoid Arthritis Patients in Spite of Different Disease Activity. SF-36 Data from a Large Prospective Observational Multicentre Study

9:00AM-11:00AM: Abstract Number: 204

Healthcare Utilization Among Young Adults Transitioning from Pediatric to Adult Care in a Safety Net Population

9:00AM-11:00AM: Abstract Number: 369

Hepatitis A Virus Vaccination in Juvenile-Onset Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 438

High Multi-Biomarker Disease Activity Score Is Associated with High Risk of Radiographic Progression in Six Cohorts

9:00AM-11:00AM: Abstract Number: 692

High Plasma Factor XIII Transglutaminase Activity Inversely Correlates with SLE Disease Activity Yet Associates with Higher Carotid Artery IMT and Low CD14+CD16+ Monocyte Levels

9:00AM-11:00AM: Abstract Number: 241

Histological and Clinical Correlates of Ultrasound Measures of Joint Inflammation: Analysis of RA Tissue Obtained By Ultrasound Guided Biopsy in Phase 1 of the Accelerating Medicines Partnership RA Network

9:00AM-11:00AM: Abstract Number: 270

HIV Infection and Avascular Necrosis in the Antiretroviral Era

9:00AM-11:00AM: Abstract Number: 687

Homocysteine Levels Are Independently Associated with Damage Accrual in Systemic Lupus Erythematosus Patients (SLE)

9:00AM-11:00AM: Abstract Number: 211

Hopes and Fears of Patients with Axial Spondyloarthritis in Spain. the Value of Patient Opinion: Results from the Spanish Atlas

9:00AM-11:00AM: Abstract Number: 92

Hospital for Special Surgery Academy of Rheumatology Medical Educators: 5 Year Outcomes Demonstrate the Value of Supporting Education Research in the Academic Environment

9:00AM-11:00AM: Abstract Number: 739

How Effective Is the Home Exercise Program for Hands in Patients with Systemic Sclerosis: Preliminary Results from a Randomized Controlled, Single-Blind, Clinical Trial

9:00AM-11:00AM: Abstract Number: 556

Identification and Validation of S100 Salivary Proteins As Putative Biomarkers for Different Subsets of Primary Sjögren’s Syndrome Patients

9:00AM-11:00AM: Abstract Number: 180

Identification of a Functional Susceptible Variant in Distal Enhancer of Mir-146a By CRISPR-Cas9

9:00AM-11:00AM: Abstract Number: 758

Identification of Biomarkers Predictive of Pulmonary Arterial Hypertension in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 181

Identification of Disease-Susceptible Lncrna Contributed to Abnormal Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 674

Identification of IRAK4-Dependent Gene Signature As a Biomarker Candidate for IRAK4 Small-Molecule Inhibitor in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 168

Identification of Novel Susceptibility Loci in a Large UK Cohort of Juvenile Idiopathic Arthritis (JIA) Cases

9:00AM-11:00AM: Abstract Number: 2

Identifying “Second Hit” Risk Factor(s) Associated with Thrombosis and Pregnancy Morbidity in Ethnically Diverse Antiphospholipid Antibodies Positive Patients

9:00AM-11:00AM: Abstract Number: 74

IL-17 Blockade Attenuates Osteoblastic Activity and Differentiation in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 659

IL-17 Producing T Cells and Its Dichotomy: A Mixed Response of the Innate and Acquired Immune System in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 34

IL-23 Regulates Development of Spontaneous Germinal Centers and Pathogenic Autoantibody Production in BXD2 Mice

9:00AM-11:00AM: Abstract Number: 78

IL-37 Is Associated with Increased Atherogenesis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 594

Imaging Biomarkers in Crohn’s Associated Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 259

Imaging for Diagnosis, Monitoring and Outcome Prediction of Large Vessel Vasculitis: A Systematic Review of the Literature and Meta-Analysis Informing the EULAR Recommendations

9:00AM-11:00AM: Abstract Number: 566

Immune Response to Seasonal Flu Vaccination in Patients with Primary Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 481

Immunocompetent Cells Expressing Citrullinated Proteins in Joint Synovium of Osteoarthritis and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 383

Immunogenicity of 13 Valent Pneumococcal Vaccine in Children with Lupus: Single Center Experience in South Texas

9:00AM-11:00AM: Abstract Number: 676

Immunosignature Autoantibody Profiles Provide Mechanistic Insight into Systemic Lupus Erythematosus and Differentiation from Symptomatically Overlapping Diseases

9:00AM-11:00AM: Abstract Number: 576

Immunosignature-Based Diagnosis and Prediction of Therapeutic Response Enables Retrospective Patient Stratification in a Phase IIa Clinical Trial for VAY736 in Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 116

Immunotherapy-Induced Rheumatic Disease: How Prepared Are Rheumatologists to Address This Emerging Condition?

9:00AM-11:00AM: Abstract Number: 98

Impact of a Lung Ultrasound Course for Rheumatology Specialist (IMPACT-2)

9:00AM-11:00AM: Abstract Number: 96

Impact of a Student Led Rheumatology Interest Group on Medical Student Interest in Rheumatology

9:00AM-11:00AM: Abstract Number: 699

Impact of Anti-RBP Antibodies on Disease Activity and Quality-of-Life in Immunosuppressant Naive Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 108

Impact of Antiphospholipid Syndrome Ibook on Medical Students’ Improvement of Knowledge: An International Randomized Controlled Experimental Study

9:00AM-11:00AM: Abstract Number: 234

Impact of Arthritis Among Populations with Chronic Health Conditions in Rural Counties of the United States – 2015

9:00AM-11:00AM: Abstract Number: 528

Impact of Comorbidities on the Occurrence of Infections in Rheumatoid Arthritis Treated By Biologic Agents

9:00AM-11:00AM: Abstract Number: 743

Impact of Detect on Right Heart Catheterization Referral and Results; Data from a Prospective, Unselected, Systemic Sclerosis Cohort

9:00AM-11:00AM: Abstract Number: 428

Impact of Smoking Cessstion Advise in Patients with Rheumatoid Arthritis to Help Quit Smoking

9:00AM-11:00AM: Abstract Number: 133

Impact of the Five Components of the Euroqol 5-Dimensions Instrument on Healthcare and Work-Loss Costs in Rheumatoid Arthritis: Observational Data from Southern Sweden

9:00AM-11:00AM: Abstract Number: 129

Impact of the Multi-Biomarker Disease Activity Score Results on Whether Rheumatologists Changed Biologic Therapy for RA Patients

9:00AM-11:00AM: Abstract Number: 200

Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project

9:00AM-11:00AM: Abstract Number: 430

Implementation of a Treat-to-Target Remission Strategy for Rheumatoid Arthritis in Australian Public and Private Rheumatology Clinics – Identification of Clinician and Patient Barriers

9:00AM-11:00AM: Abstract Number: 187

Improved Identification of Pseudogout in Electronic Medical Records By Adding Text String Searching to a Billing Code Algorithm

9:00AM-11:00AM: Abstract Number: 508

Improved Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Failed Adalimumab or Placebo Treatment and Were Rescued with Baricitinib

9:00AM-11:00AM: Abstract Number: 595

Improved Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Abatacept: Results from a Phase III Trial

9:00AM-11:00AM: Abstract Number: 417

Improvement in Overall Work Productivity Among Biologic-NaïVe Patients with Rheumatoid Arthritis Treated with Tocilizumab Subcutaneous Injection: A Prospective, Real World, Observational Study in Japan

9:00AM-11:00AM: Abstract Number: 376

Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial

9:00AM-11:00AM: Abstract Number: 633

Improvement of Joint Inflammation As Assessed By MRI and Power Doppler Ultrasound (PDUS) in an Open Label Study in Patients with Active Psoriatic Arthritis Treated with Secukinumab.

9:00AM-11:00AM: Abstract Number: 602

Improvements in Work Productivity with up to 104 Weeks of Apremilast Monotherapy: Results from a Phase 3b, Randomized, Controlled Study in Biologic-NaïVe Subjects with Active Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 100

Improving Internal Medicine Resident’s Knowledge through a Web-Based Musculoskeletal Educational Module

9:00AM-11:00AM: Abstract Number: 458

Improving Knowledge of Rheumatoid Arthritis Clinical Trial Results Among Rheumatologists: Effect of an Online Educational Intervention

9:00AM-11:00AM: Abstract Number: 721

Improving the Quality of Care in Systemic Lupus Erythematosis (SLE) through Time-Structured, Information Technology-Enhanced, Quality Improvement Indicator-Driven Patient Management

9:00AM-11:00AM: Abstract Number: 52

In Vivo Effect of Opticin Deficiency in a Surgically Induced Mouse Model of Osteoarthritis

9:00AM-11:00AM: Abstract Number: 723

Incidence and Variability of Cardiovascular Risk Factors in Female Lupus Patients: A 3-Year Follow-up

9:00AM-11:00AM: Abstract Number: 815

Incidence in Large Vessel GCA in Northern Italy during a 11-Year Period

9:00AM-11:00AM: Abstract Number: 813

Incidence of Herpes Zoster in Patients with Polymyalgia Rheumatica: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 142

Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada

9:00AM-11:00AM: Abstract Number: 545

Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry

9:00AM-11:00AM: Abstract Number: 102

Incorporating Temporal Artery Ultrasound in a UK District General Hospital with No Prior Colour Doppler Sonography Service: An Encouraging Preliminary Analysis

9:00AM-11:00AM: Abstract Number: 761

Increased Expression of the TNF Superfamily Member LIGHT/TNFSF14 and Its Receptor (TNFRSF14) in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 488

Increased Expression of TNF-α and PAD-2 in Human Monocytes Following Treatment with Protein Modified with Malondialdehyde-Acetaldehyde (MAA) and Citrulline

9:00AM-11:00AM: Abstract Number: 18

Increased Frequency of Nailfold Videocapillaroscopy Abnormalities in Primaryantiphospolipid (PAPS) Patients

9:00AM-11:00AM: Abstract Number: 766

Increased Plasma Levels of Hsp90 Are Associated with More Severe Organ Involvement in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 549

Increases in Lipid Levels Following Sirukumab Treatment Are Associated with Suppression of Inflammation in Rheumatoid Arthritis: Results from Two Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 199

Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study

9:00AM-11:00AM: Abstract Number: 388

Induction of Anti-Citrullinated Protein Antibodies By Peptidyl Arginine Deiminase Immunization: A New Model for the Development of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 591

Inflammation on MRI of Spine and Sacroiliac Joints Is Highly Predictive of Structural Damage in Axial Spondyloarthritis: The 5 Years Data of the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 588

Inflammatory Lesions of the Sacroiliac Joints, but Not of the Spine, Are of High Utility for Recent Onset Axial Spondyloarthritis Recognition

9:00AM-11:00AM: Abstract Number: 208

Influence of Depression on Healthcare Expenditures Among Adults with Spondylosis, Intervertebral Disc Disorders and Other Back Problems in the United States

9:00AM-11:00AM: Abstract Number: 468

Initiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort

9:00AM-11:00AM: Abstract Number: 655

Innate Lymphoid Cells – New Players in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 619

Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 628

Integrated Efficacy Results from Two Phase 3 Trials of Ixekizumab for the Treatment of Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 616

Integrated Safety Summary of Tofacitinib in Psoriatic Arthritis Clinical Studies

9:00AM-11:00AM: Abstract Number: 770

Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis

9:00AM-11:00AM: Abstract Number: 351

Integration of Electronically Captured Patient-Reported Outcomes in a Pediatric Rheumatology Clinic Visit

9:00AM-11:00AM: Abstract Number: 166

Integrative Systems Biology Approach Identifies Key Transcription Factors and Novel Rheumatoid Arthritis (RA) and Individualized Therapeutic Targets

9:00AM-11:00AM: Abstract Number: 203

Intensive Care Unit Admissions Among Patients with Rheumatic Diseases at a Tertiary Care Center

9:00AM-11:00AM: Abstract Number: 754

Interferon Siganture in Systemic Sclerosis Lung Microvascular Endothelial Cells

9:00AM-11:00AM: Abstract Number: 367

Interleukin-1 Receptor Antagonist Is a Potential Treatment for Undifferentiated Autoinflammatory Syndromes

9:00AM-11:00AM: Abstract Number: 634

International League of Associations for Rheumatology. Systematic Review of the Literature to Inform Treatment Recommendations for Psoriatic Arthritis in Resource-Poor Countries

9:00AM-11:00AM: Abstract Number: 599

Intravenous Golimumab in Adult Patients with Active Psoriatic Arthritis: Efficacy and Safety through Week 24

9:00AM-11:00AM: Abstract Number: 177

Intronic Variants of the B-Cell Proliferator RASGRP3 Affect Its Expression, and Might Contribute to Lupus Risk

9:00AM-11:00AM: Abstract Number: 652

Investigating the Role of Mechanical Stress in Spondyloarthritis Pathogenesis

9:00AM-11:00AM: Abstract Number: 51

Irisin Ameliorates Infrapatellar Adiposity in Knee Osteoarthritis Pathogenesis By Orchestrating Adipokine Signaling

9:00AM-11:00AM: Abstract Number: 629

Is Earlier Golimumab Treatment Initiation in Psa and As Patients Associated with Improved Outcomes?

9:00AM-11:00AM: Abstract Number: 574

Is Elastography a New Tool to Differentiate Sjögren Syndrome to Sicca Syndrome?: Results of the Elsa (elastography of salivary glands) Study

9:00AM-11:00AM: Abstract Number: 492

Is Leukotoxin_A Produced By Aggregatibacter Actynomycetemcomitans Important for Initiating Autoimmune Responses Underlying Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 158

Is Lu Eight-Brocades Exercise Beneficial for Patients with Fibromyalgia?

9:00AM-11:00AM: Abstract Number: 191

Is the Nature of Rheumatology Practice Changing? Damage and Distress Contribute a Greater Proportion to Decision-Making Than Inflammation in Contemporary Care

9:00AM-11:00AM: Abstract Number: 569

Is the Oral Microbiome Involved in the Pathogenesis of Sjogren’s Syndrome?

9:00AM-11:00AM: Abstract Number: 640

Is There a Relationship between Spondyloarthritis and Periodontitis? a Case-Control Study

9:00AM-11:00AM: Abstract Number: 542

Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?

9:00AM-11:00AM: Abstract Number: 668

Is Uric Acid Level a Predictor of Long-Term Renal Outcome in Lupus Nephritis?

9:00AM-11:00AM: Abstract Number: 605

Ixekizumab Exhibits a Favorable Safety Profile during 24 Weeks of Treatment in Subjects with Active Psoriatic Arthritis: Integrated Safety Analysis of Two Randomized, Placebo Controlled, Phase III Clinical Trials

9:00AM-11:00AM: Abstract Number: 597

Ixekizumab Improves Patient-Reported Outcomes through 52 Weeks in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to Tumor Necrosis Factor-Inhibitors

9:00AM-11:00AM: Abstract Number: 624

Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two Year Results from a Phase 3 Trial

9:00AM-11:00AM: Abstract Number: 217

Keeping a Balance: Social Engagement and Care Giving

9:00AM-11:00AM: Abstract Number: 194

Kinesiophobia Moderates the Association between Anxiety and Disability in Chronic Low Back Pain

9:00AM-11:00AM: Abstract Number: 148

Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis?

9:00AM-11:00AM: Abstract Number: 548

LDL and HDL Changes with Sirukumab Treatment Are Anti-Atherogenic: Results from Two Phase 3 Trials in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 515

Leukopenia and Tumor Necrosis Factor Alpha Inhibitor Therapy

9:00AM-11:00AM: Abstract Number: 457

Levels of Satisfaction with RA Treatment and Associated Alignment between Rheumatologists and Their Patients across Latin America

9:00AM-11:00AM: Abstract Number: 285

Liver X Receptor-α (LXRα) Modulates Macrophage Phenotype and Disease Activity in SLE

9:00AM-11:00AM: Abstract Number: 824

Long Term Efficacy and Safety of Intravenous and Subcutaneous Biologics in Large Vessels Vasculitis: 21 Patients Belonging to a Single Italian Center from 2011 to 2017

9:00AM-11:00AM: Abstract Number: 231

Long Term Survival of Biological Agents in Patients with Axial Spondyloarthritis. the Impact of Sociodemographic Factors in Latin-America

9:00AM-11:00AM: Abstract Number: 601

Long-Term (4-Year) Efficacy and Safety of Apremilast Monotherapy in DMARD-Naive Subjects with Active Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 632

Long-Term Golimumab Retention Rate in Patients with Psoriatic Arthritis. Is Concomitant DMARD Important?

9:00AM-11:00AM: Abstract Number: 715

Long-Term Outcome of Demyelnating Syndrome in Systemic Lupus Erythematosus: A Longitudinal Study

9:00AM-11:00AM: Abstract Number: 713

Long-Term Outcomes in Prolonged Low Disease Activity Are Comparable to Complete Clinical Remission in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 547

Long-Term Risk of Serious Infections in Patients with Rheumatoid Arthritis Treated with Rituximab: 5 Year Data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 509

Long-Term Safety and Efficacy of Upadacitinib (ABT-494), an Oral JAK-1 Inhibitor in Patients with Rheumatoid Arthritis in an Open Label Extension Study

9:00AM-11:00AM: Abstract Number: 550

Long-Term Safety of Tocilizumab from Large Clinical Trial and Postmarketing Populations

9:00AM-11:00AM: Abstract Number: 371

Longer Term Outcomes of Chronic Relapsing Multifocal Osteomyelitis in a UK Tertiary Adolescent and Young Adult Rheumatology Centre

9:00AM-11:00AM: Abstract Number: 785

Longitudinal Angiographic Findings in Patients with Takayasu’s Arteritis

9:00AM-11:00AM: Abstract Number: 32

Longitudinal Associations between Rheumatoid Factor and Ex Vivo Cytokine Production Reveal Novel Mechanistic Insights into Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 60

Low and Moderate Intensity Exercise Suppresses Inflammatory Responses in an Acute Mouse Model of Gout and Suggests Therapeutic Efficacy

9:00AM-11:00AM: Abstract Number: 582

Low Dose Computed Tomography Detects More Progression of Bone Formation in Comparison to Conventional Radiography in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 20

Low Molecular Weight BAFF Receptor Antagonists Restrain Infiltration of B Cells into Organs of Autoimmune Model Mice By Suppressing B Cell Activation

9:00AM-11:00AM: Abstract Number: 500

Low Patient Global Assessment Scores in Rheumatoid Arthritis Are Associated with Pain and Physical Function in Patients Treated with Tofacitinib: A Post-Hoc Analysis of Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 600

Low Rates of Major Adverse Cardiac Events, Malignancies, and Serious Infections in Subjects with Psoriasis and Psoriatic Arthritis Treated with Apremilast for ≥156 Weeks: Pooled Analysis from the Esteem and Palace 1-3 Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 665

Low Vitamin D Is Associated with End Stage Renal Disease in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 664

Low Vitamin D Is Associated with Thrombosis in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 188

Lupus Low Disease Activity State Is Associated with Reduced Direct Medical Costs in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 719

Lupus Nephritis in Isolation or Accompanied By Extra-Renal Manifestations: Early Lessons from the Accelerating Medicines Partnership

9:00AM-11:00AM: Abstract Number: 762

M10, a Caspase Cleavage Product of the Hepatocyte Growth Factor Receptor, Downregulates Bone Morphogenetic Protein-9-Induced Smad1/5/8 Phosphorylation and Collagen Production in Human Lung Fibroblasts

9:00AM-11:00AM: Abstract Number: 420

Machine Learning in Rheumatology: Development and Validation of a Predictive Model for Rheumatoid Arthritis Mortality Using Random Survival Forests

9:00AM-11:00AM: Abstract Number: 54

Maintaining Angiogenesis Prevents Glucocorticoid Induced Osteonecrosis

9:00AM-11:00AM: Abstract Number: 146

Major Cardiovascular Events Among an Inception Cohort of Seniors with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 406

Mapping Changes in Monocyte and Macrophage Populations in the Synovium: An Aging Study in Arthritic KRN Ag7 Mice

9:00AM-11:00AM: Abstract Number: 789

Markers of Inflammation and Patient-Reported Measures As Predictors of Relapse in Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 179

Mass Spectrometry Imaging of Synovium: A Novel Approach to Classify the Rheumatoid and Psoriatic Arthritis Patients

9:00AM-11:00AM: Abstract Number: 788

Mast Cell Mediated Inhibition of Systemic IL-6 in candida Albicans Water-Soluble Fraction (CAWS) Induced Model of Large Vessel Vasculitis

9:00AM-11:00AM: Abstract Number: 552

Mast Cells Are Involved in the Pathogenesis of Sjögren Syndrome By Inducing Tissue Fibrosis

9:00AM-11:00AM: Abstract Number: 800

Measurement of Serum Cytokines during the Apparent Remission State of Takayasu Arteritis – What Do Cytokines Tell Us?

9:00AM-11:00AM: Abstract Number: 338

Measurement Properties of Paindetect, a Neuropathic Pain Screening Tool, for Evaluating Pain Phenotype in Patients with Rheumatoid Arthritis: Developing Neuropathic Pain Scale As a Measure of Treatment Outcome By Applying Rasch Analysis

9:00AM-11:00AM: Abstract Number: 763

Mechanisms of Insulin-like Growth Factor-II-Mediated Fibrosis

9:00AM-11:00AM: Abstract Number: 449

Medical Bugs for Pain Relief in Patients with Rheumatoid Arthritis, a Systematic Review

9:00AM-11:00AM: Abstract Number: 97

Medical Student Interest in Rheumatology As a Career

9:00AM-11:00AM: Abstract Number: 473

Medication Utilization Patterns of Rheumatoid Arthritis Patients Receiving Anti-TNF Infusion in Community Rheumatology Practices in the United States: Will Differences in Dosing and Administration Efficiencies between Intravenous Golimumab and Infliximab Have a Cost Impact for Payers?

9:00AM-11:00AM: Abstract Number: 670

Membrane Attack Complex (MAC) Deposition in Lupus Nephritis Is Associated with Hypertension and Poor Clinical Response to Treatment

9:00AM-11:00AM: Abstract Number: 284

Metabolic Activity Sustains Macrophage Cytokine Production in Rheumatoid Arthritis and Coronary Artery Disease

9:00AM-11:00AM: Abstract Number: 15

Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 493

Methotrexate Is an Antibacterial Drug Metabolized By Human Gut Bacteria

9:00AM-11:00AM: Abstract Number: 443

Methotrexate Treatment Strategies in an Early Rheumatoid Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 446

Methotrexate Use and Fatigue in Rheumatoid Arthritis Patients: Results from a National Patient Registry

9:00AM-11:00AM: Abstract Number: 793

Metotrexate in the Treatment of Giant Cell Arteritis: To be or Not to be

9:00AM-11:00AM: Abstract Number: 88

Mind Map Use in Rheumatology Education

9:00AM-11:00AM: Abstract Number: 567

Minor Salivary Gland Histopathology, Major Salivary Gland Ultrasonography, and Secretory Function in Smoking Patients with Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 643

Mir-10b-5p Is a IL-22 Regulator in CD4+T Cells from Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 63

MiR-146a a Key Player in Bone Metabolism

9:00AM-11:00AM: Abstract Number: 301

MiR-221-3p Overexpression Impairs Anti-Inflammatory Activity of TLR4-Stimulated M2-Macrophages

9:00AM-11:00AM: Abstract Number: 48

Modulation of Subchondral Bone Turnover Is Associated with Alteration of Cartilage Tissue Quality

9:00AM-11:00AM: Abstract Number: 564

Molecular Identification of a Ro-Specific Salivary IgA Repertoire with Unique Clonal Signatures in Primary Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 772

Molecular Mechanism for the Therapeutic Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers of Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 477

Monoclonal ACPA-IgG Feature Extensive Fab Glycosylation

9:00AM-11:00AM: Abstract Number: 504

Monotherapy with Filgotinib, a JAK1-Selective Inhibitor, Reduces Disease-Related Biomarkers in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 812

Mortality Risk and Cause-Specific Mortality in Polymyalgia Rheumatica: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 235

MRI in Rheumatoid Arthritis: Does Quantifying the Number of Erosive Lesions Improve Detection of Subtle Erosive Progression Compared to the Omeract RA MRI Scoring System?

9:00AM-11:00AM: Abstract Number: 759

Multi Dimensional Analysis of the Immunome in Systemic Sclerosis Reveals Functionally Related Abnormalities in MAIT and B Cell Compartments

9:00AM-11:00AM: Abstract Number: 414

Multi-Biomarker Disease Activity and Autoantibody Status Lead to Cost Effective Tapering Algorithms in Rheumatoid Arthritis Patients in Sustained Remission

9:00AM-11:00AM: Abstract Number: 361

Multi-National Observational Patient Diary Study to Assess Disease Burden of Periodic Fever Syndromes (PFS), Including Colchicine-Resistant Familial Mediterranean Fever (crFMF), TNF-Receptor Associated Periodic Syndrome (TRAPS) and Mevalonate Kinase Deficiency (MKD)

9:00AM-11:00AM: Abstract Number: 354

Multidomain Functional Assessment in a Cohort of Patients with Systemic Lupus Erythematosus: A Pilot Study

9:00AM-11:00AM: Abstract Number: 297

Multiplexed Characterization of Circulating and Joint-Derived Human Neutrophils in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 378

Musculoskeletal Features in Copa Syndrome

9:00AM-11:00AM: Abstract Number: 267

Musculoskeletal Ultrasound As a Diagnostic Tool for Eosinophilic Fasciitis and Correlation with MRI Findings

9:00AM-11:00AM: Abstract Number: 736

N-Terminal Pro-Brain Natriuretic Peptide Is Disproportionately Elevated in Scleroderma Associated Pulmonary Arterial Hypertension Compared to Idiopathic Pulmonary Arterial Hypertension

9:00AM-11:00AM: Abstract Number: 247

Near Infrared Indocyanine Green Imaging Reveals Diminished Flow in Basilic Associated Lymphatic Vessels in the Hands of Rheumatoid Arthritis Patients during Flare

9:00AM-11:00AM: Abstract Number: 794

Negative Temporal Artery Biopsies: Comparison between Biopsy-Negative GCA and Non-GCA Patients

9:00AM-11:00AM: Abstract Number: 292

Neutrophil Extracellular Traps Are Induced By Adenosine and Stimulate Release of TNF Alpha from Macrophages in Deficiency of Adenosine Deaminase 2 (DADA2)

9:00AM-11:00AM: Abstract Number: 169

New Autoinflammatory Phenotype Associated with Homozygous AGBL3 Variant

9:00AM-11:00AM: Abstract Number: 422

No Added Predictive Value of Serum Calprotectin for Treatment Response to Adalimumab or Etanercept in RA Patients

9:00AM-11:00AM: Abstract Number: 537

No Effect of Baseline Serum CRP Levels on Clinical Efficacy Parameters in Rheumatoid Arthritis Patients Treated with Filgotinib: Post Hoc Analysis from Two Phase 2B Studies

9:00AM-11:00AM: Abstract Number: 139

No Effect of Tumor Necrosis Factor-a Inhibitors on Renal Function in Patients with Rheumatoid Arthritis from Kobio Registry from 2012 to 2016

9:00AM-11:00AM: Abstract Number: 661

Normal Human Enthesis Contains a Resident Population of γδT-Cells

9:00AM-11:00AM: Abstract Number: 712

Novel Electronic Health Record Method Reveals That dsDNA Antibody-Negative Systemic Lupus Erythematosus Is Associated with Pain, Sleep, and Mood Disorders

9:00AM-11:00AM: Abstract Number: 377

Novel Insights into Periodic Fever Syndromes

9:00AM-11:00AM: Abstract Number: 476

Novel Interaction between Anti-Citrulline Monoclonal Antibodies and Apoptotic Cells Is Mediated through Citrullinated Nuclear Antigens

9:00AM-11:00AM: Abstract Number: 756

Novel Machine Learning Classifier Accurately Predicts Intrinsic Molecular Subsets for Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 55

Nrf2 Inhibits Apoptosis and Suppresses Oxidative Stress By Activating NOX4/ERK1/2/ELK1 Signaling Axis in Human Chondrocytes

9:00AM-11:00AM: Abstract Number: 359

Nurse Telephone Education for Promoting a Treat-to-Target Approach in Recently Diagnosed Rheumatoid Arthritis Patients – a Preliminary Review

9:00AM-11:00AM: Abstract Number: 119

Occupational Exposure to Asbestos and Risk of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 132

Occupational Physical Workload and Development of Anti-Collagen Type II Antibodies in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 190

Opioid Dispensation Among Systemic Lupus Erythematosus (SLE) Patients Who Persistently Frequent the Emergency Department (ED)

9:00AM-11:00AM: Abstract Number: 705

Optimization of a Cost-Effective Diagnostic ANA Algorithm

9:00AM-11:00AM: Abstract Number: 172

Optimizing Precision Medicine By Using Genetics to Assign Diagnostic Prior Probabilities to Patients with Synovitis

9:00AM-11:00AM: Abstract Number: 326

Osteoporosis and Vertebral Fractures Are Associated with Disease Activity, Low Vitamin D Levels and Spinal Radiographic Damage in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 303

Outcomes after Hip Fracture in the Elderly: Does Social Isolation Matter?

9:00AM-11:00AM: Abstract Number: 186

Paediatric Musculoskeletal (MSK) Triage in the Community – Rightpath – a Pilot Study

9:00AM-11:00AM: Abstract Number: 316

Pain, Fatigue and Function in Patients with Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder – Relationship with Perceived Benefits and Barriers to Exercise

9:00AM-11:00AM: Abstract Number: 196

Patient Assistance Program Outcomes in a Community Clinic Setting

9:00AM-11:00AM: Abstract Number: 192

Patient Education Materials in Rheumatology: Only Adequate at Best

9:00AM-11:00AM: Abstract Number: 353

Patient Experiences of Rheumatoid Arthritis Models of Care: An International Survey

9:00AM-11:00AM: Abstract Number: 143

Patient Rheumatoid Arthritis Data from the Real World (PARADE) Study: Preliminary Results from an Apple Researchkit™ Mobile App-Based Real World Study in the United States

9:00AM-11:00AM: Abstract Number: 337

Patient-Reported Flares Were Correctly Predicted By an Algorithm Using Machine-Learning Statistics on Activity Tracker Data on Steps, in a Longitudinal 3-Month Study of 170 Patients with Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA)

9:00AM-11:00AM: Abstract Number: 501

Patient-Reported Outcomes of Long-Term Upadacitinib Use in Patients with Rheumatoid Arthritis: Interim Analysis Results of a Phase 2, Open-Label Extension Study

9:00AM-11:00AM: Abstract Number: 336

Patient–Reported Barriers to Achieving Rheumatoid Arthritis Disease Control

9:00AM-11:00AM: Abstract Number: 358

Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 152

Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset

9:00AM-11:00AM: Abstract Number: 350

Patients with Gout Consider Zero Flares over the Previous Six or Twelve Months Necessary for a Remission State

9:00AM-11:00AM: Abstract Number: 120

Patients with Rheumatoid Arthritis Have Higher Lifetime Professional and Non-Professional Exposure to Silica Dust Particles Compared to General Population

9:00AM-11:00AM: Abstract Number: 339

Patients’ Attitudes and Experiences of Transitional Care in Paediatric Rheumatology: A Systematic Review of Qualitative Studies

9:00AM-11:00AM: Abstract Number: 362

Patients’ Experiences and Attitudes about Non-Medical Switching of Biologics: Results from an Online Patient Survey

9:00AM-11:00AM: Abstract Number: 224

Patterns of Methotrexate Use in African Countries with Low Versus Medium/High Human Development Index: Preliminary Results of Semi-Structured Interviews

9:00AM-11:00AM: Abstract Number: 93

Peer-Developed E-Learning Resource Can Address Rheumatology Knowledge Gaps in Junior Learners

9:00AM-11:00AM: Abstract Number: 213

Perception of Access to Mental Health Services in Publicly Insured Vs Privately Insured Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 355

Perceptions and Outcomes of Pregnancy and Lactation in Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 147

Performance of Cardiovascular Risk Age and Vascular Age Estimations in Predicting Cardiovascular Events in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 559

Performance of Multiple Platforms for Autoantibody Testing in Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 726

Performance of the American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the Scleroderma Lung Study-I

9:00AM-11:00AM: Abstract Number: 801

PET-CT Findings and Clinical Outcomes in Takayasu Arteritis – Does 18F-Fluorodeoxyglucose Uptake in Arteries Predict Relapses?

9:00AM-11:00AM: Abstract Number: 395

Pharmacological and Safety Profiles of Cyclin-Dependent Kinase 4/6 Inhibitor, Candidate for Development As Rheumatoid Arthritis Therapeutic Option

9:00AM-11:00AM: Abstract Number: 210

Pharmacovigilance Surveillance of Autoimmune Diseases Induced By Biological Agents: A Review of 12013 Cases (aeBIOGEAS-SEMI Registry)

9:00AM-11:00AM: Abstract Number: 372

Phenotype of Chronic Recurrent Multifocal Osteomyelitis in a Tertiary Referral Centre: The Great Ormond Street Hospital Experience

9:00AM-11:00AM: Abstract Number: 396

Phospho-STAT1 Inhibition Is the Initial Step after Tofacitinib Treatment in Rabbits with Severe Chronic Synovitis

9:00AM-11:00AM: Abstract Number: 84

Physiological Autoantibodies Against the Endthelin Receptor Type-a Are Critically Involved in the Homeostasis of Immune Cells

9:00AM-11:00AM: Abstract Number: 466

Plasma Cytokines at Diagnosis May Predict Non-Response to Methotrexate in Patients with Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 757

Plasmacytoid Dendritic Cells Activated through TLR8 Promote Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 77

Platelets Induce IL-1b Production in Human Monocytes through NLRP3 Inflammasome Activation

9:00AM-11:00AM: Abstract Number: 53

Poly-γ-Glutamic Acid Inhibits RANKL- Induced Osteoclast Differentiation and Prevents Bone Destruction in Rheumatoid Arthritis: Human and CIA Mouse Model

9:00AM-11:00AM: Abstract Number: 122

Poor Prognostic Factors at the Start of Methotrexate Therapy Are Not Associated with Worse Treatment Response: Results from the Rheumatoid Arthritis Medication Study

9:00AM-11:00AM: Abstract Number: 702

Positive Direct Coombs’ Test in the Absence of Hemolytic Anemia Predicts High Disease Activity and Poor Renal Response in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 11

Possible Therapeutics for Antiphospholipid Antibody Related Thrombocytopenia: A Systemic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 431

Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data

9:00AM-11:00AM: Abstract Number: 238

Power Dopper Ultrasonography Detects Superior Efficacy of Non-TNF Biologics Compared to Cycling of TNF Inhibitors in RA Patients Inadequate Response to First TNF Inhibitors

9:00AM-11:00AM: Abstract Number: 790

Pre-Clinical Evidences of Immunomodulatory Activities of Tuftsin-Phosphorylcholine on Samples from Patients with Giant Cell Arteritis in Comparison to Corticosteroids

9:00AM-11:00AM: Abstract Number: 175

Precisely Controlled Differential Gene Expression System to Investigate the Effect of eQTL

9:00AM-11:00AM: Abstract Number: 448

Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards

9:00AM-11:00AM: Abstract Number: 744

Prediction of All-Cause Mortality and Pulmonary Arterial Hypertension (PAH) Progression in Systemic Sclerosis (SSc), an Echocardiography Study

9:00AM-11:00AM: Abstract Number: 138

Prediction of Cardiovascular Events in Rheumatoid Arthritis Patients Using a Multi-Biomarker of Disease Activity

9:00AM-11:00AM: Abstract Number: 740

Prediction of Fibrosis Progression in Systemic Sclerosis By Collagen Biomarkers

9:00AM-11:00AM: Abstract Number: 731

Prediction of Progression of Interstitial Lung Disease in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 275

Predictive Factors of Cytomegalovirus Infection in Patients with Connective Tissue Diseases Treated with Immunosuppressive Drugs

9:00AM-11:00AM: Abstract Number: 7

Predictive Value for Thrombosis of Double or Triple Positivity in Secondary APS Depends on the Component Assays and the Type of Thrombosis

9:00AM-11:00AM: Abstract Number: 433

Predictors of Earlier Biologic Initiation Among Patients with Rheumatoid Arthritis Starting Methotrexate

9:00AM-11:00AM: Abstract Number: 631

Predictors of Long-Term Retention of Methotrexate and Other Dmards with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry

9:00AM-11:00AM: Abstract Number: 524

Predictors of Mortality in RA Patients before Biologic Therapy

9:00AM-11:00AM: Abstract Number: 349

Preferences and Satisfaction in a Pediatric Multidisciplinary Infusion Center

9:00AM-11:00AM: Abstract Number: 6

Pregnancy Outcomes in a Cohort of Women with Antiphospholipid Syndrome. 25- Years Long-Term Observation

9:00AM-11:00AM: Abstract Number: 356

Preliminary Real World Data on Switching Patterns between Etanercept, Its Recently Marketed Biosimilar Counterpart and Its Competitor Adalimumab, Using Swedish Prescription Registry

9:00AM-11:00AM: Abstract Number: 253

Presence of Bone Marrow Edema and Structural Lesions on Magnetic Resonance Imaging of the Sacroiliac Joints in Young Military Recruits before and after 6 Weeks of Intensive Physical Training

9:00AM-11:00AM: Abstract Number: 608

Presence of Poor Prognostic Factors May Predict Response to Abatacept in Patients with Active Psoriatic Arthritis: Results from a Post Hoc Analysis from a Phase III Study

9:00AM-11:00AM: Abstract Number: 796

Presentation and Outcome of Large-Vessel Vasculitis Diagnosed between 50 and 60 Years: Case-Control Study Based on 183 Cases

9:00AM-11:00AM: Abstract Number: 809

Prevalence and Distribution of Vascular FDG Uptake on Positron Emission Tomography (PET)-CT in Patients Suspected of Having Giant Cell Arteritis – Interim Results from the Giant Cell Arteritis and PET Scan (GAPS) Study

9:00AM-11:00AM: Abstract Number: 266

Prevalence and Pattern of Hand Osteoarthritis in a Working Population Using Ultrasound

9:00AM-11:00AM: Abstract Number: 711

Prevalence and Risk Factors of Depressive Disorders in Chinese Patients with Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 258

Prevalence of Echocardiographic Findings in Connective Tissue Diseases – a Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 151

Prevalence of Fibromyalgia in Nurses; A Cross Sectional Study

9:00AM-11:00AM: Abstract Number: 153

Prevalence of Fibromyalgia in Physician in Training; A Cross Sectional Study

9:00AM-11:00AM: Abstract Number: 523

Prevalence of Occult Hepatitis B Carrier Status and Its Associated Risk Factors in Patients with Rheumatic Diseases Undergoing Biological Therapies

9:00AM-11:00AM: Abstract Number: 269

Prevalence of Pneumococcal Vaccination in Rheumatologic Patients with Community Acquired Pneumonia. Biobadasar Registry

9:00AM-11:00AM: Abstract Number: 787

Prevalence of Relapses of Giant Cell Arteritis in Patients Treated with Corticosteroids: A Meta-Analysis

9:00AM-11:00AM: Abstract Number: 136

Prevalence of Rheumatoid Arthritis and Associated Comorbidities in the 2011-2015 Medicare Population

9:00AM-11:00AM: Abstract Number: 197

Process Evaluation of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Remain Employed

9:00AM-11:00AM: Abstract Number: 80

Production and Characterization of Human Interferon-Epsilon and Interferon-Kappa to Investigate Their Potential Role in Lupus

9:00AM-11:00AM: Abstract Number: 554

Prognostic Significance of Double Positive Anti Ro/SS-a and La/SS-B Antibodies in Patients with Primary Sjogren’s Syndrome: Prospective Salivary Gland Ultrasound Study

9:00AM-11:00AM: Abstract Number: 820

Prognostic Value of Positron Emission Tomography in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis

9:00AM-11:00AM: Abstract Number: 732

Progression of Skin Fibrosis Is Associated with Decline in Lung Function in Patients with Diffuse Cutaneous Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis

9:00AM-11:00AM: Abstract Number: 593

Progression of Structural Damage on MRI in Patients with Axial Spondyloarthritis Is Limited: The 5 –Year Results in the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 714

Prolonged Antimalarial Treatment Is Associated with Increased Risk for Elevated Myocardial Biomarkers in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 716

Prolonged Exposure to Antiphospholipid Antibodies Is Associated with Endothelial Dysfunction in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 738

Prospective Validation of the Systemic Sclerosis Skin Symptoms Patient-Reported Outcome (SSPRO) in a Phase 2 Trial of Anabasum (JBT-101) in Diffuse Cutaneous Systemic Sclerosis (dcSSc)

9:00AM-11:00AM: Abstract Number: 656

Prostaglandin E2 and Its Receptor Subtype EP4 Are Involved in Ankylosing Spondylitis Disease Progression

9:00AM-11:00AM: Abstract Number: 384

Protection Against Hepatitis B in Immunocompromised Pediatric Rheumatology and Gastroenterology Patients

9:00AM-11:00AM: Abstract Number: 39

Protein Array Technology Identifies Rituximab-Treated Non-Responder Rheumatoid Arthritis Patients to Generate New Autoantibody Repertoires during Treatment

9:00AM-11:00AM: Abstract Number: 479

Protein Carbamylation Is Induced By Activated Neutrophil: Ex Vivo Analysis

9:00AM-11:00AM: Abstract Number: 769

Proteomic Analysis of Human Fibroblasts in Systemic Sclerosis Reinforces the Role of Transforming Growth Factor-ß and Points Toward Epidermal Growth Factor Receptor / Phosphatidylinositol 3 Kinase Pathway Inhibition

9:00AM-11:00AM: Abstract Number: 765

Proteomic Analysis of Scleroderma Associated Joint Disease

9:00AM-11:00AM: Abstract Number: 335

Psoriatic Arthritis Patients Who Attain a Very Low Disease Activity State Have a Minimal Impact of the Disease on Their Lives

9:00AM-11:00AM: Abstract Number: 254

Psoriatic Arthritis Sonographic Enthesitis Scores – Systematic Review of the Literature

9:00AM-11:00AM: Abstract Number: 352

Psychometric Features of a New Methotrexate (MTX)-Specific Adherence Tool for Use in the Management of Patients with Rheumatoid Arthritis (RA): Preliminary Results from an Online Patient Community

9:00AM-11:00AM: Abstract Number: 529

Pulmonary Involvement in Our Patients with Rheumatoid Arthritis Under Biological Therapy: A Tertiary Hospital Experience

9:00AM-11:00AM: Abstract Number: 50

Quality Controls Monitoring As Indicator of Stability in Bone and Cartilage Turnover Markers for Clinical Trials

9:00AM-11:00AM: Abstract Number: 263

Quantitative Analysis of Vascular Calcification Using a Novel Semi-Automated Software

9:00AM-11:00AM: Abstract Number: 742

Quantitative CT Evalutation in Diffuse Interstitial Lung Involvement in Systemic Sclerosis: Usefulness of Lung Texture Analysis to Predict the Functional Change over Time

9:00AM-11:00AM: Abstract Number: 65

RA-Associated Antibodies Targeting Post Translational Modification Have Different Osteoclastogenetic Potential

9:00AM-11:00AM: Abstract Number: 626

Radiographic Progression of Structural Joint Damage in Patients with Active Psoriatic Arthritis Treated with Ixekizumab over 52 Weeks

9:00AM-11:00AM: Abstract Number: 825

Radiological Disease Activity Is the Major Determinant for Physicians While Deciding Active Disease in Takayasu Arteritis

9:00AM-11:00AM: Abstract Number: 382

Radiological Features Identified in the Hands of Children with Down Syndrome and Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 625

Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials

9:00AM-11:00AM: Abstract Number: 312

Rates of Total Joint Replacement Utilization in the U.S.: Future Projections to 2020-2040 Using the National Inpatient Sample

9:00AM-11:00AM: Abstract Number: 424

Re-Establishment of Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, in Rheumatoid Arthritis Patients after Temporary Discontinuation

9:00AM-11:00AM: Abstract Number: 344

Real World Clinical Trial Comparing the Patient Reported Outcomes Measurement Information System Short Forms and Profiles to CDAI Disease Classification in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 206

Real World IGRA Testing in Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 280

Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study.

9:00AM-11:00AM: Abstract Number: 21

Reciprocal Regulation of B Cells on Bleomycin-Induced Scleroderma Model: IL-6-Producing Effector B Cells Play a Pathogenic Role, While IL-10-Producing Regulatory B Cells Play a Protective Role

9:00AM-11:00AM: Abstract Number: 437

Recruitment of RA Trials in the Modern Era: Are United States-Based Trials Still Feasible?

9:00AM-11:00AM: Abstract Number: 653

Reduced Ubiquitination of Misfolded HLA-B27 Is Associated with Inefficient Degradation By ERAD and Autophagy

9:00AM-11:00AM: Abstract Number: 502

Reduction in Disease Activity in Patients with RA and an Inadequate Response to MTX: Baricitinib Compared to Adalimumab and Placebo

9:00AM-11:00AM: Abstract Number: 141

Refractory Disease in Rheumatoid Arthritis: Results from the British Society of Rheumatology Biologics Register for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 423

Refractory Pain in Spite of Inflammation Control after Start of Anti-TNF Therapy in RA: Observational Data from Southern Sweden

9:00AM-11:00AM: Abstract Number: 86

Regulation of Interleukin-1β Signaling By Inhibition of O-Glc-Nacase in Rheumatoid Arthritis Synovial Fibroblasts

9:00AM-11:00AM: Abstract Number: 73

Regulation of Th17 Cell Responses By IL-25

9:00AM-11:00AM: Abstract Number: 43

Regulation of TLR7 Signalling By UBE2L3 Dependent Linear Ubiquitination Explains Dimethyl Fumarate Suppression of Autoreactive B Cell Development in SLE

9:00AM-11:00AM: Abstract Number: 306

Relationship between Inflammatory Anterior or Posterior Arch MRI Abnormalities and Clinical Data in Low Back Pain Patients

9:00AM-11:00AM: Abstract Number: 123

Relationship between Shift Work and the Onset of Rheumatoid Arthritis; Results from a Swedish Case-Control Study

9:00AM-11:00AM: Abstract Number: 265

Reliability of an Omeract Semiquantitative Scoring System and Imaging Atlas for the Assessment of Cartilage in Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 385

Reliable Implementation of a Hepatitis B Serology Screening and Vaccination Process for Immunocompromised Pediatric Rheumatology Patients

9:00AM-11:00AM: Abstract Number: 9

Renal Protective Effect of Antiplatelet Therapy in Antiphospholipid Antibody-Positive Lupus Nephritis Patients without the Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 429

Repair of Joint Damage Is Rare in Newly Diagnosed Rheumatoid Arthritis Patients and Appears Not to Relate to Previous Suppression of Inflammation

9:00AM-11:00AM: Abstract Number: 496

Repeated Rituximab Infusions for the Therapy of Rheumatoid Arthritis Is Not Associated with Increased Rates of Serious Infections

9:00AM-11:00AM: Abstract Number: 61

Resolution of Systemic Joint Inflammatory Processes and Regeneration of Existing Bone Damage upon TNF Blockade As Monitored By In Vivo Multimodal PET-CT Imaging in Progressed Experimental Arthritis

9:00AM-11:00AM: Abstract Number: 498

Response to Abatacept of Different Patterns of Interstitial Lung Disease in Rheumatoid Arthritis. Multicenter Study of 63 Patients

9:00AM-11:00AM: Abstract Number: 42

Resveratrol Regulates Sirt1 to Control B Cells Activation and Plasma B Cells Differentiation

9:00AM-11:00AM: Abstract Number: 277

Rheumatic Conditions Appearing De Novo after Infection with Chikungunya Virus in Venezuelan Patients

9:00AM-11:00AM: Abstract Number: 137

Rheumatoid Arthritis and the Risk for Interstitial Lung Disease: A Comparison of Risk Associated with Biologic and Conventional Dmards

9:00AM-11:00AM: Abstract Number: 244

Rheumatoid Arthritis Imaging on PET-CT Using a Novel Folate Receptor Ligand for Macrophage Targeting

9:00AM-11:00AM: Abstract Number: 475

Rheumatoid Arthritis Patient Characteristics Also Predict Response to Therapy with Biologic Agents: Results from the Corrona Certain Study

9:00AM-11:00AM: Abstract Number: 440

Rheumatoid Arthritis Patient´s Journey: Delay in Diagnosis and Treatment

9:00AM-11:00AM: Abstract Number: 471

Rheumatoid Arthritis Patients Resistant to Biologic Therapy, Are They Different?

9:00AM-11:00AM: Abstract Number: 165

Rheumatoid Arthritis Risk Polymorphisms in CCR6, SNP and Estrogen-Dependent Response to Immune Mediator Gene Expression, and NF-κb Transcriptional Activity: Crosstalk between the Immune and Endocrine Systems

9:00AM-11:00AM: Abstract Number: 106

Rheumatology Fellows Teaching in a Consult Setting: Pilot Project at Two Training Hospitals

9:00AM-11:00AM: Abstract Number: 101

Rime (Reporter-Interpreter-Moderator-Educator) Evaluation Tool to Assess Fellows in Rheumatology

9:00AM-11:00AM: Abstract Number: 317

Risk Factors for Blood Transfusions Following Total Joint Arthroplasty in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 717

Risk Factors for Neuropsychiatric Systemic Lupus Erythematosus and Its Recurrence

9:00AM-11:00AM: Abstract Number: 819

Risks of Non-Cardiovascular Corticosteroid Related Adverse Events and Cancer in Giant Cell Arteritis: A French Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 649

Role of Eicosanoids As Biomarkers in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 651

Role of Mir-21-5p As a Potential Biomarker of Psoriatic Arthritis and Response to Treatment

9:00AM-11:00AM: Abstract Number: 752

Role of the Six-Minute Walk Test in Systemic Sclerosis: Five Years Evolution

9:00AM-11:00AM: Abstract Number: 389

S-110483 a New Potent EP4 Receptor Antagonist with Immunomodulatory and Analgesic Activities

9:00AM-11:00AM: Abstract Number: 390

S-110483, a Novel and Selective EP4 Receptor Antagonist with Anti-Bone Destruction Activities

9:00AM-11:00AM: Abstract Number: 612

Safety and Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis over a 6 Month Period

9:00AM-11:00AM: Abstract Number: 725

Safety and Efficacy of Anabasum (JBT-101) in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Subjects Treated in an Open-Label Extension of Trial JBT101-SSc-001

9:00AM-11:00AM: Abstract Number: 620

Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patients with Active Psoriatic Arthritis: Data from the Second Interim Analysis of OPAL Balance, an Open‑Label, Long-Term Extension Study

9:00AM-11:00AM: Abstract Number: 778

Safety Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations

9:00AM-11:00AM: Abstract Number: 322

Safety of Denosumab in a Monocentric Cohort of Kidney Transplant Recipients

9:00AM-11:00AM: Abstract Number: 511

Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 5.5 Years: An Updated Integrated Safety Analysis

9:00AM-11:00AM: Abstract Number: 544

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-06650833, a Novel, Potentially First-in-Class Inhibitor of Interleukin-1 Receptor Associated Kinase-4 (IRAK-4) in Healthy Subjects

9:00AM-11:00AM: Abstract Number: 558

Salivary Syndecan-1 Levels Are Associated with Salivary Gland Dysfunction and Immune Dysregulation in Patients with Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 28

Sapril and Sbcma As Potential Biomarkers of B Cell Hyperactivation in Rheumatoid Arthritis: A Cluster Analysis Approach

9:00AM-11:00AM: Abstract Number: 748

Scleromyxedema Phenotype Pre- and Post-Treatment with Intravenous Immunoglobulin

9:00AM-11:00AM: Abstract Number: 823

Seasonal Variation in Giant Cell Arteritis and Polymyalgia Rheumatica Hospitalizations: Data from Nationwide Inpatient Sample

9:00AM-11:00AM: Abstract Number: 176

SEC16A and Antigen Presentation Abnormalities in the Pathogenesis of Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 46

Secondary Light Chain Editing and Allelic Inclusion in Antibody Secreting Cells from the Minor Salivary Gland

9:00AM-11:00AM: Abstract Number: 606

Secukinumab Demonstrates Consistent Safety over Long-Term Exposure in Patients with Psoriatic Arthritis and Moderate to Severe Plaque Psoriasis: Updated Pooled Safety Analyses

9:00AM-11:00AM: Abstract Number: 621

Secukinumab Provides Sustained Improvement in Major and Moderate Response of Disease Activity Index for Psoriatic Arthritis (DAPSA): 2-Year Results from a Phase 3 Study

9:00AM-11:00AM: Abstract Number: 622

Secukinumab Provides Sustained Minimal Disease Activity (MDA) and Remission Related to Disease Activity Index for Psoriatic Arthritis (DAPSA): 2-Year Results from a Phase 3 Study

9:00AM-11:00AM: Abstract Number: 618

Secukinumab Sustains Individual Clinical Responses over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial

9:00AM-11:00AM: Abstract Number: 607

Secukinumab Treatment of Psoriatic Arthritis and Moderate to Severe Psoriasis Relieves Anxiety/Depression up to 52 Weeks: An Overview from Secukinumab Phase 3 Clinical Trials

9:00AM-11:00AM: Abstract Number: 328

Secular Trends in the Risk of Fragility Fracture Among Patients with Rheumatoid Arthritis: A General Population-Based Study

9:00AM-11:00AM: Abstract Number: 698

Selected Nailfold Videocapillaroscopy Changes Are Linked to SLE Onset in a Cohort of Uctd Subjects

9:00AM-11:00AM: Abstract Number: 407

Selective Inhibition of Tfh Cells By a Small Molecule Inhibitor Abrogates Progression of Experimental Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 81

Selective Inhibition of the Immunoproteasome Subunit LMP7 Is Not Sufficient for Blocking Cytokine Production or Attenuating Progression of Experimental Arthritis

9:00AM-11:00AM: Abstract Number: 810

Sensitivity of Temporal Artery Biopsy in Giant Cell Arteritis: Systematic Literature Review and Meta-Analysis of Clinical Data

9:00AM-11:00AM: Abstract Number: 802

Sensorineural Hearing Loss in Takayasu’s Arteritis

9:00AM-11:00AM: Abstract Number: 771

Serological Biomarkers of Collagen Formation Is Increased in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 805

Serological Immune-Inflammatory Markers of the First RCT about Tocilizumab to Treat Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 332

Serum 25-Hydroxyvitamin D, Acute Phase Reactants and Disease Activity in Rheumatologic Diseases

9:00AM-11:00AM: Abstract Number: 286

Serum Amyloid a Aggravates Rheumatoid Arthritis By Activating NFAT5-Mediated Migration of Macrophages

9:00AM-11:00AM: Abstract Number: 691

Serum Anti-NR2 Has a Better Specificity Than Sensitivity in Diagnosing Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)

9:00AM-11:00AM: Abstract Number: 421

Serum Calprotectin Is Not Predictive for Successful Dose Reduction or Discontinuation of TNF Inhibitors in RA Patients with Low Disease Activity

9:00AM-11:00AM: Abstract Number: 782

Serum IL-6, SAA and Calprotectin As Biomarkers in Giant Cell Arteritis and Polymyalgia Rheumatica

9:00AM-11:00AM: Abstract Number: 426

Serum Levels of the Anti-TNF Biologics Correlate with Clinical Efficacy in Patients with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 694

Serum Wisteria Floribunda Agglutinin-Positive Mac-2-Binding Protein Can Reflect Systemic Lupus Erythematosus Activity

9:00AM-11:00AM: Abstract Number: 538

Severe Adverse Drug Reactions Due to Disease Modifying Drugs in Patients with Incident Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 780

Short and Long-Term Follow-up with Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 49 Patients of Clinical Practice

9:00AM-11:00AM: Abstract Number: 635

Short-Term Efficacy and Safety of New Biological Agents Targeting the IL-6, IL-12/23 and IL-17 Pathways for Active Psoriatic Arthritis: A Network Meta-Analysis of Randomised Controlled Trials

9:00AM-11:00AM: Abstract Number: 366

Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom

9:00AM-11:00AM: Abstract Number: 570

Signalling Pathways Identified in Salivary Glands from Primary Sjögren’s Syndrome Patients Reveal Enhanced Adipose Tissue Development, As Demonstrated By Microarray Analysis, Real-Time PCR and Immunohistochemistry

9:00AM-11:00AM: Abstract Number: 26

Single B Cell Analysis Revealed the Relationship Among the Cytokine Profile, Antibody Affinity, and Pathogenic Roles of Autoantigen-Reactive B Cells in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 31

Single Cell Analysis Revealed That the Response to Cyclophosphamide Therapy Is Regulated By B Cells in Systemic Sclerosis-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 467

Smoking and Opioid Use Is Associated with Symptom Severity in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 124

Smoking and Rheumatoid Arthritis Susceptibility; Quantification of the Impact of Cumulative Dose, Frequency and Duration of Smoking, and Smoking Cessation

9:00AM-11:00AM: Abstract Number: 786

Smoking As a Risk Factor for Giant Cell Arteritis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 126

Smoking Is Causally Associated with Disease Activity in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 218

Social Factors and Racial Disparities in Total Hip Arthroplasty Outcomes

9:00AM-11:00AM: Abstract Number: 441

Social Media Based, Direct-to-Patient Study Designed for Development of “from Home” Testing for Rheumatoid Arthritis Patients Is Feasible and Engaged Individuals with Distinct Clinical Characteristics

9:00AM-11:00AM: Abstract Number: 454

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Correlates with Disease Activity in Early Rheumatoid Arthritis and Reflects Joint Damage over Time

9:00AM-11:00AM: Abstract Number: 677

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts the Development of Organ Damage over 5 Years in Systemic Lupus Erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

9:00AM-11:00AM: Abstract Number: 30

Specificity of Salivary Gland-Derived Monoclonal Antibodies from Sjogren’s Syndrome Patients Using Human Proteome Arrays

9:00AM-11:00AM: Abstract Number: 484

Sputum Neutrophils Demonstrate Increased Neutrophil Extracellular Trap Formation in RA-Free Subjects at-Risk of Future RA

9:00AM-11:00AM: Abstract Number: 690

SSA Antibodies Are Associated with Valvular Abnormalities in SLE Patients without Clinical Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 660

Strain-Dependent IL-17A Secretion By CD4-CD8- DN αβ T Cells Correlates with Disease Susceptibility in Murine Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 491

Streptococcus Species Enriched in the Oral Cavity of RA Patients: A Persistent Source of Peptidoglycan-Polysaccharide Polymers Which Drive Disseminated Synovial Inflammation

9:00AM-11:00AM: Abstract Number: 573

Subepithelial Infiltrate of the Vagina in Primary Sjogren’s Syndrome: The Cause of Vaginal Dryness?

9:00AM-11:00AM: Abstract Number: 727

Survival and Clinical-Capillaroscopic Characteristics of French Canadian Systemic Sclerosis Patients: Analysis Based on Systemic Sclerosis Autoantibodies and the Novel Anti-BICD2 Autoantibody

9:00AM-11:00AM: Abstract Number: 728

Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed By the Compass-31 Questionnaire

9:00AM-11:00AM: Abstract Number: 678

Systemic Hypertension Is Associated with Presence of Vascular Injury on Lupus Nephritis Renal Biopsies: A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 68

Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2

9:00AM-11:00AM: Abstract Number: 103

Teaching Musculoskeletal Examination to Internal Medicine Residents in Digital Age

9:00AM-11:00AM: Abstract Number: 797

Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Retrospective Study of 50 Cases

9:00AM-11:00AM: Abstract Number: 580

Tenascin-C, a TLR 4 Endogenous Ligand Levels Are Increased in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 320

Teriparatide Compared with Risedronate and the Risk of Clinical Vertebral Fractures: 2-Year Results of a Randomized, Double-Dummy Clinical Trial

9:00AM-11:00AM: Abstract Number: 730

The Association of Pulmonary Hypertension with Isolated Nucleolar Serum Autoantibodies in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 232

The Charla De Lupus (Lupus Chat)® Program: Assessing the Needs of Teens and Young Adults with Lupus and Their Caregivers to Develop a Family Model Nutrition and Fitness Intervention

9:00AM-11:00AM: Abstract Number: 89

The CLASS-Rheum (Critical Literature Assessment Skills Support – Rheumatology) Question-Based Tool Is Associated with Sustained Improvement in Knowledge of Relevant Epidemiology and Biostatistics in Rheumatology Fellows

9:00AM-11:00AM: Abstract Number: 245

The Clinical Utility of Splenic Fluorodeoxyglucose Uptake for Diagnosis and Prognosis in Patients with Macrophage Activation Syndrome

9:00AM-11:00AM: Abstract Number: 555

The Corrected QT(QTc) Interval Is Associated with Myocardial Fibrosis in Primary Sjögren Syndrome, Assessed By a Cardiac Magnetic Resonance Approach: A Prospective Pilot Study at a Single Center

9:00AM-11:00AM: Abstract Number: 109

The Creation of a Structured Curriculum Outline for the Expansion of a Rheumatology Practice to Include Nurse Practitioners and Physician Assistants

9:00AM-11:00AM: Abstract Number: 71

The Critical Role of Interleukin-33 in Promoting Angiogenesis and Regulates Inflammation through Mast Cells in Takayasu Arteritis

9:00AM-11:00AM: Abstract Number: 272

The Difference in the Clinical Characteristics between Cytomegalovirus Disease and Asymptomatic Cytomegalovirus Reactivation in Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 237

The Discrepancy between the EULAR Response Criteria and Ultrasonography Assessment for Monitoring Therapeutic Response in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 300

The DNA-Binding Protein ARID3a Is Associated with Interferon Alpha Production in Lupus Patient Plasmacytoid Dendritic Cells and Neutrophils

9:00AM-11:00AM: Abstract Number: 64

The Effect of Adenosine A2A Receptor Stimulation on Mitochondrial Metabolism in the Pathogenesis and Treatment of Osteoarthritis

9:00AM-11:00AM: Abstract Number: 637

The Effect of Biologic Therapies on the Gut Microbial Composition in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 69

The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models

9:00AM-11:00AM: Abstract Number: 563

The Effect of Non-Invasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients with Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 313

The Effect of Obesity on Walking; Comparison of the Spatiotemporal, Kinematic and Kinetic Parameters of Young Obese and Non-Obese Healthy Women

9:00AM-11:00AM: Abstract Number: 161

The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences

9:00AM-11:00AM: Abstract Number: 804

The Efficacy and Safety of the Anti-IL-6 Receptor Antibody Tocilizumab for Polymyalgia Rheumatica Patients with Resistance or Intolerance to Glucocorticoids and Methotrexate

9:00AM-11:00AM: Abstract Number: 753

The Histone Demethylase Jumonji Domain-Containing Protein 3 (JMJD3) As Central Mediator of Fibroblast Activation

9:00AM-11:00AM: Abstract Number: 773

The Immunophenotyping of Peripheral Blood Associates with Nailfold Microvascular Changes in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 198

The Impact of Electronic Consults (E-Consults) on Positive ANA Referrals in a Veteran Population

9:00AM-11:00AM: Abstract Number: 230

The Impact of Limited Health Literacy on Patient-Reported Outcomes (PROs) in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 348

The Impact of Rheumatoid Arthritis-Sustained Remission on Patient´s Reported Outcomes Differs Accordingly to Each Particular Outcome

9:00AM-11:00AM: Abstract Number: 416

The Impact of Therapy on Anti-Carbamylated Protein Antibody Isotypes and Serostatus in Patients with Early RA Treated with Abatacept and MTX

9:00AM-11:00AM: Abstract Number: 822

The Incidence Rate of Deep Vein Thrombosis and/or Pulmonary Embolism in Patients with Giant Cell Arteritis – Single Center Observational Study

9:00AM-11:00AM: Abstract Number: 497

The JAK1 Selective Inhibitor Filgotinib Regulates Both Enthesis and Colon Inflammation in a Mouse Model of Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 482

The Link between ACPA and Erosion Development: Is ACPA Sufficient? an Association Study in Clinically Suspect Arthralgia

9:00AM-11:00AM: Abstract Number: 518

The Occurrence of Shingles and the Effect of Zoster Vaccination with the Use of Methotrexate in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 494

The Oral Microbiome Is Altered in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 67

The Oxygen Sensor PHD1 Is an Indispensable Regulator of Arthritis Development

9:00AM-11:00AM: Abstract Number: 345

The Patient Experience of Musculoskeletal Imaging Tests for Investigation of Inflammatory Arthritis: A Mixed Methods Study

9:00AM-11:00AM: Abstract Number: 319

The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab

9:00AM-11:00AM: Abstract Number: 324

The Predictors of the Efficacy of Denosumab, a Monoclonal Antibody to RANK Ligand, on Osteoporosis in Rheumatoid Arthritis Patients from Japanese Multicenter Study

9:00AM-11:00AM: Abstract Number: 683

The Presence of Anti-Ro and Anti-La Antibodies Is Associated with Tubulointerstitial Damage in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 811

The Presence of Giant Cells in the Temporal Artery Biopsy Is Associated with Reduced Risk of Future Large Vessel Involvement in Patients with Biopsy-Proven Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 72

The Presence of IgM Rheumatoid Factor Impede Immunodetection of Tnfa on Circulating Extracellular Vesicles Obtained from Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 288

The Rheumatoid Arthritis Susceptibility Gene C5orf30 Is an Immunomodulator in Macrophages

9:00AM-11:00AM: Abstract Number: 273

The Risk Factors of Developing Adult T Cell Leukemia (ATL) in Human T Cell Leukemia Virus Type 1 (HTLV-1) Positive Patients with Rheumatoid Arthritis in Endemic Area, Japan; A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 393

The Role of Follicular Helper 17 T Cells in Glucose-6-Phosphate Isomerase Induced Arthritis

9:00AM-11:00AM: Abstract Number: 506

The Selective JAK1 Inhibitor Upadacitinib Has No Effect on Pharmacokinetics of the Hormonal Contraceptives Levonorgestrel and Ethinylestradiol

9:00AM-11:00AM: Abstract Number: 453

The Therapy with Tocilizumab Is Not Associated with Periarticular Demineralisation and Finger Joint Space Narrowing in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 19

The Transcription Factor Specificity Protein 1 up-Regulates IL-21 Receptor Expression on B Cells in Rheumatoid Arthritis Leading to Altered Cytokine Production and Maturation

9:00AM-11:00AM: Abstract Number: 271

The Trend of Incidence Rate, Frequency and HLA Phenotype of Reactive Arthritis and Uveitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20-Year, Two-Center Retrospective Study

9:00AM-11:00AM: Abstract Number: 159

The Use of “Fibromyalgia Rapid Screening Tool” for Detection of Fibromyalgia in Patients with Chronic Arthritis Treated with Full and Tapered Biological Disease-Modifying Antirheumatic Drugs

9:00AM-11:00AM: Abstract Number: 257

The Use of Positron Emission Tomography (PET)-Scan for the Quantitative Assessment of Interstitial Lung Disease in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 279

the Usefulness of Cytomegalovirus Infection Strategy in Patients with Connective-Tissue Disease, Based on the Guidelines of the Japan Society for Hematopoietic Cell Transplantation 2011

9:00AM-11:00AM: Abstract Number: 693

The Utility of a Rise in Anti – Double Stranded DNA Antibodies for Predicting Disease Flares in Systemic Lupus Erythematosus. a Meta-Analysis

9:00AM-11:00AM: Abstract Number: 577

The Value of C-Reactive Protein As a Predictor of Radiographic Spinal Progression Is Strongly Dependent on β-Fibrinogen and Factor XIII a-Subunit Genotypes in Patients with Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 282

The Value of Imaging As an Early Noninvasive Test for Prosthetic Joint Septic Arthritis

9:00AM-11:00AM: Abstract Number: 774

The αV Integrin Inhibitor Abituzumab Inhibits Myofibroblast Differentiation

9:00AM-11:00AM: Abstract Number: 399

Therapeutic Effect of Rosiglitazone-Mediated Dendritic Cells in Established Arthritis in Mice

9:00AM-11:00AM: Abstract Number: 17

Thrombotic Events in Pediatric Systemic Lupus Erythematosus: A Preliminary Analysis of a Large, Single-Center Cohort

9:00AM-11:00AM: Abstract Number: 456

Time from First Symptom Onset to First Advanced Therapy Amongst RA Patients in Latin America

9:00AM-11:00AM: Abstract Number: 513

Time to Achieve Moderate/Low Disease Activity and Remission in RA Patients on Baricitinib Compared to Adalimumab, Methotrexate, and Placebo

9:00AM-11:00AM: Abstract Number: 452

Time to First Treatment Is Associated with a Refractory Course of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 675

Tissue-Based Biomarkers in Cutaneous Lupus Erythematosus: Type I IFN Responsive Protein Mxa and a Marker for Lymphocytic Inflammation (CD45) Correlate with CLASI Cross-Sectionally and Longitudinally

9:00AM-11:00AM: Abstract Number: 76

TNF-α Potentiates Uric Acid-Induced Interleukin-1β Secretion in Human Neutrophils

9:00AM-11:00AM: Abstract Number: 447

Tocilizumab Had Acceptable Retention Rate in Both Randomized Controlled Trials and Observational Studies: Systematic Review of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 623

Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 507

Tofacitinib Monotherapy Improves Left Ventricular Mass and Cardiac Output in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 522

Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 9 Years

9:00AM-11:00AM: Abstract Number: 311

Total Ankle Arthroplasty for Rheumatoid Arthritis Cases in This Biologics Era: Mid to Long-Term Follow-up

9:00AM-11:00AM: Abstract Number: 243

Tracer Uptake from High Resolution Bone SPECT/CT Is Linked to Response in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 256

Tracking Digital Ulcers in Systemic Sclerosis: Feasibility Study Assessing Lesion Area from Patient-Recorded Smartphone Photographs

9:00AM-11:00AM: Abstract Number: 24

Trafficking of Innate B Cells to the Lungs As a Novel Mechanism in a Model of Pulmonary Lupus and Vasculitis

9:00AM-11:00AM: Abstract Number: 115

Training the Next Generation of Investigative Rheumatologists: Results of the Usbji’s Young Investigator Initiative for Academic Rheumatologists

9:00AM-11:00AM: Abstract Number: 174

Transcriptional Profiling of Synovial Macrophages from RA Patients to Capture Disease Heterogeneity

9:00AM-11:00AM: Abstract Number: 775

Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes

9:00AM-11:00AM: Abstract Number: 380

Treatment Outcomes of Down Syndrome Arthropathy

9:00AM-11:00AM: Abstract Number: 212

Treatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the US

9:00AM-11:00AM: Abstract Number: 749

Treatment with Cyclophosphamide for Systemic Sclerosis-Interstitial Lung Disease Does Not Lead to a Sustained Improvement in Lung Function in Two Independent Cohorts

9:00AM-11:00AM: Abstract Number: 105

Tweeting the Meeting: Analysis of Twitter Use during the American College of Rheumatology 2016 Annual Meeting

9:00AM-11:00AM: Abstract Number: 305

Ultrasonographic Evaluation of the Femoral Cartilage, Achilles Tendon and Plantar Fascia in Young Women Wearing High-Heeled Shoes

9:00AM-11:00AM: Abstract Number: 239

Ultrasound Abnormalities Predict Arthritis Development in ACPA and/or RF Positive Arthralgia Patients

9:00AM-11:00AM: Abstract Number: 261

Ultrasound CUT-Off in GIANT CELL Arteritis a Solution to Arteriosclerosis Pitfall in the Halo Sign

9:00AM-11:00AM: Abstract Number: 669

Unbiased Screening of Urinary Protein Biomarkers for Glomerular Filtration Rate Normalization

9:00AM-11:00AM: Abstract Number: 341

Understanding Perceptions and Experience of Gout through Linguistic Analysis of Online Search Activities

9:00AM-11:00AM: Abstract Number: 156

Unexpectedly High Prevalence of Immunoglobulin Deficiency in Fibromyalgia – II

9:00AM-11:00AM: Abstract Number: 521

Update on the Clinical Phase 1 and Phase 2 Trials Investigating the Fully Human Immunocytokine Dekavil (F8IL10) in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 667

Urinary Metabolomic Fingerprint As Diagnostic Biomarker for Clinical Significant Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 663

Urinary Tumor-Necrosis Factor-like Weak Inducer of Apoptosis Is an Important Biomarker for Renal Lupus

9:00AM-11:00AM: Abstract Number: 128

Use of Machine Learning and Traditional Statistical Methods to Classify RA-Related Disability Using Administrative Claims Data

9:00AM-11:00AM: Abstract Number: 260

Use of Positron Emission Tomography for the Diagnosis of Aortitis. a Study of 170 Patients from a Single Center

9:00AM-11:00AM: Abstract Number: 460

Usefullness of Serum Angiogenic and Proinflammatory Cytokines to Discriminate between 6 Sets of Remission Criteria and Biomarkers of Radiographic Progression and Clinical Flare in RA in Clinical Remission. Pre-Eliminary Results of a Study of 5 Years of Follow-up

9:00AM-11:00AM: Abstract Number: 304

Usefulness of Consecutive Doppler Ultrasound Examinations for Detecting Deep Venous Thrombosis during the Perioperative Period in Patients with Osteoporotic Fractures of the Proximal Femur

9:00AM-11:00AM: Abstract Number: 117

Using Goutpro to Make Medical Trainees Gout Pros- a Single Blinded Randomized Control Study

9:00AM-11:00AM: Abstract Number: 104

Utility of a Virtual Rheumatology Clinic for Community Based Internal Medicine Residency Program

9:00AM-11:00AM: Abstract Number: 370

Validation of 2016 ACR/EULAR Classification Criteria of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis in Japanese Patients

9:00AM-11:00AM: Abstract Number: 248

Validation of Objective Quantification System for Disease Progression in Patients with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 586

Validation of Online Calibration Modules for the Spondyloarthritis Research Consortium of Canada MRI Scores Based on Real-Time Experiential Learning

9:00AM-11:00AM: Abstract Number: 94

Validity Evidence for an Objective Structured Clinical Examination Station to Assess Knee Arthrocentesis Skill

9:00AM-11:00AM: Abstract Number: 464

Value of Matrix Metalloproteinase-3 Regarding Prediction for Joint Destruction at 1 Year Is Different between Sexes in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 701

Variability in ICAP (International Consensus on ANA Patterns) Pattern Reporting in Testing for Antinuclear Antibodies (ANA) By Indirect Immunofluorescence Assay (IFA)

9:00AM-11:00AM: Abstract Number: 700

Variability in Method of Testing for Antinuclear Antibodies (ANA): A Survey of Participants in the College of American Pathologist’s (CAP) Proficiency Testing Program

9:00AM-11:00AM: Abstract Number: 472

Viral Hepatitis Influences Patient Reported Outcomes Measures in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 666

Vitamin D Deficiency Is Associated with Increased Serum Cholesterol Among Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 346

What Are We Measuring? Influence of Contextual Factors on RAPID3 Scores in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 131

What Does It Mean to Have Rheumatoid Arthritis Now? a Current Burden of Disease Assessment in the United States

9:00AM-11:00AM: Abstract Number: 343

What Is the Impact of Functional Medicine on Patient Reported Outcomes in Inflammatory Arthritis?

9:00AM-11:00AM: Abstract Number: 205

What Is the Value of the Prior Authorization Process in Specialty Drug Therapy?

9:00AM-11:00AM: Abstract Number: 249

Where to Look for Uric Acid Crystals? Results from a Norwegian Ultrasound Study

9:00AM-11:00AM: Abstract Number: 592

Which Imaging Outcomes for AxSpA Are Most Sensitive to Change? a 5-Year Analysis of the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 83

Whole Blood Stimulations Identify Elevated T Cell Cytokines and Altered Granulocyte/Dendritic Cell Signaling in SLE Patients with Variable Disease Activity

9:00AM-11:00AM: Abstract Number: 363

Work Productivity Benefit in Patients with Rheumatoid Arthritis Initiating Etanercept in the United States

9:00AM-11:00AM: Abstract Number: 590

X-Ray Spine Lesions Are Rare and Not Discriminant for Axial Spondyloarthritis Recognition in Patients with Recent Onset Chronic Back Pain

9:00AM-11:00AM: Abstract Number: 155

Xerostomia in Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 325

Zoledronic Acid Did Not Impaired Renal Function in Patients with Osteoporosis

9:00AM-11:00AM: Abstract Number: 37

β2-Glycoprotein I Binds to Necroptotic Cells and Serves As a Target for SLE Autoantibodies

11:00AM-12:30PM: Abstract Number: 830

Performance on Quality Measures in the RISE Registry and the Merit-Based Incentive Payment System (MIPS)

11:00AM-12:30PM: Abstract Number: 827

Temporary Methotrexate Discontinuation for 2 Weeks Improves Immunogenicity of Seasonal Influenza Vaccination in Patients with Rheumatoid Arthritis: A Randomized Clinical Trial

11:00AM-12:30PM: Abstract Number: 826

TGF-β-Induced Epigenetic Silencing of SOCS3 Facilitates STAT3 Signaling to Promote Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis

11:00AM-12:30PM: Abstract Number: 828

The Impact of the Duration of Bisphosphonate Drug Holidays on Hip Fracture Rates

11:00AM-12:30PM: Abstract Number: 829

Unraveling Race and Social Context in Understanding Disparities in Lupus Mortality in the United States

2:30PM-4:00PM: Abstract Number: 848

“Suddenly You Are a Person at Risk of Developing Rheumatoid Arthritis!” Different Perspectives of Individuals on Predictive Testing – Results of an International Qualitative Interview Study

2:30PM-4:00PM: Abstract Number: 885

48-Week Complete Remission By Ethnic, Sex and Age Subgroups in Patients with Active Lupus Nephritis Treated with Voclosporin

2:30PM-4:00PM: Abstract Number: 882

A New Model of Care for Improving Early Rheumatology Access of Psoriatic Arthritis Patients

2:30PM-4:00PM: Abstract Number: 887

A Randomized, Placebo-Controlled, Double-Blind, Ascending-Dose, Safety, and Pharmacokinetics Study of CC-220 in Subjects with Systemic LUPUS Erythematosus

2:30PM-4:00PM: Abstract Number: 894

All Oral Interferon-Free Antivirals for Hepatitis C Virus Cryoglobulinemia Vasculitis: A Long Term Follow up Multicenter International Study

2:30PM-4:00PM: Abstract Number: 853

Anti-TIF-1 Antibody Positivity Is Associated with a Five-Fold Increase in Cancer Risk in the Idiopathic Inflammatory Myopathies

2:30PM-4:00PM: Abstract Number: 879

Association of Venous Thromboembolism with Spondyloarthopathies Among Hospitalized Patients – Data from National Inpatient Sample

2:30PM-4:00PM: Abstract Number: 889

Attainment of Low Disease Activity By Patients with Systemic Lupus Erythematosus Starting with High Disease Activity in a 24-Week, Randomized, Placebo-Controlled, Phase IIb Study of Atacicept (ADDRESS II)

2:30PM-4:00PM: Abstract Number: 851

Autoantibodies Predict Long Term Survival in Myositis Associated Interstitial Lung Disease

2:30PM-4:00PM: Abstract Number: 836

B Cell Receptor Sequencing of Anti-Citrullinated Protein Antibody Expressing B Cells Indicates a Selective Advantage for the Introduction of N-Glycosylation Sites during Somatic Hypermutation

2:30PM-4:00PM: Abstract Number: 868

Baseline Troponin Levels Are Associated with Mortality in a Cohort of Patients with Inflammatory Polyarthritis: Results from the Norfolk Arthritis Register

2:30PM-4:00PM: Abstract Number: 886

CC-220 Decreases B-Cell Subsets and Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus (SLE) Patients and Is Associated with Skin Improvement: Pharmacodynamic Results from a Phase IIa Proof of Concept Study

2:30PM-4:00PM: Abstract Number: 861

CD11b+Gr1dim tolerogenic Dendritic Cell-like Cells Suppress the Progression of Interstitial Lung Disease in SKG Mice

2:30PM-4:00PM: Abstract Number: 884

Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients with Psoriatic Arthritis: An Integrated Analysis across Phase 3 and Long-Term Extension Studies

2:30PM-4:00PM: Abstract Number: 833

Chronic Cutaneous Lupus Erythematosus Patients Have a Breakdown in Autoreactive VH4.34 Antibody Tolerance While Maintaining Tolerance to dsDNA and Chromatin

2:30PM-4:00PM: Abstract Number: 834

Citrulline-Polyspecific B Cell Antigen Receptors Arising from Somatic Hypermutation within Clades Demonstrate Pathogenicity in Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 871

Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus in Patients without Obstructive Coronary Artery Disease

2:30PM-4:00PM: Abstract Number: 870

Detection of Left Ventricular Regional Function in Rheumatoid Arthritis Patients without Cardiac Symptons, As Assessed By Feature Tracking Cardiac Magnetic Resonance Imaging

2:30PM-4:00PM: Abstract Number: 878

Diagnosis of Salivary Gland Lymphoma in Sjogren’s Syndrome Utilizing Ultrasound-Guided Core Needle Biopsies

2:30PM-4:00PM: Abstract Number: 874

Effect of Rituximab on a Salivary Gland Ultrasound Score in Primary Sjögren’s Syndrome: Results of Multicentre Double-Blind Randomised Controlled Trial Sub-Study

2:30PM-4:00PM: Abstract Number: 860

Effective Treatment of Persistent Arthritis Pain Requires Co-Modulation of TNF and Type I Interferon

2:30PM-4:00PM: Abstract Number: 845

Effectiveness of Brief Group Psychoanalytic Psychotherapy in Patients with Systemic Lupus Erythematosus and Follow-up

2:30PM-4:00PM: Abstract Number: 893

Efficacy and Safety of Belimumab in Combination with Azathioprine for Remission Maintenance in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: A Multicenter Randomized, Placebo-Controlled Study

2:30PM-4:00PM: Abstract Number: 876

Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjögren Syndrome: Analysis of 9302 Patients from the Big Data International Sjögren Cohort

2:30PM-4:00PM: Abstract Number: 863

Functionally Distinct Pathogenic Subsets of Fibroblasts Exist within the Inflamed Synovial Membrane and Mediate Specific Aspects of Inflammatory Disease Pathology

2:30PM-4:00PM: Abstract Number: 835

Generation of an Efficient CRISPR-Cas9 Editing Technique in Human Primary B Cells for the Targeted Study of Autoimmune Susceptibility Genes

2:30PM-4:00PM: Abstract Number: 892

Health-Related Quality of Life in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Randomized Controlled Phase 3 Trial

2:30PM-4:00PM: Abstract Number: 867

Highly Sensitive Cardiac Troponin-I in Peripheral Blood Predicts Cardiovascular Events in Patients with Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 858

Identification of Clinically Relevant Pain Profiles in Individuals with Active RA

2:30PM-4:00PM: Abstract Number: 859

Identifying Pain Susceptibility Phenotypes in Those Free of Knee Pain with or at Risk for Knee Osteoarthritis and Their Relation to Developing Knee Pain

2:30PM-4:00PM: Abstract Number: 864

IL-9-Producing Innate Lymphoid Cells – Keyplayers That Orchestrate Resolution of Chronic Inflammation in Arthritis

2:30PM-4:00PM: Abstract Number: 850

Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System

2:30PM-4:00PM: Abstract Number: 862

iNKT Mediated Immunoregulatory Feedback Control Development of Autoimmune Arthritis in Mice

2:30PM-4:00PM: Abstract Number: 831

Interferon-Alpha Disrupts Tolerance in a Mouse Model of B Cell Anergy

2:30PM-4:00PM: Abstract Number: 866

Interferon-Alpha Overexpression Triggers an Expansion of Highly Suppressive Regulatory T Lymphocytes Protecting Against Experimental Arthritis

2:30PM-4:00PM: Abstract Number: 865

Lasp-1 Regulates Cell-Matrix and Cell-Cell Contacts in Arthritic Mouse Models

2:30PM-4:00PM: Abstract Number: 891

Long-Term Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis Treated Continuously over 52 Weeks: Results from Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial and Open-Label Extension in Japan

2:30PM-4:00PM: Abstract Number: 877

Modification of the Classification Criteria for Primary Sjögren Syndrome: An International Vignette Survey

2:30PM-4:00PM: Abstract Number: 840

Mortality Post Hip Fracture in Rheumatoid Arthritis Compared to General Population Controls, a Population-Based Study

2:30PM-4:00PM: Abstract Number: 872

Myocardial Abnormalities Improve in RA Patients Treated Actively – a Cardiac MRI Follow-up Study

2:30PM-4:00PM: Abstract Number: 841

Optimal Regimens of Sulfamethoxazole-Trimethoprim for Chemoprophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Diseases: 52-Week Follow-up of a Non-Blinded, Randomized Controlled Trial

2:30PM-4:00PM: Abstract Number: 888

Phase 3 Trial Results with Blisibimod, a Selective Inhibitor of B-Cell Activating Factor, in Subjects with Moderate-to-Severe Systemic Lupus Erythematosus

2:30PM-4:00PM: Abstract Number: 854

Predictive Modeling of Mortality in Polymyositis/Dermatomyositis Patients with Interstitial Lung Disease Based on Combination of Serum Myositis-Specific Autoantibodies and Conventional Biomarkers

2:30PM-4:00PM: Abstract Number: 855

Rapid and Sustained Pain Improvement in Rheumatoid Arthritis Patients Treated with Baricitinib Compared to Adalimumab or Placebo

2:30PM-4:00PM: Abstract Number: 838

Rates of New-Onset Pulmonary Disease Among Patients with Systemic Lupus Erythematosus in Sweden

2:30PM-4:00PM: Abstract Number: 857

Relation of Pain Sensitization to Low Physical Function: The Multicenter Osteoarthritis Study

2:30PM-4:00PM: Abstract Number: 837

Rheumatoid Arthritis and Risk for Chronic Obstructive Pulmonary Disease or Asthma Among Women during 38 Years of Prospective Follow-up

2:30PM-4:00PM: Abstract Number: 842

Risk of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologic Vs. Non-Biologic Dmards

2:30PM-4:00PM: Abstract Number: 852

RNAseq Detection of Gene Dysregulation in PBMCs from Juvenile Dermatomyositis, Positive for p155/140 Myositis Specific Antibody

2:30PM-4:00PM: Abstract Number: 875

Serum Autoantibody Profiling of Primary Sjoegren’s Syndrome Patients Reveals Novel Biomarkers Associated with the Disease, Disease Activity, and Clinical Response to VAY736

2:30PM-4:00PM: Abstract Number: 832

Single Cell Analysis Reveals Heterogeneity of Type I IFN Gene Expression in Developing Autoreactive B Cells

2:30PM-4:00PM: Abstract Number: 846

Social Support in Couples-Focused Physical Activity Interventions for People with Hip or Knee Osteoarthritis: What Kinds of Partner Support Are Associated with Increases in Physical Activity and Reductions in Sedentary Behavior?

2:30PM-4:00PM: Abstract Number: 844

Social Support, Stress and Health Outcomes in Systemic Lupus Erythematosus: Georgians Organized Against Lupus (GOAL) Cohort

2:30PM-4:00PM: Abstract Number: 890

Synergetic B-Cell Immunomodulation with Rituximab and Belimumab Combination Treatment in Severe, Refractory SLE

2:30PM-4:00PM: Abstract Number: 895

Temporal Trends in Incidence and Outcomes of End-Stage Renal Disease Due to Granulomatosis with Polyangiitis in the US from 1995-2014

2:30PM-4:00PM: Abstract Number: 847

The Mediational Role of Helplessness in Psychological Outcomes in Systemic Lupus Erythematosus

2:30PM-4:00PM: Abstract Number: 883

The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Ankylosing Spondylitis: A General Population-Based Study

2:30PM-4:00PM: Abstract Number: 843

The Role of Personality in Patients with Fibromyalgia

2:30PM-4:00PM: Abstract Number: 896

The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: A Systematic Review and Meta-Analysis

2:30PM-4:00PM: Abstract Number: 880

Tofacitinib Treatment in Patients with Psoriatic Arthritis and Rates of Radiologic Progression According to Baseline CRP Levels: Results from a Phase 3 Clinical Study

2:30PM-4:00PM: Abstract Number: 856

Trends and Predictors of Chronic Opioid Use in Individuals with RA

2:30PM-4:00PM: Abstract Number: 849

Tumor TIF1 Mutations and Loss of Heterozygosity Related to Cancer Associated Myositis

2:30PM-4:00PM: Abstract Number: 873

Type I High-IFN Gene Signature in Associated with Higher Essdai at Enrollmment and Follow-up in the Prospective Multicenter Assess Cohort of 395 Patients

2:30PM-4:00PM: Abstract Number: 839

Use of Bisphosphonate and Risk of Incident Atrial Fibrillation in a Population-Based Study

2:30PM-4:00PM: Abstract Number: 881

Ustekinumab Is Superior to TNF Inhibitor Treatment in Resolving Enthesitis in Psa Patients with Active Enthesitis- Results from the Enthesial Clearance in Psoriatic Arthritis Study

2:30PM-4:00PM: Abstract Number: 869

Utility of Carotid Ultrasound Compared to Framingham Risk Score in Predicting Cardiovascular Mortality in Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 938

A Germline Macrophage Activation Syndrome-Associated Nlrc4 Mutation Causes Chronic, Systemic, Non-Hematopoietic IL-18 Elevation and Intestinal MHC-II Upregulation

4:30PM-6:00PM: Abstract Number: 906

Anp32a Is a Critical Regulator of Oxidative Stress in Cartilage and Protects Against Osteoarthritis

4:30PM-6:00PM: Abstract Number: 948

Application of a Diagnostic Algorithm to Identify Inflammatory Myopathy in Systemic Sclerosis

4:30PM-6:00PM: Abstract Number: 920

Area-Level Predictors of Medication Nonadherence Among U.S. Medicaid Beneficiaries with Lupus: A Multilevel Study

4:30PM-6:00PM: Abstract Number: 932

Association of Varus Knee Thrust during Walking to Worsening Knee Pain over Two Years

4:30PM-6:00PM: Abstract Number: 945

Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival

4:30PM-6:00PM: Abstract Number: 898

B Cell Specific TLR9 Suppresses Disease in Murine Lupus

4:30PM-6:00PM: Abstract Number: 922

Biologic DMARD Prescribing Patterns in Elderly Patients with Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 923

Can Education Mitigate the Effect of Poverty on Total Knee Replacement (TKR) Outcomes?

4:30PM-6:00PM: Abstract Number: 900

Choroid Plexus Tertiary Lymphoid Structures in Lupus: A Novel Neuro-Immune Interface

4:30PM-6:00PM: Abstract Number: 946

Clinical and Serological Features of Systemic Sclerosis in a Multicenter African American Cohort: Analysis of the Genome Research in African American Scleroderma Patients Clinical Database

4:30PM-6:00PM: Abstract Number: 951

Cross Sectional Analysis of Citrullinated-Synovial Antigen-Specific CD4+ T Cells in an RA Cohort Demonstrates Antigen Based Differences in T Cell Frequency, Phenotype and the Influence of Immunotherapy

4:30PM-6:00PM: Abstract Number: 897

Cutaneous Lupus Is Driven By an Exaggerated Interferon Kappa Loop Which Primes for Interferon Alpha Responses

4:30PM-6:00PM: Abstract Number: 904

Deficient Autophagy Induces Lamin a/C Accumulation in Aging and Osteoarthritis

4:30PM-6:00PM: Abstract Number: 918

Development and Validation of a Clinical Rule to Facilitate Recognition of Clinical Arthritis By General Practitioners

4:30PM-6:00PM: Abstract Number: 921

Discordant Patient-Physician Assessments of Disease Activity and Its Persistence Adversely Impact Quality of Life and Work Productivity in United States Hispanics with Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 927

Do Familiarity with Centers for Disease Control Guidelines, Continuing Education, and Provider Characteristics Influence Adherence to Chronic Pain Management Practices and Opioid Prescribing?

4:30PM-6:00PM: Abstract Number: 931

Dose-Response Effects of Tai Chi and Physical Therapy Exercise Interventions in Symptomatic Knee Osteoarthritis

4:30PM-6:00PM: Abstract Number: 934

Effectiveness of FX006 Intra-Articular Injection in Patients with Knee Osteoarthritis Who Present with and without Clinical Inflammation at Baseline: A Pooled Analysis of Data from 3 Double-Blind, Randomized, Parallel-Group Clinical Trials

4:30PM-6:00PM: Abstract Number: 930

Efficacy and Safety of Modified-Release Prednisone in Managing Moderate Activity SLE during Pregnancy: An Implemented Case-Control Study

4:30PM-6:00PM: Abstract Number: 902

Evidence for Inhibition of Osteoclastogenesis By Cytomegalovirus Infection: Implication in RA Bone Erosion and Identification of a Cellular Protein As a Therapeutic Target

4:30PM-6:00PM: Abstract Number: 907

Five-Year Evolution of the Center of Excellence in Musculoskeletal Care and Education: A National Resource for the Continuum of Health Professions Education and Scholarship

4:30PM-6:00PM: Abstract Number: 912

Has the Attractiveness of a Career in Rheumatology Changed for the Better? Comparison of Trends in the Rheumatology Fellowship Match from 2014 to 2017 with 2008 to 2013

4:30PM-6:00PM: Abstract Number: 913

High Erythrocyte Levels of the n-6 Polyunsaturated Fatty Acid Linoleic Acid Are Associated with Lower Risk of Subsequent Rheumatoid Arthritis in a Southern European Nested Case-Control Study

4:30PM-6:00PM: Abstract Number: 919

HLA Type Imputation in the Genome Research in African American Scleroderma Patients (GRASP) Cohort Reveals Strong Associations of African Ancestry MHC Class II Types with Scleroderma and Lack of Class I HLA Type Associations

4:30PM-6:00PM: Abstract Number: 911

How Well Do Rheumatology Fellows Manage Acute Infusion Reactions? a Pilot Curricular Intervention

4:30PM-6:00PM: Abstract Number: 950

Identification of Naturally Processed Immunodominant Topoisomerase I Epitopes in Patients with Systemic Sclerosis

4:30PM-6:00PM: Abstract Number: 940

IL1RN Variation Is Associated with Systemic Juvenile Idiopathic Arthritis and Predicts Non-Response to Anakinra Treatment

4:30PM-6:00PM: Abstract Number: 908

Impact of a National Training Program on Primary Care Providers Utilization of Knee MRI

4:30PM-6:00PM: Abstract Number: 903

Increased Expression of CCN4/WISP1 in Osteoarthritic Articular Cartilage Is Epigenetically Regulated and Disrupts Cartilage Homeostasis

4:30PM-6:00PM: Abstract Number: 936

Knee Confidence Trajectories over 8 Years and Factors Associated with Poor Trajectories: Data from the Osteoarthritis Initiative

4:30PM-6:00PM: Abstract Number: 916

Long Term Effects of Early Childhood Thymectomy: A Population-Based Cohort Study of Association with Autoimmune Disease, Cancer, Infectious and Atopic Diseases

4:30PM-6:00PM: Abstract Number: 944

Long-Term Survival and Follow-up of Anti-Th/to Antibody Positive Systemic Sclerosis Patients

4:30PM-6:00PM: Abstract Number: 933

Longitudinal Association between Sleep Quality and Knee Pain in the Multicenter Osteoarthritis Study

4:30PM-6:00PM: Abstract Number: 954

Microrna-21 Is a Critical Regulator of Autoimmunity through Promoting Effector and Metabolic Function of Pathogenic TH17 Cells

4:30PM-6:00PM: Abstract Number: 899

Neutrophil Gene Signature and Low Density Granulocyte Subsets Associate with Coronary Plaque Burden and Vascular Inflammation in Systemic Lupus Erythematosus

4:30PM-6:00PM: Abstract Number: 947

Norway As a National Reference Population for Systemic Sclerosis; Preliminary Results from a Complete, Nationwide Cohort

4:30PM-6:00PM: Abstract Number: 914

Occupational Exposure to Combustion Products and Risk of Developing Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 928

Online Consultation for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tool: A Study of Medical Economics

4:30PM-6:00PM: Abstract Number: 925

Open-Source Conensus-Based Models to Improve the Cost-Effectiveness of Rheumatology Care

4:30PM-6:00PM: Abstract Number: 953

Persistence of Pathogenic CD4 Memory T Cells Revealed through Cytometry Time of Flight in Juvenile Idiopathic Arthritic Patients with Disease Resurgence upon Withdrawal of Anti-TNFA Biologics

4:30PM-6:00PM: Abstract Number: 915

Pesticide Exposure and Risk of Systemic Lupus Erythematosus in an Urban Population of Predominantly African-American Women

4:30PM-6:00PM: Abstract Number: 924

Prevalence of Juvenile Idiopathic Arthritis in the Alaska Native Population

4:30PM-6:00PM: Abstract Number: 917

Prospective Association of Metabolic Syndrome with Incident Symptomatic Interphalangeal Osteoarthritis but Not Thumb Based or Erosive Hand Osteoarthritis

4:30PM-6:00PM: Abstract Number: 905

Regenerating Cartilage and Reversing Osteoarthritis (OA) Stimulation of Adenosine A2A Receptors (A2AR) Increases Cartilage Volume and Matrix in Vitro and In Vivo

4:30PM-6:00PM: Abstract Number: 926

Relationship of Traumatic Knee Injuries to Early-Onset Knee Osteoarthritis in Young Military Officers

4:30PM-6:00PM: Abstract Number: 935

Results from a 52 Week Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for the Treatment of Knee Osteoarthritis

4:30PM-6:00PM: Abstract Number: 941

Ro/SSA Autoantibody Exposed Neonates Have an Expansion of NK Cells and a Discernible Type II IFN Signature with High IFNγ in Peripheral Blood

4:30PM-6:00PM: Abstract Number: 901

Role of Epstein Barr Virus Serologic Reactivation in Transitioning to Systemic Lupus Erythematosus in at Risk Individuals

4:30PM-6:00PM: Abstract Number: 942

Role of the Pyrin Inflammasome in Resistance to Yersinia Pestis: A Possible Selective Advantage for Carriers of MEFV Mutations

4:30PM-6:00PM: Abstract Number: 949

Sequence Homology and Immune Reactivity between T Cell Epitopes of Related Gut Microbes and Two Novel Autoantigens Provide a Link between Microbial and Host Immunity in Patients with Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 952

Serine Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Regulator of T Lymphocyte Homeostasis In Vivo and Its Deficiency Associates with Lymphopenia in SLE Patients

4:30PM-6:00PM: Abstract Number: 939

Stimulator of Interferon Genes (STING)-Induced Endothelial-Mesenchymal Transition (EndMT) Contributes to Interstitial Lung Disease in Sting-Associated Vasculopathy with Onset in Infancy (SAVI) Patients

4:30PM-6:00PM: Abstract Number: 943

The Course of the Forced Vital Capacity during Treatment for Systemic Sclerosis-Related Interstitial Lung Disease Predicts Long-Term Survival in 2 Independent Cohorts

4:30PM-6:00PM: Abstract Number: 910

Training Adult Rheumatology Fellows in Young Adult Transition and Transfer Skills

4:30PM-6:00PM: Abstract Number: 937

Treatment Response in Polyarticular JIA Is Associated with Transcriptional Changes and Chromatin Reorganization in CD4+ T Cells

4:30PM-6:00PM: Abstract Number: 909

Two-Year Impact of a Continuing Professional Education Program to Train Primary Care Providers to Perform Arthrocentesis

4:30PM-6:00PM: Abstract Number: 929

Variation in SLE-Related Pain – a Seven Year Follow-up Study

9:00AM-11:00AM: Abstract Number: 1588

“Neoplasia in Patients with Systemic LUPUS Erythematosus in Spain: Relesser Registry DATA”

9:00AM-11:00AM: Abstract Number: 1614

“Do You Know What I Mean?” a Tool to Understand What Lupus Patients Comprehend

9:00AM-11:00AM: Abstract Number: 1753

“Recurrent Venous Thromboembolic Events in Granulomatosis with Polyangiitis Patients”

9:00AM-11:00AM: Abstract Number: 1275

101 Juvenile Myositis Patients Characterized By Myositis Specific Antibodies: Disease Activity and Damage over 60 Months

9:00AM-11:00AM: Abstract Number: 1355

14-3-3η: Useful for More Than the Diagnosis of Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 1643

15 Year Comparative Analysis of Cardiovascular Events in Female Subjects with Lupus Versus Controls

9:00AM-11:00AM: Abstract Number: 1699

A 10-Year National Trend in Acute Coronary Syndrome Among Hospitalized Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1142

A Case Control Study of Anakinra Use for Acute Gout in a VA Patient Cohort Reveals Association with East Asian Descent, High Urate Burden, and Increased Co-Morbidities and All-Cause Mortality

9:00AM-11:00AM: Abstract Number: 1134

A Case Series of Gout and Downs Syndrome – a New Paradigm for Detecting Disease Associations Using Big Data

9:00AM-11:00AM: Abstract Number: 1055

A Combination of Self-Reported Symptoms and ACPA Testing Can Identify Individuals with Previously Undiagnosed Inflammatory Arthritis in a Health-Fair Setting

9:00AM-11:00AM: Abstract Number: 959

A Disintegrin and Metalloprotease -17 Is Overexpressed on Rheumatoid Arthritis Osteoblasts and Is Regulated with TNF-α Stimulation

9:00AM-11:00AM: Abstract Number: 957

A Disintegrin and Metalloprotease 15 Is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and Mediates Angiogenesis

9:00AM-11:00AM: Abstract Number: 1703

A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation, Multi-Center Study of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells in Patients with Rheumatoid Arthritis and Incomplete Response to at Least One Tnfα Inhibitor

9:00AM-11:00AM: Abstract Number: 1328

A Dual ICOS/CD28 Antagonist ICOSL Variant Ig Domain (vIgDTM) Potently Suppresses Mouse Collagen-Induced Arthritis and Human Xenograft Graft Vs. Host Disease (GvHD)

9:00AM-11:00AM: Abstract Number: 1163

A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

9:00AM-11:00AM: Abstract Number: 1104

A Genome-Wide Association Study of Gout in People of European Ancestry

9:00AM-11:00AM: Abstract Number: 1474

A Higher DAS28P, the Subjective Proportion of the DAS28, Predicts a Favorable Response to Abatacept in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1647

A Lupus Low Disease Activity State Is Associated with Reduced Flare, Lower Organ Damage Accrual, and Better Quality of Life in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1567

A Mitogen-Associated Protein Kinase (MAPK) Associated Kinase 2 Inhibitor Decreases in Vitro Th17 and Monocyte Inflammatory Responses in Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1094

A Model for Improved Management of Fragility Fractures: Navigating the Fracture Liaison Service

9:00AM-11:00AM: Abstract Number: 1179

A Multi-Organ Inflammatory Condition with Features of Idiopathic Multicentric Castleman’s Disease and IgG4-Related Disease: An Unrecognized Mimicker of IgG4-RD

9:00AM-11:00AM: Abstract Number: 1589

A Multicriteria Decision Analysis for the Development of New Systemic Lupus Erythematosus Classification Criteria

9:00AM-11:00AM: Abstract Number: 1090

A Multidisciplinary Performance Improvement Approach to Achieving Goal Serum Uric Acid Levels in Patients with Gout

9:00AM-11:00AM: Abstract Number: 1549

A Non-Medical Switch from Originator Infliximab to Biosimilar CT-P13 in 36 Patients with Ankylosing Spondylitis: 6 – Months Clinical Outcomes from the Czech Biologic Registry Attra

9:00AM-11:00AM: Abstract Number: 1331

A Pathogenic Role of Porphyomonas Gingivalis Fimbriae (FimA) in Periodontitis-Associated Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1022

A Personalized Medicine Approach to Improve the Prediction of Azathioprine-Induced Pancreatic Injury: Preliminary Results

9:00AM-11:00AM: Abstract Number: 1202

A Phase 2A, Placebo-Controlled, Randomized Study of ABT-981, an Anti-Interleukin-1Alpha and -1Beta Dual Variable Domain Immunoglobulin, to Treat Erosive Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1329

A Quantitative Framework for Evaluating Drug Combination Treatment in Rat Collagen-Induced-Arthritis Model

9:00AM-11:00AM: Abstract Number: 1176

A Randomized, Open-Label, Dose-Ranging Study of Oral Delayed Release Prednisone in Patients with Untreated Polymyalgia Rheumatica

9:00AM-11:00AM: Abstract Number: 1193

A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical Trial of the First-in-Class Imidazoline-2 Receptor Ligand CR4056 in Pain from Knee Osteoarthritis and Disease Phenotypes

9:00AM-11:00AM: Abstract Number: 1257

A Scoping Review of Contextual Factors of Patient Decision Aids in Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1186

A Simple, Self-Assembled Hydrogel Depot for Localized Treatment of Post-Traumatic Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1372

A Single Immunosignature Test Accurately Discriminates RA from Related Autoimmune and Inflammatory Disorders

9:00AM-11:00AM: Abstract Number: 1468

Abatacept Retention Rates, Overall and By Participating Country, and Prognostic Factors of Retention in Patients with RA: 2-Year Results from a Real-World Observational Study

9:00AM-11:00AM: Abstract Number: 1073

Aberrant Cell Signaling in Peripheral Blood Mononuclear Cells upon Interferon Alpha Stimulation in Patients with Primary Sjögren’s Syndrome Associates with Type I Interferon Signature

9:00AM-11:00AM: Abstract Number: 1318

Abnormal Cerviovaginal Cytology in Adolescents with Systemic Lupus Erythematosus: A Retrospective Case Series

9:00AM-11:00AM: Abstract Number: 1731

Abnormal Responses of γδ T Cell Subsets to Stimulation with Cardiolipin and Zoledronate in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1719

Accelerated Wound Healing in Megakaryocyte/Platelet-Specific Fli1 Knockout Mice Due to the up-Regulated Expression of Interferon-γ

9:00AM-11:00AM: Abstract Number: 996

Accuracy of Canadian Administrative Health Data in Identifying Patients with Psoriasis and Psoriatic Arthritis Using Primary Care Medical Records As the Reference Standard

9:00AM-11:00AM: Abstract Number: 1630

Achievement of Lupus Low Disease Activity State (LLDAS) in the Early Phase of Systemic Lupus Erythematosus Prevent Damage Accrual

9:00AM-11:00AM: Abstract Number: 970

ACPA Activate Challenged Synovial Fibroblasts through a PAD Dependent Mechanism: A Potential Explanation of the “Second Hit Model” in RA

9:00AM-11:00AM: Abstract Number: 1063

Activation of Toll-like Receptor 2 in Human Synovium Explants Increase Tissue Turnover and Secretion of Interleukin-6

9:00AM-11:00AM: Abstract Number: 1240

Active Disease Is Associated with Dependency in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1185

Acupotomy Therapy for Joint Pain Relief of Knee Osteoarthritis-Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 961

Adalimumab Reduces CXCR4 Expression during Inflammatory Arthritis and in Fibroblast-like Synoviocytes and Osteoclasts Under Chronic TNF Exposure

9:00AM-11:00AM: Abstract Number: 960

ADAM-17 Is Expressed on Rheumatoid Arthritis Synovial Fibroblasts and Mediates Monocyte Migration and Adhesion

9:00AM-11:00AM: Abstract Number: 1443

Adverse Drug Reactions Due to Disease Modifying Drugs in a Cohort of Patients with Incident Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1776

Adverse Events for Discontinuation of Immunosuppressants and Outcome of Their Re-Administration in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Study in Japan

9:00AM-11:00AM: Abstract Number: 1390

Agreement between the DAS28-ESR and the DAS28-CRP and Factors Related to the Discrepancies between Disease Activity Levels According to These 2 Scores in Patients with Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1177

Airway Findings in Patients with Relapsing Polychondritis

9:00AM-11:00AM: Abstract Number: 1105

Allopurinol Dose Escalation to Achieve Serum Urate below 6mg/Dl: An Open Label Extension Study

9:00AM-11:00AM: Abstract Number: 1121

Allopurinol Treatment for Gout: How Long to Reach Serum Urate Goal?

9:00AM-11:00AM: Abstract Number: 1326

Alpha-Glucosidase Inhibitors Alter Gut Microbiota and Ameliorate Collagen-Induced Arthritis

9:00AM-11:00AM: Abstract Number: 1397

American College of Rheumatology Response Rates Determined Using 28 Versus 68/66 Joint Count in Patients with Rheumatoid Arthritis Receiving Tofacitinib in Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 1737

An Abundance of Butyrate-Producing Bacterium in the Intestine and Increased Foxp3 Gene Expression of T Cells in Patients with Relapsing Polychondritis

9:00AM-11:00AM: Abstract Number: 1681

An Evaluation of Two Novel Techniques Utilising a Smartphone Digital Camera in the Assessment of Nailfold Capillaries in Suspected Scleroderma-Spectrum Disorders: A Single-Center Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 1107

An Illness By Any Other Name: The Effect of Changing the Disease Label of Gout on the Perceptions of the Illness and Its Management

9:00AM-11:00AM: Abstract Number: 1012

Analysis of microRNAs in Familial Mediterranean Fever

9:00AM-11:00AM: Abstract Number: 1770

ANCA-Associated Vasculitis (AAV) in Younger Vs Older Patients: Comparison of Clinical, Serologic and Outcome Differences and Their Implications for Management

9:00AM-11:00AM: Abstract Number: 1324

Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction of hTNF-Transgenic Arthritis Mice

9:00AM-11:00AM: Abstract Number: 1308

Answering Reproductive Health Questions That Your Patients Want to Know: Impediments to Family Building and Risks of Contraception

9:00AM-11:00AM: Abstract Number: 1357

Anti-Cyclic Citrullinated Peptide Antibody Positive Rheumatoid Arthritis Patients with Comorbid Post-Traumatic Stress Disorder Have Higher Serum Cytokine Expression

9:00AM-11:00AM: Abstract Number: 1274

Anti-MDA5 Autoantibodies Associated with Juvenile Dermatomyositis Constitute a Distinct Phenotype in North America

9:00AM-11:00AM: Abstract Number: 1669

Anti-Mitochondria DNA Antibody As an Improved Biomarker for Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1666

Anti-Mitochondrial Autoantibodies in Systemic Lupus Erythematosus and Their Association with Disease Manifestations

9:00AM-11:00AM: Abstract Number: 1592

Antimalarial-Induced Cardiomyopathy in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1085

Application of Lupus Nephritis Quality Measures to Understand Gaps in Care for SLE

9:00AM-11:00AM: Abstract Number: 1194

Are Bisphosphonates Efficacious in Knee Osteoarthritis? A Meta-Analysis of Randomized Controlled Trials

9:00AM-11:00AM: Abstract Number: 1244

Are Chinese-American Rheumatology Patients Who Use Traditional Chinese Medicine Less Adherent to Prescribed Western Medications?

9:00AM-11:00AM: Abstract Number: 1133

Are We Ready? Changes in the Profile of Gout Patients over the Last 25 Years

9:00AM-11:00AM: Abstract Number: 963

Artesunate Inhabits Migration and Invasion of Fibroblast-like Synoviocytes and Matrix Metalloproteinases Expression Via Suppression of PI3K/Akt Pathway in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1148

Arthritis after Cancer Immunotherapy: Symptom Duration and Treatment Response

9:00AM-11:00AM: Abstract Number: 1597

Arthritis and Hydroxychloroquine Are Associated with Decreased Risk of Macrophage Activation Syndrome Among Adults Hospitalized with SLE

9:00AM-11:00AM: Abstract Number: 1004

Arthritis Impact at the State and County Level — United States, 2015

9:00AM-11:00AM: Abstract Number: 1337

ASN002, a Novel Dual SYK/JAK Inhibitor, Demonstrates Strong Efficacy in a Rat Model of Collagen-Induced Arthritis

9:00AM-11:00AM: Abstract Number: 1289

Assessing ACR/EULAR Provisional 2017 Classification Criteria for Granulomatosis with Polyangiitis (GPA) in a Cohort of 376 Children with Small to Medium Vessel Chronic Vasculitis – a Pediatric Vasculitis Initiative (PedVas) Study

9:00AM-11:00AM: Abstract Number: 1060

Assessing Interferon Regulatory Factor 5 (IRF5) Function in Human Primary Immune Cells with Cell-Penetrating Peptides

9:00AM-11:00AM: Abstract Number: 1282

Assessing the Prevalence of Juvenile Systemic Sclerosis in Childhood Using Administrative Claims Data from the United States

9:00AM-11:00AM: Abstract Number: 1362

Assessing the Quality, Reliability and Readability of Online Health Information Regarding Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1615

Assessment of a Cognitive Impairment Measure in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1648

Assessment of Outcome in Lupus Nephritis Patients: A Retrospective Analysis of a Single Center Cohort over 20 Years

9:00AM-11:00AM: Abstract Number: 1106

Association between ABCG2 rs2231142 and Poor Response to Allopurinol: Replication and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1484

Association between Primary Sjogren’s Syndrome, Arterial Stiffness and Subclinical Atherosclerosis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1485

Association between Primary Sjogren’s Syndrome, Cardiovascular and Cerebrovascular Events: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 999

Association between Smoking with Spinal Level of Stiffness and Functional Limitation in Patients with Axial Spondyloarthritis: Results from the Spanish Atlas

9:00AM-11:00AM: Abstract Number: 1028

Association of a Non-Synonymous, Loss-of-Function, Variant in NOD2 with Reduced Tissue Damage in ACPA +Ve RA

9:00AM-11:00AM: Abstract Number: 1751

Association of a TNFSF4 Upstream Region Single Nucleotide Polymorphism with Susceptibility to Proteinase 3-ANCA Positive Vasculitis in a Japanese Population

9:00AM-11:00AM: Abstract Number: 1226

Association of Dorsal Flat Vertebra/Platyspondylia As a Form of Vertebral Dysplasia within Type II Collage Disorders

9:00AM-11:00AM: Abstract Number: 1762

Association of ETS1 Polymorphism in 3’ Untranslated Region with Susceptibility to Granulomatosis with Polyangiitis and Proteinase 3-ANCA Positive Vasculitis in a Japanese Population

9:00AM-11:00AM: Abstract Number: 977

Association of Leisure-Time Physical Activity with Late-Life Mobility Limitation Among Women with Total Joint Replacement for Hip or Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1454

Association of Poor Prognostic Factors with Medication Persistence Among Adult RA Patients within a Community of Rheumatology Clinics

9:00AM-11:00AM: Abstract Number: 988

Association of Ultraviolet-B Radiation and Risk of SLE Among Women in the Nurses’ Health Studies

9:00AM-11:00AM: Abstract Number: 1622

Associations Among Classification Criteria Items within Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1146

Associations between Gout and Cancer in an Nhanes Cohort

9:00AM-11:00AM: Abstract Number: 1219

Associations between Muscle Mass and Function with Bone Microarchitecture and Bone Strength in Postmenopausal Women

9:00AM-11:00AM: Abstract Number: 1271

Associations between Systemic Lupus Susceptibility (SLE) Loci and Anti-Phospholipid Antibody (aPL) Positivity in Childhood-Onset SLE (cSLE)

9:00AM-11:00AM: Abstract Number: 964

Atherogenic Potency of Plasma from Persons with Autoimmune Rheumatic Disorders: Comparative Effects on Cholesterol Flux in Human Macrophages

9:00AM-11:00AM: Abstract Number: 1628

Atrial Fibrillation/Flutter Hospitalizations Among Patients with SLE and Diabetes Compared to the General U.S. Medicaid Population

9:00AM-11:00AM: Abstract Number: 1182

Autoantibody Profiling in Prostvac and Ipilimumab Treated Prostate Cancer Patients Reveals Potential Biomarkers of Immune-Related Adverse Events

9:00AM-11:00AM: Abstract Number: 1617

Autoimmune Diseases in Patients with Cutaneous Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1745

Autophagic Memory in Stress Experienced Human T Cells

9:00AM-11:00AM: Abstract Number: 1551

Avoidance of Physical Activity Leads to Reduced Inflammatory Enthesitis on Ultrasound

9:00AM-11:00AM: Abstract Number: 1695

Baseline Characteristics and Outcomes in a Retrospective Cohort of Patients with Systemic Sclerosis Related Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 1400

Beneficial Effect of Anti-IL-6 Blockade on Insulin Resistance and Insulin Sensitivity in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1571

Bimekizumab Dual Inhibition of IL-17A and IL-17F Provides Evidence of IL-17F Contribution to Chronic Inflammation in Disease-Relevant Cells

9:00AM-11:00AM: Abstract Number: 1046

Biological and Targeted Synthetic Dmards’ Prior Authorization Time Is Significantly Reduced with Pharmacy Presence in the Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 1562

Biological DMARD Efficacy in Psoriatic Arthritis: A Systematic Review and Meta-Analysis on ACR Response Criteria, PASI Response Criteria, HAQ-DI, Enthesitis and Dactylitis Outcomes

9:00AM-11:00AM: Abstract Number: 1211

Biomarkers Predictive of Pain Improvement in Knee Osteoarthritis Subjects Treated with the Anti-IL-1α/β Dual Variable Domain Immunoglobulin ABT-981

9:00AM-11:00AM: Abstract Number: 1037

Biosimilar Knowledge Among US Rheumatologists – a Survey

9:00AM-11:00AM: Abstract Number: 1036

Blood Glucose Changes Surrounding Initiation of Tumor-Necrosis Factor Inhibitors and Conventional Disease-Modifying Anti-Rheumatic Drugs in Veterans with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1267

Blood Pressure Control over Time in Childhood-Onset Systemic Lupus Erythematous

9:00AM-11:00AM: Abstract Number: 1634

Body Mass Index and Disease Activity in Systemic Lupus Erythematosus- a Paradoxical Relationship?

9:00AM-11:00AM: Abstract Number: 1636

Body Mass Index at Disease Onset Is Predictive of Future Organ Damage in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1472

Body Mass Index Does Not Affect Response to Rituximab in Patients with Rheumatoid Arthritis: Results from Turkbio Registry

9:00AM-11:00AM: Abstract Number: 1224

BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment

9:00AM-11:00AM: Abstract Number: 1225

BONE Mineral Density and Vertebral Fractures in Gaucher Disease Patients Treated with Imiglucerase

9:00AM-11:00AM: Abstract Number: 1183

Bone Sarcoidosis: A Multicenter Study

9:00AM-11:00AM: Abstract Number: 1594

Bone Turnover Markers in Adults with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1735

Brain Infiltrating CD4 T Cells Have a Pathogenic T Follicular Helper-like Phenotype in Neuropsychiatric Lupus

9:00AM-11:00AM: Abstract Number: 1057

Budgetary Impact Analysis of Real-World Dosing Patterns in Matched Cohorts of Rheumatoid Arthritis Patients Treated with Infliximab or Golimumab Intravenous Anti-TNF Medications

9:00AM-11:00AM: Abstract Number: 1033

Burden of Illness in Patients with RA and Anti-Cyclic Citrullinated Peptide Positivity

9:00AM-11:00AM: Abstract Number: 1437

C-Reactive Protein Levels in Patients with or without Structural Progression: A Post-Hoc Analysis from a Phase 3 Tofacitinib Trial

9:00AM-11:00AM: Abstract Number: 1635

Cachexia in Systemic Lupus Erythematosus- an Underrecognized Syndrome

9:00AM-11:00AM: Abstract Number: 1218

Caffeine Consumption and Risk of Osteoporosis: A Cross Sectional Study of 3, 210 Patients from the National Health and Nutrition Examination Survey

9:00AM-11:00AM: Abstract Number: 1396

Can 3 0-10 Physician Visual Analog Scales (VAS) to Assess Levels of Inflammation, Damage and Distress Offer Comprehensive Quantitative Data That May be As Informative As Detailed, Formal Swollen and Tender Joint Counts?

9:00AM-11:00AM: Abstract Number: 1130

Can Alcohol Intake in Moderation Lower the Risk of Myocardial Infarction and Mortality Even Among Gout Patients?

9:00AM-11:00AM: Abstract Number: 1701

Can Durometer Differentiate Limited Versus Diffuse Cutaneous Systemic Sclerosis?

9:00AM-11:00AM: Abstract Number: 1606

Cancer in an SLE Inception Cohort: Smoking May out-Perform Tumor Markers As a Risk Predictor

9:00AM-11:00AM: Abstract Number: 976

Cannabinoid Receptor 2 Agonist (JWH-015) Inhibits Interleukin-1β-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts

9:00AM-11:00AM: Abstract Number: 1061

Cardiac Endothelial Cell Transcriptome Analyses Support a Pathological Role of Metabolic and Inflammasome Genes in Anti-SSA/Ro-Associated Congenital Heart Block

9:00AM-11:00AM: Abstract Number: 1646

Cardiovascular disease in Systemic Lupus Erythematosus. The road to hell is paved with good intentions

9:00AM-11:00AM: Abstract Number: 1490

Cardiovascular Morbidity and Mortality in Primary Sjögren Syndrome: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1748

Cbl-b Associates with Bcl-6 and Is Differentially Expressed in Circulating Follicular T Helper Cells of Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1518

Certolizumab Pegol Effectiveness and Retention Rate in Psoriatic Arthritis. Real Life Data

9:00AM-11:00AM: Abstract Number: 1519

Certolizumab Pegol Effectiveness in Radiographic and Non-Radiographic Axial Spondyloarthritis. a Natiowide Study

9:00AM-11:00AM: Abstract Number: 1558

Changes in Blood Pressure with TNF Inhibitors for Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1627

Changes in Heart Rate Variability Reflect Changes in Clinical Status and Patient Reported Outcomes in Systemic Lupus Erythematosus: A Longitudinal Analysis

9:00AM-11:00AM: Abstract Number: 1467

Changes in the Immune Response of RA Patients Induced By 1 Year of Tocilizumab

9:00AM-11:00AM: Abstract Number: 1309

Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database

9:00AM-11:00AM: Abstract Number: 1525

Characteristics and Treatment Patterns Among Patients with Psoriatic Arthritis Initiating Subcutaneously Administered Biologics: Descriptive Analyses from a US Claims Database

9:00AM-11:00AM: Abstract Number: 1493

Characteristics of Korean Primary Sjogren’s Syndrome and Comparison of 3 Different Classification Criteria for Primary Sjogren’s Syndrome: Data from Korean Kiss Cohort

9:00AM-11:00AM: Abstract Number: 1419

Characteristics of Patients with Early Rheumatoid Arthritis Who Have a Delayed Response to Treatment with Methotrexate in Monotherapy or in Combination with Adalimumab

9:00AM-11:00AM: Abstract Number: 1382

Characteristics of Patients with Rheumatoid Arthritis and Atlanto-Axial Pannus

9:00AM-11:00AM: Abstract Number: 1064

Characterization of Human Tolerogenic Dendritic Cells Generated with Protein Kinase C Inhibitor and Induction from Patients with Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 1215

Chest Radiography As a Screening Tool to Detect Fragile Spine Fractures

9:00AM-11:00AM: Abstract Number: 1754

Childhood- Vs. Adult-Onset ANCA-Associated Vasculitides: A Nested, Matched Case–Control Study from the French Vasculitis Study Group Registry

9:00AM-11:00AM: Abstract Number: 1626

Childhood-Onset Predicts Increased Steroid-Related Damage Among Adults with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1251

Chinese Patient Reported Index with Rheumatoid Arthritis (CPRI-RA): Reliability, Validity and Agreement with DAS28 and HAQ

9:00AM-11:00AM: Abstract Number: 1584

Chlamydia-Infected Macrophages: “Trojan Horses” for Dissemination of IL-23 and TNF-Mediated Inflammation in SKG Mouse Reactive Arthritis

9:00AM-11:00AM: Abstract Number: 1206

Chondroitin Sulfate Reduces Pain and Improves Function in Knee Osteoarthritis Significantly Better Than Placebo, Independently of the Definition of Responders

9:00AM-11:00AM: Abstract Number: 1187

Chondroitin Sulfate/Glucosamine Hydrochloride Induce a Reduction in Adrenergic Serum Markers in Osteoarthritis Patients Similar to That Produced By Celecoxib

9:00AM-11:00AM: Abstract Number: 1102

Choosing Unwisely: HLA-B27 Testing and Adherence to Choosing Wisely Practices in a Large Integrated Academic Healthcare System

9:00AM-11:00AM: Abstract Number: 1367

Circulating Microbial Small RNAs Are Altered in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1243

Clarifying Patient-Determined Barriers in Living with Systemic Lupus Erythematosus Treatment: A Qualitative Ethnographic Approach

9:00AM-11:00AM: Abstract Number: 1709

Classical Monocytes in the Pathogenesis of Early Diffuse Cutaneous Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1497

Clinical and Laboratory Features of Patients with Focal Lymphocytic Sialadenitis on Minor Salivary Gland Biopsy for Sicca Symptoms: A 16 Year Experience

9:00AM-11:00AM: Abstract Number: 1513

Clinical Characteristics and Peripheral Joint Involvement at the Time of Diagnosis of Non-Radiographic Axial Spondyloarthritis Patients in the United States and Europe

9:00AM-11:00AM: Abstract Number: 1161

Clinical Characteristics of Ocular Sarcoidosis: A Population Based Study 1976-2013

9:00AM-11:00AM: Abstract Number: 1165

Clinical Characteristics of Patients with Late-Onset Familial Mediterranean Fever in Japan

9:00AM-11:00AM: Abstract Number: 1110

Clinical Features and Risk of Recurrent Attack in Gout Patients According to Serum Urate Levels during an Acute Gout Attack

9:00AM-11:00AM: Abstract Number: 1149

Clinical Implications of Ultrasonography (US) in Monitoring Disease Activity of Relapsing Polychondritis (RP) and Comparative Investigation By US between Auricle of RP, Repeated Trauma and Healthy Subject

9:00AM-11:00AM: Abstract Number: 1151

Clinical Manifestations of BehçEt’s Disease Depending on Sex and Age: Nationwide Japanese Registration

9:00AM-11:00AM: Abstract Number: 1280

Clinical Outcomes of Juvenile Dermatomyositis Patients Treated with TNF-Inhibitors: A Retrospective Chart Review Katelyn Banschbach1, Ellen Go1 and Stacey Tarvin2, 1Indiana University School of Medicine, 2riley Hospital for Children, Indiana University

9:00AM-11:00AM: Abstract Number: 1207

Clinical Relevance of Structural Measures in Knee Osteoarthritis: Baseline Values and Change from Baseline Discriminate Patients Subsequently Receiving Knee Replacement

9:00AM-11:00AM: Abstract Number: 1067

Clinical Significance of Anti-Dense Fine Speckled 70 and Dense Fine Speckled Pattern in Diagnosis of Systemic Autoimmune Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 1096

Clinical Significance of RNP Antibodies in Diagnosis of Systemic Autoimmune Rheumatic Disease When Detected By Multiplex Immunoassay

9:00AM-11:00AM: Abstract Number: 1446

Clinical Significance of Serum Levels of ROM (reactive oxygen metabolities) at 12 Weeks during Treatment with Biologic Agents As a Predictor for the 52-Week Remission

9:00AM-11:00AM: Abstract Number: 1272

Cluster Analysis of Autoantibodies and Their Relationship with Demographic and Clinical Features in Pediatric Systemic Lupus Erythematosus in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry

9:00AM-11:00AM: Abstract Number: 1768

Cocaine and ANCA Associated Vasculitis-like Syndromes – a Case Series

9:00AM-11:00AM: Abstract Number: 1247

Coexisting Fibromyalgia in Patients with Rheumatoid Arthritis Worsens Scores for Pain, Physical Function and Depression

9:00AM-11:00AM: Abstract Number: 1475

Collection of Anti-Rheumatic Medication Data from Both Patients and Rheumatologists Shows Strong Agreement in a Real World Clinical Cohort

9:00AM-11:00AM: Abstract Number: 1674

Combining Medications That Lower Systemic Oxidative Stress Is Associated with Less Atherosclerosis in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1100

Communication between Inpatient and Outpatient Specialty Clinicians: Developing a Better Understanding of Patients with Rheumatoid Arthritis Who Are Admitted to the Hospital

9:00AM-11:00AM: Abstract Number: 1538

Comparative Effectiveness of Early Versus Delayed Anti-TNF-α Treatment in Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1546

Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data

9:00AM-11:00AM: Abstract Number: 1230

Comparative Study of Frax® Score in Ecuadorian Population

9:00AM-11:00AM: Abstract Number: 1502

Comparison of Classification Criteria for Sjögren’s Syndrome from 2002 and 2016 in an Incident Cohort Diagnosed 2007 to 2011 from Stockholm County Sweden

9:00AM-11:00AM: Abstract Number: 1270

Comparison of Clinical and Serological Features of Juvenile and Adult-Onset Neuropsychiatric Lupus in Spanish Patients

9:00AM-11:00AM: Abstract Number: 1394

Comparison of Improvements in Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort

9:00AM-11:00AM: Abstract Number: 1534

Comparison of Long Term Anti-Tnf Survival in Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis; Data from Turkbio Registry

9:00AM-11:00AM: Abstract Number: 1540

Comparison of Radiologic Parameters of Ankylosing Spondylitis Treated with Anti-TNF-α Versus Non-Steroidal Anti-Inflammatory Drugs and Sulfasalazine

9:00AM-11:00AM: Abstract Number: 1507

Comparison of the Clinical and Imaging Arms of the Assessment of Spondyloarthritis International Society Classification Criteria and Parameters of Objective Inflammation in Patients with Non-Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1043

Comparison of the Costs for Hyaluronic Acid and Total Knee Arthroplasty in the Treatment of OA for the Blue Cross/Blue Shield Patient Population

9:00AM-11:00AM: Abstract Number: 1132

Compensated Polarized Microscopy for Crystal Identification Shows High Reliability Among Multiple Observers

9:00AM-11:00AM: Abstract Number: 1671

Complement C4 Gene Copy Number Variations Bestow Large Ranges of Serum C4 Protein Levels in Chinese Patients with Systemic Lupus Erythematosus (SLE) and Contribute to Organ and Cardiovascular Damages over Time

9:00AM-11:00AM: Abstract Number: 1018

Comprehensive Identification of Differentially Methylated Regions Associated with Systemic Sclerosis in Dermal Fibroblasts from African-American Patients

9:00AM-11:00AM: Abstract Number: 1342

Comprehensive Provider Judgment Outweighs Disease Activity Measures in the Decision to Not Escalate Therapy in Patients with Moderate to Severe Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1287

Cone Beam Computed Tomography for the Assessment of Linear Scleroderma of the Face

9:00AM-11:00AM: Abstract Number: 1301

Congenital Heart Defects in Children Born to Mothers with Rheumatic Disease and Anti-Ro and/or Anti-La Antibodies

9:00AM-11:00AM: Abstract Number: 1435

Consistent Inhibition of Joint Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis: Pooled Analysis of Phase 2 and 3 Studies

9:00AM-11:00AM: Abstract Number: 1307

Contraceptive Use in Patients with Rheumatologic Disease on Teratogenic Medications: Rate of Use and Related Factors

9:00AM-11:00AM: Abstract Number: 1488

Correlation between Lung Ultrasound, HRCT Findings and Pulmonary Function Tests in Primary Sjögren’s Syndrome (pSS)-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 1458

Correlation of Multi-Biomarker Disease Activity Score with Clinical Disease Activity Measures for the JAK1-Selective Inhibitor Filgotinib As Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1365

Correlation of the Multi-Biomarker Disease Activity Score with Composite Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1442

Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries

9:00AM-11:00AM: Abstract Number: 1465

Cost per Response for Abatacept Versus Adalimumab in Patients with Seropositive, Erosive, Early Rheumatoid Arthritis in the US, Germany, Spain and Canada

9:00AM-11:00AM: Abstract Number: 1047

Cost-Effectiveness of Drug-Level Guided Adalimumab Dosing

9:00AM-11:00AM: Abstract Number: 1059

Cost-Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1199

Costs Associated with Osteoarthritis Care Using Intra-Articular Hyaluronic Acid: Analysis of an Administrative Database

9:00AM-11:00AM: Abstract Number: 1434

COX-2 Inhibitor Contributes Cell Death in Rheumatoid Arthritis Fibroblast-like Synoviocytes Via PI3K/AKT/mTOR Signaling Pathway Triggered By Autophagy

9:00AM-11:00AM: Abstract Number: 1323

Crucial Roles for Toll-like Receptor 9 in the Pathogenesis of Erosive Autoimmune Arthritis and during Osteoclastogenesis

9:00AM-11:00AM: Abstract Number: 1734

CXCR5+ CD4 T Cells Signature Differentiates Takayasu Arteritis from Giant Cell Arteritis

9:00AM-11:00AM: Abstract Number: 1413

Cytokine-Induced Aire Activity in Rheumatoid Arthritis Fibroblast-like Synoviocytes Regulates Expression of Interferon-γ Response Genes

9:00AM-11:00AM: Abstract Number: 1672

Cytokines and Autoantibody Cluster-Interaction in Systemic Lupus Erythematosus. a Systems Medicine Approach

9:00AM-11:00AM: Abstract Number: 1663

De Novo Mutation in ΑCΑCΒ in Childhood Onset SLE Highlights a Novel Role As Modulator of Nucleic Acid Sensor-Driven Type I Interferon Responses

9:00AM-11:00AM: Abstract Number: 987

Death Certificates Do Not Accurately Identify SLE Patients

9:00AM-11:00AM: Abstract Number: 1577

Deciphering the Role of the Tissue Microenvironment in Shaping the Immune Landscape in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1385

Decisional Conflict in Doctor – Patient Discussions about Disease Modifying Anti-Rheumatic Drugs

9:00AM-11:00AM: Abstract Number: 965

Decoy Receptor 3 up-Regulates Cadherin 2 in Rheumatoid Synovial Fibroblasts

9:00AM-11:00AM: Abstract Number: 1327

Decreased Inflammatory Arthritis in Human Serum Paraoxonase 1 Transgenic Mice

9:00AM-11:00AM: Abstract Number: 1692

Decreased Lean Body Mass, Body Fat and Bone Mineral Density in Scleroderma Patients Are Associated with Disease Activity and Physical Activity

9:00AM-11:00AM: Abstract Number: 1736

Deep Immunophenotyping of T-Lymphocytes with a 37-Channel Mass Cytometry (CyTOF) Panel for the Identification of Pathological Cell Functions and the Prediction of Response to Biologic Drugs in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1713

Defining Genetic Risk for Scleroderma Renal Crisis in RNA-Polymerase III Antibody Positive Patients

9:00AM-11:00AM: Abstract Number: 1565

Depression and Fatigue in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1537

Determinants of Patient-Reported Improvement after Administration of Biological Treatment in Axial Spondyloarthritis: A Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 1031

Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure during Pregnancy

9:00AM-11:00AM: Abstract Number: 1489

Development and Validation of a Questionnaire to Assess Healthcare Utilization and Access in Cohorts of Patients with Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1449

Development of a Predictive Score of Successful TNF Inhibitor Tapering in Patients with Rheumatoid Arthritis Remission

9:00AM-11:00AM: Abstract Number: 1371

Development of an Adjusted Multi-Biomarker Disease Activity (MBDA) Score for Rheumatoid Arthritis (RA) That Accounts for Age, Sex and Adiposity, with Subsequent Evaluation of Ability to Predict Risk for Radiographic Damage

9:00AM-11:00AM: Abstract Number: 1593

Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan

9:00AM-11:00AM: Abstract Number: 1118

Diabetes and Gout: Real-World Evidence Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization

9:00AM-11:00AM: Abstract Number: 1376

Diagnostic Performance of 7 Different Anti-Cyclic Citrullinated Peptide Antibody and 6 Rheumatoid Factor Assays in a Primary Diagnostic, Consecutive Rheumatological Population in a Secondary Care Hospital

9:00AM-11:00AM: Abstract Number: 978

Dietary Patterns and Risk of Developing Knee Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 1479

Difference in Clinical Presentation between Female and Male Patients with Primary Sjogren’s Syndrome at Diagnosis and in Long-Term Follow-up

9:00AM-11:00AM: Abstract Number: 1221

Differences in BONE Metabolism between Intermittent and Continuous Treatment with LHRH Agonists in Prostate Cancer Patients

9:00AM-11:00AM: Abstract Number: 1203

Differences in Serum Protein Biomarkers between Combined Glucosamine and Chondroitin Versus Celecoxib Treatment in a Randomized, Double-Blind Trial in Osteoarthritis Patients

9:00AM-11:00AM: Abstract Number: 1679

Different Cut-Offs for Renal Resistive Index Reflect Renal and Other Organ Involvement and Predict Worsening in SSc Patients

9:00AM-11:00AM: Abstract Number: 1761

Differential Characteristics of MPO-ANCA Positive and Negative Eosinophilic Granulomatosis with Polyangiitis

9:00AM-11:00AM: Abstract Number: 1581

Differential Involvement of Synovial and Entheseal Inflammation in Mediating Pathological IL23 Axis Signaling in Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1706

Dipeptidyl-Peptidase-4 (DPP4) Promotes Fibroblast Activation and Is a Potential Molecular Target for Treatment of Fibrosis

9:00AM-11:00AM: Abstract Number: 1554

Discontinuation and Switching Patterns By TNFi Line of Therapy in Patients with Psoriatic Arthritis—Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry

9:00AM-11:00AM: Abstract Number: 1553

Discontinuation of Tumor Necrosis Factor Inhibitor Therapy in US Patients with Ankylosing Spondylitis: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry

9:00AM-11:00AM: Abstract Number: 1428

Discovery and Characterization of JNJ-61178104, a Bispecific Antibody Against Human Tumor Necrosis Factor (TNF) Alpha and Interleukin (IL)-17A

9:00AM-11:00AM: Abstract Number: 1629

Disease Activity Is an Independent Predictor of Leukopenia in a Large International SLE Cohort

9:00AM-11:00AM: Abstract Number: 1363

Disease Duration and Shared Epitope, but Not Smoking History, Are Associated with Peptidylarginine Deiminase 4-Antibody Development in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1702

Disease Progression in Systemic Sclerosis Patients with Concomittant or Isolated Interstitial Lung Disease and Pulmonary Arterial Hypertension in the Scleroderma Cohort Singapore

9:00AM-11:00AM: Abstract Number: 1258

Divided By a Common Language: Challenges in Physician-Patient Communication Limit Patient Understanding and Support in Systemic Sclerosis with Interstitial Lung Disease (SSc-ILD)

9:00AM-11:00AM: Abstract Number: 986

Do Death Certificates Underestimate the Burden of Rare Diseases: The Example of Systemic Lupus Erythematosus Mortality in Sweden

9:00AM-11:00AM: Abstract Number: 1527

Do TNF Inhibitors Alter the Natural History of Ankylosing Spondylitis By Impacting the Incidence and Prevalence of Comorbidities and Extra-Articular Manifestations?

9:00AM-11:00AM: Abstract Number: 1547

Dose Tapering of TNFi in Patients with Axial Spondyloarthritis: An Observational Cohort Study from Nationwide Korean College of Rheumatology Biologic Registry (KOBIO)

9:00AM-11:00AM: Abstract Number: 1710

Down-Regulation of microRNA-126 in Scleroderma Microvascular Endothelial Cells Enhances the Transition of Endothelial to Mesenchymal Cells (Endo-MT) Induced By TGFβ through Down-Regulating PI3/Akt Signaling Pathway By Targeting PIK3R2

9:00AM-11:00AM: Abstract Number: 1616

Early and Late Onset Biopsy Proven Lupus Nephritis without Other Associated Autoimmune Diseases: Severity and Long-Term Outcome

9:00AM-11:00AM: Abstract Number: 1759

Economic Evaluation of Rituximab Versus Azathioprine for Maintenance Treatment of ANCA-Associated Vasculitis. a Prospective, Multicenter Study

9:00AM-11:00AM: Abstract Number: 1707

Effect of Anabasum (JBT-101) on Gene Expression in Skin Biopsies from Subjects with Diffuse Cutaneous Systemic Sclerosis (dcSSc) and the Relationship of Baseline Molecular Subsets to Clinical Benefit in the Phase 2 Trial

9:00AM-11:00AM: Abstract Number: 1220

Effect of Anti-Diabetic Medications on Fracture Risk in Type II Diabetes Mellitus

9:00AM-11:00AM: Abstract Number: 1108

Effect of Body Mass Index on Serum Urate and Renal Uric Acid Handling Responses to an Oral Inosine Load

9:00AM-11:00AM: Abstract Number: 1445

Effect of Methotrexate (MTX), and MTX Plus Colchicine (CCH) on the Expression and Activity of NLRP3 Inflammasome in Patients with Early Rheumatoid Arthritis (RA)

9:00AM-11:00AM: Abstract Number: 1596

Effect of the Metabolic Syndrome on Organ Damage, Renal Function and Mortality in Patients with Systemic Lupus Erythematosus: A Longitudinal Analysis

9:00AM-11:00AM: Abstract Number: 1476

Effect of Treat-to-Target Tocilizumab- and Methotrexate-Based Strategies on Health-Related Quality of Life in Newly Diagnosed Rheumatoid Arthritis Patients: Results of the U-Act-Early Trial

9:00AM-11:00AM: Abstract Number: 1128

Effect of Urate-Lowering Treatment on the Risk of Urolithiasis in People with Gout

9:00AM-11:00AM: Abstract Number: 1392

Effect Size Comparison of Ultrasound Measures in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1517

Effectiveness and Retention Rate of Certolizumab Pegol in Spondyloarthritis. Real Life Data

9:00AM-11:00AM: Abstract Number: 1684

Effectiveness and Safety of Tacrolimus Following Intravenous Cyclophosphamide Pulse Therapy As the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 1145

Effectiveness of a Multidisciplinary Gout Clinic on Timely Achievement of Serum Uric Acid Goals

9:00AM-11:00AM: Abstract Number: 1516

Effectiveness of Certolizumab Pegol in Patients with Uveitis Associated to Spondyloarthritis Refractory to Other Tumour Necrosis Factor Inhibitors

9:00AM-11:00AM: Abstract Number: 1205

Effectiveness of Low-Dose Radiation Therapy on Symptoms in Knee Osteoarthritis: First Results of a Triple Blinded, Randomized Controlled Trial

9:00AM-11:00AM: Abstract Number: 1093

Effectiveness of the Outreach Model for Rheumatology Specialty Clinics to On-Reserve First Nations in Canada: System-Level and Individual Measures of Performance and Outcomes

9:00AM-11:00AM: Abstract Number: 1114

Effects of Diacerein Controlled Release Tablets in Serum Uric Acid Reduction in Treating Subjects with Gout

9:00AM-11:00AM: Abstract Number: 1531

Effects of Intravenous Golimumab on Patient-Reported Outcomes in Active Ankylosing Spondylitis: 28-Week Results of the Phase 3 Trial

9:00AM-11:00AM: Abstract Number: 1191

Efficacy and Safety of Cntx-4975 in Subjects with Moderate to Severe Osteoarthritis Knee Pain: 24-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

9:00AM-11:00AM: Abstract Number: 1195

Efficacy and Safety of Subcutaneous Tanezumab in Patients with Knee or Hip Osteoarthritis (NCT01089725)

9:00AM-11:00AM: Abstract Number: 1694

Efficacy of an Intensive 24-Week Physiotherapy Programme in Scleroderma Patients – Preliminary Data from a Single-Center Controlled Study

9:00AM-11:00AM: Abstract Number: 1556

Efficacy of Biologics and New Anti-Inflammatory Agents Used in the Treatment of Active Psoriatic Arthritis: Systematic Literature Review and Network Meta-Analysis of the Evidence.

9:00AM-11:00AM: Abstract Number: 1048

Efficacy of Educating Visiting Pharmacists Regarding Drug Administration for Patients with Rheumatoid Arthritis Who Poorly Adhere to Treatment Regimens

9:00AM-11:00AM: Abstract Number: 1112

Efficacy of High Dose Versus Moderate Dose Prednisone in the Treatment of Acute Gout

9:00AM-11:00AM: Abstract Number: 1687

Efficacy of Rituximab for Connective Tissue Disease-Associated Interstitial Lung Disease: A Single Center Study of 28 Patients

9:00AM-11:00AM: Abstract Number: 1533

Efficacy of Switching Biological Dmards in Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review

9:00AM-11:00AM: Abstract Number: 1080

Electronic Patient Reported Outcomes Increase Pediatric Rheumatology Clinic Operations Efficiency While Increasing Patient and Caregiver Satisfaction

9:00AM-11:00AM: Abstract Number: 1566

Elevated IL-1 Expression Levels in Mesenchymal Stem Cells Derived from Spondyloarthitis Patients Might be Linked to Increased Osteoblast Mineralization

9:00AM-11:00AM: Abstract Number: 1254

Eliciting the Research Priorities of Parents and Children with Juvenile Myositis

9:00AM-11:00AM: Abstract Number: 1084

Emdhaq: (electronic multidimensional health assessment questionnaire) to Record and Document eRAPID3 (electronic routine assessment of patient index data3) and eFAST3 (electronic fibromyalgia assessment screening tool3) in Routine Rheumatology Care

9:00AM-11:00AM: Abstract Number: 1608

Entheseal Involvement in Systemic Lupus Erythematosus: An Ultrasound Study

9:00AM-11:00AM: Abstract Number: 1168

Eosinophilic Fasciitis: Baseline Retrospective Evaluation of Clinical Characteristics and Prognosis in a Cohort of 83 Patients

9:00AM-11:00AM: Abstract Number: 982

Epidemiology and Mortality in Systemic Sclerosis in South Korea: A Nationwide Population-Based Study

9:00AM-11:00AM: Abstract Number: 1379

Epithelial Neutrophil-Activating Peptide 78/C-X-C Motif Chemokine 5 in the Insulin Resistance of Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1233

Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience

9:00AM-11:00AM: Abstract Number: 1217

Evaluation of Post Fracture Management in Males at a Veterans Affairs Health System

9:00AM-11:00AM: Abstract Number: 1366

Evaluation of Synovial Fluid 14-3-3η Protein As a Marker of Joint Damage in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1545

Evaluation of the Adherence to Recommendations for Tnfα Blockers Use and Its Impact over 5 Years of Follow-up in Early Axial Spondyloarthritis. Data from the DESIR Cohort

9:00AM-11:00AM: Abstract Number: 1441

Evaluation of Ultrasound-Detecting Efficacy of Abatacept By Profiling Multiple Serum Cytokines, Chemokines and Bone-Related Biomarkers in Rheumatoid Arthritis Patients: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study

9:00AM-11:00AM: Abstract Number: 1248

Evaluation of Validated Patient Reported Outcome Measures to Assess Sensitivity to Change in Patients with Systemic Sclerosis and Gastroesophageal Reflux Disease —a Scleroderma Clinical Trials Consortium Collaborative Project

9:00AM-11:00AM: Abstract Number: 1056

Evolution of Health Care Consumption in the Knee and Hip Osteoarthritis Long Term Assessment Cohort, a French Population Based Cohort of Symptomatic Knee and/or Hip OA Patients

9:00AM-11:00AM: Abstract Number: 1568

Existence of IL-6 and IL-17 Mediated Inflammation Amplifier Loop in Reactive Arthritis

9:00AM-11:00AM: Abstract Number: 1197

Exploring Determinants Predicting Response to Intra-Articular Hyaluronic Acid Treatment in Symptomatic Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1285

Extracutaneous Involvement Is Common in Juvenile Localized Scleroderma and Associated with a Higher Level of Perceived Disease Impact

9:00AM-11:00AM: Abstract Number: 1229

Factors Affecting FRAX Score Calculation & Treatment in Practice

9:00AM-11:00AM: Abstract Number: 1125

Factors Associated with Acute Gouty Arthritis in Patients Hospitalized with Acute Coronary Syndromes and Congestive Heart Failure

9:00AM-11:00AM: Abstract Number: 1685

Factors Associated with the 6-Minute Walk Distance in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1653

Factors Influencing on Health-Related Quality of Life in Female Systemic Lupus Erythematosus Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 1439

Factors Influencing the Prescription of Tocilizumab Alone or in Combination with Dmards in Rheumatoid Arthritis Patients in a Real Life Setting. Pooled Analysis of 2 Observational Studies

9:00AM-11:00AM: Abstract Number: 1602

Fatigue in Systemic Lupus: The Role of Disease Activity and Its Mediators

9:00AM-11:00AM: Abstract Number: 1388

Fatigue Is Strongly Associated with the Patient Global Assessment and May Affect Disease Severity and Clinical Remission in Patients with Rheumatoid Arthritis: A Cross-Sectional Study from IORRA, a Large Observational Cohort of Japanese Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1354

Fatigue, Poor Health and Mood Disturbance Persist in Rheumatoid Arthritis and Psoriatic Arthritis Patients Despite Disease Remission: The OPAL Deeper Study

9:00AM-11:00AM: Abstract Number: 1189

Favorable Human Safety, Pharmacokinetics and Pharmacodynamics of the Adamts-5 Inhibitor GLPG1972, a Potential New Treatment in Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1740

Fc-Derived Immunodominant Peptides Stimulate Natural Regulatory T Cells: A New Avenue to Overcome Defects in the Fc Antigen Processing and Restore Immune Regulation in Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1541

First Line Biological Treatment in Ankylosing Spondylitis, Prescription Rates, Baseline Demographics and Disease Activity. a Collaboration between Biological Registers in the Five Nordic Counties

9:00AM-11:00AM: Abstract Number: 1471

Flare Incidence and Predictive Factors in a Population of Patients with Rheumatoid Arthritis Under Optimised Treatment with Adalimumab and Infliximab

9:00AM-11:00AM: Abstract Number: 1374

Flares in Patients with Rheumatoid Arthritis Are Strongly Associated with Worse Clinical Outcomes but Are Difficult to Predict

9:00AM-11:00AM: Abstract Number: 1700

Focusing on Pulmonary Vascular Disease at Early Stage of Systemic Sclerosis: Exercise-Induced Pulmonary Arterial Hypertension and Gene Co-Expression Networks Involved in Its Pathogenesis

9:00AM-11:00AM: Abstract Number: 1375

Foot Arthritis : Poor Prognosis Factor in RA

9:00AM-11:00AM: Abstract Number: 1214

Fracture Incidence and Characteristics in Young Adults Age 18 to 49 Years: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 1505

Gender Bias in the Inheritance of Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1026

Gene Expression Analysis Reveals Common Pathways of Tissue Pathogenesis in Lupus Organ Involvement

9:00AM-11:00AM: Abstract Number: 1727

Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of Interferon-Associated Genes in CD4+ and CD8+ T Cells

9:00AM-11:00AM: Abstract Number: 1266

Geographic Variation in Use of Echocardiography at Diagnosis and Detection of Acute Cardiac Disease in Youth with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1343

Gingival Bleeding and Periodontitis in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study

9:00AM-11:00AM: Abstract Number: 1098

Glucose-6-Phosphate Dehydrogenase Testing in a US Veterans Healthcare System: Are We Ordering Unnecessary Tests?

9:00AM-11:00AM: Abstract Number: 1473

Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): Interim Results from a Non-Interventional Trial in Germany

9:00AM-11:00AM: Abstract Number: 1520

Golimumab Retention Rate in Patients with Spondyloarthitis. Differences between Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1140

Gout Characteristics and Its Association with the Presence of Cardiovascular Disease: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 1599

GRADE-Based Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada

9:00AM-11:00AM: Abstract Number: 1237

Group Strength Training in Rheumatology Patients: Results of an Exercise Survey

9:00AM-11:00AM: Abstract Number: 1278

Growth and Puberty in Juvenile Dermatomyositis a Longitudinal Multinatinal Cohort Study

9:00AM-11:00AM: Abstract Number: 1574

Gut Microbiota Perturbations in Reactive Arthritis

9:00AM-11:00AM: Abstract Number: 1021

GWAS of Gout in Patients with Hyperuricemia Identified Many Possible New Candidate Risk Alleles

9:00AM-11:00AM: Abstract Number: 1620

Habitual Physical Activity, Sedentary Behavior and Cardiovascular Disease Risk Burden in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1003

Hair Treatments and the Risk of Systemic Lupus Erythematosus: the Michigan Lupus Epidemiology & Surveillance (MILES) Program

9:00AM-11:00AM: Abstract Number: 1452

Handling of Missing Data, Protocol Violation and Performance of Intention-to-Treat Analysis in the Randomized Controlled Trials of Drug Therapy of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1030

Healthcare Service Utilization and Costs of Certolizumab Pegol Versus Infliximab Treatment in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1054

Healthcare Utilization Profiles in Rheumatoid Arthritis – a Cluster Analysis

9:00AM-11:00AM: Abstract Number: 985

Heart Failure Hospitalizations Among SLE and Diabetes Mellitus Patients Compared to the General U.S. Medicaid Population

9:00AM-11:00AM: Abstract Number: 1049

Heart Rate Variability Testing with Autonomic Nervous System Optimization: Could It Change the Course of Spending for Rheumatoid Arthritis Patients in the U.S.? an Exploratory Minimal Model Analysis

9:00AM-11:00AM: Abstract Number: 1099

Hepatitis B Reactivation in Rheumatologic Patients

9:00AM-11:00AM: Abstract Number: 1074

High Cholesterol Levels By ApoE Defenciency Reduce Bone Destruction in Murine Antigen-Induced Arthritis Via Inhibition of Osteoclastogenesis

9:00AM-11:00AM: Abstract Number: 1638

High Genetic Risk Score Is Associated with Increased Organ Damage in SLE

9:00AM-11:00AM: Abstract Number: 1126

High Osteoprotegerin:RANKL Ratios in Synovial Fluid Correlate with the Presence of Calcium Pyrophosphate Crystals

9:00AM-11:00AM: Abstract Number: 1170

High Output Flow Cytometry Array Classifies Subjects with Uveitis Due to Behcet’s Disease and Sarcoidosis

9:00AM-11:00AM: Abstract Number: 1539

High Retention Rate and Sustained Responses with Secukinumab 150mg in Patients with Active Ankylosing Spondylitis: 3-Year Results from a Phase 3 Study

9:00AM-11:00AM: Abstract Number: 1662

High Type I Interferon Activity Is Associated with Active Class Ⅲ/Ⅳ Lupus Nephritis in European-American Lupus Patients Independent of dsDNA Antibodies

9:00AM-11:00AM: Abstract Number: 1024

High-Throughput Proteomic Profiling Identifies Dysregulated Proteins in Neonatal-Onset Multisystem Inflammatory Disease (NOMID) That Respond to IL-1blocking Treatment

9:00AM-11:00AM: Abstract Number: 1680

Higher Baseline Monocyte Count Is Associated with More Extensive Skin Involvement and Higher Mortality in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1370

Higher Disease Activity in Current Smokers with Established RA: Is It Disease, Damage or Disability?

9:00AM-11:00AM: Abstract Number: 1416

Higher Expression of Type 1 Interferon in Synovitis of Patient with Undifferentiated Arthritis before They Met Rheumatoid Arthritis Criteria Compared to Established Rheumatoid Arthritis. a Retrospective Study with 14 Years of Follow-up

9:00AM-11:00AM: Abstract Number: 1075

Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor and Cytotoxic Potential of NK Cells in Patients with Behcet Disease

9:00AM-11:00AM: Abstract Number: 1426

Higher Levels of Interleukin-6 As Well As Soluble Interleukin-6 Receptor Leads to Worse Clinical and Radiographic Prognosis in Rheumatoid Arthritis Patients Treated with Tocilizumab

9:00AM-11:00AM: Abstract Number: 990

Higher Omega-6 to Omega-3 Fatty Acid Ratio Is Associated with Increased Odds of Inflammatory Arthritis in a Health Fair Population Positive for Anti-Citrullinated Protein Antibodies (ACPA)

9:00AM-11:00AM: Abstract Number: 1580

HLA-B27/ Human β2-Microglobulin (β2m) Transgenic Drosophila Expresses Specific Cross-Vein Less (CVL) and Small-Eye Phenotypes Resulting from Disruption of the BMP/TGFβ Signaling Pathway

9:00AM-11:00AM: Abstract Number: 1013

HLA-Class II Associations with ANCA-Associated Vasculitis in the Japanese Population: Different Features from European Populations

9:00AM-11:00AM: Abstract Number: 1670

HMGB1-TLR4 Axis in Patients with Neuropsychiatric Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1631

Hospital Readmissions for SLE in the United States: A National Database Study

9:00AM-11:00AM: Abstract Number: 1234

How Machine Learning Statistics Can Change the Game of Data Analysis in Rheumatology: The Example a Study with 170 Patients with Rheumatoid Arthritis (ra) or Axial Spondyloarthritis (axspa)

9:00AM-11:00AM: Abstract Number: 1361

How Often Do Rheumatologists Use Valid Prognostic Factors of Rheumatoid Arthritis? the Progresar Project

9:00AM-11:00AM: Abstract Number: 1747

Human C-C Chemokine Receptor-6 (CCR6)+ Th Memory Cells, Including Th17 and Th17.1 Cells, Change into Anti-Inflammatory Cells with Regulatory Capacity upon Exposure to Vitamin D

9:00AM-11:00AM: Abstract Number: 1673

Human C4 Gene Copy Number Influences Cell-Bound Complement Activation Product (CB-CAP) C4d in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1726

Human Skin in Organ Culture As an Ex Vivo Model for Assessing the Fibrotic Effects of Bleomycin

9:00AM-11:00AM: Abstract Number: 1407

Huntingtin Interactin Protein 1 (HIP1) Regulates Invasiveness, Actin Filament and Lamellipodia Formation in Rheumatoid Arthritis Fibroblast-like Synoviocytes (FLS)

9:00AM-11:00AM: Abstract Number: 1404

Hydrogen Sulfide Metabolism and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1297

Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data

9:00AM-11:00AM: Abstract Number: 1296

Hydroxychloroquine Level Decreases throughout Pregnancy: Implications for Maternal and Neonatal Outcomes

9:00AM-11:00AM: Abstract Number: 1601

Hydroxychloroquine Non-Adherence Is Associated with Higher Sledai Scores in a Predominantly Hispanic Population

9:00AM-11:00AM: Abstract Number: 1157

Hypocomplementemia Is Closely Related to IgG Subclasses Other Than IgG4 in IgG4-Related Disease

9:00AM-11:00AM: Abstract Number: 1668

Identification of a Serum Measure of Lupus Nephritis Activity That Detects Molecular Pathways and Mechanisms Implicated in Renal Damage

9:00AM-11:00AM: Abstract Number: 1722

Identification of a Sub-Population of Autoantibodies Targeting BICD2 Cross-Reacting with CENP-a Derived Peptides in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1010

Identification of Circulating Biomarkers of Disease Activity and Organ Involvement in ANCA-Associated Vasculitis By Targeted Proteomics

9:00AM-11:00AM: Abstract Number: 1334

Identification of Key Regulators for Resolution of Chronic Inflammatory Arthritis through a Systems Approach

9:00AM-11:00AM: Abstract Number: 984

Identification of Key Screening Characteristics for Systemic Lupus Erythematosus Natural History

9:00AM-11:00AM: Abstract Number: 1659

Identification of Long Noncoding RNA RP11-2B6.2 As a Positive Regulator through Type I Interferon Pathway in Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 983

Identifying Exposures to Chemicals in Patients with SLE – a Non-Targeted Exposome Approach Reveals Enrichment for Phthalates

9:00AM-11:00AM: Abstract Number: 975

IL-17A Induced Autophagy That the Proliferation of Rheumatoid Arthritis Fibroblast-like Synoviocytes through Down-Regulation of PI3K/AKT/mTOR Signaling Pathway

9:00AM-11:00AM: Abstract Number: 1576

IL-23 Promotes Fecal Microbiota Dysbiosis Associated with Susceptibility to Spondyloarthritis and Ileitis in ZAP-70 Mutant SKG Mice

9:00AM-11:00AM: Abstract Number: 973

IL-6 and TNF-a Cooperate to Modulate the Cell Cycle of RA-Fibroblast-like Synoviocytes Via Cyclin Dependent Kinase Inhibitors

9:00AM-11:00AM: Abstract Number: 1730

IL-6 Mediates Activation of Macrophages in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1325

Immune Responses to Peptides Containing Homocitrulline or Citrulline in the DR4-Transgenic Mouse Model of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1155

Impact of Adalimumab on Immunosuppressant Use in Patients with Active and Inactive Non-Infectious Intermediate, Posterior, or Pan-Uveitis in the Ongoing Open Label Study: Visual-III

9:00AM-11:00AM: Abstract Number: 1422

Impact of Adalimumab on Prednisone Use in Patients with Rheumatoid Arthritis in a Real World Setting – Results from the Corrona Registry

9:00AM-11:00AM: Abstract Number: 1470

Impact of Anti-Drug Antibody and Injection Site Reaction on Efficacy: 24-Week Results from a Phase III Study Comparing SB4 (etanercept biosimilar) with Reference Etanercept in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1222

Impact of Bariatric Surgery on Bone Mineral Density : Observational Study of 110 Patients Followed up in a Specialised Centre for the Treatment of Obesity in France

9:00AM-11:00AM: Abstract Number: 1453

Impact of Biological and Targeted Synthetic Dmards on Work in Patients with Chronic Inflammatory Arthritides : A Meta Analysis of Randomized Controlled Trials and Controlled Cohorts

9:00AM-11:00AM: Abstract Number: 1162

Impact of Bone Localization on the Prognostic of Langerhans Cell Histiocytosis: A Monocentric Retrospective Study

9:00AM-11:00AM: Abstract Number: 1129

Impact of Diuretics on Urate Lowering Therapy in Patients with Gout: Analysis of an Inception Cohort

9:00AM-11:00AM: Abstract Number: 989

Impact of DMARD Treatment on Risk of Repeat Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis

9:00AM-11:00AM: Abstract Number: 1344

Impact of Fibromyalgic RA on Composite Scores; Results from a Longitudinal Study of RA Patients Initiating Bdmard Therapy

9:00AM-11:00AM: Abstract Number: 1424

Impact of Glucocorticoid Therapy on the Efficacy of SC Abatacept or Adalimumab in RA Patients with Inadequate Response to MTX: A Post Hoc Analysis of Data from a Head-to-Head Trial

9:00AM-11:00AM: Abstract Number: 1038

Impact of Patient Support Program Utilization on Patient Activation Measure Scores Among Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1383

IMPACT of Smoking in the Expression of Periodontitis and Anticitrullinated Protein Antibodies in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1242

Impact of Social Support and Illness Perception on the Transition of Pediatric SLE Patients to Adult Care

9:00AM-11:00AM: Abstract Number: 1053

Impact of Step Therapy Protocols on North Carolina Rheumatologists’ Job Satisfaction and the Quality of Care Received By Their Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1521

Impact of Time Since Diagnosis, Age, and Number of Prior Non-Steroidal Anti-Inflammatory Drugs on 52-Week Clinical Response to Adalimumab in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1068

Impact of TNF Antagonist Treatment on the Gut Microbiome In Vivo

9:00AM-11:00AM: Abstract Number: 1265

Impaired Cardiac Function in Juvenile Mixed Connective Tissue Disease Compared with Controls

9:00AM-11:00AM: Abstract Number: 1338

Important Role of CD11c+ Dendtritic Cells in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1515

Improvements in Enthesitis Scores with Certolizumab Pegol Treatment in Males and Females with Active Axial Spondyloarthritis Are Maintained to Week 204

9:00AM-11:00AM: Abstract Number: 1530

Improvements in Sleep Problems and Pain in Patients with Active Ankylosing Spondylitis Treated with Intravenous Golimumab: 28-Week Results of the Phase III Trial

9:00AM-11:00AM: Abstract Number: 1081

Improving Patient-Reported Outcomes Collection and Documentation for Patients with Rheumatoid Arthritis at Multilingual, Safety Net Hospital Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 1676

Improving Sensitivity to Change of the Modified Rodnan Skin Score over Time

9:00AM-11:00AM: Abstract Number: 1402

In RA, Becoming Seronegative over the 1st Year of DMARD Treatment Does Not Improve Chances of Drug-Free Remission in the Long-Term

9:00AM-11:00AM: Abstract Number: 966

In Search of Mechanisms Underlying Fibroblast-like Synoviocyte Cell-to-Cell Cargo Transfer

9:00AM-11:00AM: Abstract Number: 955

In Vitro Effects of CR6086, a Potent ProstaglandinE2 Subtype 4 Receptor Antagonist, on Bone Erosive Pathways

9:00AM-11:00AM: Abstract Number: 1573

In Vivo Phosphorylation of p38 in Monocytes Is Enhanced in Patients with Axial Spondyloarthritis (axSpA) at the Time of Diagnosis

9:00AM-11:00AM: Abstract Number: 1387

In-Depth Temperature of Small and Large Joints Assessed By Microwave Radiometry As an Additional Biomarker in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1478

Inadequate Clinical Response to Sirukumab, an Anti-IL-6 Monoclonal Antibody, Can be Predicted after a Single Dose of Treatment in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 997

Incidence and Clinical Characteristics of Active Tuberculosis in a Cohort of Patients with Inflammatory Arthritis Treated with TNF-Inhibitors

9:00AM-11:00AM: Abstract Number: 1625

Incidence and Outcomes of Venous Thromboembolism in Hospitalized Patients with Systemic Lupus Erythematosus: Results from Nationwide Inpatient Sample Database 2003-2011

9:00AM-11:00AM: Abstract Number: 1777

Incidence and Prevalence of Granulomatosis with Polyangiitis and Microscopic Polyangiitis in a Health Management Organization: A 15-Year Study

9:00AM-11:00AM: Abstract Number: 1483

Incidence of Cancer in a Cohort of Patients with Primary Sjögren Syndrome

9:00AM-11:00AM: Abstract Number: 1364

Incidence of Rheumatoid Arthritis in a Cohort of First Degree Relatives from the Studies of the Etiology of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1429

Incidence Rates of Adverse Events with Death As an Outcome during Abatacept Treatment in RA: Results from an Integrated Data Analysis from 16 Clinical Trials

9:00AM-11:00AM: Abstract Number: 1769

Incidence, Predictors, and Outcome of Diffuse Alveolar Hemorrhage in Patients with MPO-ANCA Positive Microscopic Polyangiitis: A Multi-Center Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 1583

Increase in Arginase Activity and Related Arginine Metabolites in Patients with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA): Potential Mechanisms for Endothelial Dysfunction

9:00AM-11:00AM: Abstract Number: 993

Increase in Prevalence of Psoriasis Arthritis over Time: Analysis of Claims Data from 65 Million People in Germany from 2009 to 2012

9:00AM-11:00AM: Abstract Number: 1611

Increased Body Mass Index May Not be a Risk Factor for the Development of Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 1733

Increased Differentiation Resistance of Regulatory T Cells to Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 1160

Increased Incidence of Upper and Lower Gastrointestinal Events in Patients with Sarcoidosis: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 1667

Increased Levels of BAFF in SLE Patients Correlates with Neutrophil Activation and Autoantibody Production

9:00AM-11:00AM: Abstract Number: 1766

Increased Renal Damage in Hypocomplementemic Patients with ANCA- Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1729

Increased Serum Levels of Micro-RNA 30d and Micro-RNA 423-5p in 2 Independent Cohorts of Patients with Morphea

9:00AM-11:00AM: Abstract Number: 1071

Increased Susceptibility of SLE-Prone Mice to Pulmonary Haemophilus Influenzae Infection Was Attributed to Dysfunctions of Innate Immune Responses

9:00AM-11:00AM: Abstract Number: 1095

Increasing Lipid Panel Monitoring in a Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 994

Increasing Population Burden of Psoriatic Disease in Ontario, Canada – a Longitudinal Cohort Study

9:00AM-11:00AM: Abstract Number: 1293

Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies

9:00AM-11:00AM: Abstract Number: 1641

Indications for Initial Renal Biopsy in Systemic Lupus Erythematosus: A Systematic Review of the Literature

9:00AM-11:00AM: Abstract Number: 1462

Induction of Immune Tolerance through an Epitope-Specific Vaccine Induces Clinical Amelioration in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1542

Inequity in Biologic DMARD Prescription for Spa across the Globe: Results from the Multi-Centre, Cross-Sectional, ASAS Comospa Study

9:00AM-11:00AM: Abstract Number: 1223

Inflammatory Bowel Diseases and the Risks of Fracture and Low Mineral Density: Review of the Literature and Meta-Analysis of Observational Cohorts

9:00AM-11:00AM: Abstract Number: 1450

Influence of Immunogenicity to the First Anti-TNF Therapy on Response to the Second Biologic Agent in RA Patients

9:00AM-11:00AM: Abstract Number: 1315

Influence of Rheumatoid Arthritis and Axial Spondyloarthritis on Pregnancy Complications, Pregnancy Outcome and Delivery Mode

9:00AM-11:00AM: Abstract Number: 1039

Influences for Therapeutic Changes in Rheumatoid Arthritis Patients from the Veterans Affairs Rheumatology Arthritis Registry Who Have Moderate to High Disease Activity

9:00AM-11:00AM: Abstract Number: 1705

Inhibition of EZH2 Stops Fibrosis and Improves Angiogenesis in Scleroderma

9:00AM-11:00AM: Abstract Number: 956

Inhibition of Fucosylation in Endothelial Cells Reduces Rheumatoid Arthritis Angiogenesis

9:00AM-11:00AM: Abstract Number: 1714

Inhibition of Hedgehog Acyltransferase Alleviates the Profibrotic Effects of Transforming Growth Factor β in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1321

Inhibition of the Mechanistic Target of Rapamycin Pathway and Glutaminolysis Facilitates the Expansion of Myeloid-Derived Suppressor Cells and Synergistically Ameliorates Arthritis in SKG Mice

9:00AM-11:00AM: Abstract Number: 1078

Initial Combination Therapy Versus Step-up Therapy Is More Effective and Less Costly As a Treat to Target Strategy for RA: A Markov Model Based upon the Dutch Rheumatoid Arthritis Monitoring Registry Cohorts

9:00AM-11:00AM: Abstract Number: 1188

Initial Estimates of Efficacy of Intra-Articular 2.5% Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis: An Observational Proof-of-Concept Study

9:00AM-11:00AM: Abstract Number: 1141

Initial Results of a Clinical Study to Determine Whether a Tolerizing Regimen of Pegloticase Can Increase the Frequency of Subjects Having Sustained Lowering of Serum Urate

9:00AM-11:00AM: Abstract Number: 1144

Initiating Colchicine and Urate-Lowering Therapy Reduces Baseline Inflammation, and Improves Vascular Endothelial but Not Smooth Muscle Function in Gout Subjects: Resistance to Endothelial Improvement Among Patients with Cardiovascular Comorbidities

9:00AM-11:00AM: Abstract Number: 1725

Insulin-like Growth Factor Binding Protein-4 Exerts Anti-Fibrotic Effects and Its Levels Are Reduced in SSc-Associated Lung Fibrosis

9:00AM-11:00AM: Abstract Number: 1463

Interaction between Methotrexate and BAFF for Preventing Immunization Against TNF-α Inhibitors By Increasing Adenosine and Regulatory B-Cell Subsets

9:00AM-11:00AM: Abstract Number: 1655

Interferon b Blockade Rescues Human BM-MSC Osteoblastogenesis Defects in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1728

Interferon Gamma (IFN-γ) Subpopulations in Skin Homing T Cells of Localized Scleroderma

9:00AM-11:00AM: Abstract Number: 1369

Interferon Gamma Signature Genes and CXCL10 As New Biomarkers in Early Stage of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1658

Interferon Related Soluble Mediator Concentrations Significantly Correlate with Disease Activity in SLE Patients with Active Interferon Pathways

9:00AM-11:00AM: Abstract Number: 1152

Interleukin-37 As an Independent Disease Activity Marker of Adult-Onset Still’s Disease

9:00AM-11:00AM: Abstract Number: 1756

Interstitial Lung Disease in ANCA Associated Vasculitis: A Distinct or an Incomplete Subset in ANCA Vasculitis Patients?

9:00AM-11:00AM: Abstract Number: 1486

Interstitial Lung Disease in Primary Sjögren’s Syndrome : Clinical Presentation, Serological Biomarkers and Long Term Outcome

9:00AM-11:00AM: Abstract Number: 1198

Intra-Articular Hyaluronic Acid Delay to Total Knee Arthroplasty By Number of Injection Courses Received: Analysis of an Administrative Database

9:00AM-11:00AM: Abstract Number: 1066

Invention and Phenotypic Evaluation of Human IgG4-Knock-in Mice

9:00AM-11:00AM: Abstract Number: 1097

Investigating Opportunities for Cost Conscious Care: A Review of Physician Practice in Ordering Anti-Nuclear Antibody Testing at an Academic Community Hospital

9:00AM-11:00AM: Abstract Number: 1269

Investigating Time Trends in Incident Pediatric Lupus across Ethnic Groups in Toronto, Canada—a Large, Multiethnic Metropolitan Area

9:00AM-11:00AM: Abstract Number: 1017

Investigation of Differential Methylation As a Potential Biomarker of Methotrexate Response in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1455

Investigation of Poor Prognostic Factors Among Rheumatoid Arthritis Patients in Turkbio Registry

9:00AM-11:00AM: Abstract Number: 1138

Investigation on Allele Frequency of Rs3117583 and Rs9263726 in Patients with Hyperuricemia or Gout

9:00AM-11:00AM: Abstract Number: 1742

Involvement of T Helper 17 Cells in Inflammatory Arthritis Depends on the Host Intestinal Microbiota

9:00AM-11:00AM: Abstract Number: 1356

Is ACPA-Positive RA Still a More Severe Disease Than ACPA-Negative RA? a Longitudinal Cohort Study in RA-Patients Treated from 2000 Onwards

9:00AM-11:00AM: Abstract Number: 1340

Is Depression in Patients with Rheumatoid Arthritis Associated with Disease Activity? Comparative Study between Germany and Brazil

9:00AM-11:00AM: Abstract Number: 980

Is Intra-Articular Injection of Synvisc Associated with a Delay to Knee Arthroplasty in Knee OA Patients?

9:00AM-11:00AM: Abstract Number: 1438

Is It Necessary to Weight By Weight the Dosage of MTX in RA Patients? Results from Obsevational Analysis of Baseline Data of a Phase III Trial

9:00AM-11:00AM: Abstract Number: 1353

Is Joint Damage Due to Secondary Osteoarthritis (OA) Clinically As Important As Inflammation in Contemporary Management of Rheumatoid Arthritis (RA)?

9:00AM-11:00AM: Abstract Number: 1512

Is Sacroiliac Imaging the All-Decisive Factor in the Diagnosis of Early Axial Spondyloarthritis? Data from the Spondyloarthritis Caught Early (SPACE) Cohort

9:00AM-11:00AM: Abstract Number: 1491

Is There a Seasonal Effect on Fatigue, Pain, and Dryness in Primary Sjögren’s Syndrome? Data from the Prospective Assess Cohort and from 3 Randomized Controlled Trials

9:00AM-11:00AM: Abstract Number: 1569

Isotretinoin Induced Seronegative Spondyloarthropathy: Magnetic Resonance Imaging As Diagnostic and Prognostic Biomarker

9:00AM-11:00AM: Abstract Number: 972

JAK/STAT Mediated Inhibition of Mir-23a~24-2~27a Cluster Potentiates Activation of CD14+ Monocytes in Treatment-Resistant RA

9:00AM-11:00AM: Abstract Number: 1575

JMJD3 Epigenetically Regulate Ankylosing Spondylitis Inflammation through Th17 Differentiation

9:00AM-11:00AM: Abstract Number: 1015

Key Genes and Pathways between Rheumatoid Arthritis and Osteoarthritis By Integrative Genome-Wide Gene Expression Profiling Analysis

9:00AM-11:00AM: Abstract Number: 1459

Lack of Drug-Drug Interaction between Filgotinib, a JAK-1 Selective Inhibitor, and a Representative Hormonal Contraceptive Medication, Levonorgestrel/Ethinyl Estradiol

9:00AM-11:00AM: Abstract Number: 1304

Lack of Uptake of Prophylactic Human Papilloma Virus (HPV) Vaccination Among Women with SLE in Saginaw Valley, a High Risk Population

9:00AM-11:00AM: Abstract Number: 1089

Large Variations in Tuberculosis Testing for New Biologic Users with Rheumatoid Arthritis Among Providers in the RISE Registry

9:00AM-11:00AM: Abstract Number: 1120

Less Than Half of Patients Treated with High-Dose Allopurinol Reach Serum Uric Acid Target

9:00AM-11:00AM: Abstract Number: 1644

Less Than Seven Hours of Sleep per Night Is Associated with Transitioning to Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 974

Leucine-Rich α-2 Glycoprotein Promotes Lung Fibrosis By Modulating TGF-β Signaling in Fibroblasts

9:00AM-11:00AM: Abstract Number: 1208

Levels of Serum Biomarkers from a Two-Year Multicentre Trial Are Associated with Treatment Response on Knee Osteoarthritis Cartilage Loss As Assessed By MRI: An Exploratory Study

9:00AM-11:00AM: Abstract Number: 1721

Long Noncoding RNA H19X Is a Key Regulator of Apoptosis and Proliferation of Fibroblasts in Systemic Sclerosis and Other TGFβ-Driven Fibrotic Diseases

9:00AM-11:00AM: Abstract Number: 1115

Long-Term Adherence to Urate-Lowering Therapy in Gout: Do Not Blame on the Patients

9:00AM-11:00AM: Abstract Number: 1498

Long-Term Cohort of Patients with a Clinical Diagnosis of Sjogren’s Syndrome: Activity Index and Patient Reported Outcome Performance

9:00AM-11:00AM: Abstract Number: 1563

Long-Term Effects of TNF-Alpha Inhibitors on Bone Mineral Density and the Incidence of Vertebral Fractures in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1292

Long-Term Follow-up of 320 Chilren Born to Mothers with Systemic Autoimmune Diseases: A Multicentre Survey from 24 Rheumatology Centers in Italy

9:00AM-11:00AM: Abstract Number: 1500

Longitudinal Analysis of Different Therapeutic Strategies in Patients with Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1495

Longitudinal Changes in EULAR Sjögren’s Syndrome Patient Reported Index in Routine Clinical Practice

9:00AM-11:00AM: Abstract Number: 1639

Longitudinal Evolution in a Nationwide Cohort Originally Classified As Mixed Connective Tissue Disease

9:00AM-11:00AM: Abstract Number: 1277

Longitudinal Predictors of Physical Function in Juvenile Myositis

9:00AM-11:00AM: Abstract Number: 1677

Low Baseline Impedance in Proximal Esophagus and Decreased Pspw Index May Related with Pathogenesis of Interstitial Lung Disease in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1378

Low HDL Level As a Clinical Marker of Disease Activity in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1260

Lupus Diagnosis: Process and Patient Experience

9:00AM-11:00AM: Abstract Number: 1605

Lupus Low Disease Activity State Protects Against Most Subtypes of Organ Damage in SLE

9:00AM-11:00AM: Abstract Number: 1603

Lupus Low Disease Activity State: Can We Relax the Definition and Still Achieve Low Risk of SLE-Related Damage?

9:00AM-11:00AM: Abstract Number: 1600

Lupus Nephritis Is Associated with Increased Rates of Hospitalization for Adverse Events on a Glucocorticoid Toxicity Index and in-Hospital Mortality Compared with Non-Renal Lupus and Matched Controls: An Analysis of Insurance Claims Data

9:00AM-11:00AM: Abstract Number: 1302

Luteinized Unruptured Follicle Syndrome in Young Female with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 1359

M-DAS28, M-SDAI and M-CDAI Performance in a Cohort of RA Patients with and without Concomitant Fibromyalgia

9:00AM-11:00AM: Abstract Number: 1147

Macrophage Activation Syndrome or Acquired Hemophagocytic Lymphohistiocytosis in Adults: Demographics, Clinical Characteristics, and Survivorship in an American Academic Medical Center

9:00AM-11:00AM: Abstract Number: 1499

Major Salivary Gland Ultrasonography Bed-Side and Still Image Scoring – a Pilot Comparison in Juvenile Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1283

Male Patients Have a More Severe Course As Female Patients with Diffuse Juvenile Systemic Scleroderma? Results from the Juvenile Scleroderma Inception Cohort Www.Juvenile-Scleroderma.Com

9:00AM-11:00AM: Abstract Number: 1116

Management of Acute Gout in Hospitalized Patients and Risk Factors for Xanthine Oxidase Inhibitor (XOI) Discontinuation or Dose Reduction

9:00AM-11:00AM: Abstract Number: 1139

Management of Gout – a Survey for Healthcare Providers in South Australia

9:00AM-11:00AM: Abstract Number: 1124

Marked Variability of Circulating Urate Concentrations in Banked Samples Based on Sample Type and Assay

9:00AM-11:00AM: Abstract Number: 1310

Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy

9:00AM-11:00AM: Abstract Number: 1044

Medical Care Costs Associated with Rheumatoid Arthritis in the US: A Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1403

Mediterranean Diet Is Inversely Associated with Risk of Rheumatoid Arthritis: A Swedish Population Based Case-Control Study

9:00AM-11:00AM: Abstract Number: 998

Mental Health in Patients with Axial Spondyloarthritis: Increasing Our Understanding of the Disease. Results from the Spanish Atlas

9:00AM-11:00AM: Abstract Number: 1724

Metabolic Regulation of Fibrosis in Systemic Sclerosis: The CD38-NAD+ Link

9:00AM-11:00AM: Abstract Number: 1406

Methods for Generating Multiple High-Dimensional Analyses of Cryopreserved Synovial Tissue Developed By the Accelerating Medicines Partnership RA/SLE Network

9:00AM-11:00AM: Abstract Number: 1572

MHC Associations of Ankylosing Spondylitis in East Asians Are Driven By HLA-B Amino-Acid Position 97, Confirming Findings in European Descent Subjects

9:00AM-11:00AM: Abstract Number: 1712

Microbial and Metabolic MULTI-Omic Correlations in Systemic Sclerosis Patients

9:00AM-11:00AM: Abstract Number: 1351

Minimal Clinically Important Improvement (MCII) of RAPID3 (ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3), an INDEX of ONLY Patient Self-Report Scores in Rheumatoid Arthritis (RA): Similar Performance to DAS28 and CDAI

9:00AM-11:00AM: Abstract Number: 1715

Mitochondrial DNA Mutations and Respiratory Chain Dysfunction in Lung Fibrosis of Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1011

Mitochondrial Haplogroups-Mediated Methylation Regulates Apoptosis in Osteoathritis Cartilage

9:00AM-11:00AM: Abstract Number: 1417

Mitophagy Defect in Fibroblast-like Synoviocytes of Rheumatoid Arthritis Is Improved By Pyruvate Treatment

9:00AM-11:00AM: Abstract Number: 969

Modulation of Cartilage Degradation Biomarkers Reflect the Activation and Inhibition of Pro-Inflammatory Cytokine Signaling in an Ex Vivo Model of Bovine Cartilage

9:00AM-11:00AM: Abstract Number: 1708

Molecular Imaging Biomarkers for Personalized Medicine Strategies in Systemic Sclerosis-Related Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 1019

Molecular Profiling of RA Patients Suggests a Differential Involvement of Adaptive and Innate Cell Populations in Response to Anti-TNF Treatment

9:00AM-11:00AM: Abstract Number: 1427

Monitoring of Absolute Lymphocyte Count in Patients with Rheumatoid Arthritis Treated with Tofacitinib

9:00AM-11:00AM: Abstract Number: 1579

Monocyte-Derived Dendritic Cells (MDDCs) from Spondyloarthritis (SpA) Patients Exhbit a Coordinated Downregulation of the Cholesterol (chol) Biosynthesis Pathway That Relates to Lipid Overload

9:00AM-11:00AM: Abstract Number: 1570

Monocytes from Male Patients with Ankylosing Spondylitis Display Decreased Osteoclastogenesis and Decreased RANKL/OPG Ratio

9:00AM-11:00AM: Abstract Number: 968

Mononuclear Phagocytes Mediate Systemic Autoimmune Disease-Related Valvular Heart Disease Via Inflammatory Cytokine Production and Recruitment of Tissue-Reparative macrophages

9:00AM-11:00AM: Abstract Number: 1591

Monophasic Disease Course Pattern in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1504

More Than 10 Percent Patients with Recent Onset Chronic Mechanical Back Pain Fulfill the Modified NY Criteria for Sacroiliitis

9:00AM-11:00AM: Abstract Number: 1333

Mortality of Tumor Necrosis Factor Transgenic Arthritic Mice with Interstitial Lung Disease Occurs with Pulmonary Arteriole Thickening and Right Ventricular Hypertrophy but Is Not Associated with Inducible Nitric Oxide Synthase Dependent Inflammatory Cell Infiltration

9:00AM-11:00AM: Abstract Number: 1008

mtDNA Cybrids from OA Patients Are Less Efficient Using Glycolysis and Are More Susceptible to Apoptosis Under Stress Conditions

9:00AM-11:00AM: Abstract Number: 1746

mTOR Pathway Activation in Takayasu Arteriti

9:00AM-11:00AM: Abstract Number: 1065

Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus Is Realted to an Intrinsic Defect in the Ca2+/Calcineurin/NFAT1 Signaling Pathway

9:00AM-11:00AM: Abstract Number: 1180

Multicenter Study on the Rate of Renal Function Deterioration in IgG4-Related Tubulointerstitial Nephritis

9:00AM-11:00AM: Abstract Number: 1072

Mutated Peptidylarginine Deiminase from Porphyromonas Gingivalis Is a Target in Rheumatoid Arthritis and Citrullinates Major RA-Autoantigens

9:00AM-11:00AM: Abstract Number: 1587

Mycobacterial Infection in Systemic Lupus Erythematosus: Clinical Significance and Associated Factors. Data from the Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)

9:00AM-11:00AM: Abstract Number: 1171

Mycophenolate Mofetil May Improve Interstitial Pneumonia with Autoimmune Features

9:00AM-11:00AM: Abstract Number: 1782

Mycophenolic Acid Decreases IL-10 and IL-6 Production By B Cells of Granulomatosis with Polyangiitis Patients and Healthy Controls in Vitro

9:00AM-11:00AM: Abstract Number: 1276

Nail Fold Capillary Changes Are Associated with Pulmonary, but Not with Cardiac Involvement in Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 1690

Nailfold Capillary Counts Are Associated with Clinical Manifestations in Connective Tissue Disease Japanese Patitents

9:00AM-11:00AM: Abstract Number: 1159

National Recommendations on the Use of Immunomodulatory Drugs in Patients with NON-Infectious NON-Malignant Anterior Uveitis

9:00AM-11:00AM: Abstract Number: 1613

Natural History of Disease Activity and Damage in Patients with Cutaneous Lupus Erythematosus on Standard of Care Treatments Using Longitudinal Registries from Two Academic Dermatology Centers

9:00AM-11:00AM: Abstract Number: 1561

Network Meta-Analysis of Targeted Immunomodulators in the Treatment of Biologic-NaïVe Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1773

New Use for an Old Drug: Hydroxychloroquine for the Treatment of ANCA Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 967

NF-κb-Inducing Kinase Regulates LTβR-Driven NF-κb Signaling and Inflammatory Activation of Endothelium

9:00AM-11:00AM: Abstract Number: 1772

Non-Protocolized Re-Biopsy in Patients with ANCA-Associated Glomerulonephritis: ¿Is It Necessary?

9:00AM-11:00AM: Abstract Number: 1704

Non-Randomized Controlled Trial to Evaluate the Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1210

Non-Responders to Total Joint Replacement Therapy in Osteoarthritis Patients and Novel Metabolic Markers

9:00AM-11:00AM: Abstract Number: 1009

Novel Non-Coding RNAs Associated with Rheumatoid Arthritis in Asians By Gene-Based Testing

9:00AM-11:00AM: Abstract Number: 1723

Nuclear Magnetic Resonance Based Metabolomics Study Identifies Highly Discriminatory Metabolites in 87 Systemic Sclerosis Patients

9:00AM-11:00AM: Abstract Number: 1317

Obstetric Outcomes in Women with Rheumatoid Arthritis: Results from Nationwide Inpatient Sample Database 2003-2011

9:00AM-11:00AM: Abstract Number: 1150

Ocular Involvement Is Exclusive with Genital Ulcer and Skin Lesion in the Early Phase of Behçet’s Disease: Nationwide Japanese Registration.

9:00AM-11:00AM: Abstract Number: 1216

Odontoid Fractures in the Elderly: An Unknown Osteoporotic Fracture?

9:00AM-11:00AM: Abstract Number: 1779

Off-Label Use of Biological Therapies in Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)

9:00AM-11:00AM: Abstract Number: 1550

One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept – an Observational Study from the Danish Danbio Registry

9:00AM-11:00AM: Abstract Number: 1548

Opioid Use in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1313

Oral Corticosteroid Use during Pregnancy and Risk of Preterm Birth in Women with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1190

Orosomucoid 2 Serves As Predictor of Therapeutic Response in Osteoarthritis Patients Treated with Chondroitin Sulfate/Glucosamine Hydrochloride

9:00AM-11:00AM: Abstract Number: 1227

Osteoporosis and Breast Cancer: Can FRAX-Based Risk Factors Accurately Predict Further Fractures at This Setting?

9:00AM-11:00AM: Abstract Number: 1250

Outcomes in Real-World Patients with Early Aggressive Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1335

p62/SQSTM1 Modulates Bone Erosions in a Murine Model of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1678

Pathogenic Mechanisms of Esophageal Peristaltic Dysfunction By High Resolution Manometry in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1192

Patient Characteristics That Predict the Effect of Laparoscopic Adjustable Gastric Band Weight Loss Surgery on Knee Osteoarthritis Pain

9:00AM-11:00AM: Abstract Number: 1393

Patient Characteristics, Treatment Strategy or Investigator Effect: An Analysis of Factors Driving Variation in Outcomes in Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1273

Patient Health Questionnaire-9 Utilization for the Detection of Depression in Adolescents and Young Adults with Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 1246

Patient Preferences Associated with the Use of Treatments for Psoriatic Arthritis: Results of a Conjoint Analysis

9:00AM-11:00AM: Abstract Number: 1536

Patient Preferences in Medication for Treatment of Spondyloarthritis: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 1253

Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1395

Patient Reported Outcomes in Rheumatoid Arthritis: Best Domain, Best Interface

9:00AM-11:00AM: Abstract Number: 1299

Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1477

Patient-Reported Outcomes As Independent Measures of Treatment Success with Sirukumab, an Anti-IL6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis: Post-Hoc Analysis of 2 Placebo-Controlled Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 1522

Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1423

Patterns of Prednisone Use in US Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine Clinical Practice

9:00AM-11:00AM: Abstract Number: 1235

Perceived Stress and Fatigue in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1040

Perceptions of US Community Rheumatologists on Biosimilars

9:00AM-11:00AM: Abstract Number: 1696

Performance of Forced Vital Capacity and Lung Diffusion Cut-Points for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1286

Performance of Juvenile Scleroderma Classification Criteria for Juvenile Systemic Sclerosis. Results from the Jssc Inception Cohort

9:00AM-11:00AM: Abstract Number: 1457

Perioperative Management of Methotrexate and Tumor Necrosis Factor Inhibitor Combination Therapy in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1332

Periostin Deficiency Exacerbates Joint Inflammation and Bone Destruction in Mouse Models of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1401

Persistence of Mast Cell-Rich Synovitis Is Associated with Lack of Response to Synthetic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1001

Persistence, Discontinuation, and Switching Patterns Among Ankylosing Spondylitis Patients Newly Initiating Biologic Therapy

9:00AM-11:00AM: Abstract Number: 1552

Persistency of Tumor Necrosis Factor Inhibitor Therapy in US Patients with Ankylosing Spondylitis: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry

9:00AM-11:00AM: Abstract Number: 1259

Perspectives of Young People with Juvenile Idiopathic Arthritis, Their Caregivers, and Health Care Providers on Transition to Adult Care: Informing Development of a Transition Toolkit

9:00AM-11:00AM: Abstract Number: 1752

Pharmacokinetics of Rituximab and Clinical Outcomes in Patients with ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1514

Phenotype Differences in HLA-B27 Positive Versus Negative Patients with Ankylosing Spondylitis in a Population That Show Relatively Weaker Association with HLA-B27

9:00AM-11:00AM: Abstract Number: 1070

Phenotypic Characterization of Peripheral Basophil Perturbations in the Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 1167

Phenotypical Features of Patients with Rheumatologic Manifestations of Common Variable Immunodeficiency

9:00AM-11:00AM: Abstract Number: 1209

Phospholipase A2 Group 5 Is a Potential Therapeutic Target for Osteoarthritis Treatment

9:00AM-11:00AM: Abstract Number: 1384

Physician Global Assessments for Disease Activity in Rheumatoid Arthritis Are All over the Map!

9:00AM-11:00AM: Abstract Number: 1781

Pituitary Disease and Granulomatosis with Polyangiitis: A Collaborative Canadian Case Series and Review of the Literature

9:00AM-11:00AM: Abstract Number: 1281

Plasma CXCL4 As a Biomarker in Juvenile Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1303

Polycystic Ovarian Syndrome in Rheumatic Disease

9:00AM-11:00AM: Abstract Number: 1228

Postmenopausal Breast Cancer Patients on Aromatase Inhibitor Therapy and Their Increased Risk of Fragility Fracture

9:00AM-11:00AM: Abstract Number: 1213

Prediction Model for the Two-Year Risk of Fracture Among Older US Women

9:00AM-11:00AM: Abstract Number: 1654

Predictive Factors According to Type of Infection in Systemic Lupus Erythematosus Patients: Data from a Multi-Ethnic, Multi-National, Latin-American Cohort

9:00AM-11:00AM: Abstract Number: 1460

Predictive Factors Associated with Successful Down-Titration of Biologics for Rheumatoid Arthritis Patients in Clinical Practice

9:00AM-11:00AM: Abstract Number: 1306

Predictors of Contraceptive Use Among Reproductive-Age Women with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1560

Predictors of Long-Term Modified Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated with Adalimumab

9:00AM-11:00AM: Abstract Number: 1311

Pregnancy Outcome in Chinese Women with Rheumatic Disease Treated By Leflunomide (LEF)

9:00AM-11:00AM: Abstract Number: 1295

Pregnancy Outcome in Patients with SLE Compared to Patients with Other Inflammatory Rheumatic Diseases: Real World Data from a Prospective Pregnancy Register

9:00AM-11:00AM: Abstract Number: 1312

Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis; Hur-BIO Real Life Experiences

9:00AM-11:00AM: Abstract Number: 1314

Pregnancy Outcomes in Patients with Psoriasis: A Nationwide Population-Based Study

9:00AM-11:00AM: Abstract Number: 1482

Preliminary Population-Based Incidence and Prevalence Estimates of Primary Sjogren’s Syndrome from the Manhattan Lupus Surveillance Program

9:00AM-11:00AM: Abstract Number: 1034

Presence of Anti-Cyclic Citrullinated Peptide Antibodies Is Associated with Better Treatment Response to Abatacept but Not to TNF Inhibitors in Patients with RA: A Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1290

Preterm Birth Phenotypes in Women with Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 1291

Preterm Delivery Phenotypes in SLE Pregnancies

9:00AM-11:00AM: Abstract Number: 1595

Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry

9:00AM-11:00AM: Abstract Number: 1050

Prevalence and Predictors of Knee Replacement Overuse and Underuse in the US

9:00AM-11:00AM: Abstract Number: 1771

Prevalence and Prognostic Relevance of Cardiovascular Involvement in ANCA-Associated Vasculitis: A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 1122

Prevalence of Chronic Kidney Disease and Uncontrolled Serum Uric Acid Levels in US Adult Gout Population: Results from the National Health and Nutrition Examination Survey 2007–2012

9:00AM-11:00AM: Abstract Number: 1623

Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By a Comprehensive Neuropsychological Battery

9:00AM-11:00AM: Abstract Number: 1621

Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By the Automated Neuropsychological Assessment Metrics

9:00AM-11:00AM: Abstract Number: 1612

Primary Respiratory Disease in Patients with Systemic Lupus Erythematosus: Data from the Spanish Rheumatology Society Lupus Registry (RELESSER) Cohort

9:00AM-11:00AM: Abstract Number: 1780

Prognostic Factors in Patients with Granulomatosis with Polyangiitis Requiring Hospitalization- a 10 Year Nationwide Analysis

9:00AM-11:00AM: Abstract Number: 1660

Prolactin Induces an Interferon Signature in Monocytes and Drives IRF1-HAT Interactions

9:00AM-11:00AM: Abstract Number: 1590

Prolonged Antimalarial Treatment Increases the Risk for Severe Brady-Arrhythmias in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1778

Prophylactic Treatment and Incidence of Pneumocystis Jirovecci Pneumonia in Japanese Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1448

Prospective, Intervention, Multicenter, Non-Inferiority Study of Utility of Therapeutic Drug Monitoring with Respect to the Efficacy and Cost of Adalimumab Tapering in Patients with Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1111

Protective Effect of Allopurinol Use on Kidney Function Among Patients with Gout and Chronic Kidney Disease

9:00AM-11:00AM: Abstract Number: 1411

Protein Tyrosine Phosphatase Non-Receptor 22 / C-Src Tyrosine Kinase Complex Down-Regulated in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1062

Ptpn22 Regulates Synovial Slam Family Receptor Expression during Toll-like Receptor-Driven Suppression of Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 991

Publication Timeliness of the Randomized Controlled Trials of Drug Therapy for Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1760

Pulmonary Manifestations in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Multicenter Cohort Analysis

9:00AM-11:00AM: Abstract Number: 1027

Quantification of Leukocytes’ Secretome to Guide Diagnosis and Treatment Options in Patients with Suspected Chronic Auto-Inflammatory Syndromes

9:00AM-11:00AM: Abstract Number: 1698

Quantitative Analyze of Peripheral Vascular Bed in Patients with Systemic Sclerosis By Using Photoacoustic Imaging Technology: A Pilot Study

9:00AM-11:00AM: Abstract Number: 1204

Radiographic Outcomes Were Associated with Pain and Function Responses: Post-Hoc Analysis of Results from a Phase 2 Study of a Small Molecule Wnt Pathway Inhibitor, SM04690, for Knee Osteoarthritis Treatment

9:00AM-11:00AM: Abstract Number: 1123

Random Urinary Uric Acid/Creatinine Ratio Is Useful in the Estimation of 24-Hour Urine Uric Acid Excretion in Patients with Gout

9:00AM-11:00AM: Abstract Number: 1169

Rapid Improvement with Tocilizumab in Refractory and Severe Uveitic Cystoid Macular Edema

9:00AM-11:00AM: Abstract Number: 1511

Real-Life Performance of the ASAS Health Index in Routine Care of Patients with Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1543

Real-World Effectiveness of TNF Inhibition in Spondyloarthritis. Data from a Large Nationwide Prospective Cohort – the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1252

Real-World Oral Methotrexate Adherence Measured Electronically in Patients with Established Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1524

Real-World Use of Secukinumab Among Biologic-NaïVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States

9:00AM-11:00AM: Abstract Number: 1041

Real-World Utilization of Biosimilars for Management of Rheumatoid Arthritis (RA) in the US

9:00AM-11:00AM: Abstract Number: 1201

Reducing Heterogeneity in OA Clinical Trials: Data from a Phase 2 Study of SM04690, a Novel, Intra-Articular, Wnt Pathway Inhibitor in Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1464

Relation of HLA-DRB1 Genotype to the Efficacies of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1212

Relation of Incident Bisphosphonate Use to Bone Marrow Lesion Volume in Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1358

Relationship between Serum Protein Pattern and High Disease Activity in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1263

Relevance and Utility of Patient Reported Outcomes Measurement Information System (PROMIS®) Instruments in SLE: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 1042

Remote Management of Osteoporosis Screening and Treatment in US Veterans Using a Bone Health Team: A Cost-Effectiveness Analysis

9:00AM-11:00AM: Abstract Number: 1288

Renal Disease Course in Pediatric Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis in the First 12-Months – a Pediatric Vasculitis Initiative (PedVas) Study

9:00AM-11:00AM: Abstract Number: 1127

Replication of Genetic Association of Peroxisome Proliferator-Activated Receptor Gamma-1B with Gout in a New Zealand Polynesian Sample Set

9:00AM-11:00AM: Abstract Number: 1559

Residual Disease Activity in Psoriatic Arthritis Triggers Treatment Adjustment in Only a Quarter of Patients in Daily Clinical Practice

9:00AM-11:00AM: Abstract Number: 1586

Resistant Hypertension Is Associated with Inflammation, Renal Function, and Increased Mortality in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1184

Response to Methotrexate and Glucocorticoid Injection in New Onset Arthritis after Checkpoint Inhibitor Therapy

9:00AM-11:00AM: Abstract Number: 1082

Responsiveness and Minimally Clinically Important Differences of Promis Measures in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1264

Responsiveness of Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests (CATs) in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1330

Rhesus Theta Defensin 1 (RTD-1) Suppresses Disease-Associated Genes and Induces Anti-Inflammatory Expression Signature in Synovial Tissues of Rat Model of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1173

Rheumatic Immune Related Adverse Events Due to Programmed Cell Death Protein 1 (PD-1) Inhibition for Cancer: Comprehensive Analysis of a Whole Cancer Cohort

9:00AM-11:00AM: Abstract Number: 1156

Rheumatic Immune Related Adverse Events from Checkpoint Inhibitor Therapy for Cancer: Long-Term Follow up Data

9:00AM-11:00AM: Abstract Number: 1153

Rheumatic Manifestations of Whim Syndrome

9:00AM-11:00AM: Abstract Number: 1083

Rheumatoid Arthritis Patients Achieved Better Quality of Life Than Systemic Lupus Erythematosus Patients at Sustained Remission: The Impact of Disease Diagnosis on Health-Related Quality of Life Outcomes

9:00AM-11:00AM: Abstract Number: 1087

Rheumatology Clinic Smoking Cessation Protocol Markedly Increases Quit Line Referrals

9:00AM-11:00AM: Abstract Number: 1279

Risk Factors for Achieving a Drug-Free Remission in Patients with Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 1268

Risk Factors for Bone Loss in Juvenile-Onset Systemic Lupus Erythematosus: A Prospective Study

9:00AM-11:00AM: Abstract Number: 1618

Risk Factors for Development of Early Infectious and Non-Infectious Complications in Systemic Lupus Erythematosus Patients Undergoing Major Surgery

9:00AM-11:00AM: Abstract Number: 1750

Risk of Cardiovascular and Thrombotic Disease Among Patients with Incident ANCA-Associated Vasculitis: A 20 Year Population Based Cohort Study

9:00AM-11:00AM: Abstract Number: 1113

Risk of Cardiovascular Events in Older Patients with Gout Initiating Probenecid Versus Allopurinol: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 1691

Risk of Development of Definite Disease in Patients with Early Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1035

Risk of Hospitalization Among RA Patients with Multiple Autoimmune Co-Morbidities Differs By DMARD Treatment

9:00AM-11:00AM: Abstract Number: 1481

Risk of Ischemic Heart Disease in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis of Observational Studies

9:00AM-11:00AM: Abstract Number: 1480

Risk of Ischemic Stroke in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1316

Risk of Preterm Delivery Associated with Perinatal Exposure to Dmards in Women with Inflammatory Arthritis: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 1758

Risk of Serious Infection in Granulomatosis with Polyangiitis or Microscopic Polyangiitis: Long-Term Outcomes of 126 Wegent Trial Patients

9:00AM-11:00AM: Abstract Number: 1175

Rituximab for Idiopathic and IgG4-Related Retroperitoneal Fibrosis

9:00AM-11:00AM: Abstract Number: 1757

Rituximab for Induction and Maintenance Therapy of Granulomatosis with Polyangiitis: A Single-Center Cohort Study on 114 Patients

9:00AM-11:00AM: Abstract Number: 1585

Role of Corticosteroids in Subclinical Atherosclerosis in SLE: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1339

Role of Hexokinase-2 in Synovial Lining Hypertrophy in Murine Arthritis

9:00AM-11:00AM: Abstract Number: 1642

Role of Plaque in Predicting Cardiovascular Events in Women with Lupus over a 20 Year Followup

9:00AM-11:00AM: Abstract Number: 962

Role of Syndecans in Cytokine Mediated Inflammation in Rheumatoid Arthritis Synovial Fibroblasts

9:00AM-11:00AM: Abstract Number: 1582

RORγt Inhibition Selectively Targets Pathogenic Subsets of Human iNKT and γδ-T Cells Enriched in Spondyloarthritis While Preserving Tissue Protective IL-22 Responses

9:00AM-11:00AM: Abstract Number: 1196

Safety and Efficacy of ABT-981, an Anti–Interleukin-1α/β Dual Variable Domain (DVD) Immunoglobulin, in Subjects with Knee Osteoarthritis: Results from the Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Trial

9:00AM-11:00AM: Abstract Number: 1532

Safety and Efficacy of Intravenous Golimumab in Adult Patients with Active Ankylosing Spondylitis: Results through 1 Year

9:00AM-11:00AM: Abstract Number: 1755

Safety of Methotrexate and Low-Dose Trimethoprim-Sulfamethoxazole in Patients with ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1487

Salivary Gland Ultrasonography (SGUS) and Subclinical Parotid Involvement: Usefulness of Sgus in the Identification of a Subset of Patients with Sjögren’s Syndrome at Higher Risk for Extraglandular Disease Manifestations

9:00AM-11:00AM: Abstract Number: 1231

Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence

9:00AM-11:00AM: Abstract Number: 1086

Screening and Intervention of Depression in Rheumatoid Arthritis and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1651

Screening in Patients at High Risk of Hydroxychloroquine Retinal Toxicity

9:00AM-11:00AM: Abstract Number: 1529

Secukinumab Demonstrates Consistent Safety over Long-Term Exposure (up to 3 years) in Patients with Active Ankylosing Spondylitis: Pooled Analysis of Three Phase 3 Trials

9:00AM-11:00AM: Abstract Number: 1523

Secukinumab Demonstrates Rapid and Sustained Efficacy in Ankylosing Spondylitis Patients with Normal or Elevated Baseline CRP Levels: Pooled Analysis of Two Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 1528

Secukinumab Provides Rapid and Sustained Pain Relief in Ankylosing Spondylitis Patients with Normal or Elevated Baseline CRP Levels and Correlated with Improvement in Fatigue

9:00AM-11:00AM: Abstract Number: 1346

Selective Effect of Rituximab on IgG4 Anti-CCP Autoantibodies in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1743

Serine Arginine/Rich Splicing Factor 1 (SRSF1) Increases IL-2 Production in T Cells By Increasing the Expression of NFAT and c-Fos

9:00AM-11:00AM: Abstract Number: 1664

Serum FAS, Ferritin, Igfbp2, sTNFR2 As Markers for Tracking Mucocutaneous and Musculoskeletal Flares in SLE Patients

9:00AM-11:00AM: Abstract Number: 1380

Serum Galectin-3 in Rheumatoid Arthritis Compared with Healthy Controls and Subjects with Prediabetes before and after High-Intensity Interval Training

9:00AM-11:00AM: Abstract Number: 1181

Serum KL-6 Level Reflects Severity of Interstitial Lung Disease Associated with Connective Tissue Disease

9:00AM-11:00AM: Abstract Number: 1774

Serum Periostin As a Biomarker in Eosinophilic Granulomatosis with Polyangiitis

9:00AM-11:00AM: Abstract Number: 1389

Serum Progranulin Antibodies (PGRN-abs) in Rheumatoid Arthritis Patients Being Negative for RF-IgM and ACCP-IgG

9:00AM-11:00AM: Abstract Number: 1431

Serum Trough Levels of Adalimumab Inversely Correlate with Disease Activity in Patients with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1006

Sex Differences in Depressive Symptom Subtypes in Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1109

Sex Differences in Gout Patients: Epidemiology, Flares and Hospitalization Data in a Population Based Cohort

9:00AM-11:00AM: Abstract Number: 1501

Sexual Dysfunction and Vaginal Dryness Are Common in Female Patients with Early, Active Primary Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1637

Sexual Function in Married Indian Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1526

Shift Analysis of Spinal Radiographic Progression after 2 Years of Secukinumab in Ankylosing Spondylitis – Detailed Results from a Phase 3 Trial

9:00AM-11:00AM: Abstract Number: 1598

Shrinking Lung Syndrome in Systemic Lupus Erythematosus Patients: A Diagnosis We Should Suspect More Often

9:00AM-11:00AM: Abstract Number: 1682

Significance of Anti-Topoisomerase I Antibodies in Routine Clinical Testing

9:00AM-11:00AM: Abstract Number: 1069

Significantly Elevated Serum Protein-Adduction with 4-Hydroxy-2-Nonenal but Not Malondialdehyde in Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1509

Similarities and Differences between Non-Radiographic and Radiographic Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 1510

Similarities and Differences between Osteitis Condensans Ilii and Axial Spondyloarthritis Patients Presenting with Chronic Back Pain in a Rheumatology Setting

9:00AM-11:00AM: Abstract Number: 1506

Similarities and Differences between Patients Fulfilling Non-Radiographic Axial Spondyloarthritis and Undifferentiated Spondyloarthritis Criteria: Results from the Esperanza Cohort

9:00AM-11:00AM: Abstract Number: 1711

SIRT1 May Protect Against Systemic Sclerosis-Related Pulmonary Fibrosis By Decreasing Pro-Inflammatory and Pro-Fibrotic Processes

9:00AM-11:00AM: Abstract Number: 1381

Skeletal Muscle Cytokine and Myostatin Responses to High-Intensity Interval Training in Rheumatoid Arthritis Contrasted with Prediabetes Mellitus

9:00AM-11:00AM: Abstract Number: 1717

Skin Commensal Bacteria Might Affect Wound Repair in SSc By Preventing Fibroblast Activation and By Provoking Chronic Inflammatory Reaction

9:00AM-11:00AM: Abstract Number: 1632

SLE Characteristics Associated with Modified Framingham Risk Score in Patients without Clinical Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 1675

SLE Comprises Four Immune-Phenotypes, Which Differ Regarding HLA-DRB1 and Clinical Associations

9:00AM-11:00AM: Abstract Number: 1624

SLE Disease Activity Index Glucocorticosteroid Index (SLEDAI-2KG) Identifies More Responders Than Sledai-2K

9:00AM-11:00AM: Abstract Number: 1657

SLE Patients with Active Interferon Pathways Showed More Systemic Disease Involvement Than Patients with Inactive Interferon Pathways

9:00AM-11:00AM: Abstract Number: 1398

Sleep and Physical Activity: An Objective Profile of People with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1649

Sleep Disturbances in Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1640

SLICC Damage Index Is Associated with Tubulointerstitial Nephritis on Lupus Nephritis Biopsies

9:00AM-11:00AM: Abstract Number: 1368

Small RNA Sequencing Identifies Plasma microRNA Panel for Rheumatoid Arthritis Diagnosis

9:00AM-11:00AM: Abstract Number: 1764

Small RNA Sequencing Shows Differential Plasma Microrna Expression in Patients with ANCA-Associated Vasculitis: A Pilot Study

9:00AM-11:00AM: Abstract Number: 1683

Smoking Behaviour and the Progression of Organ Manifestations in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

9:00AM-11:00AM: Abstract Number: 1447

Smoking Reduces Efficacy of Biologics Differently By Target Cytokines in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1007

Smoking Signicantly Reduces Effectiveness and Long-Term Survival of Biologic Treatment in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1665

Soluble Programmed Cell Death Protein 1 As a Biomarker for Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1164

Spectrum of Skin Eruption and Histological Findings in Adult-Onset Still’s Disease and Significance of Atypical Persistent Skin Eruptions

9:00AM-11:00AM: Abstract Number: 1262

Stability of Two Short Medication Adherence Questionnaires over Time for Follow-up in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1088

Staff Protocol in Rheumatology Clinics Reduces Population-Level Rate of High Blood Pressure

9:00AM-11:00AM: Abstract Number: 1451

Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results

9:00AM-11:00AM: Abstract Number: 1661

STAT4 Regulates Pathogenic IL-21 and IFN-γ in Tfh Cells in Murine and Human Lupus

9:00AM-11:00AM: Abstract Number: 1688

Stem Cell-Enriched Lipotransfer Substantially Improves Measures of Appearance and Function Due to Facial Fibrosis in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1414

Stimulation with Resistin Upregulates Chemokine Production By Fibroblast-like Synoviocytes from Patients with Rheumtoid Arthritis

9:00AM-11:00AM: Abstract Number: 1535

Study of Potential Clinical and Biologic Predictors of Maintaining Good Response at 1 Year Follow-up, in Patients with Ankylosing Spondylitis Under Dose Reduction of TNFi Treatment

9:00AM-11:00AM: Abstract Number: 1025

Submetabolome Profiling with Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolite Profile with 99% Accuracy for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1002

Survival and Years of Potential Life Lost in Connective Tissue Disease and Vasculitis; Data from the Norwegian Connective Tissue Diseases and Vasculitis Registry (NOSVAR)

9:00AM-11:00AM: Abstract Number: 1430

Switching from Synthetic to Biologic Dmards – Is There an Insufficient Use of Methotrexate?

9:00AM-11:00AM: Abstract Number: 1348

Swollen Joint Count, but Not Inflammatory Cytokines, Differs By Frequency of Fish Consumption in a Cross-Sectional Rheumatoid Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 1178

Sympathetic Joint Effusion in an Urban Hospital

9:00AM-11:00AM: Abstract Number: 1456

Synergistic Reversal of Arthritis By Synoviocyte-Targeted Therapy and TNF Immunomodulation

9:00AM-11:00AM: Abstract Number: 971

Synovial Fibroblast CD318 Expression Mediates T Cell Adhesion and Migration in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1101

Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability

9:00AM-11:00AM: Abstract Number: 1052

Systematic Review of Modelling Approaches and Quality for the Cost Effectiveness of sequential Targeted Therapy in Patients with Rheumatoid Arthritis That Show an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor

9:00AM-11:00AM: Abstract Number: 1166

Systemic Degos Disease: Long Term Survival on Combined Therapy with Eculizumab and Treprostinil

9:00AM-11:00AM: Abstract Number: 1433

Tailoring Second-Line Biologic Therapy in Rheumatoid Arthritis: New Findings on the Usefulness of Antibody Status to Optimise Drug Selection

9:00AM-11:00AM: Abstract Number: 1444

Targeted Therapeutic Delivery to Cartilage with Knottin Proteins

9:00AM-11:00AM: Abstract Number: 1319

TAS05567 Is a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor That Attenuates Disease Severity in Animal Models of Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 1320

TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Ameliorates Inflammation and Bone Erosion in Murine Model for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1051

Telemedicine for Rheumatoid Arthritis in the Alaska Native Population

9:00AM-11:00AM: Abstract Number: 1609

Telomere Length and Coronary Artery Atherosclerosis in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1345

Tender Joints Have Low Associations with Patient’s Evaluation of Joint Pain and Ultrasound Findings Explored at Joint Level in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1386

Tenosynovitis in the Forefoot at Disease Presentation Is Specific for RA: Results from a Cross-Sectional MRI Study in Early Arthritis

9:00AM-11:00AM: Abstract Number: 1720

TGF-ß-Induced Tissue Fibrosis in TBRIcaCol1Cre Transgenic Mice Is Abrogated By the Second Generation Tyrosine Kinase Inhibitor SKI-606 (Bosutinib)

9:00AM-11:00AM: Abstract Number: 1076

TGF-β1 Induces AXL in Murine and Human Synovium and Protects Ankle Joints, but Not Knee Joints, during Murine Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1716

TGFβ-Dependent Upregulation of XIAP Fosters Fibroblast Activation and Tissue Fibrosis By Promoting Canonical Wnt Signaling

9:00AM-11:00AM: Abstract Number: 1420

The Ability of Patients with Early Rheumatoid Arthritis to Taper Low-Dose Glucocorticoids on Methotrexate Monotherapy and in Combination with Adalimumab

9:00AM-11:00AM: Abstract Number: 1117

the Absolute Risk of Clinically Diagnosed Gout By Serum Uric Acid Levels – Results from 30 Years Follow-up of the Malmö Preventive Project Cohort in Southern Sweden

9:00AM-11:00AM: Abstract Number: 1023

The Autoimmune Discovery Ichip Distinguishes Healthy Individuals (HC) from Those with SLE, Rheumatoid Arthritis (RA), Scleroderma (SSc), Sjogren’s Syndrome (SS), and the Anti-Phospholipid Syndrome (APS)

9:00AM-11:00AM: Abstract Number: 1408

The Cation Channel TRPV2 Decreases Rheumatoid Arthritis Fibroblast-like Synoviocyte Invasiveness By Inhibiting RhoA Activation, Cell Adhesion and Actin Cytoskeleton Changes

9:00AM-11:00AM: Abstract Number: 1732

The Characteristic T-Cell Receptor-Mediated Signaling of Peripheral Blood T Cells in Dermatomyositis and Polymyositis

9:00AM-11:00AM: Abstract Number: 981

The Common Risk Factors for Hyperuricemia and Gout Do Not Predict Incident Gout Once Hyperuricemia Is Established

9:00AM-11:00AM: Abstract Number: 1238

The Development of the Lupus Foundation of America—Rapid Evaluation of Activity in Lupus (LFA-REAL™) Patient-Reported Outcome (PRO) to Evaluate Lupus Disease Activity

9:00AM-11:00AM: Abstract Number: 1131

The Dietary Approaches to Stop Hypertension (DASH) and Mediterranean Diets and Risk of Gout in Women: 28-Year Follow-up of a Prospective Cohort

9:00AM-11:00AM: Abstract Number: 992

The Effect of Anti-TNF Therapy on Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis over One Year – Real Life Data from the Czech Biologics Registry Attra

9:00AM-11:00AM: Abstract Number: 1544

The Effect of Extraarticular Manifestations on Tumor Necrotic Factor α Inhibitor Drug Survival in Patients with Ankylosing Spondylitis: Nationwide Data from the Korean College of Rheumatology Biologics (KOBIO) Registry

9:00AM-11:00AM: Abstract Number: 1767

The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months

9:00AM-11:00AM: Abstract Number: 1440

The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated with Tofacitinib

9:00AM-11:00AM: Abstract Number: 1261

The Effects of Disease Burden, Helplessness, and Pain on Depressive Symptoms in Rheumatoid Arthritis and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1466

The Effects of Rituximab and B-Cells Depletion on the Inflammatory and Pro-Thrombotic Profile of Leucocytes of Rheumatoid Arthritis Patients and on the Vascular Endothelium

9:00AM-11:00AM: Abstract Number: 1749

The Epidemiology of ANCA Associated Vasculitis in the U.S.: A 20 Year Population Based Study

9:00AM-11:00AM: Abstract Number: 995

The Epidemiology of Psoriatic Arthritis in Israel – a Population-Based Study

9:00AM-11:00AM: Abstract Number: 1016

The Genetic Biomarkers to Predicting Response of TNF Inhibitors Treatment in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1610

The Impact of Alcohol Use on Cardiovascular Events and Overall Mortality in Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1341

The Impact of Anti-Cyclic Citrullinated Peptide Seropositivity on Erosion Prevalence Among Patients with RA of Varying Disease Duration

9:00AM-11:00AM: Abstract Number: 1619

The Impact of Disease Characteristics on Habitual Physical Activity and Sedentary Behavior Among Patients with Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 1135

the Incidence of Knee Chondrocalcinosis and Its Risk Factors in Community-Based Cohort

9:00AM-11:00AM: Abstract Number: 1020

The Inflammatory and Proliferative Synovial Lesion in Post-Infectious Lyme Arthritis Results from Impaired Wound Healing

9:00AM-11:00AM: Abstract Number: 1236

The Influence of Testimonials on Patient Decision-Making

9:00AM-11:00AM: Abstract Number: 1578

The Initiation, but Not the Persistence, of Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats Is Crucially Dependent on the IL-23 Axis

9:00AM-11:00AM: Abstract Number: 1300

The Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): Report of the First Year of Activity

9:00AM-11:00AM: Abstract Number: 1077

The Lectin Pathway of the Complement System Is Activated in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1284

The Localized Scleroderma Quality of Life Instrument (LoSQI): Initial Validation in Pediatric Localized Scleroderma

9:00AM-11:00AM: Abstract Number: 1650

The Montreal Cognitive Assessment Questionnaire (MoCA): A Promising Screening Tool for Cognitive Dysfunction in SLE

9:00AM-11:00AM: Abstract Number: 1092

The Ottawa Biologics Safety and Screening Tool

9:00AM-11:00AM: Abstract Number: 1143

The Patient Education for Gout Patients Ameliorate the Patients’ Satisfaction and Serum Uric Acid Level

9:00AM-11:00AM: Abstract Number: 1738

The Pattern of Proinflamatory Cytokine Expression By CD4+ T Lymphocytes Segregates the Clinical Response to Methotrexate in Recently Diagnosed Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1232

The Perceived Impact of Recent-Onset Psoriatic Arthritis Is Different between Genders: A Spanish Multicenter Experience

9:00AM-11:00AM: Abstract Number: 1496

The Performance of Different Classification Criteria in Patients with Primary Sjogren’s Syndrome and Analysis of Their Contribution for Definitive Diagnosis, When Either Criteria Used Alone or in Combination

9:00AM-11:00AM: Abstract Number: 1045

The Potential Value of a Shared Decision-Making Intervention for Choices Regarding Triple Therapy in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1503

The Prevalence of Axial Spondyloarthritis in Israel

9:00AM-11:00AM: Abstract Number: 1005

The Prevalence of Patellofemoral Osteoarthritis in China: A Multi-Center Population-Based Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 1432

The Prognostic Value of IgA Subtypes of Rheumatoid Factor and Anti-Citrullinated Protein Antibodies (ACPA) for Prediction of Therapeutic Responses to TNF Inhibitory Therapy in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1461

The Relationship between Serum IL-37 and Disease Activity in Patients with Rheumatoid Arthritis: Post-Hoc Analysis of Planetra Study

9:00AM-11:00AM: Abstract Number: 1352

The Relevance of Elevated CRP As an Inclusion Criterion in Clinical Trials in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1014

The Rheumatic Disease Data Refinery: A Case Study in Integrative Genomics Reveals Complex IFN Signatures in Therapeutic Studies in SLE

9:00AM-11:00AM: Abstract Number: 1718

The Role and Function of Monocyte-Derived Fibroblast-like Cells in Multi-Organ Fibrosis in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1377

The Serum Levels of Semaphorin 4D Are Associated with Disease Activity As Well As Radiographic Progression in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1091

The Utility of Electronic Consultation in the Management of Gout at the Veterans Affairs Medical Center

9:00AM-11:00AM: Abstract Number: 1775

The Utility of the ACR/EULAR 2017 Provisional Classification Criteria for Granulomatosis with Polyangiitis in Korean Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1783

The Value of a Combination of Serum Proteins to Identify Response to Induction Therapy Among Patients with ANCA-Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1418

The Value of Adalimumab Trough Levels and Clinical Assessments in Predicting Clinical Response in Patients with Established Rheumatoid Arthritis and an Inadequate Response to Methotrexate

9:00AM-11:00AM: Abstract Number: 1436

Therapeutic Drug Monitoring on Rheumatoid Arthritis Patients with Reduced Doses of Intravenous Tocilizumab

9:00AM-11:00AM: Abstract Number: 1763

Time to Diagnosis of ANCA-Associated Vasculitides : Data from French Vasculitis Study Group Registry

9:00AM-11:00AM: Abstract Number: 1294

Time to Pregnancy in Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1322

Tissue Folate Dysregulation Is Associated with Disease Activity and Methotrexate Response in Collagen-Induced Arthritis

9:00AM-11:00AM: Abstract Number: 1399

Tissues Are Differently Modulated By Tocilizumab and Methotrexate; Assessment of Connective Tissue Metabolites in the Ambition Study

9:00AM-11:00AM: Abstract Number: 1415

TNF-Induced IRF1 Is Critical for the Inflammatory Gene Expression in Fibroblast-like Synoviocytes

9:00AM-11:00AM: Abstract Number: 1693

To What Extend Do Auto-Antibodies Help to Identify High-Risk Patients in Systemic Sclerosis?

9:00AM-11:00AM: Abstract Number: 1645

Tobacco Exposure and Relationship with Severe Damage in Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 1421

Tofacitinib Monotherapy Improves Arterial Stiffness in Conventional Dmards Active Rheumatoid Arthritis Patients. a Cohort Study

9:00AM-11:00AM: Abstract Number: 1741

Tolerance and Efficiency of Anti-Programmed Death 1 Antibodies in Patients with Cancer and Preexisting Autoimmune or Inflammatory Diseases

9:00AM-11:00AM: Abstract Number: 1686

Topical Nitroglycerine (NTG) Vs Matching Vehicle in Secondary Raynaud Phenomenon (RP) – a Double-Blind Crossover Study of Subjective and Physiologic Responses to Controlled Cold Challenge

9:00AM-11:00AM: Abstract Number: 1492

Total Body Water Correlates with Ocular Sicca Symptoms in Primary SjöGren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1298

Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation

9:00AM-11:00AM: Abstract Number: 1103

Towards Recommendations on Functional Assessment Status Measures for Rheumatoid Arthritis: Preliminary Results from a Systematic Review

9:00AM-11:00AM: Abstract Number: 1652

Trajectories of Quality of Life in an Iception Cohort of Lupus Patients and Their Determinants

9:00AM-11:00AM: Abstract Number: 1744

Transciptome Profile of Inflammation Inducted Circulating Effector and Regulatory T Cells Is Dominated By HLA-DR Pivoted Functional Networks in Active Juvenile Idiopathic Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1245

Transition in Work Status and Quality of Life in People with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1079

Treat to Target Adherence Measurement Tool Performance in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1349

Treat to Target: What’s the Target?

9:00AM-11:00AM: Abstract Number: 1555

Treatment Changes By Joint Activity and Skin Severity in Patients with Comorbid Psa and Pso

9:00AM-11:00AM: Abstract Number: 1158

Treatment of Non-Infectious Uveitis: A Comparative Long-Term Study between Biologic Therapy with Adalimumab and Two Conventional Disease-Modifying Antirheumatic Drugs

9:00AM-11:00AM: Abstract Number: 1469

Treatment Paradigms in Real-World Practice: Biologic Agent Use Prior to and after Discontinuation of Abatacept

9:00AM-11:00AM: Abstract Number: 1425

Treatment Patterns in Patients with Rheumatoid Arthritis Newly Initiated on Biologic and Non-Biologic Therapy Enrolled in a North American Clinical Registry

9:00AM-11:00AM: Abstract Number: 1557

Treatment Patterns in Psoriatic Arthritis: Experience from a Real-World Setting

9:00AM-11:00AM: Abstract Number: 1564

Treatment Patterns, Survival and Long-Term Effectiveness of Biological Agents in Psoriatic Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1032

Trends in Hospitalizations Following Heart Failure Diagnosis in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 958

Tumor Necrosis Factor-α Induces Production of Eotaxin-1/CCL11 from Fibroblast-like Synoviocyte in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1607

Tumor-Related Autoantibodies and Cancers in SLE: A Case-Control Study from a Single Centre

9:00AM-11:00AM: Abstract Number: 1656

Type I Interferon Drives the Dysregulation of Plasmacytoid and Myeloid Dendritic Cells in Systemic Lupus Erythematosus and Antiphospholipid Syndrome

9:00AM-11:00AM: Abstract Number: 1410

Tyrosine Kinase Receptor Axl Is Down Regulated in Highly Inflamed Rheumatoid Synovium and Negatively Correlates with Markers of Disease Activity

9:00AM-11:00AM: Abstract Number: 1347

Ultrasonography and Synovial Histology in the RA Patients in Remission

9:00AM-11:00AM: Abstract Number: 1350

Ultrasound Detected Tenosynovitis in Rheumatoid Arthritis Patients in Clinical Remission

9:00AM-11:00AM: Abstract Number: 1373

Ultrasound of Subtalar Joint Synovitis in Patients with Rheumatoid Arthritis: Results of an Omeract Reliability Exercise Using Consensual Definitions

9:00AM-11:00AM: Abstract Number: 1391

Ultrasound Response to Tocilizumab in Surgically Replaced Joints and Surgically Operated Joint Areas of Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1119

Uncontrolled Gout Patients with Higher Heart Failure Hospitalization Rates in US

9:00AM-11:00AM: Abstract Number: 1241

Understanding Differences in Patient Definitions of RA Flares Using Omeract Core Domains

9:00AM-11:00AM: Abstract Number: 1697

Unique Characteristics of Scleroderma Among African Americans: A Population Based Study

9:00AM-11:00AM: Abstract Number: 1336

Unique Role for miR429 in RA and Acute Model of Arthritis

9:00AM-11:00AM: Abstract Number: 1200

Updating the Knee Osteoarthritis Intra-Articular Corticosteroid Meta-Analysis with Two Large Trials of Extended-Release Triamcinolone Acetonide (FX006) Versus Placebo

9:00AM-11:00AM: Abstract Number: 1256

Uptake of Influenza and Pneumococcal Vaccination in Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1137

Urate Lowering to ACR-Recommended Targets Allows Significant Improvement of Severe Gout: A Monocentric Prospective Trial in Vietnam, Using a Systematic Treatment Protocol

9:00AM-11:00AM: Abstract Number: 1136

Urate-Lowering Treatment and Risk of Total Joint Replacement in Patients with Incident Gout: A Population-Based Cohort and Nested Case-Control Study

9:00AM-11:00AM: Abstract Number: 1409

Ursolic Acid Promotes Apoptosis of Rheumatoid Athritis Synovial Fibroblasts By Upregulating Noxa Expression and Recruiting E3 Ligase Mule to Degrade Mcl-1

9:00AM-11:00AM: Abstract Number: 1633

Use of Emergency Department (ED) and Resulting Hospitalization By Patients with Systemic Lupus Erythematosus (SLE) in a Predominantly Afro-Caribbean Inner-City Cohort

9:00AM-11:00AM: Abstract Number: 1305

Use of Estrogen-Containing Contraceptives Among SLE Women with and without Contraindications to Estrogen

9:00AM-11:00AM: Abstract Number: 1154

Use of Including Serum Ferritin and Heme Oxygenase 1 in the Yamaguchi’s Classification for Adult-Onset Still’s Disease: A Multicenter Retrospective Study

9:00AM-11:00AM: Abstract Number: 1000

Use of Mutual Information Theory in Development and Refinement of a Predictive Model for Early Identification of Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1689

Using Electronic Health Record Algorithms to Accurately Identify Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1405

Using Flow and Mass Cytometry to Demonstrate Robust Tissue Processing to Query Molecular Heterogeneity in Phase 1 of the Accelerating Medicines Partnership (AMP) – RA Network

9:00AM-11:00AM: Abstract Number: 1255

Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Clinician Perspective

9:00AM-11:00AM: Abstract Number: 1172

Utility of Interstitial Pneumonia with Autoimmune Features (IPAF) Proposed Criteria in the Classification of Patients with CTD-Associated Interstitial Lung Disease in a Single Centre

9:00AM-11:00AM: Abstract Number: 1494

Validation of New Criteria in “The Guidance for Diagnosis of Sjögren’s Syndrome in Pediatric Patients”

9:00AM-11:00AM: Abstract Number: 1604

Validation of Remission and Lupus Low Disease Activity State As Predictors of Organ Damage in SLE

9:00AM-11:00AM: Abstract Number: 1508

Validation of Self-Reported Inflammatory Back Pain Score Compared to Rheumatology Consultation in University Students

9:00AM-11:00AM: Abstract Number: 1765

Validation of the ACR EULAR Provisional 2017 Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Patients with ANCA Associated Vasculitis

9:00AM-11:00AM: Abstract Number: 1360

Validation of the Health Assessment Questionnaire-Upper Extremity (HAQUP) in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1058

Variation in DMARD Therapy Following Methotrexate Failure for Newly-Identified Rheumatoid Arthritis in a National Veterans Health Administration Cohort

9:00AM-11:00AM: Abstract Number: 1739

Vδ1, Vδ2, and Other γδT Cells in Blood and Synovium of Rheumatoid Arthritis and Other Autoimmune Arthritides

9:00AM-11:00AM: Abstract Number: 1239

Web Based Educational Intervention to Improve Cardiovascular Disease Knowledge Among RA Patients

9:00AM-11:00AM: Abstract Number: 1249

What Factors Predict Good Patient Experiences of Switching from Reference Etanercept (EnbrelTM) to an Etanercept Biosimilar (BenepaliTM) in a South West London General Hospital?

9:00AM-11:00AM: Abstract Number: 979

What Have We Learned from Trajectory Analysis of Clinical Outcomes in Osteoarthritis?

9:00AM-11:00AM: Abstract Number: 1029

What to Measure after Arthroplasty? Confirmation of a Core Domain Set

9:00AM-11:00AM: Abstract Number: 1174

Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?

9:00AM-11:00AM: Abstract Number: 1412

Yra-1909 suppresses Production of Pro-Inflammatory Mediators and MMPs through Downregulating Akt, p38, JNK and NF-κb Activation in Rheumatoid Arthritis Fibroblast-like Synoviocytes

11:00AM-12:30PM: Abstract Number: 1788

Dose Intra-Articular Injection of Corticosteroids Increase the Risk of Knee Osteoarthritis Progression? Data from the Osteoarthritis Initiative

11:00AM-12:30PM: Abstract Number: 1787

Efficacy and Safety of Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

11:00AM-12:30PM: Abstract Number: 1789

Improved Survival with Transplantation in Granulomatosis with Polyangiitis in the United States: Data from the US Renal Data System

11:00AM-12:30PM: Abstract Number: 1786

Lupus Nephritis Is Linked to Immunity to an Intestinal Commensal Lachnospiracaea Species

11:00AM-12:30PM: Abstract Number: 1785

Serious or Opportunistic Infections in Infants Born to Pregnant Women with Rheumatoid Arthritis and Treated with a Biologic Medication

11:00AM-12:30PM: Abstract Number: 1784

The Novel Anti-CD40 Monoclonal Antibody CFZ533 Shows Beneficial Effects in Patients with Primary Sjögren’s Syndrome: A Phase IIa Double-Blind, Placebo-Controlled Randomized Trial

2:30PM-4:00PM: Abstract Number: 1803

A Cluster Analysis Approach to Patient-Physician Discordance in Rheumatoid Arthritis Activity Evaluations Optimally Differentiates and Predicts Clinical, Functional and Quality of Life Outcomes

2:30PM-4:00PM: Abstract Number: 1831

A Positive MRI of the Sacroiliac Joints Is Not Specific for Axial Spondyloarthritis but Frequently Occurs in Healthy Individuals

2:30PM-4:00PM: Abstract Number: 1810

A Systematic Review of the Impact of Anti-Rheumatic Drugs upon Male Fertility and Paternal Exposure Peri-Conception

2:30PM-4:00PM: Abstract Number: 1817

Abatacept Shows Better Sustainability Than TNF Inhibitors When Used Following Initial Biologic DMARD Failure in the Treatment of RA: 8 Years of Real-World Observations from the Rhumadata® Clinical Database and Registry

2:30PM-4:00PM: Abstract Number: 1836

Amelioration of Neuropsychiatric Systemic Lupus Erythematosus By Fingolimod-Mediated Sphingosine-1-Phosphate Receptor Modulation

2:30PM-4:00PM: Abstract Number: 1796

Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis: Results of Phase II of a Cluster Randomized Controlled Trial

2:30PM-4:00PM: Abstract Number: 1830

Bone Marrow Edema in Sacroiliac Joints of Young Athletes Is Common and Shows Most Frequently in the Posterior Lower Ilium

2:30PM-4:00PM: Abstract Number: 1841

Can Systemic Lupus (SLE) Disease Activity be Consistently Scored and Interpreted with Simple, Rapid Outcome Measures?

2:30PM-4:00PM: Abstract Number: 1844

Circulating Cytokine Profiles Reflect ANCA Specificity in Patients with ANCA-Associated Vasculitis

2:30PM-4:00PM: Abstract Number: 1825

Comparative Analysis of Achievement of Individual Important Response Measured By DAS28dcrit in a Randomized Head-to-Head Trial of Tocilizumab Vs. Adalimumab in Active Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 1840

Comparison of Different Definitions of Remission in Systemic Lupus Erythematosus (SLE)– a Study Based on the BLISS-76 Clinical Trial

2:30PM-4:00PM: Abstract Number: 1827

Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Data from a Phase 3 Trial

2:30PM-4:00PM: Abstract Number: 1845

Comparison of Magnetic Resonance Angiography (MRA) and 18f-Fluorodeoxyglucose Positron Emission Tomography (PET) in Large Vessel Vasculitis

2:30PM-4:00PM: Abstract Number: 1805

Construct Validity of RAPID3 for Measurement of Disease Activity in Psoriatic Arthritis

2:30PM-4:00PM: Abstract Number: 1819

Delay of Diagnosis and Treatment in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity

2:30PM-4:00PM: Abstract Number: 1802

Detection of Flare over the Past 3 Months in Rheumatoid Arthritis: Cross-Cultural Equivalence of the Self-Report Flare-RA Questionnaire

2:30PM-4:00PM: Abstract Number: 1839

Development and Validation of a Novel Evidence-Based Lupus Multivariable Outcome Score for Clinical Trials

2:30PM-4:00PM: Abstract Number: 1818

Development of Abatacept- and Adalimumab-Specific Predictive Models of Response to Therapy in RA Using Data from a Head-to-Head Study

2:30PM-4:00PM: Abstract Number: 1837

Development of Murine SLE in the Absence of BAFF

2:30PM-4:00PM: Abstract Number: 1792

Distinct and Overlapping Activities of IL-17A and TNF on the Expression of Proinflammatory Cytokines and MMPs in Psoriatic Arthritis: Rationale for Anti-IL-17A/Anti-Tnfalpha Combination Therapy?

2:30PM-4:00PM: Abstract Number: 1800

Do Patient Reported Outcome Measurement Information System (PROMIS) Computer Adaptive Tests Correlate with Disease Activity in Juvenile Idiopathic Arthritis?

2:30PM-4:00PM: Abstract Number: 1821

Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study

2:30PM-4:00PM: Abstract Number: 1798

Effective Implementation and Evaluation of Quality Improvement Initiatives in a Safety Net Hospital Rheumatology Clinic

2:30PM-4:00PM: Abstract Number: 1850

Efficacy of Zoledronic Acid and Denosumab in the Treatment of Patients with Low Back Pain and Modic Changes: A Proof of Principle Trial

2:30PM-4:00PM: Abstract Number: 1838

Estimating Duration of Response in Systemic Lupus Erythematosus (SLE) Trials

2:30PM-4:00PM: Abstract Number: 1824

Evaluation of Pneumococcal and Tetanus Vaccine Responses in Patients with Rheumatoid Arthritis Receiving Baricitinib: Results from a Long-Term Extension Trial Substudy

2:30PM-4:00PM: Abstract Number: 1853

Exercise and Adherence over Two Years: Beliefs of Adults with Knee Osteoarthritis

2:30PM-4:00PM: Abstract Number: 1855

Feasibility and Preliminary Effects of a Novel Rehabilitation Strategy to Improve Hand and Arm Function in Systemic Sclerosis

2:30PM-4:00PM: Abstract Number: 1832

Gut Dysbiosis Contributes to Autoimmune Pathogenesis in Lupus-Prone Mice

2:30PM-4:00PM: Abstract Number: 1854

Identifying Vulnerable Patient Populations Based on Age and Physical Function on Clinical Outcomes Following Total Knee Arthroplasty

2:30PM-4:00PM: Abstract Number: 1795

IL-7 in Primary Sjogren Syndrome (pSS) Is Secreted By Salivary Gland Epithelial Cells after IFN Stimulation and Is Associated with B-Cell Activation

2:30PM-4:00PM: Abstract Number: 1851

Improving Walking Ability in Degenerative Lumbar Spinal Stenosis: A Randomized Trial Comparing 2 Self-Management Training Programs

2:30PM-4:00PM: Abstract Number: 1846

Increased CD38hiCD27+ Plasmablast Frequency in Remission Predicts Relapsing Disease in Granulomatosis with Polyangiitis Patients

2:30PM-4:00PM: Abstract Number: 1797

Insights from Treating to Target in Rheumatoid Arthritis at an Academic Medical Center

2:30PM-4:00PM: Abstract Number: 1793

Interleukin-17 Is Not a Determinant for the Pro- or Anti-Inflammatory Character of Interleukin-22 in Experimental Arthritis

2:30PM-4:00PM: Abstract Number: 1833

iRhom2 Deficiency Protects Fcgr2b-/- Lupus-Prone Mice from Kidney Damage By Modulating ADAM17-Dependent Shedding of TNF-α and EGFR Ligand

2:30PM-4:00PM: Abstract Number: 1809

Lack of Placental Transfer of Certolizumab Pegol during Pregnancy: Results from a Prospective, Postmarketing, Multicenter, Pharmacokinetic Study

2:30PM-4:00PM: Abstract Number: 1808

Long-Term Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus

2:30PM-4:00PM: Abstract Number: 1811

Lupus Patients, and Their Sisters, Have Higher Miscarriage Rates Than Healthy Women

2:30PM-4:00PM: Abstract Number: 1823

Methotrexate Requires High Serum BAFF Levels to Prevent Immunization Against TNF-α Inhibitors

2:30PM-4:00PM: Abstract Number: 1835

Microglial Defects Contribute to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus

2:30PM-4:00PM: Abstract Number: 1848

NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis (TA) and Relationship with Disease Activity

2:30PM-4:00PM: Abstract Number: 1794

Overexpression of Interleuk-22 Induces Expression of the Negative Immune-Regulator SOCS3 and Potently Reduces Collagen-Induced Arthritis in Mice

2:30PM-4:00PM: Abstract Number: 1804

Patient-Reported Outcomes and Damage Predict Mortality in Lupus

2:30PM-4:00PM: Abstract Number: 1829

Patterns and Predictors of Progression of Sacroiliitis in Psoriatic Arthritis and Its Relationship with Human Leukocyte Antigen (HLA) Alleles. Results from the Toronto Cohort

2:30PM-4:00PM: Abstract Number: 1815

Patterns of Methotrexate Use and Discontinuation in a U.S. Rheumatoid Arthritis Registry

2:30PM-4:00PM: Abstract Number: 1806

Performance of the Brief Index of Lupus Damage (BILD) in a Multi-Ethnic Population-Based Systemic Lupus Erythematosus (SLE) Cohort

2:30PM-4:00PM: Abstract Number: 1812

Preeclampsia and Incident Cardiovascular Disease in SLE Pregnancy

2:30PM-4:00PM: Abstract Number: 1807

Psychometric Evaluation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) in Inflammatory Arthritis

2:30PM-4:00PM: Abstract Number: 1801

Quantifying Clinical and Economic Outcomes Associated with Chronic Corticosteroid Exposure in a US Population

2:30PM-4:00PM: Abstract Number: 1813

Rates of Contraceptive Use and Unintended Pregnancy in Teen Girls Prescribed Teratogenic Medications

2:30PM-4:00PM: Abstract Number: 1826

Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS) Related Remission: 2-Year Results from a Phase 3 Study

2:30PM-4:00PM: Abstract Number: 1828

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 2-Year Results from a Phase 3 Study

2:30PM-4:00PM: Abstract Number: 1834

Selective Inhibitors of Nuclear Export Prevent Lupus Progression By Targeting Germinal Center Formation and Autoreactive Antibody Secreting Cells

2:30PM-4:00PM: Abstract Number: 1843

Serum Albumin at 12 Months Post Biopsy Has Excellent Sensitivity and Specificity for Favorable 4 Year Renal Outcome in Lupus Nephritis (LN)

2:30PM-4:00PM: Abstract Number: 1816

Sex Differences in Orthopedic Surgery Among Patients with Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 1790

Sphingosine -1 Phosphate Receptor-1-Mediated Endothelial Cell Barrier Function Protects Against Immune Complex-Induced Vascular Injury: A Potential Novel Therapeutic Target for SLE

2:30PM-4:00PM: Abstract Number: 1842

Subsetting Systemic Lupus Erythematosus By Interferon Gene Signatures and Serologies (anti-dsDNA and Low Complement) Uncovers Significant Clinical Diversity

2:30PM-4:00PM: Abstract Number: 1820

Sustained Effectiveness after Remission Induction with Methotrexate and Step-Down Glucocorticoids in Patients with Early Rheumatoid Arthritis Following a Treat-to-Target Strategy after 2 Years

2:30PM-4:00PM: Abstract Number: 1791

TET1 Is an Important Transcriptional Activator of the Tnfa Locus in Macrophages

2:30PM-4:00PM: Abstract Number: 1822

The Effect of Sarilumab in Combination with Dmards on Fasting Glucose and Glycosylated Hemoglobin in Patients with Rheumatoid Arthritis with and without Diabetes

2:30PM-4:00PM: Abstract Number: 1847

The IgG4:IgG RNA Ratio in Peripheral Blood Perfectly Differentiates Active Disease from Remission in Granulomatosis with Polyangiitis. a New Disease Activity Marker?

2:30PM-4:00PM: Abstract Number: 1799

Time to First Appointment Among Young Adults Transitioning from Pediatric to Adult Rheumatologic Care in a Safety Net Population

2:30PM-4:00PM: Abstract Number: 1814

Time Trends over a Decade Show Earlier Intensified Medication Strategies and Improved Outcomes in Canadians with Early Inflammatory Arthritis

2:30PM-4:00PM: Abstract Number: 1849

Urinary Epidermal Growth Factor and Monocyte Chemoattractant Protein-1 As Biomarkers of Renal Involvement in ANCA-Associated Vasculitis

2:30PM-4:00PM: Abstract Number: 1852

Validating Patient Reported Outcomes in Older Veterans with Chronic Back Pain

4:30PM-6:00PM: Abstract Number: 1876

A Non-Invasive Ultrasound Surface Wave Elastography Technique for Assessing Interstitial Lung Disease

4:30PM-6:00PM: Abstract Number: 1917

A Novel Type I Interferon Biomarker on B Cell Predicts with Disease Activity in SLE and Can be Measured By Cell Surface Tetherin (CD317)

4:30PM-6:00PM: Abstract Number: 1902

A Pattern of Higher Serum Levels of IL-10 and MMP-3, Along with Lower IL-6R, Identify RA Patients with Interstitial Lung Disease

4:30PM-6:00PM: Abstract Number: 1904

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study of Upadacitinib (ABT-494), a Selective JAK-1 Inhibitor, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Conventional Synthetic Dmards

4:30PM-6:00PM: Abstract Number: 1860

A Trial Testing Strategies to Enhance Patient Understanding of Drug Information: Experience Recruiting Subjects through an Online Patient Community

4:30PM-6:00PM: Abstract Number: 1892

A20 Haploinsufficiency: Clinical Phenotypes and Disease Course of Patients with This Newly Recognized Autoinflammatory Disease

4:30PM-6:00PM: Abstract Number: 1927

Anti-Fibrotic Mechanisms of Endostatin-Derived Peptide Are the Result of Reduction in Pro-Fibrotic Mediators and Promotion of Extracellular Matrix Degradation

4:30PM-6:00PM: Abstract Number: 1875

Assessment of Structural Damage of the Thumb Base in Patients with Hand Osteoarthritis: Comparing the Newly Developed Omeract Magnetic Resonance Imaging Scoring System with Standard Radiography

4:30PM-6:00PM: Abstract Number: 1868

Association between Brain-Derived Neurotrophic Factor Gene Polymorphisms and Fibromyalgia in a Korean Population: A Multi-Center Study

4:30PM-6:00PM: Abstract Number: 1862

Association between Hydroxychloroquine Nonadherence and Adverse Outcomes Among Patients with Systemic Lupus Erythematosus

4:30PM-6:00PM: Abstract Number: 1918

Blood Levels of Complement Split Product iC3b and C3 Outperform Traditional Biochemical Measures of SLE Disease Activity in Associating with Active and Clinically Meaningful Changes

4:30PM-6:00PM: Abstract Number: 1912

Broad Immunophenotyping Results: CCR10 Expressing CD8 T Cells Distinguish Psoriatic Arthritis from Psoriasis Limited to Skin Involvement

4:30PM-6:00PM: Abstract Number: 1903

Can Achieving Sustained DAS Remission Prevent Arterial Stiffness Progression in Early Rheumatoid Arthritis – a Post-Hoc Analysis of a Randomized Controlled Study

4:30PM-6:00PM: Abstract Number: 1867

Can Vs. Do: Using Walking Speed and Moderate-to-Vigorous Physical Activity to Predict Incident Low Health-Related Quality of Life and Disability

4:30PM-6:00PM: Abstract Number: 1880

Cancer Immunotherapy in Patients with Preexisting Rheumatologic Disease: The Mayo Clinic Experience

4:30PM-6:00PM: Abstract Number: 1926

Cardiac Remodeling in Systemic Sclerosis: TGF-β/Fra2-Dependent Autophagy As a Novel Target for Heart Fibrosis

4:30PM-6:00PM: Abstract Number: 1922

Cell Type Specific Gene Expression Analysis of Early Systemic Sclerosis Skin Shows a Prominent Activation Pattern of Innate and Adaptive Immune System in the Prospective Registry for Early Systemic Sclerosis (PRESS) Cohort

4:30PM-6:00PM: Abstract Number: 1886

Continued Fracture Risk Reduction after 12 Months of Romosozumab Followed By Denosumab through 36 Months in the Extension of the Phase 3 Fracture Study in Postmenopausal Women with Osteoporosis

4:30PM-6:00PM: Abstract Number: 1874

Development of an Ultrasonographic Enthesitis Score for Psoriatic Arthritis Patients

4:30PM-6:00PM: Abstract Number: 1914

Discovery of a Novel CD8+ T Cell Population in Ankylosing Spondylitis Implicates Gut-Joint Trafficking in the Disease

4:30PM-6:00PM: Abstract Number: 1900

Effect of Age and Body Mass Index (BMI) on Multi-Biomarker Disease Activity (MBDA) Score in Patients with Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 1888

Effect of Denosumab Compared with Risedronate on Percentage Change in Lumbar Spine Bone Mineral Density at 12 Months in Subgroups of Glucocorticoid-Treated Individuals

4:30PM-6:00PM: Abstract Number: 1869

Effects of Add-on Transcranial Direct Current Stimulation on Pain in Korean Patients with Fibromyalgia

4:30PM-6:00PM: Abstract Number: 1885

Epidemiology of Hospitalized Adult Onset Still’s Disease in United States

4:30PM-6:00PM: Abstract Number: 1910

ERAP1 Deficiency Implicates Long Peptides in Protection from HLA-B27-Induced Experimental Spondyloarthritis

4:30PM-6:00PM: Abstract Number: 1873

Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale

4:30PM-6:00PM: Abstract Number: 1861

Evaluation of a Longstanding Telephone Peer Counseling Service on People with Systemic Lupus Erythematosus and Their Loved Ones

4:30PM-6:00PM: Abstract Number: 1894

Genetic Phenotypes Impacting Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF, TRAPS and Hids/Mkd: Results from Cluster Study

4:30PM-6:00PM: Abstract Number: 1915

Gut-Derived TNF As Risk Factor for the Development of Sacroiliac Inflammation

4:30PM-6:00PM: Abstract Number: 1871

Identifying Pain Sites Highly Associated with the Fibromyalgia (FM) Phenotype

4:30PM-6:00PM: Abstract Number: 1857

If Mobile Advertising Is the Future, the Future Is Now: Productivity of Digital Ads By Terminology and Delivery Device.

4:30PM-6:00PM: Abstract Number: 1896

IL-18 As a Diagnostic Biomarker, Differentiating Systemic JIA from Acute Leukaemia, Severe Bacterial Infections and Other Auto-Immune Disorders

4:30PM-6:00PM: Abstract Number: 1911

Impaired Control of Autoreactive T Cell Expansion Is Coupled with Type-1 Regulatory T Cell Deficiency in BALB/c ZAP70W163C Mutant Mice

4:30PM-6:00PM: Abstract Number: 1863

Inflammatory Dietary Pattern and Risk of Developing Rheumatoid Arthritis in Women

4:30PM-6:00PM: Abstract Number: 1913

Inter-Omic Analysis Reveals Functional Relationship between Diverse Gut Microbiota and Dysregulated Host Immune Response in HLA-B27-Mediated Experimental Spondyloarthritis

4:30PM-6:00PM: Abstract Number: 1909

Long Term Safety of Filgotinib in the Treatment of Rheumatoid Arthritis: Week 84 Data from a Phase 2b Open-Label Extension Study

4:30PM-6:00PM: Abstract Number: 1908

Long-Term Efficacy and Safety Results of a Global Phase 3 Trial of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment

4:30PM-6:00PM: Abstract Number: 1864

Longitudinal Changes in Serum Uric Acid Levels and Associated Risk of Cardiometabolic Events and Renal Insufficiency in Gout Patients

4:30PM-6:00PM: Abstract Number: 1891

Low Alkaline Phosphatase Levels: Could It be Hypophosphatasia?

4:30PM-6:00PM: Abstract Number: 1879

Majority of Rheumatoid Arthritis Patients in Clinical Remission As Defined By DAS-28, CDAI, SDAI and RAPID-3 Have No Signal on Ultrasound Power Doppler

4:30PM-6:00PM: Abstract Number: 1859

Meeting the Needs of Rheumatology Health Professional Learners: the Success of the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Online Educational Products

4:30PM-6:00PM: Abstract Number: 1884

Mepolizumab for the Treatment of Patients with Eosinophilic Granulomatosis with Polyangiitis: Post-Hoc Results of a Phase III Randomized, Placebo-Controlled Trial

4:30PM-6:00PM: Abstract Number: 1865

Novel Approach to Arthritis Surveillance Suggests a Much Higher Prevalence of Arthritis Among US Adults Than Previous Estimate

4:30PM-6:00PM: Abstract Number: 1899

Osteopontin and Leptin Are Associated with Erosive Disease in an Inception Cohort of Rheumatoid Arthritis Treated-to-Target with Combination Conventional DMARD Therapy

4:30PM-6:00PM: Abstract Number: 1898

Overweight/Obesity Affect Histological Features of Synovial Membrane of Rheumatoid Arthritis Patients from Disease Onset to Stable Remission Achievement

4:30PM-6:00PM: Abstract Number: 1856

Patient and Physician Perspectives on Content Value for Educational Material Regarding Rare Rheumatic Diseases

4:30PM-6:00PM: Abstract Number: 1883

Patterns of Osteoarticular Involvement in SAPHO Syndrome: A Cluster Analysis Based on Whole Body Bone Scintigraphy in 157 Patients

4:30PM-6:00PM: Abstract Number: 1890

Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed By 24 Months of Alendronate

4:30PM-6:00PM: Abstract Number: 1893

Pharmacokinetics (PK), Pharmacodynamics (PD), and Proposed Dosing of Oral Janus Kinase (JAK)1 and JAK2 Inhibitor Baricitinib in Patients with IFN-Mediated Autoinflammatory Diseases (AIDs)

4:30PM-6:00PM: Abstract Number: 1889

Safety and Efficacy of Denosumab Among Subjects with Mild-to-Moderate Chronic Kidney Disease (CKD) in the “Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months” Extension Study

4:30PM-6:00PM: Abstract Number: 1907

Safety, Pharmacokinetics, and Efficacy of E6011, an Anti-Fractalkine Monoclonal Antibody, in a First-in-Patient Phase 1/2 Study on Rheumatoid Arthritis: 52-Week Results

4:30PM-6:00PM: Abstract Number: 1895

Serum Interleukin 18 As a Biomarker for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome and Use of Recombinant Human IL-18 BP in a Patient with Refractory Disease

4:30PM-6:00PM: Abstract Number: 1923

Single Cell RNA Sequencing Reveals a Signature of Endothelial Injury in Scleroderma Skin

4:30PM-6:00PM: Abstract Number: 1905

Sustained Response Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: Results from a Randomized Controlled Trial

4:30PM-6:00PM: Abstract Number: 1920

Tacrolimus Induces Remission in Refractory and Relapsing Lupus Nephritis By Decreasing P-Glycoprotein Expression and Function on Peripheral Blood Lymphocytes

4:30PM-6:00PM: Abstract Number: 1887

Ten-Year Continued Nonvertebral Fracture Reduction in Postmenopausal Osteoporosis with Denosumab Treatment

4:30PM-6:00PM: Abstract Number: 1925

TGFβ Promotes Fibrosis By MYST1-Dependent Epigenetic Regulation of Autophagy

4:30PM-6:00PM: Abstract Number: 1872

The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia

4:30PM-6:00PM: Abstract Number: 1897

the Ferritin to ESR Ratio: A Simple Measure to Distinguish Macrophage Activation Syndrome from Systemic Arthritis Flare

4:30PM-6:00PM: Abstract Number: 1916

The Interferon Gamma Release Assay Is a Novel Predictor of Disease Activity in Systemic Lupus Erythematosus

4:30PM-6:00PM: Abstract Number: 1924

The Nuclear Receptor ROR-Alpha As a Key Checkpoint of Tissue Repair

4:30PM-6:00PM: Abstract Number: 1877

The Performance of MRI Using the 3D Volumetric Interpolated Breath-Hold Sequence (VIBE) Technique to Detect Structural Changes in Patients with Early Axial Spondyloarthritis in Comparison to Conventional Radiography and Computed Tomography

4:30PM-6:00PM: Abstract Number: 1919

The SLE-Key Test Detects an SLE Serologic Signature That Persists over Time and Is Independent of Disease Activity

4:30PM-6:00PM: Abstract Number: 1881

The Utility of Autoimmune Serologies in Recurrent and Chronic Inflammatory Eye Disease

4:30PM-6:00PM: Abstract Number: 1878

The Utility of the Omeract Ultrasound Tenosynovitis Scoring System in Multicenter Clinical Trials

4:30PM-6:00PM: Abstract Number: 1882

Thymus and Activation-Regulated Chemokine (TARC) As Biomarker for IgG4-Related Disease

4:30PM-6:00PM: Abstract Number: 1906

Tofacitinib with and without Methotrexate Versus Adalimumab with Methotrexate for the Treatment of Rheumatoid Arthritis: Patient-Reported Outcomes from a Phase 3b/4 Randomized Trial

4:30PM-6:00PM: Abstract Number: 1901

Unfavorable Body Composition Already at the Onset of Clinical Arthritis

4:30PM-6:00PM: Abstract Number: 1921

Urine Angiostatin and VCAM-1 Surpass Conventional Metrics in Predicting Elevated Renal Pathology Activity Indices in Lupus Nephritis

4:30PM-6:00PM: Abstract Number: 1866

Use of Aromatase Inhibitors and Risk of Arthritis and Musculoskeletal Problems Among Taiwanese Women with Breast Cancer: A Nationwide Claims Analysis

4:30PM-6:00PM: Abstract Number: 1858

Utilizing Needs Assessment Data to Establish Foundational Training for Adult and Pediatric Nurse Practitioners (NP) and Physician Assistants (PA) Entering Rheumatology Practice

4:30PM-6:00PM: Abstract Number: 1870

Validation of an Electronic Version of the Michigan Body Map

9:00AM-11:00AM: Abstract Number: 2628

Raynaud’s Symptoms and Pregnancy Induced Hypertension in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2213

“Generalized Osteoarthritis”: Update to a Systematic Review

9:00AM-11:00AM: Abstract Number: 2008

“Intrathoracic Manifestations of Connective Tissue Diseases on High Resolution Computed Tomography”

9:00AM-11:00AM: Abstract Number: 2327

14-3-3η (eta) Protein in Juvenile Idiopathic Arthritis (JIA) Patients

9:00AM-11:00AM: Abstract Number: 2003

18 FDG PET/CT Predicts Decline in Functional Respiratory TESTS in Systemic Sclerosis Patients but NOT in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2658

4-Hydroxy-2-Nonenal Serum Protein-Adducts and Anti-4-Hydroxy-2-Nonenal-Protein Adduct Antibodies in SLE

9:00AM-11:00AM: Abstract Number: 2734

A Comparison of Current Practice to New Vasculitis Treatment Guidelines

9:00AM-11:00AM: Abstract Number: 2360

A Correlation Study between Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis and Nailfold Videocapillaroscopy

9:00AM-11:00AM: Abstract Number: 1944

A Dual Role for IL-23 Receptor Signaling in Normal Bone Remodeling Versus Inflammation-Mediated Bone Damage during Arthritis

9:00AM-11:00AM: Abstract Number: 2343

A Genome-Wide Association Study Suggests the HLA Class II Region As the Major Susceptibility Locus for IgA Vasculitis

9:00AM-11:00AM: Abstract Number: 2212

A Metabolite of C-Reactive Protein, a Marker of Disease Actvity, Is Prognostic of Radiographic Knee OA

9:00AM-11:00AM: Abstract Number: 2550

A New and Simpler Tool for Global Psoriatic Arthritis Assessment: Simplified Composite Psoriatic Disease Activity Index (sCPDAI)

9:00AM-11:00AM: Abstract Number: 2348

A New Cause of Mendelian Lupus Due to IKZF1 Mutation Underlines the B Cell Landscape Heterogeneity in Monogenic Lupus

9:00AM-11:00AM: Abstract Number: 2208

A Novel Omeract MRI Scoring System Providing Insights in the Association of MRI Synovitis and Bone Marrow Lesions with Pain in Thumb Base Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2637

A Novel Regulatory Antigen Presenting B Cell and Memory Regulatory T Cell Subsets Are Enriched during the Quiescent Phase of Childhood Onset Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2071

A Novel Selective URAT1 Inhibitor, Tei-a, with Potent Uricosuric Property

9:00AM-11:00AM: Abstract Number: 2018

A Novel Ultrasound Scoring System for the Pediatric Knee

9:00AM-11:00AM: Abstract Number: 2072

A Pharmacokinetic and Pharmacodynamic Evaluation of URC102, a Potent and Selective Inhibitor of URAT1, after Single and Multiple Oral Administrations in Healthy Volunteers

9:00AM-11:00AM: Abstract Number: 2441

A Phase III, Multicenter, Double-Blind, Randomized, Parallel-Group Study to Evaluate the Similarities between LBEC0101 and Etanercept Reference Product in Terms of Efficacy and Safety in Patients with Active Rheumatoid Arthritis Inadequately Responding to Methotrexate

9:00AM-11:00AM: Abstract Number: 2398

A Population-Based Cohort Study of Chronic Obstructive Pulmonary Disease Among Patients with Rheumatoid Arthritis: Comorbidity and Mortality

9:00AM-11:00AM: Abstract Number: 2624

A Renal Biopsy Should Not Delay Treatment Initiation in Suspected Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 2742

A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts

9:00AM-11:00AM: Abstract Number: 2232

A Role for CCR2 in Chronic Behavioral and Neuroimmune Changes in the DMM Model of Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2074

A Series of Double-Blind, Placebo-Controlled, Randomized, Multicenter, Phase 2 Studies to Evaluate the Efficacy, Safety, and Dose-Response Relationship of Orally Administered URC102, a Novel URAT1 Inhibitor, in Korean Patients with Gout

9:00AM-11:00AM: Abstract Number: 2750

A Serum Metabolomic Analysis in Behcet’s Disease: A Preliminary Study

9:00AM-11:00AM: Abstract Number: 2058

A Study on Febuxostat Prescribing Practices for Patients with Chronic Gout Previously Managed with Allopurinol at the Veterans Affairs Puget Sound

9:00AM-11:00AM: Abstract Number: 2609

A Systematic Literature Mining and Gene Expression Analysis Identifies Possible Drug Candidates for Repositioning in Lupus

9:00AM-11:00AM: Abstract Number: 2128

A Systematic Review of the Management of Patients with Preexisting Rheumatologic Diseases Receiving Checkpoint Inhibitors for Cancer

9:00AM-11:00AM: Abstract Number: 2169

A Two-Center Experience with Rituximab in Patients with Primary Idiopathic Myositis and Overlap Myositis: A Retrospective Observational Study

9:00AM-11:00AM: Abstract Number: 1932

A2A Adenosine Receptor (A2AR) Stimulation Modulates NR4A2 Orphan Receptor Expression during Osteoclast Differentiation

9:00AM-11:00AM: Abstract Number: 1937

Abaloparatide, an Osteoanabolic PTHrP Analog, Increased Bone Mineral Density in Rabbits with Glucocorticoid Induced Osteopenia

9:00AM-11:00AM: Abstract Number: 2705

Aberrant Expression and Function of Human Circulating T Follicular Helper Cells and Its Subsets in IgG4 Related Disease

9:00AM-11:00AM: Abstract Number: 2421

Aberrant Expression of CaMK4 in CD4 Positive T Cells Predicts Poor Response to Treatment in Patients with Active Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2652

Abnormal Expression of Long Noncoding RNA Lncrna-CMPK2 Facilitates Neutrophils Interferon Production By TLR7/8 Agonist Stimulation in SLE

9:00AM-11:00AM: Abstract Number: 2549

Achievement of Minimal Disease Activity Is Associated with Improvements in Health-Related Quality of Life and Productivity in Psoriatic Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2431

Acquisition of Protective Alleles in Women with Rheumatoid Arthritis through Microchimerism

9:00AM-11:00AM: Abstract Number: 2283

Adalimumab Therapy in Juvenile Idiopathic Arthritis: Addition of Lidocaine for Prevention of Injection Site Pain or Not? That Is the Question. a Comparison Study

9:00AM-11:00AM: Abstract Number: 2723

Adalimumab Therapy Optimization in Refractory Uveitis Due to Behçet’s Disease after Achieving Remission. interventional Versus Control Group

9:00AM-11:00AM: Abstract Number: 2135

ADAM-17 Is Expressed in the Inflammatory Myopathy, and Is Involved with Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2043

Adherence to American College of Rheumatology Guidelines for Prevention of Glucocorticoid-Induced Osteoporosis in Patients with Polymyalgia Rheumatica

9:00AM-11:00AM: Abstract Number: 1943

Adipocytokines in an Osteoarthritis Mouse Model

9:00AM-11:00AM: Abstract Number: 2333

Adjudication of Infections from the Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (PHARMACHILD) Treated with Biologic Agents and/or Methotrexate with a Focus on Opportunistic Infections

9:00AM-11:00AM: Abstract Number: 2543

Agreement between Paper and Pencil VAS at the Clinic and Electronic VAS at Home in Psoriatic Arthritis and Its Impact on Minimal Disease Activity

9:00AM-11:00AM: Abstract Number: 2087

Allelic Variants of ABCG2 and Gout Risk

9:00AM-11:00AM: Abstract Number: 2059

Allopurinol Dose-Titration Patterns Relative to Serum Uric Acid Levels in Gout Patients: US Electronic Health Record Data

9:00AM-11:00AM: Abstract Number: 2656

Alterations of the Splicing Machinery Components in Leukocytes from Systemic Lupus Erythematosus Patients Influences Its Development and Atherothrombotic Profile and Drives the Therapeutic Response

9:00AM-11:00AM: Abstract Number: 2426

Altered Frequencies of Circulating Follicullar T Helper Cell Counterparts and Their Subsets but Not of Peripheral Helper T Cells, Are Associated with Increased Circulating Plasmablasts in Seropositive Early RA Patients

9:00AM-11:00AM: Abstract Number: 2006

Altered Microcirculation As a Proxy for Inflammation in Hand Osteoarthritis Can Reliably be Assessed Using Fluorescence Optical Imaging

9:00AM-11:00AM: Abstract Number: 2403

Amylin in the Insulin Resistance of Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1956

An Approach to Linkage of Registry Data to Medicare Claims Using Multiple Non-Unique Identifiers

9:00AM-11:00AM: Abstract Number: 2196

An Exploratory Analysis of Physical Activity Levels and the Presence of Bone Marrow Lesions in Adults with Knee Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2100

An International Consensus Exercise to Develop Candidate Items for Classification Criteria in Relapsing Polychondritis

9:00AM-11:00AM: Abstract Number: 2273

An Open-Label Extension Study to Assess the Long-Term Safety of Etanercept in Pediatric Patients with Extended Oligo, Enthesitis Related, and Psoriatic Juvenile Idiopathic Arthritis: 6-Year Data from the Clipper Studies

9:00AM-11:00AM: Abstract Number: 2224

Analgesic Potential of NEO6860, a Modality Selective TRPV1 Antagonist, in Osteoarthritis Knee Pain: Results of a Randomized, Controlled, Proof-of-Concept Trial

9:00AM-11:00AM: Abstract Number: 2650

Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data

9:00AM-11:00AM: Abstract Number: 2050

Analysis of Data Collected from Right and Left Limbs: Accounting for Dependence and Improving Statistical Efficiency in Musculoskeletal Research

9:00AM-11:00AM: Abstract Number: 1995

Analysis of Erosion Volume of the Distal Radius By HR-pQCT in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2680

Analysis of Prognostic Determinants of Scleroderma-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension

9:00AM-11:00AM: Abstract Number: 2139

Analysis of Required Dose of Corticosteroid As Maintenance Therapy and Related Factors in Patients with Polymyositis/Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2494

Analysis of the Efficacy, Safety and Continuation Rate of Abatacept in Elderly Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2132

Angiogenesis and VEGF-Expressing Cells Are Identified Predominantly in the Fascia Rather Than the Muscle in the Early Phase of Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2145

Anti-CXCR3 Antibody Suppresses Inflammation in C Protein-Induced Myositis Model

9:00AM-11:00AM: Abstract Number: 2721

Anti-IL6-Receptor Tocilizumab in Refractory Uveitis Associated to Extraocular Manifestations in Patients with Behçet’s Disease. Multicenter Study

9:00AM-11:00AM: Abstract Number: 1949

Anti-Inflammatory Effects of Standardized Platelet-Rich Plasma Releasates in Knee and Hip OA Chondrocytes

9:00AM-11:00AM: Abstract Number: 2111

Anti-N-Methyl-D-Aspartate Receptor Encephalitis – Expanding Our Understanding of the Clinical Needs of Pediatric Patients with This Complex Disorder

9:00AM-11:00AM: Abstract Number: 2664

Anti-SSA (Ro52/Ro60) and SSB Autoantibodies in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2649

Anti-Suprabasin Antibody; A Novel Autoantibody May Contribute to the Pathogenesis of Neuropsychiatric Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2112

Anti-TNFα Versus Rituximab in Refractory Peripheral Ulcerative Keratitis Associated to Rheumatic Diseases. Multicenter Study of 24 Patients

9:00AM-11:00AM: Abstract Number: 2335

Antiendothelial Cell Antibodies in Juvenile Dermatomyositis: A Proteomics-Based Approach

9:00AM-11:00AM: Abstract Number: 2613

Antimalarial Drug Toxicities in Rheumatic Skin Disease Patients

9:00AM-11:00AM: Abstract Number: 2052

Apply Musculoskeletal Ultrasonography to Predict Chronic Gouty Arthritis in Patients with Chronic Kidney Diseases

9:00AM-11:00AM: Abstract Number: 2529

Appraisal of the Contest Questionnaire in the Screening for Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2724

Apremilast for Refractory Mucocutaneous Ulcers of Behçet’s Disease. National Multicenter Study of 14 Cases

9:00AM-11:00AM: Abstract Number: 2584

Apremilast in Patients with Lupus Rashes

9:00AM-11:00AM: Abstract Number: 2216

Are Adults with Arthritis Advised to Exercise By Their Health Care Providers? National Health Interview Survey, 2002 and 2014

9:00AM-11:00AM: Abstract Number: 1993

Are MRI-Detected Erosions Specific for RA? a Large Explorative Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 2351

Are Sedentary Behavior and Reduced Physical Activity Associated with Long-Term Cardiovascular Risk in Individuals with Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 2500

Are Work Outcomes Improved in Axial Spondyloarthritis (axSpA) Patients with Biologic Therapy? Results from the British Society for Rheumatology Register

9:00AM-11:00AM: Abstract Number: 2089

Arhalofenate Acid Inhibits Urate Crystal-Induced Inflammatory Responses through Activation of AMP-Activated Protein Kinase (AMPK) Signaling

9:00AM-11:00AM: Abstract Number: 2355

Arterial Wave Reflection and Subclinical Atherosclerosis in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2257

Assessing the Impact of a Digital Health Coaching Program for Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2301

Assessing the Utility and Impact of Musculoskeletal Ultrasound in a Large Pediatric Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 2727

Assessment of Damage and Prognosis in Patients with Adult IgA Vasculitis: Retrospective Multicentered Cohort Study

9:00AM-11:00AM: Abstract Number: 2476

Assessment of Dose Dependent Effects of Vobarilizumab, an Anti-IL6 Receptor (IL-6R) Nanobody®, on Systemic Biomarkers in Patients with Moderate-to-Severe Rheumatoid Arthritis (RA): Results of Two Phase 2b Studies

9:00AM-11:00AM: Abstract Number: 2011

Assessment of Methods to Quantitatively Evaluate Global Synovitis Activity with FDG-PET/CT

9:00AM-11:00AM: Abstract Number: 2413

Assessment of the Most Distal Sensory Nerves in Patients with Rheumatoid Arthritis with Normal Value of Standard Nerve Conduction Studies

9:00AM-11:00AM: Abstract Number: 2361

Associated Factors of Hypertension and Hyperglycemia Related to Steroid Pulse in Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 1971

Association between Genetic Variants and the Presence of Rheumatoid Arthritis-Related Autoimmunity and Progression to Classified Rheumatoid Arthritis in an at-Risk Population

9:00AM-11:00AM: Abstract Number: 2465

Association between Methotrexate Use and Effects of Treatment with a Second Biologic Agent in Rheumatoid Arthritis: A Multiple Imputation Approach

9:00AM-11:00AM: Abstract Number: 2192

Association between Mitochondrial DNA (mtDNA) Haplogroups and Bone Marrow Lesions at 24 Months in Osteoarthritis Subjects: Subjets from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2202

Association between Oxidative Balance Score and Osteoarthritis in Korean Adults: The Korea National Health and Nutrition Examination Survey (2014–2015)

9:00AM-11:00AM: Abstract Number: 2623

Association between Smoking Status and the Clinical and Serological Characteristics at the Onset of Systemic Lupus Erythematosus. an Inception Cohort Analysis

9:00AM-11:00AM: Abstract Number: 2187

Association of Circulating microRNAs with Prevalent and Incident Osteoarthritis in Women: The Ofely Study

9:00AM-11:00AM: Abstract Number: 1963

Association of Corticosteroid Exposure with Ophthalmologic Complications and Systemic Adverse Events in Non-Infectious Uveitis Patients Using Administrative Claims in the United States

9:00AM-11:00AM: Abstract Number: 1954

Association of CRP with BMI in Males and Females

9:00AM-11:00AM: Abstract Number: 2203

Association of Hip Bone Geometry and Volumetric Density with Hip Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2136

Association of HLA-DQA1*05 with the Presence of Interstitial Lung Disease Independent of Autoantibody Status in Caucasian Patients with Polymyositis and Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2651

Association of ITGAM Polymorphism rs1143679 with Susceptibility to Systemic Lupus Erythematosus in North Indian Population

9:00AM-11:00AM: Abstract Number: 2122

Association of Retroperitoneal Fibrosis with Malignancy

9:00AM-11:00AM: Abstract Number: 2591

Association of Smoking and Cutaneous Manifestations in Systemic Lupus Erythematosus (SLE): Post-Hoc Results from Phase IIb Studies of Anifrolumab and Sifalimumab

9:00AM-11:00AM: Abstract Number: 1975

Association of the 16519 Polymorphism in Patients with Fibromyalgia. Case-Control Study

9:00AM-11:00AM: Abstract Number: 2148

Association of the Paraoxonase 1 Q192R Genetic Polymorphism with Disease Activity in Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2118

Asymptomatic Tendinitis of Flexor Digitorum Tendons in Patients with Type 2 Diabetes : A Single-Center, Cross-Sectional Prevalence Study

9:00AM-11:00AM: Abstract Number: 2121

Autoantibodies As Biomarkers for the Identification of Pre-Clinical Stages of Autoimmune Diseases: Demonstration of Inflammatory and Fibrotic Activity in the Liver of Asymptomatic and Biochemically Normal Individuals with Anti-Mitochondria Antibodies

9:00AM-11:00AM: Abstract Number: 2142

Autoantibodies Recognizing Cytosolic 5’-Nucleotidase 1A Are Associated with More Severe Disease in Patients with Juvenile Myositis

9:00AM-11:00AM: Abstract Number: 2712

Autoimmune Arthritis in IL-1 Receptor Antagonist-Deficient Mice Is Associated with a Pathogenic Conversion of Foxp3+ Regulatory T Cells into Th17 Cells

9:00AM-11:00AM: Abstract Number: 2316

Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) – a Patient Reported Outcome

9:00AM-11:00AM: Abstract Number: 2002

Baseline 18F Sodium Fluoride Uptake of Vertebral Bodies but Not Vertebral Corners on Positron Emission Tomography Is Associated with Changes in Bone Mineral Density at Lumbar Vertebrae in Ankylosing Spondylitis: A 1-Year Longitudinal Study

9:00AM-11:00AM: Abstract Number: 2593

Baseline Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab

9:00AM-11:00AM: Abstract Number: 2526

Baseline Data from the Recent-Onset Psoriatic Arthritis Registry of the Spanish Society of Rheumatology

9:00AM-11:00AM: Abstract Number: 2434

Baseline Expressions of Cellular microRNA-31 and microRNA-10a Predict Remission and Low Disease Activity in Patients with Early Rheumatoid Arthritis after Six and Twelve Months of Therapy

9:00AM-11:00AM: Abstract Number: 2201

Baseline Periarticular Tibial Knee Bone Mineral Density Is Associated with Change in Static Alignment

9:00AM-11:00AM: Abstract Number: 2720

Behcet’s Disease in Southeastern Michigan: A Single Center Comparative Study

9:00AM-11:00AM: Abstract Number: 2397

Bilateral Femoral DXA Scan in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1936

Bimekizumab Blocks T Cell-Mediated Osteogenic Differentiation of Periosteal Stem Cells: Coupling Pathological Bone Formation to IL-17A and IL-17F Signaling

9:00AM-11:00AM: Abstract Number: 2278

Biologic Switching Among JIA Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry

9:00AM-11:00AM: Abstract Number: 2405

Biological Function Integrated Prediction of Severe Radiographic Progression in Rheumatoid Arthritis: A Nested Case Control Study

9:00AM-11:00AM: Abstract Number: 2332

Biomarkers for the Diagnosis and the Identification of Risk of Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA)

9:00AM-11:00AM: Abstract Number: 2442

Biosimilar Candidate BI 695501 and Adalimumab Reference Product Have Similar Efficacy and Safety in Patients with Moderately-to-Severely Active Rheumatoid Arthritis (RA): 1-Year Results from a Phase III Study

9:00AM-11:00AM: Abstract Number: 2287

Biosimilar Use in Children and Young People with Juvenile Idiopathic Arthritis in a Real-World Setting in the United Kingdom

9:00AM-11:00AM: Abstract Number: 2495

Biosimilarity between Humira® and the Biosimilar Candidate SB5 in Product Quality

9:00AM-11:00AM: Abstract Number: 2110

Blood Group ”a“ Was Increased in FMF Patients and Blood Group ”0“ May be Associated with Colchicine Resistance

9:00AM-11:00AM: Abstract Number: 2378

Body Mass Index and Persistence of Conventional Dmards and TNF Inhibitors in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2671

Bosentan in Scleroderma Renal Crisis: A National Open Label Prospective Study

9:00AM-11:00AM: Abstract Number: 2319

Bradycardia after High-Dose Solu-Medrol

9:00AM-11:00AM: Abstract Number: 2561

BTK Inhibition Ameliorates Renal Disease in Spontaneous Murine Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 1958

Burden of Rheumatic Disease Among Korean Women in Childbearing Years Based on the National Health Insurance Service-National Sample Cohort

9:00AM-11:00AM: Abstract Number: 2117

C-Reactive Protein and Serum Amyloid a in Sepsis, Acute Appendicitis and Familial Mediterranean Fever

9:00AM-11:00AM: Abstract Number: 2086

Calcium Pyrophosphate Crystal Size, Shape and Appearance Variability

9:00AM-11:00AM: Abstract Number: 2244

Can Achieving Remission Improve Work Ability and Quality of Life in Early Rheumatoid Arthritis (RA) Patients? a Prospective Cohort Study

9:00AM-11:00AM: Abstract Number: 2545

Can Achieving Sustained Minimal Disease Activity (MDA) Prevent Progression of Subclinical Atherosclerosis? a Two-Year Prospective Cohort Study in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2719

Can Annexin A1 Expression on Neutrophils Distinguish Adult IgA Vasculitis from Other Small Vessel Vasculitides?

9:00AM-11:00AM: Abstract Number: 2293

Can We Predict Achievement of Clinically Inactive Disease and Sustained Remission in Children with Juvenile Idiopathic Arthritis?

9:00AM-11:00AM: Abstract Number: 2182

Cardiovascular Events in Patients with Diffuse Idiopathic Skeletal Hyperostosis. a 10 Years Follow-up Study

9:00AM-11:00AM: Abstract Number: 2352

Cardiovascular Safety during Treatment with Baricitinib in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2576

Caspase 8 in Dendritic Cells Suppresses IRF5 Activation through Endosomal TLR Signaling to Prevent SLE-like Disease

9:00AM-11:00AM: Abstract Number: 1972

Causes of Death in 350 Patients with Systemic Autoimmune Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 2713

CD318 Is a New Ligand for CD6

9:00AM-11:00AM: Abstract Number: 2146

CD4+CXCR4+t Cells in Patients with Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2424

CD8-Positive Lymphocytes in Biopsy Specimens Predict Spontaneous Regression of Lymphoproliferative Disorders in Patients with Rheumatoid Arthritis Treated with Methotrexate

9:00AM-11:00AM: Abstract Number: 2344

Cell-Bound Complement Activation Products As Markers of Disease Flares in Childhood Onset Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1985

Cervical Spine Radiographs in Fibromyalgia Patients Show Reduced Cobb Angle and Suggest the Presence of Increased Muscle Pressure As a Cause of the Illness

9:00AM-11:00AM: Abstract Number: 2538

Change in Self-Reported Health Status and Fatigue before and after the Diagnosis of Psoriatic Arthritis- the Nord-Trondelag Health Study (HUNT)

9:00AM-11:00AM: Abstract Number: 1996

Changes in Cartilage Matrix Measured By MR T1ρ Are Correlated with Changes in Bone Erosion Volume Measured By HR-pQCT Three Months after MTX and Anti-TNF Treatment in Patients with Rheumatoid Arthritis: A Multi-Modality Imaging Study

9:00AM-11:00AM: Abstract Number: 1992

Changes in Clinical Disease Activity Are Associated with Changes in the Total MRI Inflammation Score in Rheumatoid Arthritis Patients Who Are Escalating Therapy in a Treat-to-Target (T2T) Regimen

9:00AM-11:00AM: Abstract Number: 2663

Changes in Disability over Time, and Their Relationship with Degree of Skin Thickening, in Patients with Limited and Diffuse Cutaneous Systemic Sclerosis: A Retrospective Cohort Study

9:00AM-11:00AM: Abstract Number: 2537

Changes in Severity, Functional Status, and Wellbeing over Time Among Individuals with Ankylosing Spondylitis (AS) in Canada: Results from the RHUMADATA® Multicentre Registry

9:00AM-11:00AM: Abstract Number: 2328

Characterisation of Lipid Mediator Profile and Immune Cells in Synovial Fluid of Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2687

Characteristic of Pulmonary Arterial Hypertension in Patients with Anti-U1RNP Antibody-Positive-Connective Tissue Diseases Is Determined By the Underlying Disease Rather Than Autoantibody Profile

9:00AM-11:00AM: Abstract Number: 2519

Characteristics of Eye Diseases in Patients with Ankylosing Spondylitis in Korea: A Single-Center Survey

9:00AM-11:00AM: Abstract Number: 2173

Characteristics Unique to MDA5 and Anti-Ro/SSA-52 Kda Dual Antibody Positive Patients with Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 2345

Characterization of Adenosine Deaminase 2 Variants Identified in an International Pediatric Vasculitis Cohort

9:00AM-11:00AM: Abstract Number: 2627

Characterization of Emergency Department Visits in an Urban Underserved Lupus Cohort

9:00AM-11:00AM: Abstract Number: 2346

Chemokine Ligand 9 (CXCL9) [Monokine Induced By Gamma Interferon (MIG)] As a Predictor of Active Disease Status in Localized Scleroderma

9:00AM-11:00AM: Abstract Number: 2358

Chest Pain and Angina Pectoris in Rheumatoid Arthritis: Frequency and Prediction of Cardiovascular Mortality

9:00AM-11:00AM: Abstract Number: 1934

Chondrocytes Derived from Mesenchymal Stem Cells Differentiated in the Presence of Plasma-Derived Extracellular Vesicles from Osteoarthritic Patients Express Disease-Related Genes

9:00AM-11:00AM: Abstract Number: 2143

Circulating Endothelial Cells and Endothelial Activation Markers As Disease Activity Measures in Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 2435

Circulating Mirnas As Potential Biomarkers of Cardiovascular Disease in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2035

Clinical Audit of Hydroxychloroquine Dosing and Toxicity Screening in Patients with Inflammatory Arthritis and Connective Tissue Diseases

9:00AM-11:00AM: Abstract Number: 2733

Clinical Characteristics and Treatment Outcomes of Patients with Behçet’s Disease and Vascular Involvement

9:00AM-11:00AM: Abstract Number: 2133

Clinical Characteristics of the Patients with Recurrent Myositis in Polymyositis and Dermatomyositis: A Retrospective Study

9:00AM-11:00AM: Abstract Number: 2137

Clinical Factors Associated with Long-Term Damage and Calcinosis in an Adult-Age Referral Population of Juvenile Myositis Patients

9:00AM-11:00AM: Abstract Number: 2299

Clinical Features and Characteristics of Juvenile Idiopathic Arthritis-Associated Uveitis in Japan：the First Report from the Pediatric Rheumatology Association of Japan (PRAJ)

9:00AM-11:00AM: Abstract Number: 2730

Clinical Features and Treatment of Central Nervous System Vasculitis Associated with Acute Posterior Multifocal Placoid Pigment Epitheliopathy

9:00AM-11:00AM: Abstract Number: 2555

Clinical History of Psoriatic Arthritis over Four Decades

9:00AM-11:00AM: Abstract Number: 2661

Clinical Impact of Selenium and Vitamin C Deficiency in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2082

Clinical Presentation, Management, and Prognosis of Pseudogout in Prosthetic Joint Implant Patients: A Retrospective Study

9:00AM-11:00AM: Abstract Number: 2475

Clinical Remission in Subjects with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab As Monotherapy or in Combination with Methotrexate or Other Synthetic Dmards: A Real-World Clinical Trial

9:00AM-11:00AM: Abstract Number: 2160

Clinical Significance of Anti-Aminoacyl tRNA Synthetase Antibodies Which Are Positive By ELISA but Not By Immunoprecipitation – the Variations of Antigen Recognition and the Association with Interstitial Lung Diseases but Not Myositis –

9:00AM-11:00AM: Abstract Number: 2407

Clinical Significance of Elevated Anti-Cyclic Citrullinated Protein Antibody Titers in Patients with Pulmonary Hypertension

9:00AM-11:00AM: Abstract Number: 2097

Clinical Significance of KL-6 and SP-D As Serum Markers for Interstitial Lung Disease in Patients with Connective Tissue Disease

9:00AM-11:00AM: Abstract Number: 2172

Clinical Significance of Serum Levels of Anti-Transcriptional Intermediary Factor 1-γ Antibody in Patients with Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2088

Clinical Significance of Urate Deposition in Tendon: A Dual-Energy CT Study

9:00AM-11:00AM: Abstract Number: 2530

Clinical Specialty Setting As a Determinant for Disease Management in Patients with Psoriatic Arthritis: An Interim Analysis of the Cross-Sectional Observational Study

9:00AM-11:00AM: Abstract Number: 2163

Clinical Utilization Patterns and Performance of Commercial Myositis Autoantibody Panels in Routine Practice

9:00AM-11:00AM: Abstract Number: 2176

Clusterin Is Upregulated in Muscle Tissue and Serum in Idiopathic Inflammatory Myopathies and Is Associated with Clinical Disease Activity

9:00AM-11:00AM: Abstract Number: 2226

Cntx-4975 (Trans-Capsaicin) Injection Provides Clinically Meaningful Pain Reduction in Subjects with Painful Intermetatarsal Neuroma (Morton’s Neuroma): A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

9:00AM-11:00AM: Abstract Number: 2225

Cntx-4975 (Trans-Capsaicin) Injection Provides Clinically Meaningful Pain Reduction in Subjects with Painful Intermetatarsal Neuroma (Morton’s Neuroma): An Open-Label, Ascending-Dose Study

9:00AM-11:00AM: Abstract Number: 2108

Colchicine Treatment May be Protective Against Ventricular Arrhythmias in FMF Patients

9:00AM-11:00AM: Abstract Number: 2688

Collagen Metabolite Biomarker Levels Are Associated with the Amount of Fibrosis in Internal Organs in Systemic Sclerosis Patients

9:00AM-11:00AM: Abstract Number: 2198

Combinatorial Peripheral Blood Inflammatory and MRI-Based Biomarkers Predict Radiographic Joint Space Narrowing in Knee OA

9:00AM-11:00AM: Abstract Number: 2217

Combined Impacts of Lifestyle Factors on Knee Osteoarthritis in the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2260

Communication Strategies Are Highly Important to Avoid Nocebo Effect When Performing Non-Medical Switch from Originator Product to Biosimilar Product: Danish Results from Applying the Parker Model a Qualitative 3-Step Research Model

9:00AM-11:00AM: Abstract Number: 2450

Comparative Effectiveness of Abatacept Versus TNFi in Patients with RA Who Are CCP+ in the United States Corrona Registry

9:00AM-11:00AM: Abstract Number: 2076

Comparative Effectiveness of Allopurinol Versus Febuxostat in Preventing Incident Dementia in the Elderly

9:00AM-11:00AM: Abstract Number: 2449

Comparative Effectiveness of Tocilizumab (TCZ) Monotherapy with Tumor Necrosis Factor Inhibitors (TNFi) in Combination with Varying Doses of Methotrexate (MTX) in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2222

Comparative Risk of Respiratory Depression in Patients Treated with Opioids for Non-Malignant Pain

9:00AM-11:00AM: Abstract Number: 2290

Comparing Effectiveness of Early Initiation of Biologic Treatment for Newly Diagnosed Juvenile Idiopathic Arthritis Using a Novel Statistics Causal Inference Method Applied to Observational Data

9:00AM-11:00AM: Abstract Number: 2179

Comparing Observed with Expected Assessments of Osteoarthritic Pain over Time: Application of Successive Prediction to Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2746

Comparison between IgG and IgM Type Anti-Alpha-Enolase Antibody in Patients with Behcet’s Disease According to the Disease Severity

9:00AM-11:00AM: Abstract Number: 2551

Comparison between Two Cut-Off Values of Disease Activity in Psoriatic Arthritis Index and Validation of Its Simplified Clinical Version in Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2093

Comparison of Clinical and Laboratory Features of Patients with and without Allergic Conditions in IgG4-Related Disease: A Single-Center Experience in Japan

9:00AM-11:00AM: Abstract Number: 2161

Comparison of Clinical Characteristics between African American and Caucasian Patients with Polymyositis and Dermatomyositis and Their Response to Conventional Treatment

9:00AM-11:00AM: Abstract Number: 2156

Comparison of Patients with Dermatomyositis in a Specialty Clinic Versus Clinical Trial with Anabasum (JBT-101), a Cannabinoid Receptor Type 2 Agonist

9:00AM-11:00AM: Abstract Number: 2536

Comparison of Quality-of-Life, Function and Psoriasis Measures in Minimal Disease Activity and DAS28 States in Routine Care of Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2678

Comparison of Scleroderma Associated Isolated Pulmonary Arterial Hypertension and Pulmonary Hypertension with Concomitant Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2487

Comparison the Long-Term Clinical Outcomes between Non Anti-TNF Versus Anti-TNF in RA Patients Who Failed to a First Anti-TNF

9:00AM-11:00AM: Abstract Number: 2582

Compliance and Persistence with Hydroxychloroquine in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2028

Compliance with Pneumococcal Vaccination in Rheumatic Disease Patients on Immunosuppressive Medications

9:00AM-11:00AM: Abstract Number: 2053

Computed Tomography Dependent Diagnosis of Crowned Dens Syndrome; A Cervical Manifestation of Patients with Calcium Pyrophosphate Dihydrate Crystal Deposition Disease

9:00AM-11:00AM: Abstract Number: 2218

Concurrent Change in Quadriceps Strength and Physical Function over 5 Years in the Multicenter Osteoarthritis Study

9:00AM-11:00AM: Abstract Number: 2214

Contrary to Current Understanding of Osteoarthritis Pathogenesis, Only Gender and Radiographic Status Predict Progression: A Machine Learning Study of 9,254 Knees from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2655

Contribution of Monocytes to Circulating microRNAs Related to Cardiovascular Disease in Systemic Lupus Erythematosus. Effects of In Vivo Treatment with Rituximab

9:00AM-11:00AM: Abstract Number: 2682

Correlation between Capillaroscopic Patterns of Nailfold Microangiopathy and Three Different Methods to Assess Dermal Thickness in Systemic Sclerosis Patients

9:00AM-11:00AM: Abstract Number: 2340

Correlation of Type I Interferon Score and CXCL10 (C-X-C Motif Chemokine Ligand 10) with Cutaneous and Muscular Disease Activity in Juvenile Dermatomyositis Patients

9:00AM-11:00AM: Abstract Number: 1950

Cross-Sectional Analysis of Foot Osteoarthritis Frequency and Associated Factors: The Johnston County Osteoarthritis Project

9:00AM-11:00AM: Abstract Number: 1942

CTLA4-Ig Directly Inhibits Osteoclast Generation from Human Peripheral Monocytes and Tumor Necrosis Factor α-Treated Inflammatory Monocytes

9:00AM-11:00AM: Abstract Number: 2321

Current Practices and New Directions in Occupational and Physical Therapy for Children with Rheumatic Diseases in the Biologic Era

9:00AM-11:00AM: Abstract Number: 2533

Current Psa Therapy Impacts the Relationship between the Degree of Skin Invlovment and Joint Activity

9:00AM-11:00AM: Abstract Number: 2710

CXCR3+CCR6+CD4+ T Cells (Th1Th17) and RF As Novel Predictive Markers for Clinical Response to Abatacept Treatment in Patients with Rheumatoid Arthritis: The 52-Week Analysis

9:00AM-11:00AM: Abstract Number: 2483

Cycling Versus Swapping in Patients with Rheumatoid Arthritis with an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor: A Systematic Review and Meta-Analysis of Observational Studies

9:00AM-11:00AM: Abstract Number: 2740

Cyclophosphamide Treatment Modulates Circulating Cell Populations in Patients with Vasculitis and Autoimmune Systemic Diseases

9:00AM-11:00AM: Abstract Number: 2507

Dactylitis and Enthesitis Predict Uveitis in Large Axial Spondyloarthropathy Cohort

9:00AM-11:00AM: Abstract Number: 2425

Decline in CD8+IFNγ+ Subset but Rise in CD8+IL17+ on Methotrexate Treatment in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2364

Decrease in Cardiovascular Event Excess Risk in Rheumatoid Arthritis Since 2000: A Meta- Analysis of Controlled Studies

9:00AM-11:00AM: Abstract Number: 2153

Decreased Lean Body Mass and Bone Mineral Density but Increased Body Fat in Myositis Patients Are Associated with Disease Duration, Inflammatory Status, Skeletal Muscle Involvement and Physical Activity

9:00AM-11:00AM: Abstract Number: 2502

Defining Clinically Important Worsening Based on ASDAS-CRP for Axial Spondyloarthritis: A Data-Based Consensus By the Assessment in Spondyloarthritis International Society (ASAS)

9:00AM-11:00AM: Abstract Number: 2020

Definition and Standardization of Inflammatory Pathology in Hand Osteoarthritis Assessed By Ultrasound: Results from a Delphi Process and Reliability Testing in the Omeract Ultrasonographer Group in Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2306

Demographic and Clinical Characteristics of Hispanic Children with Juvenile Idiopathic Arthritis: An International, Multicenter Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 2159

Dermatomyositis Acute Onset/Flares Following Ingestion of Isalean® Herbal Supplement: Clinical and Immunostimulatory Findings

9:00AM-11:00AM: Abstract Number: 2477

Descriptive Patterns of Switches and Swaps in Patients with Rheumatoid Arthritis Initially Treated with Anti-TNF Agents in First Intention between 2000 and 2006, and 2007 and 2015 – Experience from a Real-World Database RHUMADATA®

9:00AM-11:00AM: Abstract Number: 1997

Detection of Progression of Radiographic Damage Despite Early and Targeted Therapy in Inflammatory Arthritis Using High-Resolution Peripheral Quantitative Computed Tomography

9:00AM-11:00AM: Abstract Number: 2286

Determinants of Anti-Tumor Necrosis Factor Drug Use in Juvenile Spondyloarthropathy and Impact on Clinical Disease Outcomes

9:00AM-11:00AM: Abstract Number: 2047

Development and Implementation of a “Data-in-Once” Model for a Pediatric Rheumatology Learning Health System

9:00AM-11:00AM: Abstract Number: 2046

Development and Validation of a Rheumatologist Satisfaction with Practice Scale –“ the Rheumatologist Satisfaction Scale” (RSS)

9:00AM-11:00AM: Abstract Number: 1946

Development of a Multi-Component 3D Arthritic Joint Model

9:00AM-11:00AM: Abstract Number: 2659

Development of a Protocol for Single Cell Transcriptomics of Cells from Cryopreserved Lupus Nephritis Kidney Tissue and Urine for the Accelerating Medicines Partnership RA/SLE Network

9:00AM-11:00AM: Abstract Number: 2022

Diagnostic and Prognostic VALUE of Salivary GLAND Ultrasonography in Primary Sjögren’s Syndrome: a Preliminary Study

9:00AM-11:00AM: Abstract Number: 2023

Diagnostic Value of the Non-Observation of the Frontal Branch of the Temporal Arteries By Ultrasonography in the Diagnostic of Giant Cell Arteritis (GCA)

9:00AM-11:00AM: Abstract Number: 1953

Dietary Quality and Risk of SLE in the Nurses’ Health Studies

9:00AM-11:00AM: Abstract Number: 2394

Differential Effect of Corticosteroids and Biological Dmards on Five-Year Radiographic Progression in Rheumatoid Arthritis: Results from a Weighted Cumulative Exposure Model Developed on the Espoir Cohort

9:00AM-11:00AM: Abstract Number: 2726

Differentiating Features of Primary Angiitis of Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Evaluation

9:00AM-11:00AM: Abstract Number: 1939

Dipyridamole, an Ent-1 Adenosine Transporter Inhibitor, Reverts De Osteoclastic Phenotype Induced By Tenofovir

9:00AM-11:00AM: Abstract Number: 2254

Disability (HAQ) and Quality of Life (SF-12) As Related to Adherence and Health Literacyin Patients with Rheumatoid Arthritis – the Trace-Study

9:00AM-11:00AM: Abstract Number: 2234

Disability in Acute Low Back Pain: The Role of Pain Severity, Pain Catastrophizing, Depression, and Exercise

9:00AM-11:00AM: Abstract Number: 2554

Disease Activity in Psoriatic Arthritis-ESR Index Maybe a Valid Tool to Evaluate Disease Activity in Patients with Psoriatic Arthritis When CRP Is Not Available

9:00AM-11:00AM: Abstract Number: 2456

Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)

9:00AM-11:00AM: Abstract Number: 2356

Disease Severity Impacts the Relationships of Apelin Concentrations with Arterial Function in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2612

Disparities in Antimalarial Prescribing for Systemic Lupus Erythematosus Using a Real-World, Electronic Health Record

9:00AM-11:00AM: Abstract Number: 2168

Dissociation of FVC and Dlco in Patients with Dermatomyositis and Polymyositis

9:00AM-11:00AM: Abstract Number: 2007

Disturbances of the Acral Perfusion Detected By Fluorescence Optical Imaging Are Associated with the Development of Ischemic Complications in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2558

DNA Methylation-Dependent Regulation of Cathepsin E Gene Expression By the Transcription Factor Kaiso in MRL/Lpr Mice

9:00AM-11:00AM: Abstract Number: 2557

Do Psoriatic Disease Patients Who Participate in Clinical Research Differ from Those Who Do Not?

9:00AM-11:00AM: Abstract Number: 2363

Does Galectin-3 Have Utility As a Biomarker of Subclinical Cardiovascular Disease in RA Patients Independently of RA Disease Activity?

9:00AM-11:00AM: Abstract Number: 2503

Does Maastricht Ankylosing Spondylitis Enthesitis Scores Differ between Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis Patients?

9:00AM-11:00AM: Abstract Number: 2010

Does PET CT Matter in Assessing Extent of Disease in Relapsing Polychondritis – a Single Center Pilot Study

9:00AM-11:00AM: Abstract Number: 2375

Does the Body Mass Index Have Any Influence in the Characteristics of Early Arthritis Patients?

9:00AM-11:00AM: Abstract Number: 2635

Dosechecker: Solving the Hydroxychloroquine Dosing Dilemma with a Smart Phone App

9:00AM-11:00AM: Abstract Number: 2479

Duration of Response in a Phase 3 Study of Sarilumab Plus Methotrexate in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2279

Dynamics of Concomitant Therapy in Children with Juvenile Idiopathic Arthritis Treated with Etanercept

9:00AM-11:00AM: Abstract Number: 2147

Dysphagia in Inflammatory Myositis: A Study of the Structural and Physiologic Changes Resulting in Disordered Swallowing

9:00AM-11:00AM: Abstract Number: 2588

Early Exposure to Hydroxychloroquine Predicts Good Renal Response in Japanese Patients with Lupus Nephritis Class III or IV

9:00AM-11:00AM: Abstract Number: 2408

Early Frailty Syndrome in Rhematoid Arthitis: Screening Using the Frail Scale

9:00AM-11:00AM: Abstract Number: 2165

Easily Obtainable Myositis Autoantibody Panel Predictive Factors

9:00AM-11:00AM: Abstract Number: 2379

Effect of DKK-1 and Osteoprotegerin on Bone Mass in Tightly Controlled Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1951

Effect of Initiating Metformin Vs. Sulfonylureas on the Risk of Total Knee Arthroplasty

9:00AM-11:00AM: Abstract Number: 2215

Effect of Single 6 Ml Intraarticular Injection of Hylan G-F 20 in Patients with Knee Osteoarthritis: Results of a Single Centre Study

9:00AM-11:00AM: Abstract Number: 1990

Effectiveness and Durability of a Brief Multidisciplinary Treatment Program for Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 2444

Effectiveness and Safety of CT-P13 in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis: Observational Study in Republic of Korea

9:00AM-11:00AM: Abstract Number: 2447

Effectiveness and Tolerability of Benepali in Rheumatoid Arthritis Patients Switched from Enbrel

9:00AM-11:00AM: Abstract Number: 2292

Effectiveness of Common Treatment Strategies for Juvenile Arthritis in Usual Practice: Results from the Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort

9:00AM-11:00AM: Abstract Number: 2280

Effectiveness of Switching to Adalimumab As the Second- and Third-Line Biological Drug in Patients with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2583

Effects of Mycophenolate Mofetil (MMF) on Immunogenicity of Ppsv-23 Vaccine in Patients with Systemic Lupus Erythematosus and Other Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 2474

Efficacy and Safety of Extending Tocilizumab Infusion Intervals from 4 Weeks to 6 Weeks in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1974

Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Patients: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

9:00AM-11:00AM: Abstract Number: 2445

Efficacy and Safety of Rituximab Biosimilar, CT-P10, after a Single Switch from Innovator Rituximabs in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 72 Weeks

9:00AM-11:00AM: Abstract Number: 2167

Efficacy and Safety of Rituximab in Anti-Synthetase Positive and Negative Patients with Idiopathic Inflammatory Myopathy– a Registry-Based Study

9:00AM-11:00AM: Abstract Number: 2482

Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2493

Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Prior Therapies

9:00AM-11:00AM: Abstract Number: 2489

Efficacy and Survival of Biologic DMARD Therapies As Monotherapy: Real World Data

9:00AM-11:00AM: Abstract Number: 2599

Efficacy and Toxicity of Antimalarials in Systematic Lupus Erythematosus: A Systematic Review

9:00AM-11:00AM: Abstract Number: 2154

Efficacy of an Intensive 24-Week Physiotherapy Programme in Patients with Idiopathic Inflammatory Myopathies – Preliminary Data from a Single-Center Controlled Study

9:00AM-11:00AM: Abstract Number: 2455

Efficacy of Etanercept in Elderly Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2305

Efficacy of Function-Based Exercise Program on Functional Ability, Pain and Quality of Life in Children with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2470

Efficacy of Sarilumab in Combination with Csdmards in Patients with Rheumatoid Arthritis and Inadequate Response to TNF Inhibitors By Baseline Levels of Disease Activity

9:00AM-11:00AM: Abstract Number: 2468

Efficacy of Sarilumab in Patients with Rheumatoid Arthritis Who Previously Received Sarilumab or Tocilizumab

9:00AM-11:00AM: Abstract Number: 2099

Elderly – Onset Sarcoidosis: a Single Center Comparative Study

9:00AM-11:00AM: Abstract Number: 2617

Electrocardiogram Abnormalities Related to Antimalarials in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1977

Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 1978

Employment Status in Fibromyalgia: Comparison of Employed and Unemployed Patients and Predictors of Unemployed Status

9:00AM-11:00AM: Abstract Number: 2370

Endothelial Nitric Oxide Synthase Gene Polymorphism As a Risk Factor of Hypertension in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2660

Endothelin-1 and Interleukin-6 Serum Levels Are Associated with More Severe Vasculopathy in Patients  with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2681

Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome

9:00AM-11:00AM: Abstract Number: 2105

Epidemiology of Interstitial Pneumonia with Autoimmune Features

9:00AM-11:00AM: Abstract Number: 2647

Epstein Barr Virus Interluekin-10 (vIL10) in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2428

Epstein-Barr Virus Infection and Epstein-Barr Virus　Nuclear Antigen 1 Variants in the Synovial Tissue of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2221

Eradication of Hepatitis C Among US Veterans: Examination of Changes in Pain Severity and Prescription Opioid Use Following Treatment

9:00AM-11:00AM: Abstract Number: 1994

Erosion Depth Predicts Erosion Progression in Patients with Early RA: A Longitudinal Analysis Using HR-pQCT

9:00AM-11:00AM: Abstract Number: 2707

Estrogen Downregulates the Expression of Serine Arginine Splicing Factor 1 (SRSF1) in Human T Lymphocytes

9:00AM-11:00AM: Abstract Number: 2276

Etanercept (Enbrel®) Treatment Retention in the Sub-Population of Pediatric Patients from a Retrospective Cohort Study Using Canadian Claims-Level Data

9:00AM-11:00AM: Abstract Number: 2298

Etanercept, Adalimumab and Methotexate Utilization By Juvenile Idopathic Arthritis Patients and the Occurrence of Uveitis

9:00AM-11:00AM: Abstract Number: 2116

Evaluation of Connective Tissue Diseases in Patients Presenting with Interstitial Lung Disease in a Referral Center in Santiago, Chile

9:00AM-11:00AM: Abstract Number: 2393

Evaluation of Live Zoster Vaccine in a Subset of Patients with Rheumatoid Arthritis Treated with Tofacitinib with or without Methotrexate, and Adalimumab with Methotrexate: Results from a Phase 3b/4 Randomized Trial

9:00AM-11:00AM: Abstract Number: 2032

Evaluation of RA Outcome Measures between Users and Non-Users of the Patient Portal

9:00AM-11:00AM: Abstract Number: 2467

Evaluation of Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Treated with SB4 or Reference Etanercept: Results from a Phase III Study

9:00AM-11:00AM: Abstract Number: 2129

Evaluation of Suppurative Hidradenitis in Patients with Chronic Arthritis Treated with Full and Tapered Biological Disease-Modifying Antirheumatic Drugs

9:00AM-11:00AM: Abstract Number: 2330

Evidence for Alternatively Activated (M2) Macrophage Activation in Patients with Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2070

Evidence-Based Development of Criteria for Complete Response in Patients with Chronic Refractory Gout

9:00AM-11:00AM: Abstract Number: 1965

Evolution of Anti-Citrullinated Protein Antibodies in Post-Chikungunya Arthritis Patient in Dominican Republic

9:00AM-11:00AM: Abstract Number: 1987

Exercise in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 2427

Exosomes Derived from T Lymphocytes Enhance Expression of CXCL10 Induced By IFN-γin Rheumatoid Arthritis Synovial Fibroblasts Via Pattern Recognition Receptor, RIG-I

9:00AM-11:00AM: Abstract Number: 2580

Exploiting Inhibition of PD1 Signaling in a Murine Model of Anti-SSA/Ro Associated Congenital Heart Block

9:00AM-11:00AM: Abstract Number: 2597

Explorer Study: Rituximab Use in Systemic Lupus Erythematosus, a New Look on Old Data

9:00AM-11:00AM: Abstract Number: 2323

Exploring HLA-DRB1 Risk Alleles in Non-Hispanic African American Children with Juvenile Idiopathic Arthritis and Chronic Anterior Uveitis

9:00AM-11:00AM: Abstract Number: 2653

Exposure to a Periodontal Pathogen Aggregatibacter Actinomycetemcomitans Is Associated with Increased SLE Severity

9:00AM-11:00AM: Abstract Number: 2104

Exposure to Fine Particle Air Pollution and Anti-Nuclear Antibodies (ANA) in a Large Population-Based Sample

9:00AM-11:00AM: Abstract Number: 2586

Exposure-Response Modelling and Exposure-Safety Modelling Analyses in Two Phase II Studies of Atacicept in SLE

9:00AM-11:00AM: Abstract Number: 2336

Expression of Myxovirus-Resistance Protein a: A Possible Marker of Muscular Disease Activity in Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2339

Expression of Type I and Type II Interferons Is Increased in Muscle Biopsies of Juvenile Dermatomyositis Patients and Related to Clinical and Histological Features

9:00AM-11:00AM: Abstract Number: 2325

Extensive Serum Cytokine Analysis in Patients with Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2636

EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion through Junctional Adhesion Molecule-a in Lupus Patients

9:00AM-11:00AM: Abstract Number: 2049

Factor Structure and Convergent Validity of the Derriford Appearance Scale-24 Using Standard Scoring Versus Treating “Not Applicable” Responses As Missing Data: A Scleroderma Patient-Centered Intervention Network Cohort Study

9:00AM-11:00AM: Abstract Number: 2157

Factors Associated with Clinical Remission of Skin Disease in Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2683

Factors Associated with Disease Progression in Early-Diagnosed Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2235

Factors Associated with Opioid Use in End-Stage Knee, Hip and Spine Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2275

Factors Related to Sustained Discontinuation of Medications for Well-Controlled JIA in the Childhood Arthritis & Rheumatology Research Alliance Registry

9:00AM-11:00AM: Abstract Number: 2113

Familial Mediterranean Fever in Chinese Adult Patients

9:00AM-11:00AM: Abstract Number: 2016

Favourable Changes in Power Doppler Scores in the Feet over 1-Year in an Early Rheumatoid Arthritis Cohort: The Role of Rheumatoid Factor and Anti–Citrullinated Protein Antibody

9:00AM-11:00AM: Abstract Number: 2199

Feasibility of a Novel Approach to Studying Early Knee Osteoarthritis: An Offspring Study

9:00AM-11:00AM: Abstract Number: 1928

Fibroblast-like Synovial Cell Production of ED-a Fibronectin Contributes to Inflammation in Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1973

Fibromyalgia in Real Life a National French Web-Based Survey in 4516 Patients

9:00AM-11:00AM: Abstract Number: 1991

Fibromyalgia in Russian Refugees: Translation and Validation of the Revised Symptom Impact Questionnaire

9:00AM-11:00AM: Abstract Number: 2012

First Description of Tenosynovitis Prevalence in a Large Cohort of ACPA-Positive Patients

9:00AM-11:00AM: Abstract Number: 2062

Flow-Mediated Dilation As a Marker of Endothelial Dysfunction in Gout

9:00AM-11:00AM: Abstract Number: 2430

For Each HLA-DRB1 Genotype, the Likelihood to Develop RA Correlates with the Probability of Binding at Least a Peptide from PAD4

9:00AM-11:00AM: Abstract Number: 2749

Four-Distinct Phenotypes of Patients with Necrotizing Arteritis of Medium and Small Arteries

9:00AM-11:00AM: Abstract Number: 2700

Fra-2 Overexpression Leads to Systemic Autoimmunity By Affecting IL2 Dependent Treg Homeostasis

9:00AM-11:00AM: Abstract Number: 2383

Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

9:00AM-11:00AM: Abstract Number: 2307

Frequency of Comorbidities in Patients with Juvenile Ideopathic Arthritis – Results of an Observational Cohort Study

9:00AM-11:00AM: Abstract Number: 2594

Frequency of Infusions Among Patients Diagnosed with Systemic Lupus Erythematosus Initiating Treatment with Intravenous Belimumab

9:00AM-11:00AM: Abstract Number: 2248

Function, Pain, Fatigue, and Participation Are the Primary Contributors to the Patient Global Assessment in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2589

Functional and Mechanistic Characterization of Anifrolumab, a Fully Human Monoclonal Antibody Targeting the Interferon Alpha Receptor 1 for the Treatment of SLE

9:00AM-11:00AM: Abstract Number: 2171

Functional Measures and Patient Home Self-Assessments in the Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 2716

Gastrointestinal Involvement in Adult IgA Vasculitis (Henoch–Schönlein purpura): Initial Manifestations and Outcomes

9:00AM-11:00AM: Abstract Number: 2350

Gastrointestinal Microbiota in New-Onset Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2499

Gender Differences in Axial and Peripheral Spondyloarthritis: Results from the Esperanza Cohort

9:00AM-11:00AM: Abstract Number: 2368

Global Circumferential Strain By Assessed a Feature Tracking Cardiac Magnetic Resonance (CMR) Imaging Was Associated with Myocardial Fibrosis in RA Patients

9:00AM-11:00AM: Abstract Number: 2463

Golimumab in Biologic-NaïVe Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) – Subanalysis from a Non-Interventional Evaluation in Germany

9:00AM-11:00AM: Abstract Number: 2488

Golimumab Retention Rate in Patients with Rheumatoid Arthritis. Predictors of Long-Term Retention

9:00AM-11:00AM: Abstract Number: 2297

Golimumab Versus Tocilizumab in Uveitis Related to Refractory Juvenile Idiopathic Arthritis. National Multicenter Study of 33 Patients

9:00AM-11:00AM: Abstract Number: 2069

Gout Is More Frequent in Sickle Cell Disease Than the General Population

9:00AM-11:00AM: Abstract Number: 1955

Health Care Provider Advice for Weight Loss Among US Adults with Arthritis, National Health Interview Survey, 2014

9:00AM-11:00AM: Abstract Number: 2267

Health Related Quality of Life in Lupus: Self-Management- a Modifiable Predictor

9:00AM-11:00AM: Abstract Number: 2206

Healthy Weight Loss Is Associated with Improved Pain and Function over 8 Years in Overweight Subjects with Knee Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2381

Hematologic Abnormalities during the Use of Low Dose Methotrexate for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2619

Hemophagocytic Syndrome in Patients from SLE Registry from the Spanish Society of Rheumatology (RELESSER)

9:00AM-11:00AM: Abstract Number: 1976

High and Low Widespread Pain Index Fibromyalgia Patient Groups, Same, or Different?

9:00AM-11:00AM: Abstract Number: 2385

High Incidence of Hepatitis Related to HBV Reactivation in Rheumatoid Arthritis Patients with Resolved Hepatitis B Infection during Rituximab Treatment

9:00AM-11:00AM: Abstract Number: 2347

High Interferon (IFN) Signatures and Overlapping Clinical Features Characterize Subgroups of Patients with Presumed IFN-Mediated Autoinflammatory Diseases

9:00AM-11:00AM: Abstract Number: 2509

High Prevalence of Sarcopenia in Axial Spondyloarthropathy Cohort

9:00AM-11:00AM: Abstract Number: 2366

High Uric Acid As a Risk Factor for Cardiovascular Diseases in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2065

Higher Urate Volume Measured By Dual Energy Computed Tomography Is Associated with Unfavourable Cardiovascular Risks in Patients with Gout

9:00AM-11:00AM: Abstract Number: 2709

Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target for Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2416

Histopathological Change Caused By Biological Treatment in Rheumatoid Arthritis Synovial Tissue

9:00AM-11:00AM: Abstract Number: 2200

History of Walking for Exercise Is Not Associated with More Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 2037

HLA-B27 Testing in Patients >= 45 Years of Age and Subsequent Diagnosis of Late Onset Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2158

HLA-DRB1*04:03/*04:06 As the Genetic Susceptibility to Dermatomyositis Positive for Anti-Transcriptional Intermediary Factor 1-γ Antibody in Japanese Population

9:00AM-11:00AM: Abstract Number: 2643

HO-1 Expression in Monocytes Might Regulate Kidney Damage in Lupus Nephritis Patients

9:00AM-11:00AM: Abstract Number: 2614

Hydroxychloroquine Initiation Dosing Trends and Predictors in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2596

Hydroxychloroquine Use Is Associated with Decreased Dendritic Cell Activation and Thrombolytic Factors in SLE Patients

9:00AM-11:00AM: Abstract Number: 2109

Hyperferritinemic Syndrome in a General Hospital

9:00AM-11:00AM: Abstract Number: 2334

Hypermethylation of NLRP3 Promoter Region Could be Responsible for Decreased Gene Expression, Inflammasome Malfunction and Gut Dysbiosis in Juvenile Spondyloarthritis Patients

9:00AM-11:00AM: Abstract Number: 2078

Hypersensitivity Reactions with Allopurinol and Febuxostat in Adults 65 Years or Older: A Study Using the Medicare Claims Data

9:00AM-11:00AM: Abstract Number: 2602

Identification of Clinical and Serological Predictive Factors of Response to Rituximab Treatment in Systemic LUPUS Erythematosus (SLE) Patients

9:00AM-11:00AM: Abstract Number: 2125

Identification of Long-Term Prognostic Factors for Relapse or Exacerbation in Patients with Pulmonary Sarcoidosis: A Single Center Long-Term Observational Cohort Study

9:00AM-11:00AM: Abstract Number: 2134

Identification of Multiple Cancer Associated Myositis Specific Antibodies in Idiopathic Inflammatory Myopathies: A Large Longitudinal Cohort Study

9:00AM-11:00AM: Abstract Number: 2270

Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2057

Identification of Urate Deposits in Patients with Asymptomatic Hyperuricemia Using a Dual-Energy CT Scan

9:00AM-11:00AM: Abstract Number: 2698

IL-21-mTOR Axis Blocks the Differentiation and Function of SLE Tregs Via Suppression of Autophagy

9:00AM-11:00AM: Abstract Number: 2571

IL23 Deficiency Alters Thymic Selection in Lupus Prone Mice

9:00AM-11:00AM: Abstract Number: 2641

Immune Complex-Driven Neutrophil Activation in Systemic Lupus Erythematosus – Novel Biomarkers of Disease Activity and Severity

9:00AM-11:00AM: Abstract Number: 2106

Immune-Related Adverse Events in Cancer Patients Treated with Immune Check Point Inhibitors: A Single Center Experience

9:00AM-11:00AM: Abstract Number: 2415

Immunogenicity and Persistence of a Prime-Boost Re-Vaccination Strategy for Pneumococcal Vaccines (13-Valent Pneumococcal Conjugate Vaccine + 23-Valent Pneumococcal Polysaccharide Vaccine) in Patients with Rheumatoid Arthritis: A Pilot Study

9:00AM-11:00AM: Abstract Number: 2748

Immunogenicity of Infliximab Among Patients with Behcet’s Syndrome: A Controlled Study

9:00AM-11:00AM: Abstract Number: 1940

Immunologic Synovitis Score: A New Score for Synovial Membrane Characterization in Inflammatory and Non-Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 2419

Immunomodulatory Effects of Bone-Marrow Mesenchymal Stem Cells in Rheumatoid Arthitis: Influence of Disease Activity

9:00AM-11:00AM: Abstract Number: 2377

Impact of Body Mass Index and Weight Loss on Incident Disability in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2512

Impact of Inflammatory Bowel Disease in Early Spondyloarthritis in a Prospective Longitudinal Cohort

9:00AM-11:00AM: Abstract Number: 1957

Impact of Maternal Systemic Autoimmune Rheumatic Diseases on Neonatal Outcomes: A Population-Level Analysis

9:00AM-11:00AM: Abstract Number: 2246

Impact of Patient Education Tool to Increase Cardiovascular Risk Konwledge, Attitudes, and Behaviors in Patietns with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2677

Impact of Rheumatologic Evaluation and Serologic Testing on Patients with Fibrotic Interstitial Lung Disease: A Single Center Retrospective Experience

9:00AM-11:00AM: Abstract Number: 2540

Impact of Sleep on Measures of Disease Activity in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2392

Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1980

Impact of Whole-Body Cryotherapy on Gene Expression of Peripheral Blood Cells in Patients with Fibromyalgia and Association with Patient-Reported Outcomes

9:00AM-11:00AM: Abstract Number: 2029

Improved Provider Awareness and Delivery of Zoster Vaccination in Patients with Rheumatoid Arthritis Contemplating Biologic Therapy: Need to Target Eligible Patients Prescribed for Vaccination Post-Clinic

9:00AM-11:00AM: Abstract Number: 2480

Improvements in Remission and Low Disease Activity Are Achieved with Ongoing Sarilumab Treatment, in Patients with Rheumatoid Arthritis in 2 Phase 3 Studies

9:00AM-11:00AM: Abstract Number: 2040

Improving Quality of Care for Rheumatoid Arthritis Patients in an Underserved Area

9:00AM-11:00AM: Abstract Number: 1989

Improving Sleep in Fibromyalgia Patients Ameliorates Their Pain

9:00AM-11:00AM: Abstract Number: 2506

In Ankylosing Spondylitis/Axial Spondyloarthritis Smoking Is Associated with a Dose Related Elevation in CRP, Worse Disease Activity and Worse Quality of Life over One Year

9:00AM-11:00AM: Abstract Number: 2686

In Established Pulmonary Arterial Hypertension the Follow-up Cardiac Catheterization-Derived Pulmonary Artery Systolic Pressure and Vascular Resistence May be Predicted By Echocardiography- a Longitudinal Study in Two Connective Tissue Disease Cohorts

9:00AM-11:00AM: Abstract Number: 2452

In Real-World Clinical Practice, Patients Switching from IV to SC Abatacept Maintain Clinical Efficacy after Switch

9:00AM-11:00AM: Abstract Number: 2400

In Rheumatoid Arthritis: Vitamin-D Deficiency Is an Outcome and a Cause of Subclinical Renal Impairment

9:00AM-11:00AM: Abstract Number: 2411

In-Hospital Risk of Asthma in Patients with Rheumatoid Arthritis: A Cross-Sectional Nationwide Analysis

9:00AM-11:00AM: Abstract Number: 2384

Incidence and Predictors of Dyspnea on Exertion in a Prospective Cohort of Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2459

Incidence of Disease Worsening in Inflammatory Arthritis Patients on Long-Term Infliximab (Remicade®) Therapy

9:00AM-11:00AM: Abstract Number: 2520

Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World

9:00AM-11:00AM: Abstract Number: 2391

Incidence of Infections in Early Arthritis

9:00AM-11:00AM: Abstract Number: 2406

Increased Cartilage Damage in Metacarpophalangeal Joints of ACPA Positive Rheumatoid Arthritis (RA) Patients Using T2 Mapping in 3 Tesla Magnetresonance Imaging (MRI)

9:00AM-11:00AM: Abstract Number: 2691

Increased Circulating Cadherin-11 Levels in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2448

Increased Cumulative Exposure to Tumor Necrosis Factor Inhibitors Reduces Radiographic Progression in US Veterans with Rheumatoid Arthritis in Real World Clinical Practice

9:00AM-11:00AM: Abstract Number: 2527

Increased Prevalence of Subclinical Atherosclerosis in Moderate-Severe Plaque Psoriasis Patients

9:00AM-11:00AM: Abstract Number: 2310

Increased Risk of Extreme Obesity in Adults with History of Childhood Arthritis

9:00AM-11:00AM: Abstract Number: 2644

Increased Toll-like Receptor 7 Expression Promotes B Cell Abnormalities and Skewing of Cytokine and Autoantibody Profiles in SLE Patients

9:00AM-11:00AM: Abstract Number: 2289

Individualized Prediction of Early Remission on Medication in Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2638

Inducible cAMP Early Repressor Promotes Glycolysis By Inhibiting the Pyruvate Dehydrogenase Phosphatase Catalytic Subunit 2 in Th17 Cells

9:00AM-11:00AM: Abstract Number: 2603

Induction of Lupus Nephritisin in Real Situation: Cyclophosphamide or Mycophenolate Mofetil?

9:00AM-11:00AM: Abstract Number: 2140

Infections and Medications Associated with Onset of Myositis in Myovision, a National Myositis Patient Registry

9:00AM-11:00AM: Abstract Number: 2738

Infectious Complications in Systemic Necrotizing Vasculitides: Pooled Analysis of Five Prospective, Randomized, Controlled Trials

9:00AM-11:00AM: Abstract Number: 2354

Inflammatory Markers in Relation to Risk Factors for Cardiovascular Disease in the Pre-Symptomatic Phase of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2296

Infliximab Use in JIA and Uveitis: Does Methotrexate Help or Hinder?

9:00AM-11:00AM: Abstract Number: 1935

Influence of Adipokines on the Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients

9:00AM-11:00AM: Abstract Number: 2525

Influence of Cardiovascular Comorbidity on Achieving Therapeutic Goals: A Comparative Study between Recent-Onset Psoriatic Arthritis and Established Disease

9:00AM-11:00AM: Abstract Number: 2249

Influence of Large-Joint Involvement on Patient-Physician Discordance in Global Assessment of Rheumatoid Arthritis Disease Activity Analyzed By Novel Joint Index

9:00AM-11:00AM: Abstract Number: 2564

Inhibition of Neutrophil Elastase Protects Against Glomerulonephritis and Thrombosis in a Mouse Model of Lupus

9:00AM-11:00AM: Abstract Number: 2562

Inhibition of Spleen Tyrosine Kinase Improves Renal Pathology and Reduces Lymphocyte Activation in the MRL/Lpr and NZB/NZW Murine Models of Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2091

Initial Phase 2 Clinical Data of SEL-212 in Symptomatic Gout Patients: Monthly Dosing of a Pegylated Uricase (Pegsiticase) with Svp-Rapamycin Enables Sustained Reduction of Serum Uric Acid Levels By Mitigating Formation of Anti-Drug Antibodies

9:00AM-11:00AM: Abstract Number: 2252

Initial Validation of Patient-Reported Outcomes Measurement Information System (PROMIS®) in Children with Juvenile Myositis

9:00AM-11:00AM: Abstract Number: 2472

Integrated Phase 3 Safety Results of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2552

Inter-Connections between Fatigue, Pain and Patient Global Assessement in Patients with Active Spondyloarthritis Followed in the Daily Clinic

9:00AM-11:00AM: Abstract Number: 2349

Interferon Signature in Childhood Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 1930

Interleukin 1β Decreases Capacity for Repair Human Cartilage Lesions By Mesenchymal Stromal Cells on Collagen/Proteoglycan Scaffolds

9:00AM-11:00AM: Abstract Number: 2574

Interleukin-33 Ameliorates Murine Lupus Via Induction of Regulatory T Cells and M2 Macrophage Polarisation

9:00AM-11:00AM: Abstract Number: 2114

Interstitial Pneumonia with Autoimmune Features (IPAF): Are There Definable Subsets?

9:00AM-11:00AM: Abstract Number: 2166

Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Efficacy and Predictive Factors for Clinical Response

9:00AM-11:00AM: Abstract Number: 2174

Investigating Exercise- and Crossfit-Induced Rhabdomyolysis: Data from a Community Healthcare System

9:00AM-11:00AM: Abstract Number: 2211

Investigation of Self-Reported Painful Joint Count As an Outcome Measure in Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2228

Involvement of Receptor Tyrosine Kinase a Signaling in Rhumatoid Arthritis Using Trka/C Knock-in Mice: A Multimodal Approach

9:00AM-11:00AM: Abstract Number: 2511

Irritable Bowel Syndrome and Its Impact on Patient-Reported Outcomes in Axial Spondyloarthritis: Is It an Overlooked Comorbidity?

9:00AM-11:00AM: Abstract Number: 2181

Is a Decrease in MRI-Defined Inflammation Associated with a Decrease in Pain in Patients with Hand Osteoarthritis? a Two-Year Follow-up Study

9:00AM-11:00AM: Abstract Number: 2718

Is Smoking Important in Adult IgA Vasculitis?

9:00AM-11:00AM: Abstract Number: 2735

Is There an Association between Adult IgA Vasculitis and Cancer?

9:00AM-11:00AM: Abstract Number: 2304

Joint Injection Practices in Pediatric Rheumatology – Preliminary Data from an Ongoing Web Based Survey

9:00AM-11:00AM: Abstract Number: 2130

Joint Manifestations in Patients Diagnosed with Idiopathic Inflammatory Myopathy: Multicenter Registry on Inflammatory Myositis from the Rheumatology Society in Madrid, Spain

9:00AM-11:00AM: Abstract Number: 2389

Joint Surgery in Rheumatoid Arthritis 1980-2013: A Population-Based Study to Identify Risk Factors and Time Trends in Incidence

9:00AM-11:00AM: Abstract Number: 2414

Knowledge and Adherence to Current Immunization Recommendations in Patients with Rheumatoid Arthritis in Mexico

9:00AM-11:00AM: Abstract Number: 2317

Knowledge Translation in Juvenile Idiopathic Arthritis in Canada: A Focus on Parents of Children with JIA

9:00AM-11:00AM: Abstract Number: 2262

Knowledge, Beliefs and Concerns about Osteoporosis – a Qualitative Synthesis

9:00AM-11:00AM: Abstract Number: 2559

KZR-616, a Selective Inhibitor of the Immunoproteasome, Blocks the Disease Progression in Multiple Models of Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 2587

KZR-616, a Selective Inhibitor of the Immunoproteasome, Shows a Promising Safety and Target Inhibition Profile in a Phase I, Double-Blind, Single (SAD) and Multiple Ascending Dose (MAD) Study in Healthy Volunteers

9:00AM-11:00AM: Abstract Number: 2573

Lack of CD137-CD137 Ligand Signalling Aggravates Glomerulonephritis and Reduces the Survival of Lupus-Prone B6.MRLlpr Mice

9:00AM-11:00AM: Abstract Number: 2717

Late Onset of IgA Vasculitis Is Associated with More Severe Renal Involvement

9:00AM-11:00AM: Abstract Number: 2695

Latent Profile Analysis-Derived Typologies of Systemic Sclerosis Patients Using Body Image Indicators: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study

9:00AM-11:00AM: Abstract Number: 2209

Leptin and Adiponectin Mediate the Association between Body Mass Index and Hand and Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1982

Leptin, a Hypothalamic Signaling Hormone, Is Elevated in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 2250

Linguistic Differences in Gout-Related Online Content: A Comparison of Professional Health Literature for Consumers Vs Patients’ Online Discussions of Gout

9:00AM-11:00AM: Abstract Number: 2722

Long Term Follow-up and Optimization of Infliximab in Refractory Uveitis of Behçet’s Disease. Multicenter Study of 103 Cases

9:00AM-11:00AM: Abstract Number: 2747

Long Term Follow-up of Behcet’s Syndrome Patients Treated with Cyclophosphamide

9:00AM-11:00AM: Abstract Number: 2437

Long-Term Effect of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, on Radiographic Progression in Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of a Global Phase 3 Trial

9:00AM-11:00AM: Abstract Number: 2272

Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Ongoing Results from the Abatacept in JIA Registry

9:00AM-11:00AM: Abstract Number: 2440

Long-Term Efficacy, Safety and Immunogenicity Results from a Randomized, Double-Blind, Phase III Confirmatory Efficacy and Safety Study Comparing GP2017, a Proposed Biosimilar, with Reference Adalimumab

9:00AM-11:00AM: Abstract Number: 2744

Long-Term Remission in Severe Behcet’s Disease Following Withdrawal of Successful Anti-TNF Treatment

9:00AM-11:00AM: Abstract Number: 2481

Long-Term Safety of Adalimumab (HUMIRA) in Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis in 29,987 Patients Representing 56,951 Patient-Years

9:00AM-11:00AM: Abstract Number: 2736

Long-Term Survival in Systemic Necrotizing Vasculitides

9:00AM-11:00AM: Abstract Number: 2432

Longitudinal Changes in Gene Expression Associated with Disease Activity during Pregnancy and Post-Partum Among Women with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2131

Longitudinal Cohort Study of Anti-PM/Scl Myositis Patients: Mild Muscle and Lung Involvement with Prominent Perivascular Inflammation

9:00AM-11:00AM: Abstract Number: 2264

Low Educational Attainment Is Associated with Poor Patient Status in Rheumatoid Arthritis (RA) or Osteoarthritis (OA) at the Initial Rheumatology Visit, with Remarkably Similar Patterns in Either Diagnosis

9:00AM-11:00AM: Abstract Number: 2033

Low Health Literacy Does Not Impact Adherence to Hydroxychloroquine in Patients with Systemic Lupus

9:00AM-11:00AM: Abstract Number: 2373

Low or High BMI Negatively Impacts RA Disease Activity in an Asian RA Cohort

9:00AM-11:00AM: Abstract Number: 2675

Lung Transplant Trends in Patients’ with Systemic Sclerosis Using UNOS (United Network Organ Sharing) Database from 2000-2014

9:00AM-11:00AM: Abstract Number: 2642

Lupus Serum Induces Glomerular Endothelial Cell Neutrophil Adhesion in Association with Soluble Mediators of Chemotaxis and Adhesion

9:00AM-11:00AM: Abstract Number: 1999

Magnetic Resonance Imaging of Skeletal Muscles in Patients with Dermatomyositis and Polymyositis: Novel and Distinctive Characteristic Findings

9:00AM-11:00AM: Abstract Number: 2238

Mapping Paindetect, a Neuropathic Pain Screening Tool, to Patient-Reported Outcomes Measurement Information System (PROMIS) 29 in Patients with Rheumatoid Arthritis: Developing a Neuropathic Pain Scale As a Measure of Treatment Outcome

9:00AM-11:00AM: Abstract Number: 2420

Mass Cytometry Analysis of CD4+ T Cells in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2115

Mast Cell Activation Features in Ehlers-Danlos/Joint Hypermobility Patients: A Retrospective Analysis in Light of an Emerging Disease Cluster

9:00AM-11:00AM: Abstract Number: 2231

MCC22, a Novel Compound That Targets Both CCR5 and Mu Opioid Receptors, Is Highly Effective in Treating Inflammatory Arthritis Pain

9:00AM-11:00AM: Abstract Number: 2318

Measurement of Serum Infliximab and Antibody Levels As an Adjunct to Clinical Decision Making Regarding Infliximab Therapy

9:00AM-11:00AM: Abstract Number: 2542

Measuring Psoriasis Specific Impact on Quality of Life: Performance of Dlqi and Skindex-17 in Early Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2469

Median Time to Lda Is Shorter in Tocilizumab Combination Therapy with Csdmards As Compared to Monotherapy in Patients with Active Rheumatoid Arthritis and Inadequate Responses to Csdmards and/or TNF Inhibitors: Sub-Analysis of the Swiss and Austrian Patients from the ACT-SURE Study

9:00AM-11:00AM: Abstract Number: 2066

Mediation Analysis to Understand Genetic Relationships between Habitual Coffee Intake and Gout

9:00AM-11:00AM: Abstract Number: 2616

Mesenchymal Stem Cells Induce CD1c+ Tolerogenic Dendritic Cells Via up-Regulating FLT3L in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2178

Metabolic Osteoarthritis: Relation of Cardiovascular Disease and Diabetes to Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2180

Metabolic Syndrome Does Not Modify the Association between Obesity and Hip Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2189

Metabolic Syndrome Influences the Radiographic Progression of Knee Osteoarthritis and Condition the Risk of Erosive Hand OA

9:00AM-11:00AM: Abstract Number: 2521

Metabolic Syndrome Is Associated with Active Disease in Psoriatic Arthritis and May Contribute to Development of Syndesmophytes

9:00AM-11:00AM: Abstract Number: 2522

Metabolic Syndrome, NAFLD and LIVER Stiffness in Psoriatic Arthritis and Psoriasis Patients: A CROSS-Sectional Study

9:00AM-11:00AM: Abstract Number: 2295

Methotrexate As First Line Therapy in Juvenile Idiopathic Arthritis-Associated Uveitis: Myth or Reality

9:00AM-11:00AM: Abstract Number: 2453

Methotrexate Discontinuation from Combination Therapy with Adalimumab Is Not Associated with Inferior Outcomes at 6 Months

9:00AM-11:00AM: Abstract Number: 1941

Microenvironmental and Systematic Evaluation of the Immunome in Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2669

Microvascular Flow Assessed By Dynamic Optical Coherence Tomography: First Non-Invasive Quantitative Outcome Measure of Microvascular Disease in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2446

Minimal and Comparable Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Who Continued SB5 or Reference Adalimumab and Who Switched to SB5

9:00AM-11:00AM: Abstract Number: 2621

Minimal Renal Affection in Patients with Systemic LUPUS Erythematosus: Characteristics and Evolution

9:00AM-11:00AM: Abstract Number: 2436

MiR-146a Upregulates the TLR4/NF-κb Signaling Pathway to Promote Cytokine Expression and Synovial Fibroblast Proliferation in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1933

Mitochondrial ROS Activate the p38-MAPK/AP1 Pathway to Induce the Expression of Matrix Metalloproteases and IL-6 in Human Chondrocytes

9:00AM-11:00AM: Abstract Number: 2124

Mixed Connective Tissue Disorder Has Higher Prevalence of Arthritis and Use of Methotrexate Than Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2326

Modeling Transcriptional Rewiring in Neutrophils through the Course of Treated Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2314

Monoarticular Juvenile Idiopathic Arthritis: A Unique Entity?

9:00AM-11:00AM: Abstract Number: 2329

Monocytes from Patients with Enthesitis Related Arthritis Produce High Levels of Pro-Inflammatory Cytokines: Role of Endogenous Ligands

9:00AM-11:00AM: Abstract Number: 2412

Mortality and Clinical Features in Rheumatoid Arthritis and Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2665

Mortality in an Early Diffuse Cutaneous Systemic Sclerosis Cohort—Data from the Prospective Registry for Early Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2679

Mortality Is Increased in Scleroderma Associated Pulmonary Arterial Hypertension Patients with Younger Age, Lower Systolic Blood Pressure, and Lower Cardiac Index, but Not in Idiopathic Pulmonary Arterial Hypertension

9:00AM-11:00AM: Abstract Number: 2699

Mosaic, a Novel Gene, Mediating Autoimmunity in Mice

9:00AM-11:00AM: Abstract Number: 1988

Most Fibromyalgia Patients in a Rheumatology Office Practice Accept the Diagnosis of Fibromyalgia

9:00AM-11:00AM: Abstract Number: 2000

MRI Contributes to Accurate and Early Diagnosis of Non-Radiographic HLA-B27 Negative Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2711

Mucosal-Associated Invariant T Cells Are an Important Source of TNF in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1959

Multimorbidity in Patients with Sarcoidosis: A Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 2144

Multiple Serum Cytokine and Chemokine Profiling to Identify Combinational Biomarkers Toward Patients of Polymyositis/Dermatomyositis Complicated with Rapidly Progressive Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2152

Mycophenolate Mofetil Treatment with or without a Calcineurin Inhibitor in Resistant Inflammatory Myopathy

9:00AM-11:00AM: Abstract Number: 2155

Myositis As a Complication of Checkpoint Blockade at a Comprehensive Cancer Center

9:00AM-11:00AM: Abstract Number: 2566

Myxomavirus-Derived Serpin (Serp-1) Reduces Diffuse Alveolar Hemorrhage in a Murine Model of Lupus

9:00AM-11:00AM: Abstract Number: 2005

Nailfold Capillaroscopy in Systemic Sclerosis: How Many Fingers Should be Examined to Detect Abnormality?

9:00AM-11:00AM: Abstract Number: 2096

Nailfold Capillaroscopy Is an Opportunity for Telerheumatology

9:00AM-11:00AM: Abstract Number: 2162

Nailfold Videocapillaroscopy in Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 1960

National Survey of Childhood-Onset Rheumatic Diseases Followed up in the Clinical Pediatric Facilities in Japan

9:00AM-11:00AM: Abstract Number: 2170

Near Patient Detection of Anti-MDA5 Antibodies Using Photonic Ring Immunoassays

9:00AM-11:00AM: Abstract Number: 2236

Neuropathic Pain in End-Stage Hip and Knee Osteoarthritis: Differences between Men and Women and Differential Associations with Pain at Rest and Pain on Activity

9:00AM-11:00AM: Abstract Number: 2204

Neuropathic Pain in Patients with Knee Osteoarthritis and Related Factors: A Multicenter Longitudinal Study-Preliminary Report

9:00AM-11:00AM: Abstract Number: 2220

Neuropathic-like Pain Affects the Tender Joint Count and Health-Related Quality of Life in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2034

New Guidelines on Hydroxychloroquine Dosage – Where Are We?

9:00AM-11:00AM: Abstract Number: 2331

Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (sHLH)

9:00AM-11:00AM: Abstract Number: 2715

NKTR-358: A Selective, First-in-Class IL-2 Pathway Agonist Which Increases Number and Suppressive Function of Regulatory T Cells for the Treatment of Immune Inflammatory Disorders

9:00AM-11:00AM: Abstract Number: 2615

Non-Pharmacological Treatment on Fatigue, Depression, Disease Activity, and Quality of Life of Systemic Lupus Erythematosus: A Systematic Review

9:00AM-11:00AM: Abstract Number: 2601

Novel Anti-Malarial Drug Derivative Inhibited Type I Interferon Production and Autoimmune Inflammation in SLE Patient PBMC and in Trex1-/- Mouse Spleen and Heart

9:00AM-11:00AM: Abstract Number: 2175

Novel Assessment of Interstitial Lung Disease Using the “Computer-Aided Lung Informatics for Pathology Evaluation and Rating” Software System in Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 2362

Novel Biomarkers for the Prediction of Subclinical Coronary Artery Atherosclerosis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2337

Novel Serum Broad-Based Proteomic Discovery Analysis Identifies Proteins and Pathways Dysregulated in Juvenile Dermatomyositis (JDM) and Myositis Autoantibody Groups

9:00AM-11:00AM: Abstract Number: 2508

Obese Axial Spondyloarthropathy Patients Have Worse Disease Outcomes

9:00AM-11:00AM: Abstract Number: 2372

Obesity and the Impact on Treat to Target Goals and Functional Ability in RA. Results from Two Multi-Centre UK Inception Cohorts

9:00AM-11:00AM: Abstract Number: 2374

Obesity Impacts ESR and Not Other Measures of Rheumatoid Arthritis Disease Activity

9:00AM-11:00AM: Abstract Number: 2263

Obesity Independently Associates with Worse Patient Reported Outcomes in Women with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2417

Occult Coronary Plaque Presence and Burden Predict Cardiovascular Events in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1968

Occurrence of Rheumatic Diseases in a National Cohort of Hospitalizations for Progressive Multifocal Leukoencephalopathy

9:00AM-11:00AM: Abstract Number: 2409

Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results

9:00AM-11:00AM: Abstract Number: 2055

Omeract Ultrasonographic Criteria for the Diagnosis of Calcium Pyrophosphate Deposition Disease at the Metacarpal-Phalangeal, Wrist, Acromion-Clavicular and Hip Joints: An Inter-Observer and Intra-Observer Reliability Study

9:00AM-11:00AM: Abstract Number: 2739

Onco-Hematological Malignancies in Systemic Necrotizing Vasculitides: Pooled Analysis of Five Prospective, Randomized, Controlled Trials

9:00AM-11:00AM: Abstract Number: 2031

Online Viewing of Labs in RA Patients Is Not Associated with Clinically Significant Change in ESR over 18 Months Compared to Non-Viewers

9:00AM-11:00AM: Abstract Number: 2438

Open Label Transitioning from Originator Etanercept to Biosimilar SB4 Compared to Continuing Treatment with Originator Etanercept in a Historical Cohort in Rheumatic Diseases in Daily Practice

9:00AM-11:00AM: Abstract Number: 2485

Outcomes of Switching from TNF Inhibitors to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events

9:00AM-11:00AM: Abstract Number: 2240

Partnering in Research: Maximizing Benefits & Minimizing Risks in Patient-Researcher Relationships

9:00AM-11:00AM: Abstract Number: 2639

Pathological Relevance of T Follicular Helper Cell and Plasmablast in Patients with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2553

Patient and Physician Global Assessment Are Poorly Inter-Connected and Poorly Explained By Other Clinical Markers of Disease Activity in Individual Patients with Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2266

Patient Knowledge, Attitudes, and Beliefs Regarding Biologic Therapies in Ankylosing Spondylitis (AS): Insights from a Large-Scale Analysis of Social Media Platforms

9:00AM-11:00AM: Abstract Number: 2030

Patient Motivation in Inflammatory Arthritis: The Use of Ultrasound-Guided Patient Education to Endorse Medication Adherence and Facilitate Cost-Effective Targeted Management

9:00AM-11:00AM: Abstract Number: 2535

Patient Outcomes from a Tertiary Center Combined Rheumatology-Dermatology Clinic

9:00AM-11:00AM: Abstract Number: 2268

Patient Perspectives from a Qualitative Study Predict Non-Adherence in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2460

Patient-Reported Outcomes Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: Results from a Randomized Controlled Trial

9:00AM-11:00AM: Abstract Number: 2253

Patient’s Self-Monitoring of Disease Activity of Rheumatic Diseases Via Webapp – Study Design, Patient’s Perspective and Recruitment in the First 16 Months of a Swiss Multicentre, Longitudinal Study

9:00AM-11:00AM: Abstract Number: 2423

Patients with Active Rheumatoid Arthritis but Normal Levels of Acute Phase Proteins Have Altered Regulatory T Cell Function and Rapidly Progress to Biological Therapies

9:00AM-11:00AM: Abstract Number: 2084

Patients with Early Onset Gout Develop Earlier Severe Joint Involvement and Metabolic Comorbid Conditions

9:00AM-11:00AM: Abstract Number: 2633

Patients with Secondary Sjögren’s Syndrome to SLE Are Characterized By Typical Autoantibodies and a Pro-Inflammatory State

9:00AM-11:00AM: Abstract Number: 2242

Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up RA Patients with a Rheumatologist-Patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China

9:00AM-11:00AM: Abstract Number: 2241

Patterns and Outcomes on Disease Activity in Patients with Ankylosing Spondylitis (AS) Using Smart System of Disease Management (SSDM): Analysis of T2T Pattern Shift and Influential Factors

9:00AM-11:00AM: Abstract Number: 2281

Patterns of Medication Use in Non-Systemic Polyarthritis: Data from the Childhood Arthritis and Rheumatology Research Alliance Patient Registry

9:00AM-11:00AM: Abstract Number: 2320

Pediatric Rheumatology Infusion Center: Report on Therapeutic Protocols and Infusion Reactions over 4 Years

9:00AM-11:00AM: Abstract Number: 2672

Perceived Barriers to Mental Health Care Among Patients with Systemic Sclerosis: A Qualitative Study

9:00AM-11:00AM: Abstract Number: 2056

Performance and Validity of Musculoskeletal Ultrasound in the Assessment of Synovial Inflammation in Experimental Acute Gout

9:00AM-11:00AM: Abstract Number: 2694

Performance of Patient-Reported Outcomes Measurement Information Systems (PROMIS) Promis-29 and Promis Self-Efficacy in Systemic Sclerosis (SSc)

9:00AM-11:00AM: Abstract Number: 2565

Pharmacodynamic Modeling of BTK Occupancy Versus Efficacy in Ra and SLE Models Using the Novel Specific BTK Inhibitor Evobrutinib

9:00AM-11:00AM: Abstract Number: 2193

Physical Activity and Disease Progression in Persons with or at Higher Risk for Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2013

Physician Experience and Patient´s Disease Activity Affect the Impact of Musculoskeletal Ultrasound on the Treatment Decision in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2092

Pilot Clinical Study of a Novel Unobtrusive Carpal Tunnel Tissue Manipulation Device in Reducing Symptoms of Carpal Tunnel Syndrome

9:00AM-11:00AM: Abstract Number: 2708

Placental Growth Factor Regulates the Generation of T-Helper 17 Cells to Link Angiogenesis with Autoimmunity

9:00AM-11:00AM: Abstract Number: 2600

Plasma Cell and T-Cell Activity Downregulation during MMF Therapy in SLE May be Necessary for Successful Immunosuppression

9:00AM-11:00AM: Abstract Number: 2690

Plasma D-Dimer Levels Are More Frequently Elevated in Limited Than Diffuse Cutaneous Systemic Sclerosis but Do Not Reflect Disease Duration or Vasculopathy

9:00AM-11:00AM: Abstract Number: 2338

Plasma Exosomes from Children with Juvenile Dermatomyositis Are Taken up By Human Aortic Endothelial Cells and Are Associated with Altered Gene Expression in Those Cells

9:00AM-11:00AM: Abstract Number: 2606

Pneumococcal Vaccination in Patients with Systemic Lupus Erythematosus: A Multicenter Placebo-Controlled Randomized Double-Blind Study

9:00AM-11:00AM: Abstract Number: 2026

Pneumococcal Vaccination Rates: Improving Safety in Immunocompromised Patients

9:00AM-11:00AM: Abstract Number: 2365

Poor Cardiovascular Risk Management in Rheumatoid Arthritis Patients Despite an Explicit Cardiovascular Risk Management Program

9:00AM-11:00AM: Abstract Number: 2061

Population-Specific Factors Associated with Fractional Excretion of Uric Acid

9:00AM-11:00AM: Abstract Number: 2025

Potential Clinical Utility of Manu-Scan, the Novel Optical Molecular Imaging, in Patients with Hand Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2501

Potential Differences in Axial Spondyloarthritis Disease Activity Categorization Using Different Minimum Values for High-Sensitivity CRP in Ankylosing Spondylitis Disease Activity Score Calculation and Different Definitions of Disease Flare

9:00AM-11:00AM: Abstract Number: 2041

Practice Improvement Utilizing Six Sigma and Health Informatics in an Academic Setting

9:00AM-11:00AM: Abstract Number: 2027

Pre-Visit Planning Improves Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2625

Predicting Flares in Patients with Stable Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2024

Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain – an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial

9:00AM-11:00AM: Abstract Number: 2138

Predictive Factors for Achievement of Sustained Remission with Polymyositis/Dermatomyositis: A Retrospective Single Center Cohort Study in Japan

9:00AM-11:00AM: Abstract Number: 2300

Predictive Value of Magnetic Resonance Imaging in Patients with Juvenile Idiopathic Arthritis in Clinical Remission

9:00AM-11:00AM: Abstract Number: 2073

Predictors for Clinically Diagnosed Gout – Results from 30 Years Follow-up of the Malmö Preventive Project Cohort in Southern Sweden

9:00AM-11:00AM: Abstract Number: 2251

Preferences for Physical Activity: A Discrete Choice Experiment in People with Chronic Knee Pain

9:00AM-11:00AM: Abstract Number: 2646

Premature Senescence of Naive CD4+ T-Cells in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1969

Prevalence and Predictive Value over 16 Years of Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies in the General Population

9:00AM-11:00AM: Abstract Number: 2515

Prevalence and Risk Factors for Osteoporotic Fractures and Low Bone Mineral Density in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2510

Prevalence of and Factors Associated with Sarcopenia in Patients of Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2528

Prevalence of Depression and Attention Deficit Hyperactivity Disorder in Female Patients at a Combined Psoriasis-Psoriatic Arthritis Center

9:00AM-11:00AM: Abstract Number: 2387

Prevalence of Hepatitis C Virus Infection in Egyptian Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2001

Prevalence of Inflammatory Posterior Arch Abnormalities on Lumbar Spine MRI in Spondyloarthritis Patients Compared to Low Back Pain Patients

9:00AM-11:00AM: Abstract Number: 2094

Prevalence of Organ Involvement in Mixed Connective Tissue Disease

9:00AM-11:00AM: Abstract Number: 2312

Prevalence of Serum 14-3-3η (eta) in Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2745

Prevalence of Vasculitides As Extraintestinal Manifestation of Inflammatory Bowel Disease (IBD)

9:00AM-11:00AM: Abstract Number: 2068

Previous Prescription of Allopurinol Reduces the Risk of Nsaids-Related Acute Kidney Injury in Patients with Gout

9:00AM-11:00AM: Abstract Number: 2103

Problems in the Diagnosis of Familial Mediterranean Fever in Turkey

9:00AM-11:00AM: Abstract Number: 2313

Procalcitonin Differentiates Infection from Active Disease in Patients with Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2164

Prognostic Factors in Polymyositis/ Dermatomyositis Patients with Anti-Synthetase Antibodies

9:00AM-11:00AM: Abstract Number: 2568

Prophylactic and Therapeutic Administration of a JAK1-Selective Inhibitor Blocks and Reverses Nephritis and Sialadenitis in NZB/W-F1 Mice

9:00AM-11:00AM: Abstract Number: 2045

Prophylaxis of Ischemic Disease in Giant Cell Arteritis Patients: An Application of a “Big Data” Tracking Tool in the Electronic Health Record in an University-Based Medical Center

9:00AM-11:00AM: Abstract Number: 2017

Prospective Study of Bio-Free Remission Maintenance Using Ultrasonography in Rheumatoid Arthritis Patients: 52-Week Result

9:00AM-11:00AM: Abstract Number: 2311

Prospective Validation of the Juvenile Spondyloarthritis Disease Activity Index and Its Comparison with Adult Spondyloarthritis Disease Activity Scores

9:00AM-11:00AM: Abstract Number: 2123

Protein-Losing Enteropathy in Patients with Systemic Autoimmune Diseases: Characterization of 263 Cases (GEAS-SEMI Spanish Cohort)

9:00AM-11:00AM: Abstract Number: 2626

Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: Clinical Characteristics and Outcomes

9:00AM-11:00AM: Abstract Number: 2060

Pseudogout Among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease (CPPD)

9:00AM-11:00AM: Abstract Number: 2544

Psoriatic Arthritis Impact of Disease (PSAID12) in Early Psoriatic Arthritis: Pain As One of the Main Determinants of Disease Impact

9:00AM-11:00AM: Abstract Number: 2737

Pulmonary Manifestations of Primary Systemic Vasculitides

9:00AM-11:00AM: Abstract Number: 2259

Quality of Life Evaluation in New Onset Juvenile Dermatomyositis Patients from the Printo Trial

9:00AM-11:00AM: Abstract Number: 2120

Quality, Content and Readability Assessment of Patient Education Websites Relating to Ehlers-Danlos Syndrome

9:00AM-11:00AM: Abstract Number: 2610

Quantiferon Testing in a Clinical Trial of Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2141

Quantitative Nailfold Video Capillaroscopy Parameters Correlate with Dermatomyositis Activity and Damage

9:00AM-11:00AM: Abstract Number: 2322

Quantitative Proteomics Comparison of Children with Inactive and Active Uveitis

9:00AM-11:00AM: Abstract Number: 2009

Quantitative Radiographic Analysis of Interstitial Lung Disease Associated with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2572

Rab4a Control over Glycolytic Metabolism and T-Cell Lineage Specification Protects from Intra-Alveolar Hemorrhage in Mouse Model of SLE

9:00AM-11:00AM: Abstract Number: 2578

RAB4A Protects from Antinuclear Antibody Production and Nephritis in the Pristane-Induced Model of SLE

9:00AM-11:00AM: Abstract Number: 2518

Racial Differences in Clinical Characteristics and Co-Morbidities of Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2466

Radiographic Progression By Disease Activity States in Patients with Rheumatoid Arthritis Treated with SB2 or Reference Infliximab

9:00AM-11:00AM: Abstract Number: 2038

Radiological Changes Measured By MRI and High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Show Correlation with Michigan Hand Outcome Questionnaire (MHQ) in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2443

Randomized, Double-Blind, Single-Dose, Three-Arm Parallel Trial to Determine the Pharmacokinetics and Safety of GP2017, EU- and US-Adalimumab in Healthy Male Subjects

9:00AM-11:00AM: Abstract Number: 2451

Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

9:00AM-11:00AM: Abstract Number: 2054

Rapid Tophus Resolution in Chronic Refractory Gout Patients Treated with Pegloticase

9:00AM-11:00AM: Abstract Number: 1962

Rates of Malignancy Associated with Anti-TNF Agents and Subsequent Biologic Use after Malignancy Using U.S. SEER Registry Data

9:00AM-11:00AM: Abstract Number: 2673

Real-Life Treatment Strategies for Systemic Sclerosis According to Experts

9:00AM-11:00AM: Abstract Number: 2454

Real-World Consistency of Response to Adalimumab over Time in Patients with Rheumatoid Arthritis: Results from the Corrona Registry

9:00AM-11:00AM: Abstract Number: 2491

Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive Vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study

9:00AM-11:00AM: Abstract Number: 2258

Real-World Evidence Linking Health-Related Quality of Life to Work Outcomes in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2223

Reallocating Time Spent in Sleep, Sedentary Behavior and Physical Activity and Its Association with Pain and Depression

9:00AM-11:00AM: Abstract Number: 2732

Recommendations for the Management of Neuro-Behcet’s Disease By the Japanese National Research Committee for Behcet’s Disease

9:00AM-11:00AM: Abstract Number: 2395

Recommendations on the Management of Rheumatoid Arthritis in Patients with Cancer: A Systematic Review of Clinical Practice Guidelines and Consensus Statements

9:00AM-11:00AM: Abstract Number: 2676

Reduction of Dlco and FVC in Patients with GERD and Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2042

Referral Criteria to an Early Arthritis Clinic: Poor Agreement between Referring Physicians and Rheumatologists

9:00AM-11:00AM: Abstract Number: 2684

Regional and Whole Gut Transit Times in Patients with Systemic Sclerosis Using the Wireless Motility Capsule

9:00AM-11:00AM: Abstract Number: 2185

Relation of Foot Pronation to Medial Knee Load in Persons with Medial Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2184

Relation of Gait Speed to Incident Knee Replacement: The Multicenter Osteoarthritis Study

9:00AM-11:00AM: Abstract Number: 2063

Relation of Serum Urate and Gout Duration to Tophi, Urate Deposition, and Inflammation

9:00AM-11:00AM: Abstract Number: 2085

Relationship between Gout and Asthma: A National Database Analysis

9:00AM-11:00AM: Abstract Number: 1979

Relationship between Religiosity /Spirituality and Physical and Mental Outcomes in Fibromyalgia Patients

9:00AM-11:00AM: Abstract Number: 2369

Relationship of Bone Mineral Density and Inflammatory Burden with Carotid Plaque Formation in Rheumatoid Arthritis: A 5-Year Prospective Study

9:00AM-11:00AM: Abstract Number: 2693

Relationships between Levels of Patient Activation, Self-Efficacy, and Demographic Variables in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2014

Reliability of 8-Joint Ultrasonography Scores in Follow up of Biological Therapy in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2382

Reliability of the Biochemical Bone Markers CTX and P1NP during a TNF-Inhibitor Treatment Cycle in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2021

Reliability of Ultrasound Elementary Lesions in Gout: Results from an Inter- and Intra-Reading International Multicenter Exercise By 62 Sonographers

9:00AM-11:00AM: Abstract Number: 2219

Remaining Pain in DMARD-Naive Rheumatoid Arthritis Patients Treated with Baricitinib and Methotrexate

9:00AM-11:00AM: Abstract Number: 1945

Repositioning Suramin As a Cartilage-Protective Drug

9:00AM-11:00AM: Abstract Number: 2743

Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN)

9:00AM-11:00AM: Abstract Number: 2640

Response Gene to Complement-32 Expression Is Upregulated in Lupus T Cells and Promotes IL-17A Expression

9:00AM-11:00AM: Abstract Number: 2668

Responsiveness of University of California Los Angeles Scleroderma Clinical Trial Consortium (GIT2.0) and Intestinal Visual Analogue Scale to Change in Systemic Sclerosis Patients

9:00AM-11:00AM: Abstract Number: 2478

Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras – Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®

9:00AM-11:00AM: Abstract Number: 2357

Retinal Vessel Morphological Associations with Systemic Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2422

Rheumatoid Arthritis (RA) Synovial Fluid Treg Cells Secrete IL-17 and at the Same Time Are Potent Suppressors of Tresp Cell Proliferation, TNF-α and Interferon γ Production

9:00AM-11:00AM: Abstract Number: 2399

Rheumatoid Arthritis Have Lower Glomerular Filtration Rate Compared to Healthy Population: Role of Inflammation

9:00AM-11:00AM: Abstract Number: 2401

Rheumatoid Arthritis with Kidney Dysfunction Contributes to Higher Risk of Cardiovascular Disease Development

9:00AM-11:00AM: Abstract Number: 2741

Rheumatoid Factor (RF) Levels Remain Persistently Elevated 24 Weeks after Interferon (INF) Free Direct Antiviral Agents (DAA) Therapy in the Majority of RF+ HCV Infected Persons

9:00AM-11:00AM: Abstract Number: 2119

Rheumatological Immune Related Adverse Events in Malignancy Patients Treated with Anti-Programmed Cell Death (PD) 1 Antibodies

9:00AM-11:00AM: Abstract Number: 2498

Rheumatologists Use Different Cut-Offs for Disease Activity in Real Life – the Experience with Golimumab in Ankylosing Spondylitis- Subanalysis from a Non-Interventional German Study

9:00AM-11:00AM: Abstract Number: 2036

Rheumatologists’ Compliance with Screening for Viral Hepatitis B and C Prior to Initiation of Methotrexate Treatment Needs Quality Improvement

9:00AM-11:00AM: Abstract Number: 2309

Risk Factors for Arthritis and the Development of Comorbid Cardiovascular and Metabolic Disease in Children with Psoriasis

9:00AM-11:00AM: Abstract Number: 1961

Risk Factors for Low Muscle MASS in Community-Dwelling Older Women: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health Study

9:00AM-11:00AM: Abstract Number: 2188

Risk of Disability in Underweight Persons with or at Increased Risk of Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2752

Risk of Hospitalizations for Venous Thromboembolism Among Patients with Selected Systemic Vasculitides: A Nationwide Analysis

9:00AM-11:00AM: Abstract Number: 2274

Risk of Serious Events, Serious Infections, Uveitis, Crohn’s Disease, Colitis and Malignancies in Patients with Juvenile Idiopathic Arthritis on Continuous Treatment with Etanercept over Time: A Report from a Biologics Registry

9:00AM-11:00AM: Abstract Number: 1966

Risk of Tuberculosis in Biologic Users for Rheumatic Diseases: Results from the South African Biologics Registry

9:00AM-11:00AM: Abstract Number: 2402

Rituximab in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicenter Study of 32 Patients

9:00AM-11:00AM: Abstract Number: 2486

Rituximab Is an Attractive Proposition to Treat Difficult Active RA in Indian (Asia) Patients: Initial Results of a Non Commercial Initiative Using an Initial Regimen of Two 500 Mg Infusions (fortnightly) and a Third 500 Mg Infusion at 6 Weeks in Case of Inadequate Response(ACR 50)

9:00AM-11:00AM: Abstract Number: 2461

Rituximab Is Effective in the Treatment of Rheumatoid Arthritis Irrespective of Body Mass Index; Up to 48 Weeks Results from Phase 3 Study

9:00AM-11:00AM: Abstract Number: 2579

Rock-Mediated Pkca Nuclear Translocation Is Important in Neutrophil Netosis and UVB Induced-Skin Inflammation

9:00AM-11:00AM: Abstract Number: 2079

Rotator Cuff Calcific Tendinopathy: Chondrocyte-like Cells Surrounding Calcific Deposits Express TNAP and ENPP1, Two Key Enzymes of the Mineralization Process.

9:00AM-11:00AM: Abstract Number: 2227

S100A9 Induces a Pain Response during Experimentally Induced Acute Synovitis

9:00AM-11:00AM: Abstract Number: 2396

Safety and Humoral and Cell-Mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2271

Safety of Adalimumab±Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)

9:00AM-11:00AM: Abstract Number: 2277

Safety of Biologic Therapies for the Treatment of Juvenile Idiopathic Arthritis: Results from the Spanish Registry of Adverse Events with Biologic Therapies (BIOBADASER)

9:00AM-11:00AM: Abstract Number: 2581

Safety of Hydroxychloroquine Withdrawal in Older Adults with Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2126

Safety of Immune Checkpoint Inhibitors for the Treatment of Melanoma, Bronchopulmonary and Urologic Neoplasms in Patients with Preexisting Autoimmune Disease

9:00AM-11:00AM: Abstract Number: 2585

Safety Profile in SLE Patients Treated with Atacicept in a Phase IIb Study (ADDRESS II) and Its Extension Study

9:00AM-11:00AM: Abstract Number: 2592

Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous Anifrolumab in Healthy Volunteers

9:00AM-11:00AM: Abstract Number: 2607

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of BIIB059, a Monoclonal Antibody Targeting BDCA2 Following Administration of Intravenous and Subcutaneous Single or Multiple Doses in Healthy Volounters and Subjects with Active SLE

9:00AM-11:00AM: Abstract Number: 2457

Sarilumab for the Treatment of Active, Moderate-to-Severe Rheumatoid Arthritis (RA): An Analysis of Cost per Effectively Treated Patient

9:00AM-11:00AM: Abstract Number: 2247

Secondary Fibromyalgia Is Not Associated with Higher Likelihood of Patient-Physician Discordance in Global Assessment in Patients with Osteoarthritis and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2044

Secondary Prevention of Cardiovascular Disease Is Incomplete in a Systemic Lupus Erythematosus Population-Based Cohort

9:00AM-11:00AM: Abstract Number: 2546

Secukinumab Decreases Arterial Wall Inflammation in Patients with Peripheral Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2577

Segmented Filamentous Bacteria Colonization Exacerbate Lupus Nephritis in NZM2410 Mice and Causes an Expansion of Intestinal Group 3 Innate Lymphoid Cells

9:00AM-11:00AM: Abstract Number: 2685

Sensitivity and Specificity of YKL-40 for the Presence of Pulmonary Arterial Hypertension in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2569

Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Regulator of T Cell Function and Its Selective Deficiency in T Lymphocytes Leads to Autoimmunity and Lupus-like Nephritis

9:00AM-11:00AM: Abstract Number: 2410

Serious Infection Risk in Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Rheumatic Diseases: A US National Cohort Study

9:00AM-11:00AM: Abstract Number: 2728

Serum Levels of Interleukin-36 Receptor Antagonist in Behçet’s Patients

9:00AM-11:00AM: Abstract Number: 2150

Serum Microrna-1 Can be a Predictive Marker for Disease Activity of Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2080

Serum Uric Acid and Incident Dementia: A Population Based Study

9:00AM-11:00AM: Abstract Number: 2359

Severity of Ischemic and Hemorrhagic Stroke in Patients with Rheumatoid Arthritis Compared with the General Population

9:00AM-11:00AM: Abstract Number: 2563

SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice

9:00AM-11:00AM: Abstract Number: 2464

Similar Effectiveness of Both Formulations of Tocilizumab (TCZ) in Patients with Rheumatoid Arthritis (RA) Switching from Intravenous (IV) to Subcutaneous (SC) at 6 Months in Real Life

9:00AM-11:00AM: Abstract Number: 2004

Simplified Assessment in Capillaroscopy

9:00AM-11:00AM: Abstract Number: 2703

Single Cell Analysis of TCRs from CD8+ T Cells in Sjogren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2657

Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established Systemic Lupus Erythematosus (SLE)-Risk Loci in Lupus Patient Monocytes

9:00AM-11:00AM: Abstract Number: 2324

Single Cell RNA-Sequencing of Bone Marrow Macrophages Identifies a Distinct Subpopulation in Systemic JIA with Features of Interferon Response, Endocytic Vesicles and Phagocytosis

9:00AM-11:00AM: Abstract Number: 2473

Sirukumab Subcutaneous Dose Regimens Maintain Clinical Response over Dosing Intervals in Rheumatoid Arthritis Patients: Results from a Phase 3 Study

9:00AM-11:00AM: Abstract Number: 2303

Six Minute Walk Test in Childreh with Juvenile Idiopathic Arthritis: Normative Values, Prediction Equation, and Comparison to Healthy Children

9:00AM-11:00AM: Abstract Number: 2704

Skin Migratory Dendritic Cells Targeted and Tolerized By Calcitriol-Peptide Liposomes Supress Antigen-Specific Autoreactive T Cell Expansion and Memory Differentiation to Regulate Autoimmune Arthritis

9:00AM-11:00AM: Abstract Number: 2560

Spleen Tyrosine Kinase Inhibition Reveals Immune Cell Subsets of Diseased NZB/W F1 Mice That Are Reflected in Systemic Lupus Erythematosus Patient Peripheral Blood Mononuclear Cells

9:00AM-11:00AM: Abstract Number: 2077

Statin Use and Mortality in Gout: A General Population-Based Cohort Study

9:00AM-11:00AM: Abstract Number: 2149

Statin Use in a Longitudinal Cohort of Patients with Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 1967

Strongyloides Screening in Immunocompromised Immigrant Rheumatology Patients

9:00AM-11:00AM: Abstract Number: 2019

Structural Abnormalities in the Knee Detected By MRI in Middle-Aged Subjects without Radiographic Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2590

Subcutaneous Belimumab Plus Standard of Care Demonstrated Improvement in Multiple Organ Domains Versus Placebo Plus Standard of Care in Patients with Active Systemic Lupus Erythematosus (SLE)

9:00AM-11:00AM: Abstract Number: 2288

Successful Treatment of Methotrexate Intolerance in Juvenile Idiopathic Arthritis Using Eye Movement Desensitization and Reprocessing (EMDR)

9:00AM-11:00AM: Abstract Number: 2261

Supporting Smoking Cessation in RA and SLE: Identifying Patient-Centered Outcomes

9:00AM-11:00AM: Abstract Number: 2729

Surgical Therapies in the Treatment of Pulmonary Artery Involvement in Behcet’s Syndrome

9:00AM-11:00AM: Abstract Number: 2265

Survey on Gout-Related Knowledge and Perception in Inpatient Setting on Hospitalized Patients with Gout

9:00AM-11:00AM: Abstract Number: 2490

Sustained Clinical Response in Refractory Rheumatoid Arthritis Patients with a Low-Dose Rituximab Retreatment Regimen. a Single Center Experience

9:00AM-11:00AM: Abstract Number: 1929

Sustained Efficacy of Intra-Articular SB-061, a Novel Matrix Regulator Inspired By Aggrecan, in a Rat Model of Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2471

Sustained Response in a Phase 3 Study of Sarilumab Plus Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

9:00AM-11:00AM: Abstract Number: 2439

Switching from RA Originator to Biosimilar in Routine Clinical Care: Early Data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2315

Symptoms of Depression and Anxiety in Children with JIA: Relation to Other Domains of Health Related Quality of Life

9:00AM-11:00AM: Abstract Number: 2081

Synovial Fluid Leukocyte Count and Its Association with Crystal Deposition in Asymptomatic Hyperuricemia

9:00AM-11:00AM: Abstract Number: 2605

Systematic Review, and Meta-Analysis of Steroid-Sparing Effect, of Biologic Agents in Randomized Placebo-Controlled Phase 3 Trials for Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2197

Systemic Inflammation and Physical Function in Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2629

Systemic Lupus Erythematosus Patients Not Complaining Raynaud’s Phenomenon Display Lower Skin Blood Perfusion Than Healthy Subjects

9:00AM-11:00AM: Abstract Number: 2697

Systemic Sclerosis Quality of Life Questionnaire (SScQoL) Captures the Complex Problems Experienced By Patients with Scleroderma

9:00AM-11:00AM: Abstract Number: 2098

Systemic Treatment for ACUTE Anterior Uveitis ( SYNTHETIC AND BIOLOGIC DISEASE-MODIFYINGANTIRHEUMATIC DRUGS) : A Systematic Literature Review

9:00AM-11:00AM: Abstract Number: 2706

T Follicular-Helper CELLS (TFH) Enrichment and T Follicular-Regulatory CELLS (TFR) Exclusion from Ectopic Germinal Centers in Salivary Glands of Sjogren’s Syndrome Patients

9:00AM-11:00AM: Abstract Number: 2608

Tacrolimus in Non-Asian Systemic Lupus Erythematosus Patients: A Real-Life Experience from Three European Centers

9:00AM-11:00AM: Abstract Number: 2462

Tapering TNF Inhibitors in Rheumatoid Arthritis: A Retrospective Study

9:00AM-11:00AM: Abstract Number: 1931

Targeting Cartilage Aging As Osteoarthritis Therapeutics By Drug Repurposing

9:00AM-11:00AM: Abstract Number: 2256

Temporal Increases in Side Effect Concerns of Osteoporosis Medications Among Women with Previous Fractures

9:00AM-11:00AM: Abstract Number: 1938

TGFB1 Governs Osteoblast Differentiation in Ankylosing Spondylitis Via Modulating BMP2

9:00AM-11:00AM: Abstract Number: 2674

The Association between the Extent of Skin Thickness and Organ Involvement, Function and Quality of Life in Early Diffuse Cutaneous Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2667

The Association between Two Non-Invasive Methods for the Assessment of Severity of Gastrointestinal Involvement and Malnutrition in Systemic Sclerosis: Self-Reported Questionnaires and Nail Fold Video-Capillaroscopy

9:00AM-11:00AM: Abstract Number: 2622

The Benefit of Vitamin D on SLE Disease Activity Is Largely Explained By Renal Activity

9:00AM-11:00AM: Abstract Number: 1984

The Cervical Spine in Fibromyalgia Patients: Loss of Lordotic Curve Is Characteristic of Fibromyalgia and Can Assist in the Diagnosis

9:00AM-11:00AM: Abstract Number: 2282

The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Interim Report of Baseline Patient Characteristics and Treatment Choices

9:00AM-11:00AM: Abstract Number: 2101

The Clinical Characteristics of IgG4 Related Disease in China: With 346 Cases Reported

9:00AM-11:00AM: Abstract Number: 2666

The Clinical Utility of Flow-Mediated Dilation in Systemic Sclerosis Digital Ulcer Assessment

9:00AM-11:00AM: Abstract Number: 2539

The Contribution of Skin and Joint Improvements to the Health-Related Quality of Life of Patients with Active Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2102

The Difference between International Criteria for BD (ICBD) and the BD Criteria of International Study Group (ISG) in Our Behcet’s Disease (BD) Patients Who Fulfilled Japanese BD Criteria

9:00AM-11:00AM: Abstract Number: 2496

The Disease Course in Daily Clinical Practice in Radiographic and Non-Radiographic Axial Spondyloarthritis Patients; One-Year Follow-up Results of National-Subgroup of a Worldwide Observational Cohort Study

9:00AM-11:00AM: Abstract Number: 2513

The Effect of Alcohol on Disease Activity in Axial Spondyloarthritis

9:00AM-11:00AM: Abstract Number: 2367

The Effect of Glucocorticoids on Bone Mineral Density in Patients with Rheumatoid Arthritis: a Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2229

The Effect of Intra-Articular Neurotoxin on Arthritis Pain and Substance P Expression in the Dorsal Root Ganglion: Results from Murine Arthritis Models

9:00AM-11:00AM: Abstract Number: 2604

The Effect of Subcutaneous Belimumab on Corticosteroid Use in Patients with Systemic Lupus Erythematosus (SLE): A Phase 3, Randomized, Placebo-Controlled Study

9:00AM-11:00AM: Abstract Number: 2075

The Effect of Uric Acid Lowering Treatment on the Microbiome in Gout Patients

9:00AM-11:00AM: Abstract Number: 2245

The Effects of Structural Damage on Functional Disability in Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 2598

The Effects of Tai Chi on Inflammatory Mediator Secretion in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2371

The Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis Stratified By Baseline Body Mass Index

9:00AM-11:00AM: Abstract Number: 1981

The Etiology of Fibromyalgia May be Related to Increased Muscle Pressure

9:00AM-11:00AM: Abstract Number: 2662

The EULAR Systemic Sclerosis Impact of Disease (ScleroID) Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis – Preliminary Results from the Ongoing Validation Study

9:00AM-11:00AM: Abstract Number: 2570

The Functional Consequence of Human (hu)TLR8 on Macrophage Immunometabolism and Renal Inflammation in Murine Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2547

the Ideal Target for Psoriatic Arthritis? Comparison of Remission and Low Disease Activity States in a Real Life Cohort

9:00AM-11:00AM: Abstract Number: 2048

the Impact of Diagnostic Misregistration of Rheumatoid Arthritis on the Establishment of a Value Based Healthcare System

9:00AM-11:00AM: Abstract Number: 2302

The Impact of JIA on Physician and Patient-Reported Outcomes over the First Five Years Following Diagnosis

9:00AM-11:00AM: Abstract Number: 2083

The Inflammation Induced By Four Types of Calcium Pyrophosphate Crystals Depends on Their Capacity to Stimulate NF-κb and MAPK Pathways

9:00AM-11:00AM: Abstract Number: 2341

The Interaction between Genetic Risk Factors and Age of Disease Onset in Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2645

The Internalization of DNA-Antibodies By Podocytes during Lupus Nephritis

9:00AM-11:00AM: Abstract Number: 2051

The Lasso Selection Model in Rheumatology Epidemiologic Studies

9:00AM-11:00AM: Abstract Number: 2492

The Long-Term Safety and Durability of Response of Chs-0214, a Proposed Biosimilar to Etanercept: An Open-Label Safety Extension Study

9:00AM-11:00AM: Abstract Number: 2269

The Meaningful Patient Engagement in Research Framework – an Empirically Based Conceptual Framework

9:00AM-11:00AM: Abstract Number: 2177

The Medial Shift of the Tibial Articular Surface Is One Factor of Medial Osteoarthritis of the Knee

9:00AM-11:00AM: Abstract Number: 2064

The Nomenclature of Gout: A Content Analysis of Contemporary Medical Journals

9:00AM-11:00AM: Abstract Number: 2714

The Paracaspase MALT1 Plays a Central Role in the Pathogenesis of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2151

The Predictive Risk Factors for Opportunistic Infection during Treatment for Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2634

The Prevalence of Autoimmune Disease in Families of Patients with Systemic Lupus Erythematosus (SLE). a Single Centre Study

9:00AM-11:00AM: Abstract Number: 2308

The Prevalence of Comorbidities in Pediatric Psoriasis and Juvenile Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 1970

The Prevalence of Rheumatoid Arthritis and Allergic Diseases and Their Association : A Study of the Korean National Health and Nutrition Examination Survey (KNHANES)

9:00AM-11:00AM: Abstract Number: 2523

The Prevalence, Incidence and Associated Factors for Liver Abnormalities in Psoriatic Arthritis: Resutls from a Longitudinal Observational Cohort

9:00AM-11:00AM: Abstract Number: 2239

The Recall Program: Data from a Multicenter Educational Event on Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2534

the Relationship between Biological Therapy, Work Productivity, and Activity Impairment in Patients with Psoriatic Arthritis: Prospective Multicentre Observational Study

9:00AM-11:00AM: Abstract Number: 2353

The Relationship between Disease Activity, VEGF and E-Selectin Levels with Arterial Stiffness in Rheumatic Patients Treated with Biological Agents

9:00AM-11:00AM: Abstract Number: 2195

The Relationship between Self-Reported Restless Sleep and Objectively Measured Physical Activity

9:00AM-11:00AM: Abstract Number: 2532

The Relationship between the Degree of Skin Involvement and Joint Activity in Patients with Psa: Experience from the Corrona Registry

9:00AM-11:00AM: Abstract Number: 2194

The Relationship between the Number of Prescription Medications and Physical Activity Amongst Patients with or at High Risk for Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2541

The Relationship between the Patient Acceptable Symptom State (PASS) and Disease Activity in Patients with Psoriatic Arthritis (PsA)

9:00AM-11:00AM: Abstract Number: 2386

The Risk Factors of Newly Developing/Worsening Pulmonary Abnormalities in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1964

The Risk of Hydroxychloroquine Toxic Retinopathy and Its Risk Factors in the Treatment of Rheumatic Diseases: A Systematic Review

9:00AM-11:00AM: Abstract Number: 2186

The Role of Hip Injury in Pain Exacerbation in Hip Osteoarthritis: an Internet-Based Case-Crossover Study

9:00AM-11:00AM: Abstract Number: 2595

The Role of Hydroxychloroquine in the Treatment of Undifferentiated Connective Tissue Disease

9:00AM-11:00AM: Abstract Number: 2497

The Role of Individual and Country-Level Socio-Economic Factors in Work Participation in Patients with Spondyloarthritis across 22 Countries Worldwide: Results from the Comospa Study

9:00AM-11:00AM: Abstract Number: 2575

The Role of Interferon in Autoimmune-Susceptible Ro60 Knockout Mice

9:00AM-11:00AM: Abstract Number: 2233

The Role of Life Purpose in Disability and Depression in Patients with Acute Low Back Pain

9:00AM-11:00AM: Abstract Number: 2648

The SLE Risk Variant, Reference Single Nucleotide Polymorphism (rs)10499197, Upstream of Tumor Necrosis Factor Alpha-Induced Protein 3 (TNFAIP3) Modulates Enhancer Function and TNFAIP3 Gene Expression

9:00AM-11:00AM: Abstract Number: 2632

The Southern California Lupus Registry: I. Baseline Characteristics of Patients with Systemic Lupus Erythematosus in an Uncharted Territory

9:00AM-11:00AM: Abstract Number: 1983

The Types of Stress That Appear to Aggravate the Symptoms of Fibromyalgia

9:00AM-11:00AM: Abstract Number: 2380

The Use of Fibroscan in Detecting Early Liver Fibrosis in RA Patients on Long Term MTX with Normal Liver Enzymes

9:00AM-11:00AM: Abstract Number: 2517

The Usefulness of Trabecular Bone Score in Assessing the Bone Strength and Fracture Risk of Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2731

The Utility of Unbiased Metagenomic Next Generation Sequencing in the Management of Patients with CNS Vasculitis

9:00AM-11:00AM: Abstract Number: 2504

The Validation of Istanbul Back Disability Index (IBDI) in Axial Spondyloarthritis Patients

9:00AM-11:00AM: Abstract Number: 1998

The Value of Dynamic Contrast-Enhanced MRI and Delayed Gadolinium Enhanced MRI of the Cartilage in Patients with Early Rheumatoid Arthritis: Leads Local Hyperperfusion to Cartilage Loss?

9:00AM-11:00AM: Abstract Number: 2620

The Value of Repeat Biopsy in the Management of Lupus Nephritis Flares

9:00AM-11:00AM: Abstract Number: 2107

Therapeutic Response to Prednisone in Relation to Age in Polymyalgia Rheumatica: A Controlled Study

9:00AM-11:00AM: Abstract Number: 2696

Things Left Unsaid: Important Topics That Are Not Discussed between Patients with Systemic Sclerosis, Their Carers and Their Healthcare Professionals

9:00AM-11:00AM: Abstract Number: 2291

Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: First Results of Clinical Outcome after 24 Months

9:00AM-11:00AM: Abstract Number: 2210

Thumb Base Osteoarthritis: Associations between Pain and Synovitis on Ultrasound

9:00AM-11:00AM: Abstract Number: 1947

Thy1 Is a Positive Regulator of Osteoblast Differentiation and Modulates Bone Homeostasis in Obese Mice

9:00AM-11:00AM: Abstract Number: 2418

Tissue-Engineered Human Skeletal Muscle Model of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2702

Tissue-Invasive T Cells in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1948

TNF-α Overrides the Ability of RANK Ligand to Induce Osteoclast Differentiation of Classical Circulating Precursors

9:00AM-11:00AM: Abstract Number: 2701

TNFR2+ Regulatory T Cellssubpopulations ARE Highly Suppressive and Are Increased on Anti-TNF Treatment

9:00AM-11:00AM: Abstract Number: 2751

Tocilizumab in the Treatment of Severe and/or Refractory Behcet’s Disease：a Single-Centre Experience in China

9:00AM-11:00AM: Abstract Number: 2458

Tocilizumab Inhibits Progression of Erosive Joint Damage in Early Rheumatoid Arthritis More Effectively Than Step-up Methotrexate Therapy

9:00AM-11:00AM: Abstract Number: 2429

Towards Precision Medicine in Rheumatoid Arthritis (RA): Trans-Ethnic Analysis and Prioritization of SNPs in the AFF3 Locus

9:00AM-11:00AM: Abstract Number: 2516

Trabecular Bone Score As an Assessment Tool to Identify the Risk of Osteoporosis in Axial Spondyloarthritis: A Case-Control Study

9:00AM-11:00AM: Abstract Number: 2095

Traditional Disease Modifying Anti-Rheumatic Drugs (tDMARDs), Hydroxychloroquine (HCQ) and/or Sulfasalazine (SSZ), Are Rapidly Effective in Immune Checkpoint Inhibitors-Induced Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 2205

Trajectories of Knee Bone Shape Change Are Associated with Sex and Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2433

Transcriptome Analysis in Women with Rheumatoid Arthritis Who Improve or Worsen during Pregnancy

9:00AM-11:00AM: Abstract Number: 2342

Transcriptomic Analysis Reveals Mitochondrial and Monocyte Dysfunctions Are Linked to the Interferonopathy of Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2285

Treatment of Adult Juvenile Idiopathic Arthritis Patients with Biologic Agents. Data from the National Registry

9:00AM-11:00AM: Abstract Number: 2067

Treatment with Pegloticase Significantly Decreases Mean Arterial Blood Pressure in Patients with Chronic Gout

9:00AM-11:00AM: Abstract Number: 2654

Treatment-Associated DNA Methylation Patterns in Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1952

Trend of Arthrocentesis Utilization Among Inpatients over 10 Years – Data from National Inpatient Sample

9:00AM-11:00AM: Abstract Number: 2390

Trends and Predictors of Guideline Adherence for Glucocorticoid-Induced Osteoporosis Prevention in an Early Rheumatoid Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 2505

Trends in Time to Diagnosis in Spondyloarthritis Patients. Association with 2009 ASAS Classification Criteria and Clinical Presentation at Disease Onset. Data from Comospa Study

9:00AM-11:00AM: Abstract Number: 2670

Trigeminal Neuralgia in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2689

Troponinemia Independently Associates with Mortality in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 2127

Tumor Necrosis Factor Inhibitors for Sarcoidosis

9:00AM-11:00AM: Abstract Number: 2183

Two-Year Changes in Knee Osteoarthritis Symptoms: Comparing Clinical Relevance of Patient-Reported Outcomes By Anchoring to Knee Replacement

9:00AM-11:00AM: Abstract Number: 2567

Type I IFN Blockade Restores Normal Transitional B Cell Development Post-Anti-CD20 Depletion

9:00AM-11:00AM: Abstract Number: 2015

Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. Α Monocentric Preliminary Study

9:00AM-11:00AM: Abstract Number: 2725

Understanding Vasculitis Patients’ Ability to Work with Numbers

9:00AM-11:00AM: Abstract Number: 2207

Urine CTX-II, CTX-I, Osteocalcin, and Radiographic Severity of Multiple OA Knee Joints: Does CTX-II Originate from Bone or Cartilage?

9:00AM-11:00AM: Abstract Number: 2284

Use of Biological Therapies in Adult Patients Diagnosed with Juvenile Idiopathic Arthritis: Results from the Spanish Registry of Adverse Events with Biologic Therapies (BIOBADASER)

9:00AM-11:00AM: Abstract Number: 2404

Use of Dmards after the Diagnosis of Cancers in Patients with RA

9:00AM-11:00AM: Abstract Number: 2230

Use of Prescription Opioids Among Patients with Systemic Inflammatory Diseases (SID) Versus Patients with Hypertension but No Sid

9:00AM-11:00AM: Abstract Number: 2255

Using PROs to Guide Patient-Centered Conversations and Care in Inflammatory Arthritis: The Patient Perspective

9:00AM-11:00AM: Abstract Number: 1986

Using the BILAG to Assess the Activity of Lupus in Patients with Fibromyalgia

9:00AM-11:00AM: Abstract Number: 2090

Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with Veterans Affairs Medical Center

9:00AM-11:00AM: Abstract Number: 2630

Utility of the Korean Version of Systemic Lupus Activity Questionnaire, in Clinical Practice: Its Correlation with Disease Activity Indices of Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2531

Utilization of the Psoriasis Epidemiology Screening Tool to Identify Signs and Symptoms of Early Psoriatic Arthritis Among Those with Psoriasis: Analysis from the Corrona Psoriasis Registry

9:00AM-11:00AM: Abstract Number: 2294

Utilizing the Pediatric Rheumatology Care and Outcomes Improvement Network to Assess Practice Pattern Variation in Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2631

Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE

9:00AM-11:00AM: Abstract Number: 2548

Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab

9:00AM-11:00AM: Abstract Number: 2039

Validity of the Wpai-SHP in Psoriatic Arthritis and Estimation of the Minimally Important Difference

9:00AM-11:00AM: Abstract Number: 2692

Vitamin D Deficiency in Systemic Sclerosis Patients: Relations with Multiple Clinical Parameters and Standard Treatment

9:00AM-11:00AM: Abstract Number: 2611

Walk SLE – a Pilot Study Exploring Walk with Ease (WWE), a Self-Directed Walking Program, in Lupus Patients

9:00AM-11:00AM: Abstract Number: 2190

War and Arthritis

9:00AM-11:00AM: Abstract Number: 2524

Weight Change before and after Diagnosis in Patients with Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2376

Weight Histories Expose the Systematic Underestimation of the Risks of Obesity on Mortality in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2556

Were Moll and Wright Right?

9:00AM-11:00AM: Abstract Number: 2484

When Etanercept Switch Fails – Clinical Considerations

9:00AM-11:00AM: Abstract Number: 2514

When Should Lateral Dexa be Used to Measure Spine Bone Mineral Density in Axial Spondyloarthritis Patients: A Cross-Sectional Study

9:00AM-11:00AM: Abstract Number: 2618

Why Aren’t All Patients with SLE Taking Hydroxychloroquine? A Retrospective Chart Review

9:00AM-11:00AM: Abstract Number: 2191

Widespread Regulation of Gene Expression By Glucocorticoids in Chondrocytes from OA Patients As Determined By NGS-Based Genome Wide Expression Analysis

9:00AM-11:00AM: Abstract Number: 2388

Women and Men with Rheumatoid Arthritis Present with Different Risks for Glucocorticoid-Related Comorbidities

9:00AM-11:00AM: Abstract Number: 2237

Work Productivity and Activity Impairment in Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 2243

Youtube Videos on Rheumatoid Arthritis: A Qualitative Analysis of Views and Content

11:00AM-12:30PM: Abstract Number: 2753

Brain Functional Connectivity Features of Pain Centralisation Relate to Degree of ‘Fibromyalgianess’ in Rheumatoid Arthritis

11:00AM-12:30PM: Abstract Number: 2755

Comparative Risk of Biologic Therapies in Patients with Rheumatoid Arthritis Undergoing Elective Arthroplasty

11:00AM-12:30PM: Abstract Number: 2754

Comparison of Individually Tailored Vs Systematic Rituximab Regimens to Maintain ANCA-Associated Vasculitis Remissions: Results of a Prospective, Randomized–Controlled, Phase 3 Trial

11:00AM-12:30PM: Abstract Number: 2756

Effect of Baseline and Change in Effusion-Synovitis on Cartilage Damage over 18 Months in Patients with Osteoarthritis and Meniscal Tear

11:00AM-12:30PM: Abstract Number: 2757

Kidney and Skin Single-Cell RNA Sequencing in Lupus Nephritis Provides Mechanistic Insights and Novel Potential Biomarkers

11:00AM-12:30PM: Abstract Number: 2758

Response to JAK1/2 Inhibition with Baricitinib in “Candle”, “Savi” and “Candle-like” Diseases. a New Therapeutic Approach for Type I IFN-Mediated Autoinflammatory Diseases

2:30PM-4:00PM: Abstract Number: 2796

A Randomized, Double Blind Trial over 52 Weeks to Demonstrate Bioequivalence of GP2013 and Reference Rituximab in Patients with Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 2798

A Randomized, Double-Blind Study Comparing PF-06438179/GP1111, a Potential Infliximab Biosimilar, and Infliximab, Both in Combination with MTX, As Treatment for Patients with Moderate to Severe Active RA Who Have Had an Inadequate Response to MTX Therapy

2:30PM-4:00PM: Abstract Number: 2774

Activation of a Cytosolic DNA Sensor Pathway in the Etiopathogenesis of Sjögren’s Syndrome

2:30PM-4:00PM: Abstract Number: 2767

Active Yet Sedentary: The Association of Moderate to Vigorous Physical Activity and Sedentary Behavior with Incident Functional Limitation in Knee OA

2:30PM-4:00PM: Abstract Number: 2761

Adenosine Receptor Agonism Protects Against Antiphospholipid Antibody-Mediated Netosis and Venous Thrombosis

2:30PM-4:00PM: Abstract Number: 2760

Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS ACTION) Clinical Database and Repository (“Registry”) Analysis: First and Recurrent Thrombosis Risk after 1201 Patient-Years of Follow-up

2:30PM-4:00PM: Abstract Number: 2794

Apolipoprotein B Binds to Enolase-1 and Aggravates Inflammation in Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 2784

Are We over-Testing for Liver Enzyme Abnormalities in Rheumatoid Arthritis Patients Prescribed Methotrexate?

2:30PM-4:00PM: Abstract Number: 2781

Assessing RA Disease Activity with Promis Measures Using Smartphone Technology

2:30PM-4:00PM: Abstract Number: 2807

Can the Automated Neuropsychological Assessment Metrics (ANAM) Predict Cognitive Impairment Compared to a Comprehensive Neuropsychological Battery in Patients with Lupus?

2:30PM-4:00PM: Abstract Number: 2765

Centre of Pressure Characteristics during Walking in Individuals with and without First Metatarsophalangeal Joint Osteoarthritis

2:30PM-4:00PM: Abstract Number: 2795

Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized, Double-Blind Study

2:30PM-4:00PM: Abstract Number: 2775

Critical Role of Neutrophil Extracellular Traps (NETs) in Patients with Behcet’s Disease

2:30PM-4:00PM: Abstract Number: 2789

Deficiency of the Novel Rheumatoid Arthritis (RA) Risk Gene, LBH, Induces Replication Stress in RA Fibroblast-like Synoviocytes (FLS) and Exacerbates Arthritis Severity

2:30PM-4:00PM: Abstract Number: 2811

Economic Evaluation of Damage Accrual in a Nationwide Canadian SLE Cohort

2:30PM-4:00PM: Abstract Number: 2768

Effects of a Home-Based Telephone-Supported Physical Activity Program on Physical Function Among Older Adults with Chronic Low Back Pain

2:30PM-4:00PM: Abstract Number: 2801

Effects of Anti-IL17 Blockade with Secukinumab on Systemic and Local Immune Responses: A Mechanism-of-Action Study in Peripheral Spondyloarthritis

2:30PM-4:00PM: Abstract Number: 2799

Efficacy, Safety and Immunogenicity in Randomized, Double-Blind (DB) and Open-Label Extension (OLE) Studies Comparing FKB327, an Adalimumab Biosimilar, with the Adalimumab Reference Product (Humira®; RP) in Patients (pts) with Active Rheumatoid Arthritis (RA)

2:30PM-4:00PM: Abstract Number: 2797

Etanercept Biosimilar GP2015 Has Equivalent Efficacy and Safety to Etanercept Originator in Patients with Moderate to Severe Rheumatoid Arthritis: The Phase 3 Equira Study

2:30PM-4:00PM: Abstract Number: 2817

Expression Patterns of Interferon Induced Genes in Newborns Exposed to Ro/SSA Autoantibodies in Utero

2:30PM-4:00PM: Abstract Number: 2777

Factors Associated with Readiness for Adopting Osteoporosis Treatment Change

2:30PM-4:00PM: Abstract Number: 2818

Gene Expression Analysis Demonstrates That Multiple Type 1 Interferons Are Involved in Lupus Pathogenesis

2:30PM-4:00PM: Abstract Number: 2764

Gene Expression Profile in Monocytes of Antiphospholipid Syndrome Patients Reveals Novel Altered Genes and Pathways Involved in the Pathophysiology of the Disease

2:30PM-4:00PM: Abstract Number: 2812

Healthcare Resource Utilization and Costs in Patients with Systemic Lupus Erythematosus before and after Initiating Treatment with Intravenous Belimumab: A US Claims Database Analysis

2:30PM-4:00PM: Abstract Number: 2806

Integrated Longitudinal Analysis Increases Precision and Reduces Bias: A Comparative 5-Year Analysis in the DESIR Cohort

2:30PM-4:00PM: Abstract Number: 2813

Interferon-Induced APOL1 over-Expression Causes Autophagic Dysfunction and Mitochondrial Stress in Risk Variant-Carrying Endothelial Cells

2:30PM-4:00PM: Abstract Number: 2814

Interferon-β Production By B Cells Promotes B Cell Survival and Is Strongly Associated with Active Disease in African Americans with SLE

2:30PM-4:00PM: Abstract Number: 2793

Joint Location-Specific JAK-STAT Signaling in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes (FLS)

2:30PM-4:00PM: Abstract Number: 2805

Juvenile-Onset Ankylosing Spondylitis Has a Lower Rate of Radiographic Progression Than Adult-Onset Ankylosing Spondylitis

2:30PM-4:00PM: Abstract Number: 2800

Long-Term Safety and Efficacy of Biosimilar Infliximab (CT-P13) after Switching from Originator Infliximab: Results from the 26-Week Open Label Extension of a Randomized Norwegian Trial

2:30PM-4:00PM: Abstract Number: 2808

Longitudinal Assessment of Cognitive Function in SLE: Identification of Trajectories

2:30PM-4:00PM: Abstract Number: 2783

Medications Associated with Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 2763

mTORC1 Blockade with Rapamycin and N-Acetylcysteine Reduces Anti-Phospholipid Antibody Levels in Controlled Clinical Trials of Patients with SLE

2:30PM-4:00PM: Abstract Number: 2771

NOMID-Associated Complications in Mice Are Prevented By CDD-450, a Small Molecule Inhibitor of the Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) Pathway

2:30PM-4:00PM: Abstract Number: 2815

Pathological Roles By Siglec and Type I Interferons for the Development of Autoimmune Congenital Heart Block

2:30PM-4:00PM: Abstract Number: 2782

Patient Beliefs and Preference to Initiate a Proposed Medication in Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 2766

Physical Therapy Vs. Internet-Based Exercise Training for Patients with Knee Osteoarthritis: Results of a Randomized Controlled Trial

2:30PM-4:00PM: Abstract Number: 2776

Plasmacytoid Dendritic Cells in Systemic Fibrosis: Pathogenic Role in Bleomycin-Induced Fibrosis Model and Correlation with Disease in Patients with Systemic Sclerosis

2:30PM-4:00PM: Abstract Number: 2816

Prediction of Connective Tissue Disease in an at-Risk Cohort Using a Novel Interferon Stimulated Gene Expression Score

2:30PM-4:00PM: Abstract Number: 2769

Predictive Value of Leisure-Time Physical Activity in Women with Systemic Erythematosus Lupus on Physical and Mental Health

2:30PM-4:00PM: Abstract Number: 2803

Predictors of Remission Maintenance up to Week 68 and Successful Therapy Discontinuation in Patients with Non-Radiographic Axial Spondyloarthritis Who Achieved Sustained Remission on 28-Week Open-Label Adalimumab Treatment

2:30PM-4:00PM: Abstract Number: 2780

Preference Phenotypes Can be Used to Support Shared Decision Making at the Point-of-Care

2:30PM-4:00PM: Abstract Number: 2804

Pregnancy Outcomes in Patients with Ankylosing Spondylitis: A Nationwide Population Study

2:30PM-4:00PM: Abstract Number: 2778

Preventing Rheumatoid Arthritis: North American Perspectives of Patients and First-Degree Relatives on the Risk of Developing the Disease and of Potential Preventative Interventions

2:30PM-4:00PM: Abstract Number: 2791

Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) and Marginal Jawbone Loss Predates the Onset of Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 2790

Regulation of ASK1 Expression and Its Role in Rheumatoid Arthritis (RA)

2:30PM-4:00PM: Abstract Number: 2785

Serious Infections Associated with Tofacitinib in Rheumatoid Arthritis Patients Previously Treated with Methotrexate

2:30PM-4:00PM: Abstract Number: 2773

Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88

2:30PM-4:00PM: Abstract Number: 2809

Spatial Navigation Impairment Associated with Anti-NMDA Receptor Antibodies in Systemic Lupus Erythematosus

2:30PM-4:00PM: Abstract Number: 2762

Study of 60 Patients with Intrauterine Fetal Deaths Related to Antiphospholipid Syndrome

2:30PM-4:00PM: Abstract Number: 2802

Sustained Remission of Inflammation Is Associated with Reduced Structural Damage on SI Joint MRI in Patients with Early Axial Spa: Evidence to Support the Concept of Treat-to-Target

2:30PM-4:00PM: Abstract Number: 2792

Th22 Cells Are a Potent Inducer of Osteoclastogenesis in Rheumatoid Arthritis

2:30PM-4:00PM: Abstract Number: 2810

The Impact of Psychiatric Comorbidity on Health Care Utilization for Youth with Systemic Lupus Erythematosus

2:30PM-4:00PM: Abstract Number: 2779

The Patient Perspective on Bdmard Dose Reduction: A Mixed Methods Study

2:30PM-4:00PM: Abstract Number: 2759

The Risk of Ischaemic Stroke in Primary APS Patients: A Prospective Study

2:30PM-4:00PM: Abstract Number: 2788

The Risk of Major Toxicity with Aspirin for Primary Cardiovascular Prevention in Rheumatoid Arthritis Patients Using Nsaids: A Secondary Cohort Analysis of a Randomized Controlled Clinical Trial

2:30PM-4:00PM: Abstract Number: 2786

Timing of Abatacept Infusions before Elective Arthroplasty and the Risk of Post-Operative Infection

2:30PM-4:00PM: Abstract Number: 2787

Tuberculosis, Potential Opportunistic Infections, and Other Infections of Interest in Patients with Moderate to Severe Rheumatoid Arthritis in the Baricitinib Program

2:30PM-4:00PM: Abstract Number: 2772

Unbound IL-18 Distinguishes Human Macrophage Activation Syndrome from Familial Hemophagocytic Lymphohistiocytosis and Affects Innate Versus Adaptive Murine Lymphocytes Differently

2:30PM-4:00PM: Abstract Number: 2770

Using Fitbits. Fitabase®, and Remote Coaching to Increase Physical Activity in Employees with Knee Osteoarthritis Symptoms

4:30PM-6:00PM: Abstract Number: 2835

5-Year Evolution Patterns of Physical Activity and Sedentary Behavior of Patients with Symptomatic Hip and/or Knee Osteoarthritis, and Their Sociodemographic and Clinical Correlates

4:30PM-6:00PM: Abstract Number: 2828

A Graph-Theoretic-Approach Applied to Modular-Repertoire-Analysis Identifies Shared Gradual Whole Blood Interferon Signatures in Systemic Lupus Erythematosus and Primary Sjögren’s Syndrome Patients and Reveals New Interferon-Related Modules in Disease Progression

4:30PM-6:00PM: Abstract Number: 2821

A Multidisciplinary Telemedicine Program for Identification of Spondyloarthritis in Medically Underserviced Communities

4:30PM-6:00PM: Abstract Number: 2827

A Novel Statistical Method to Resolve Cellular Heterogeneity in Disease Tissues: Integrating Transcriptomic Data in Accelerating Medicines Partnership (AMP) – RA Network Phase 1 Data

4:30PM-6:00PM: Abstract Number: 2884

A Phase 2 Study of Safety and Efficacy of Anabasum (JBT-101), a Cannabinoid Receptor Type 2 Agonist, in Diffuse Cutaneous Systemic Sclerosis

4:30PM-6:00PM: Abstract Number: 2825

A Possible Environmental Origin for a Proportion of the Genetic Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

4:30PM-6:00PM: Abstract Number: 2822

A Randomized Controlled Effectiveness Trial of the Enhance-Fitness® Physical Activity Program in People with Arthritis

4:30PM-6:00PM: Abstract Number: 2889

Aminaphtone Ameliorates Clinical Symptoms and Increases Skin Blood Perfusion in Patients with Both Primary and Secondary Raynaud Phenomenon: A Six-Month Open Study

4:30PM-6:00PM: Abstract Number: 2876

Analysis of Autoantibody Reactivity to the Complete Human Peptidome By Phage Immunoprecipitation Sequencing Does Not Identify a Predominant Novel Autoantibody in Sjogren’s Syndrome

4:30PM-6:00PM: Abstract Number: 2864

Anti-Acetylated Peptide Antibodies Positive Rheumatoid Arthritis Patients Show a More Favorable Response to Tumor-Necrosis-Factor Inhibitor Treatment and Better Disease Activity Control over Time

4:30PM-6:00PM: Abstract Number: 2871

Anti-RA33 (hnRNP-A2/B1) Autoantibodies Are Associated with the Therapeutic Response to Methotrexate and Anti-TNF Treatment in Patients with Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 2838

Apoptotic Bodies Containing dsDNA Covalently Modified By Parvovirus B19 Non-Structural Protein NS1 Induce dsDNA Autoantibodies and End Organ Damage in Non-Autoimmune Mice

4:30PM-6:00PM: Abstract Number: 2845

Association between Serum Urate As a Surrogate Endpoint and Flares in People with Gout: An Ecological Study Based on a Systematic Review of Trials and Open Label Extensions

4:30PM-6:00PM: Abstract Number: 2819

Association of Socioeconomic Status with Osteoarthritis-Induced Disability Progression

4:30PM-6:00PM: Abstract Number: 2846

Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Renal-Related and Decreased Risk of Dementia-Related Death

4:30PM-6:00PM: Abstract Number: 2867

CD39 Positive Regulatory T Cells As a Biomarker of Responsiveness to Methotrexate in Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 2880

Clinical Evolution of Patients with Inflammatory Back Pain: A Population-Based Longitudinal Cohort Study

4:30PM-6:00PM: Abstract Number: 2840

Clinical Presentation and Outcomes in Patients with Prosthetic Joint Septic Arthritis Who Had One-Stage Versus Two-Stage Joint Replacement

4:30PM-6:00PM: Abstract Number: 2829

Complete Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes Reveals Unanticipated Critical Pathogenic Pathways

4:30PM-6:00PM: Abstract Number: 2888

Corticosteroid-Sparing Benefit of Intravenous Immunoglobulins in Systemic Sclerosis-Associated Inflammatory Myopathy: A Retrospective Study of 54 Patients

4:30PM-6:00PM: Abstract Number: 2833

Cost-Effectiveness of Competing Anticoagulation Strategies in Knee Replacement Patients

4:30PM-6:00PM: Abstract Number: 2837

Cross-Sectional Analysis of Chikungunya Arthritis Patients 22-Months Post-Infection Demonstrates a Lack of Viral Persistence in Synovial Fluid

4:30PM-6:00PM: Abstract Number: 2859

Development of New Juvenile Arthritis Disease Activity Score Cut-Offs for Oligoarthritis and RF-Negative Polyarthritis from a Large Multinational Cohort of Children with Juvenile Idiopathic Arthritis

4:30PM-6:00PM: Abstract Number: 2820

Disease Activity By the Sledai in Lupus Patients Who Self Report Sleep Disturbance and Sleep Impairment Using the Patient-Reported Outcomes Measurement Information System Instruments

4:30PM-6:00PM: Abstract Number: 2862

Diverse Disease Activity Measures Demonstrate That the Routine Assessment of Patient Index Data with 3 Measures (Rapid-3) Assesses Only Non Inflammatory Components of Disease and Should Not be Utilized in a Treat to Target Strategy in Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 2873

DNA Microarray Analysis Identifies Nuclear Receptor Subfamily 4 Group a Member 2 (NR4A2) As a Novel Molecule Involved in the Pathogenesis of Sjogren’s Syndrome

4:30PM-6:00PM: Abstract Number: 2878

Efficacy and Safety Results of Guselkumab in Patients with Active Psoriatic Arthritis over 56 Weeks from a Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study

4:30PM-6:00PM: Abstract Number: 2872

Elevated mTORC1 Signature in B Cells from Sjögren’s Syndrome Patients: mTOR Inhibition As a Novel Therapeutic Strategy to Halt B Cell Hyperactivity

4:30PM-6:00PM: Abstract Number: 2860

Enthesitis-Related Arthritis: Axial -Pattern Is Associated with an Expansion of Peripheral Th17 Populations .

4:30PM-6:00PM: Abstract Number: 2830

Epigenetic Cell Counting: A Novel Tool to Quantify Immune Cells in Salivary Glands Detects Robust Correlations of T Follicular Helper Cells with Immunopathology

4:30PM-6:00PM: Abstract Number: 2856

Evaluation of a Dosing Regimen for Tocilizumab in Patients Younger Than Two Years of Age with Systemic Juvenile Idiopathic Arthritis

4:30PM-6:00PM: Abstract Number: 2870

Ex Vivo Comparison of Baricitinib, Upadacitinib, Filgotinib, and Tofacitinib for Cytokine Signaling in Human Leukocyte Subpopulations

4:30PM-6:00PM: Abstract Number: 2832

Finding the Optimal Treatment Strategy for Disease Activity-Guided Dose Reduction of Adalimumab and Etanercept in Rheumatoid Arthritis: A Modelling Study

4:30PM-6:00PM: Abstract Number: 2826

Fine-Mapping Identifies Causal Variants for RA and T1D in DNASE1L3, Sirpg, MEG3, TNFAIP3 and CD28/CTLA4 Loc

4:30PM-6:00PM: Abstract Number: 2851

General and Abdominal Obesity As Risk Factors for Late-Life Mobility Limitation Among Women with Total Knee or Hip Replacement for Osteoarthritis

4:30PM-6:00PM: Abstract Number: 2834

Healthcare Cost Drivers in Rheumatoid Arthritis

4:30PM-6:00PM: Abstract Number: 2882

IgG Galactosylation Status Combined with MYOM2 SNP Precisely Predicts Anti-TNF Response in Ankylosing Spondylitis

4:30PM-6:00PM: Abstract Number: 2848

Improving Gout Outcomes: The Randomized Evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-Up) Study

4:30PM-6:00PM: Abstract Number: 2841

Infection Is the Major Trigger of Adult Hemophagocytic Syndrome, an Orphan Systemic Hyperinflammatory, Life-Threatening Disease: Analysis in 147 Patients (GEAS-SEMI Registry)

4:30PM-6:00PM: Abstract Number: 2853

Is Frailty Associated with Adverse Events after Total Joint Arthroplasty?

4:30PM-6:00PM: Abstract Number: 2850

Jakinibs Decrease Chronic Low Back Pain and Increase Function: A Proof of Concept Trial

4:30PM-6:00PM: Abstract Number: 2887

Long-Term Follow-up Report on Japanese Patients with Severe Systemic Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

4:30PM-6:00PM: Abstract Number: 2866

Microarray Pathway Analysis Comparing Baricitinib and Adalimumab in Moderate to Severe Rheumatoid Arthritis Patients, from a Phase 3 Study

4:30PM-6:00PM: Abstract Number: 2875

Molecular Features Define Unique Sjögren’s Syndrome Patient Subsets

4:30PM-6:00PM: Abstract Number: 2854

Optimizing Data Capture for Performance – Metrics Using Smartphone App Technology

4:30PM-6:00PM: Abstract Number: 2849

Pain and Functional Trajectories in Symptomatic Knee Osteoarthritis over a 12-Week Period of Non-Pharmacological Exercise Interventions

4:30PM-6:00PM: Abstract Number: 2868

Pharmacodynamic Analysis of Whole Blood Gene Expression over 2 Years in a Phase IIIb Head-to-Head Trial of Abatacept and Adalimumab in Patients with RA

4:30PM-6:00PM: Abstract Number: 2839

Practice Patterns of Pneumocystis Pneumonia Prophylaxis in Connective Tissue Diseases: a Survey of Infectious Disease Physicians

4:30PM-6:00PM: Abstract Number: 2881

Pre-Existing Psoriasis Is Predictive for Clinical Relapse after Drug-Free Remission Induced By Therapy with Golimumab in Early Peripheral Spondyloarthritis

4:30PM-6:00PM: Abstract Number: 2823

Preliminary Comparison of Patient-Centered Weight Loss Programs Starting before Versus after Knee Replacement

4:30PM-6:00PM: Abstract Number: 2877

Premature Senescence of Naive CD4+ T-Cells in Primary Sjogren’s Syndrome

4:30PM-6:00PM: Abstract Number: 2883

Prevalence of Cardiovascular Risk Factors and Subclinical Cardovacular Disease in Psoriatic Arthritis

4:30PM-6:00PM: Abstract Number: 2831

Real-World Experience with Tofacitinib Versus Adalimumab and Etanercept in Biologic-Naive Patients with RA Previously Treated with Methotrexate: Data from a US Administrative Healthcare Insurance Claims Database

4:30PM-6:00PM: Abstract Number: 2844

Risk of Cardiovascular Events in Older Patients with Gout Initiating Febuxostat Versus Allopurinol: A Population-Based Cohort Study

4:30PM-6:00PM: Abstract Number: 2886

Safety and Efficacy of Long-Time Intensified Rituximab Treatment in Patients with Systemic Sclerosis

4:30PM-6:00PM: Abstract Number: 2863

Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal

4:30PM-6:00PM: Abstract Number: 2857

Short and Long-Term Follow-up of Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis

4:30PM-6:00PM: Abstract Number: 2869

Significant Decrease of T-Cells but Not Macrophages in the Synovium of Patients with Active Rheumatoid Arthritis after Treatment with Tocilizumab

4:30PM-6:00PM: Abstract Number: 2824

Sleep and Depression Mediate the Relationship between Pain and Cognitive Dysfunction in Lupus Patients

4:30PM-6:00PM: Abstract Number: 2855

Subcutaneous Abatacept in Patients Aged 2–17 Years with Polyarticular Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Effectiveness, Safety and Immunogenicity over 2 Years

4:30PM-6:00PM: Abstract Number: 2879

Switching from Adalimumab to Chs-1420: A Randomized, Double-Blind Global Clinical Trial in Patients with Psoriasis and Psoriatic Arthritis

4:30PM-6:00PM: Abstract Number: 2885

Tadalafil Reduces Skin Fibrosis and Profibrotic Genes Expression in Patients with Systemic Sclerosis

4:30PM-6:00PM: Abstract Number: 2836

The Additional Economic Burden of Depression Among Adults with Rheumatoid Arthritis in the United States

4:30PM-6:00PM: Abstract Number: 2843

The Relationship between Serum Urate Concentration and Incident Gout: An Individual Participant Data Analysis

4:30PM-6:00PM: Abstract Number: 2847

The Sons of Gout Study. Ultrasonographic Evaluation of Asymptomatic Monosodium Urate Crystal Deposition in Sons of People with Gout

4:30PM-6:00PM: Abstract Number: 2865

The Utility and Limitations of Serum C-Reactive Protein in Appraising Synovial Inflammation

4:30PM-6:00PM: Abstract Number: 2874

Thymic Stromal Lymphopoietin (TSLP) Expression Is Associated with Lymphoproliferation and Lymphoma in Primary Sjögren’s Syndrome

4:30PM-6:00PM: Abstract Number: 2861

Treat-to-Target in Rheumatoid Arthritis: What Level of Treatment Response Is Necessary By 3 Months in Order to Achieve the Treatment Target By 6 Months? Results from the Real Life NOR-DMARD Study

4:30PM-6:00PM: Abstract Number: 2842

Usefulness of Polymerase Chain Reaction for Diagnosing Whipple’S Disease in Rheumatology

4:30PM-6:00PM: Abstract Number: 2858

Validation of Biomarkers to Predict Flare in Polyarticular JIA upon Stopping Anti-TNF Therapy

4:30PM-6:00PM: Abstract Number: 2852

Widespread Pain Prior to Total Knee Replacement (TKR) Is Associated with Increased Risk of No Clinical Improvement in Pain Among Women

9:00AM-10:30AM: Abstract Number: 2897

A Non-Coding Genetic Variant Maximally Associated with Serum Urate Levels Is Functionally Linked to HNF4A-Dependent PDZK1 Expression

9:00AM-10:30AM: Abstract Number: 2923

A Propensity Score-Matched Study of Organ Damage in Patients with Systemic Lupus Erythematosus from the BLISS Long-Term Extension Trials Versus the Toronto Lupus Cohort: A Post Hoc Longitudinal Analysis

9:00AM-10:30AM: Abstract Number: 2914

Anti-CCP Antibody Levels Are Elevated in Cervicovaginal Fluid in Association with Local Inflammation in Premenopausal Women without RA

9:00AM-10:30AM: Abstract Number: 2901

Anti-Inflammatory Mechanism of Lubricin/Proteoglycan 4 (PRG4) in Monosodium Urate (MSU)-Crystal Induced Arthritis in THP-1 Macrophages Is Mediated By NALP3 Inflammasome.

9:00AM-10:30AM: Abstract Number: 2936

B-Cell Depletion By Rituximab Affects the Distribution of Effector Th-Cell Subsets in Patients with ANCA Associated Vasculitis

9:00AM-10:30AM: Abstract Number: 2934

Comparative Analysis of the Macrophage Glycolytic Machinery in Giant Cell Arteritis (GCA) and in Coronary Artery Disease (CAD)

9:00AM-10:30AM: Abstract Number: 2920

Comparative Rates of Osteoporotic Fractures Among U.S. Medicaid Enrollees with and without Systemic Lupus Erythematosus

9:00AM-10:30AM: Abstract Number: 2910

Comparison of Clinical and Ultrasound Measures of Disease Activity in a Large National ‘Real Life’ Cohort of RA Patients

9:00AM-10:30AM: Abstract Number: 2992

Curbing the Opioid Epidemic: Predictors of Opioid Use in Juvenile Fibromyalgia Syndrome

9:00AM-10:30AM: Abstract Number: 2891

Do Certain Dmards Increase Risk of New-Onset Type 2 Diabetes in RA Patients? a Disease Risk Score Analysis Using Administrative Databases

9:00AM-10:30AM: Abstract Number: 2925

Economic Evaluation of Damage Accrual in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

9:00AM-10:30AM: Abstract Number: 2924

Effect of Antimalarials over the Different Domains of the Damage INDEX in Latin American SLE Patients

9:00AM-10:30AM: Abstract Number: 2904

Efficacy and Tolerance of TNF Alpha Inhibitor (TNFI) Treatment in Cardiac Sarcoidosis (CS)

9:00AM-10:30AM: Abstract Number: 2926

Fucosyltransferase-1 Mediates Macrophage Driven Myofibroblast Differentiation and TGF-β Signaling in Systemic Sclerosis and Bleomycin-Induced Fibrosis

9:00AM-10:30AM: Abstract Number: 2937

Genetic Variants in HLA-C and Class I Pathway Genes Influence Susceptibility to Kawasaki Disease

9:00AM-10:30AM: Abstract Number: 2908

High Disease Activity Is a Predictor of Depression and Persistent Depression in Early Rheumatoid Arthritis: Results from a Rheumatoid Arthritis Cohort

9:00AM-10:30AM: Abstract Number: 2896

Human Cartilage Influences the Crystallization of Monosodium Urate; Understanding the Link between Gout and Osteoarthritis

9:00AM-10:30AM: Abstract Number: 2921

Improved Survival Following Renal Transplantation in Waitlisted Patients with Systemic Lupus Erythematosus in the United States

9:00AM-10:30AM: Abstract Number: 2994

Improving Outcomes Using a Treat to Target Approach and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis

9:00AM-10:30AM: Abstract Number: 2915

Increased Expression of Malondialdehyde-Acetaldehyde Adducts (MAA) and Anti-Maa Antibody in Rheumatoid Arthritis-Interstitial Lung Disease

9:00AM-10:30AM: Abstract Number: 2902

Inflammatory Arthritis Due to Immune Checkpoint Inhibitors: A Persistent Problem Requiring Immunosuppression

9:00AM-10:30AM: Abstract Number: 2927

Interferon Regulatory Factor (IRF) 7 in Type I IFN Signaling Represents As a Key Upstream Regulator in Early Diffuse SSc Patients and Plays Critical Role in Pathogenesis of Fibrosis

9:00AM-10:30AM: Abstract Number: 2993

Knee Joint Sounds: A Non-Invasive Modality for Classifying Knee Joint Health in Juvenile Idiopathic Arthritis

9:00AM-10:30AM: Abstract Number: 2911

Low Appendicular Bone Mass Predicts Mortality in Patients with Rheumatoid Arthritis

9:00AM-10:30AM: Abstract Number: 2932

mTOR Pathway Is Activated in Endothelial Cells from Patients with Takayasu Arteritis and Is Modulated By Serum IgG

9:00AM-10:30AM: Abstract Number: 2931

Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems

9:00AM-10:30AM: Abstract Number: 2935

Nasal Microbiota in Patients with Granulomatosis with Polyangiitis Compared to Healthy Controls

9:00AM-10:30AM: Abstract Number: 2917

Neutrophil Activation in Rheumatoid Arthritis – Potential Biomarkers of Disease Activity and Severity

9:00AM-10:30AM: Abstract Number: 2898

New Mouse Model of Gout Risk Variant, ABCG2 Q141K, Reveals Unexpectedly Severe Molecular and Functional Defect in ABCG2 Mediated Intestinal Uric Acid Secretion

9:00AM-10:30AM: Abstract Number: 2919

Number and Type of ACPA Fine Specificities Are Correlated to High Resolution Computed Tomography Parenchymal Lungs Changes in Patients with Early Untreated Rheumatoid Arthritis

9:00AM-10:30AM: Abstract Number: 2909

Only Very High Radiographic Progression Affects HAQ-DI, Results from the Swiss Scqm Cohort

9:00AM-10:30AM: Abstract Number: 2900

Osteoarthritis-Associated Calcium-Containing Crystals and Biomaterial Microparticles Both Drive M1 Macrophage Polarization in a Syk and MAP Kinase-Dependent Manner

9:00AM-10:30AM: Abstract Number: 2922

Outcomes of Lupus Nephritis in Vulnerable Populations

9:00AM-10:30AM: Abstract Number: 2995

Pathogens in the Inflammatory Process of Periodontal Disease and Juvenile Idiopathic Arthritis

9:00AM-10:30AM: Abstract Number: 2997

Patient and Family Reported Psychosocial Areas of Concern within Pediatric Rheumatology: Quality Improvement Data and Implications for Practice

9:00AM-10:30AM: Abstract Number: 2890

Performance of Machine Learning Methods Using Electronic Medical Records to Predict Varicella Zoster Virus Infection

9:00AM-10:30AM: Abstract Number: 2892

Persistently Frequent Emergency Department (ED) Utilization Among Systemic Lupus Erythematosus (SLE) Patients

9:00AM-10:30AM: Abstract Number: 2895

Predictors of Hospitalization, Length of Stay and Costs of Care Among Children with Juvenile Dermatomyositis in the United States

9:00AM-10:30AM: Abstract Number: 2996

Resilience and Transition Readiness in Pediatric SLE Patients

9:00AM-10:30AM: Abstract Number: 2907

Salivary Gland Enlargement in IgG4-Related Disease Is Associated with Multiorgan Involvement and Higher Basal Disease Activity

9:00AM-10:30AM: Abstract Number: 2903

Serum CC-Chemokine Ligand 18 Level Is a Potential Biomarker of Disease Activity in IgG4-Related Disease

9:00AM-10:30AM: Abstract Number: 2928

STAT3 As an Important Integrator of Profibrotic Pathways in Systemic Sclerosis

9:00AM-10:30AM: Abstract Number: 2894

Synchronous Telemedicine Care in Rheumatology for a Dispersed Veterans Affairs Health System

9:00AM-10:30AM: Abstract Number: 2905

TET2 Mutation Is Significantly Associated with the Development of Autoimmune Disorder in Patients with Myelodysplastic Syndrome

9:00AM-10:30AM: Abstract Number: 2918

The Appearance of IgA RF Followed By IgG RF Is Associated with Transition to Classifiable RA in a Large Preclinical RA Cohort

9:00AM-10:30AM: Abstract Number: 2933

The Microvascular Niche Instructs Pathogenic T Cells in Medium and Large Vessel Vasculitis

9:00AM-10:30AM: Abstract Number: 2912

The Neural Correlates of Inflammation in RA: A Multi-Modal MRI Study

9:00AM-10:30AM: Abstract Number: 2913

the Periodontal Pathogen Aggregatibacter Actinomycetemcomitans Is Associated with Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis

9:00AM-10:30AM: Abstract Number: 2916

The Presence of a Large Number of Autoantibodies at Baseline Is Favourable for Early Treatment Response but Unfavourable for Drug-Free Remission in RA Patients

9:00AM-10:30AM: Abstract Number: 2893

The Use of Natural Language Processing to Identify, Retrieve, Report, and Correct Observational Data on US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry

9:00AM-10:30AM: Abstract Number: 2930

Transforming Growth Factor Beta 3 (TGFB3) – a Novel Systemic Sclerosis Susceptibility Locus Involved in Fibrosis and Th17 Cell Development Identified By Genome-Wide Association Study in African Americans from the Genome Research in African American Scleroderma Patients Consortium

9:00AM-10:30AM: Abstract Number: 2899

Trapped Crystals in Synovial Fluid: Neutrophil Extracellular Traps (NETs) from Bench to Bed-Side

9:00AM-10:30AM: Abstract Number: 2906

Use of Disease-Modifying Antirheumatic Drugs, Biologic Response Modifiers and Corticosteroids, and Subsequent Risk of Coccidioidomycosis Infection Among Medicare Beneficiaries

9:00AM-10:30AM: Abstract Number: 2929

WNT5A Promotes Tissue Fibrosis By Wnt/PCP-Dependent Activation of Latent TGF-β

11:00AM-12:30PM: Abstract Number: 2952

A Randomized Controlled Trial (RCT) of an Internet-Based Self-Management Program for Adolescents with Juvenile Idiopathic Arthritis (JIA)

11:00AM-12:30PM: Abstract Number: 2954

Achieving Balance and Diversity in Patient Engagement in Research: Perspectives from Patients

11:00AM-12:30PM: Abstract Number: 2967

Adding Ultrasound to the Treat-to-Target Strategy Shows No Benefit in Achievement of Remission: Results from the Biodam Cohort

11:00AM-12:30PM: Abstract Number: 2959

Are Patients with Overlap Features Different from Patients without? Results from the Juvenile Systemic Scleroderma Cohort Www.Juvenile-Scleroderma.Com

11:00AM-12:30PM: Abstract Number: 2974

B Cell Binding Autoreactive VH4.34 Antibodies Are Specific to Lupus, Consist of Diverse Isotypes, and Are Associated with High Disease Activity and Lupus Nephritis

11:00AM-12:30PM: Abstract Number: 2961

Body Composition and Myokine Levels in Juvenile Dermatomyositis and Associations with Physical Function

11:00AM-12:30PM: Abstract Number: 2960

Cardiovascular and Cerebrovascular Comorbidities of Juvenile Dermatomyositis in United States Children

11:00AM-12:30PM: Abstract Number: 2988

Characteristics of People with Work-Related Versus Non-Work Related Carpal Tunnel Syndrome: National Health Interview Survey, 2010 & 2015

11:00AM-12:30PM: Abstract Number: 2980

Chemokine CCL21 As a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis

11:00AM-12:30PM: Abstract Number: 2939

Clinical Correlate of Synovial Proliferation in Early Rheumatoid Arthritis

11:00AM-12:30PM: Abstract Number: 2973

Detection of Clinical Signs of Arthritis and Subclinical Evidence of Inflammation in Psoriasis Patients with Risk for Arthritis: Value of Clinical Examination, Ultrasound and Fluorescence-Optical Imaging – Results from the Prospective Multicentre Xciting Study

11:00AM-12:30PM: Abstract Number: 2948

Distinct Trajectories of Medial Fixed Joint Space Width Loss over Four Years of Follow-up Among Knees with and at Risk for Knee Osteoarthritis

11:00AM-12:30PM: Abstract Number: 2947

Do Bone Marrow Lesions Reactivate Endochondral Ossification Leading to Osteophyte Genesis? Data from the Osteoarthritis Initiative

11:00AM-12:30PM: Abstract Number: 2955

Does Guideline-Based Care Improve Outcomes That Matter to Patients? Tighter Control, Less Suffering, and Greater Well-Being over the Past Decade in Canadian RA Patients

11:00AM-12:30PM: Abstract Number: 2953

Drivers of Satisfaction with Care in Lupus

11:00AM-12:30PM: Abstract Number: 2941

Effect of Achieving Sustained SDAI Remission on Erosion Repair in Patients with Early RA: A Prospective HR-pQCT Study

11:00AM-12:30PM: Abstract Number: 2969

Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF Inhibitors: 52-Week Results from a Phase 3 Study

11:00AM-12:30PM: Abstract Number: 2981

Evaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the Fasscinate Trial

11:00AM-12:30PM: Abstract Number: 2956

Evidence Based Recommendations for Corticosteroid Tapering/Discontinuation in New Onset Juvenile Dermatomyositis Patients from the Printo Trial

11:00AM-12:30PM: Abstract Number: 2957

Factors Associated with Cardiac Dysfunction in a Longitudinal Follow-up of Neonatal Lupus

11:00AM-12:30PM: Abstract Number: 2989

Hydration and Gout: Looking at New Modes of Uric Acid Management

11:00AM-12:30PM: Abstract Number: 2976

Identification of Systemic Lupus Erythematosus Causal Risk Variant Candidates Spanning the UBE2L3 Haplotype

11:00AM-12:30PM: Abstract Number: 2946

Identifying Rapid Structural Disease Progression in Knee Osteoarthritis

11:00AM-12:30PM: Abstract Number: 2966

Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials

11:00AM-12:30PM: Abstract Number: 2945

Incident Hand OA Is Strongly Associated with Reduced Peripheral Blood Leukocyte Telomere Length

11:00AM-12:30PM: Abstract Number: 2970

Inhibition of Radiographic Progression in Psoriatic Arthritis By Adalimumab Independent of the Control of Clinical Disease Activity

11:00AM-12:30PM: Abstract Number: 2991

Is a Growing Waistline over 8 Years Associated with Incident Functional Limitation and Low Health-Related Quality of Life in Knee Osteoarthritis?

11:00AM-12:30PM: Abstract Number: 2990

Is Risk of Retinopathy Among Hydroxychloroquine Users of SLE Patients Accurate? a Simulation Study Accounting for Competing Risk of Death

11:00AM-12:30PM: Abstract Number: 2938

Is Synovial Hypertrophy without Doppler Activity in Rheumatoid Arthritis Joints Sensitive to Change ? – Results of a Longitudinal Ultrasound Study

11:00AM-12:30PM: Abstract Number: 2968

Less Fatigue in Psoriatic Arthritis after High Intensity Interval Training. a Randomized Controlled Trial

11:00AM-12:30PM: Abstract Number: 2987

Moderate and Serious Psychological Distress Among US Adults with and without Arthritis, 2002 to 2015

11:00AM-12:30PM: Abstract Number: 2977

Molecular Phenotypes Associated with Clinical Disease Activity in Adult Systemic Lupus Erythematosus

11:00AM-12:30PM: Abstract Number: 2982

Morbidity and Mortality of Scleroderma in African Americans

11:00AM-12:30PM: Abstract Number: 2962

MRI Results Following Discontinuation of Methotrexate in Patients with Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: Results from a Randomized Controlled Trial

11:00AM-12:30PM: Abstract Number: 2965

Non-Invasive Imaging Methods for Evaluating the Cardiovascular Involvement in Patients with Rheumatoid Arthritis before and after 18 Months of Treatment with Anti-TNF Drugs

11:00AM-12:30PM: Abstract Number: 2986

Omega Polyunsaturated Fatty Acids and Systemic Lupus Erythematosus (SLE): the Michigan Lupus Epidemiology & Surveillance (MILES) Program

11:00AM-12:30PM: Abstract Number: 2942

One Year Changes in Ultrasound Findings in the Feet Are Associated with Patient Reported Outcomes but Not Clinical Examination: a Prospective Observational Study of Patients with Early Rheumatoid Arthritis

11:00AM-12:30PM: Abstract Number: 2940

Outcome of Power Doppler Ultrasound-Detected Residual Synovitis in Rheumatoid Arthritis Patients with Clinical Remission: A 1 Year Longitudinal Study with Consecutive Ultrasound Examinations

11:00AM-12:30PM: Abstract Number: 2978

OX40/OX40L Axis Impairs Follicular and Natural Regulatory T Cell Function in Human Systemic Lupus

11:00AM-12:30PM: Abstract Number: 2944

Patterns and Characteristics of Accelerated Hand Osteoarthritis: Data from the Osteoarthritis Initiative

11:00AM-12:30PM: Abstract Number: 2984

Predictive Value of a Combined Index for Weight Loss in Systemic Sclerosis

11:00AM-12:30PM: Abstract Number: 2983

Predictors for Disease Worsening Defined By Organ Failure in Diffuse Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis

11:00AM-12:30PM: Abstract Number: 2951

Responsiveness of the Patient Reported Outcomes Measurement Information System to Golimumab Intravenous and Infliximab Treatment in a Real World Clinical Trial in Rheumatoid Arthritis Patients

11:00AM-12:30PM: Abstract Number: 2972

Risk of Myocardial Infarction and Cerebrovascular Accident in Ankylosing Spondylitis: A General Population-Based Study

11:00AM-12:30PM: Abstract Number: 2963

Sirukumab Improves Synovial Vascularity As Measured By Power Doppler Sonography in Rheumatoid Arthritis Patients from As Early As Week 4 in a Phase 3 Trial

11:00AM-12:30PM: Abstract Number: 2964

Structural Damage in Patients with Very Early RA Is Predicted with Clinical Measures of Baseline Disease Activity: DAS28 (CRP), SDAI, M-DAS28 and RAPID3 but Not CDAI

11:00AM-12:30PM: Abstract Number: 2979

The Expression of Mitochondrial Molecules in Microparticle Immune Complexes in the Blood of Patients with Systemic Lupus Erythematosus

11:00AM-12:30PM: Abstract Number: 2949

The Relation of Cumulative Load to Prevalent Cartilage Damage in the Knee

11:00AM-12:30PM: Abstract Number: 2943

Ultrasound Scoring of One Parotid and One Submandibular Gland in Primary Sjogren’s Syndrome – Further Increasing Feasibility in Outpatient Clinics

11:00AM-12:30PM: Abstract Number: 2975

Using Immune and Metabolic Phenotyping to Understand the Immunopathogenesis of Juvenile-Onset SLE and Stratify Patient Groups

11:00AM-12:30PM: Abstract Number: 2950

Validation of a Definition for Flare in Patients with Established Gout

11:00AM-12:30PM: Abstract Number: 2958

Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus

11:00AM-12:30PM: Abstract Number: 2971

What Do Reduced 28 Joint Counts Miss in Patients with Psoriatic Arthritis?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].